D418DADA-3145-EF11-A20D-005056B388D3,2024-07-18 14:16:30.917,NCI-2015-00054,[]," <!DOCTYPE html> <html lang=""en""> <head> 	 <meta name=""robots"" content=""noindex""> 	 <title>Clinical Trial Search Results</title> 	 <script src=""//assets.adobedtm.com/f1bfa9f7170c81b1a9a9ecdcc6c5215ee0b03c84/satelliteLib-5b3dcf1f2676c378b518a1583ef5355acd83cd3d.js""></script> 	 <script src=""https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js""></script> 	 <script src=""/CTS.Print-js/BasicCTSPrintPage.js"" type=""text/javascript""></script>  	 <link rel=""stylesheet"" id=""gFonts"" href=""https://fonts.googleapis.com/css?family=Noto+Sans:400,400i,700,700i"" /> 	 <link href=""/CTS.Print-styles/nvcg.css"" rel=""stylesheet"" /> 	 <link href=""/CTS.Print-styles/BasicCTSPrintPage.css"" rel=""stylesheet"" /> 	 <meta name=""dcterms.subject"" content=""Clinical Trials Print Results Page"" />      <meta name=""Generator"" content=""CTS.Print"" /> </head> <body> 	<div class=""wa-data-element hide"" data-prop3=""/"" data-prop6=""Comprehensive Cancer Information"" data-prop16=""Comprehensive Cancer Information"" data-prop25=""01/01/1980"" data-prop44=""Clinical Trials"" data-prop62=""Clinical Trials: Print Results Page"" data-evar44=""Clinical Trials"" data-evar62=""Clinical Trials: Print Results Page"" ></div> 	<div id=""cgovContainer""> 		<div id=""CT-results-print-banner""><img id=""NCILogo"" src=""https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/logos/nci-logo-full.svg"" alt=""NCI Logo""/></div> 		<div id=""cgvBody""> 			<div id=""bodyHeading""> 				<div id=""headingWrapper""> 					<h1 id=""ctPrintBodyHeading"">Your Clinical Trials Search Results</h1> 					<div id=""bodyHeadingLinks""> 						<a id=""printPage"" href=""javascript:window.print();"">Print</a> | 						<a id=""ctl10_EmailResults"" href=""/CTS.Print/Display?printid={0}"" target=""_blank"">E-Mail These Results</a> | 						<a id=""newSearch"" href=""/about-cancer/treatment/clinical-trials/search/advanced"">New Search</a> 					</div> 				</div> 			</div> 				<div id=""clinical-trials-print"">  					 	        		                     <p class=""printIntroText"">Here are the trials you selected from your search on 7/18/2024.</p> 					<p class=""printIntroText"">You will be able to access this page for approximately 90 days. Since trial information is updated regularly, you should check for updates to see the most current information on any of the trials below.</p>   				<div> 								<div class=""trialContainer""> 			<h2 class=""hangingIndent"">1. Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?t=C3208&st=C3471&a=24&loc=1&z=20850&zp=100&rl=2&id=NCI-2015-00054""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase II</td> 					<td>Screening</td> 					<td>Closed to Accrual</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> EAY131<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2015-00054<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/study/NCT02465060"" target=""_blank"">NCT02465060</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple myelomas that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and does not respond to treatment (refractory). Patients must have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic material (genes) of patients&#39; tumor cells. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit more from treatment which targets their tumor&#39;s particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors, lymphomas, or multiple myeloma.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SCREENING BIOPSY (STEP 0)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be &gt;= 18 years of age. Because no dosing or adverse event data are currently available on the use of study investigational agents in patients &lt; 18 years of age, children are excluded from this study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to registration; patients that are pregnant or breast feeding are excluded; a patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:  * Has achieved menarche at some point  * Has not undergone a hysterectomy or bilateral oophorectomy; or  * Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse prior to study entry, for the duration of study participation, and for 4 months after completion of study; should a patient or partner of the patient become pregnant or suspect a pregnancy while participating in this study, the treating physician should be informed immediately</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have histologically documented solid tumors or histologically confirmed diagnosis of lymphoma or multiple myeloma requiring therapy and meet one of the following criteria: * Patients must have progressed following at least one line of standard systemic therapy and there must not be other approval/standard therapy available that has been shown to prolong overall survival (i.e. in a randomized trial against another standard treatment or by comparison to historical controls); patients who cannot receive other standard therapy that has been shown to prolong overall survival due to medical issues will be eligible, if other eligibility criteria are met; if the patient is currently receiving therapy, the clinician must have assessed that the current therapy is no longer benefitting the patient prior to enrolling on MATCH, regardless of whether it is considered standard OR * Patients for whose disease no standard treatment exists that has been shown to prolong overall survival * NOTE: No other prior malignancy is allowed except for the following: * Adequately treated basal cell or squamous cell skin cancer * In situ cervical cancer * Adequately treated stage I or II cancer from which the patient is currently in complete remission * Any other cancer from which the patient has been disease-free for 5 years</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have measurable disease</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet the criteria below * Tumor tissue for the confirmation of “rare variant” by the MATCH assay is to be submitted, preferably from the same time of collection as that used to determine patient candidacy for treatment arm assignment ** Registration to Step 0 must occur after stopping prior systemic anti-cancer therapy. There is no specific duration for which patients must be off treatment prior to registration to Step 0, as long as all eligibility criteria are met ** Patients may have received other non-targeted, immunotherapy or targeted treatment between the prior genetic testing at the outside lab and registration to Step 0. The decision to stop such treatment in favor of participation in MATCH, if no further clinical benefit is expected, is per the treating physician&#39;s discretion. Documentation of a lack of response to the prior treatment is not required in these cases ** Patients with an applicable “rare variant” must be able to meet the eligibility criteria for the appropriate subprotocols within 4 weeks following notification of treatment assignment ** Patient meets one of the following criteria: *** Patient is a candidate for Z1M based on local Clinical Laboratory Improvement Act (CLIA) assessment of mismatch repair deficiency (MMRd) by immunohistochemistry (IHC) or microsatellite instability (MSI) status by polymerase chain reaction (PCR), adequate tumor tissue is available for submission for mandatory central screening IHC and the patient will be able to meet the eligibility criteria for Z1M within 4 weeks following notification of treatment assignment OR *** The sites have received results from one of the designated outside laboratories indicating a “rare variant” that is an actionable Mutation of Interest (aMOI) for specific select subprotocols * NOTE: There is no particular window of time after receiving the sequencing report notification of potential eligibility from an outside lab in which the patient must be registered to Step 0, but treatment slots will be assigned on a first come, first serve basis to those who do register to Step 0, and are not held for those notified of potential eligibility who do not register to Step 0 * NOTE: Treatment assignment (and the start of the associated deadline for Step 1 registration) may occur shortly after Step 0 registration. Note that certain “rare variant” arms require submission of archival tissue for central IHC testing to determine treatment assignment. For those arms, adequate tissue for the central IHC is required to be available for submission * NOTE: Other potential aMOIs that would be eligibility criteria for “NON RARE” arms, as determined by the designated laboratories, are not applicable for this process in MATCH</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not require the use of full dose coumarin-derivative anticoagulants such as warfarin; low molecular weight heparin is permitted for prophylactic or therapeutic use; factor X inhibitors are permitted * NOTE: Warfarin may not be started while enrolled in the EAY131 study * Stopping the anticoagulation for biopsy should be per site standard operating procedure (SOP)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =&lt; 1 and a life expectancy of at least 3 months</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not currently be receiving any other investigational agents</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not have any uncontrolled intercurrent illness including, but not limited to: * Symptomatic congestive heart failure (New York Heart Association [NYHA] classification of III/IV) * Unstable angina pectoris or coronary angioplasty, or stenting within 6 months prior to registration to Step 0, 2, 4, 6 * Cardiac arrhythmia (ongoing cardiac dysrhythmias of National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version [v]4 grade &gt;= 2) * Psychiatric illness/social situations that would limit compliance with study requirements * Intra-cardiac defibrillators * Known cardiac metastases * Abnormal cardiac valve morphology (&gt;= grade 2) documented by echocardiogram (ECHO) (as clinically indicated); (subjects with grade 1 abnormalities [i.e., mild regurgitation/stenosis] can be entered on study); subjects with moderate valvular thickening should not be entered on study * NOTE: To receive an agent, patient must not have any uncontrolled intercurrent illness such as ongoing or active infection; patients with infections unlikely to be resolved within 2 weeks following screening should not be considered for the trial</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be able to swallow tablets or capsules; a patient with any gastrointestinal disease that would impair ability to swallow, retain, or absorb drug is not eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients who are human immunodeficiency virus (HIV)-positive are eligible if:  * CD4+ cell count greater or equal to 250 cells/mm^3 * If patient is on antiretroviral therapy, there must be minimal interactions or overlapping toxicity of the antiretroviral therapy with the experimental cancer treatment; for experimental cancer therapeutics with CYP3A/4 interactions, protease inhibitor therapy is disallowed; suggested regimens to replace protease inhibitor therapy include dolutegravir given with tenofovir/emtricitabine; raltegravir given with tenofovir and emtricitabine; once daily combinations that use pharmacologic boosters may not be used * No history of non-malignancy acquired immune deficiency syndrome (AIDS)-defining conditions other than historical low CD4+ cell counts * Probable long-term survival with HIV if cancer were not present</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Any prior therapy, radiotherapy (except palliative radiation therapy of 30 gray [Gy] or less), or major surgery must have been completed &gt;= 4 weeks prior to start of treatment; all adverse events due to prior therapy have resolved to a grade 1 or better (except alopecia and lymphopenia) by start of treatment; palliative radiation therapy must have been completed at least 2 weeks prior to start of treatment; the radiotherapy must not be to a lesion that is included as measurable disease * NOTE: Prostate cancer patients may continue their luteinizing hormone-releasing hormone (LHRH) agonist * NOTE: For patients entering the study via the original screening process, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results; however, lack of response must be documented prior to registration to Step 1; new non-protocol treatment will NOT be permitted as intervening therapy after registration to Step 0; the only intervening treatment permitted is prior therapy that the patient already received prior to Step 0 registration; the decision to stop the intervening non-protocol treatment will be left up to the treating physician if patient has an aMOI; however, patients will need to be off such therapy for at least 4 weeks before receiving any MATCH protocol treatment * NOTE: For patients entering the study via a designated outside laboratory, no intervening systemic non-protocol treatment is permitted after Step 0 registration; all other eligibility requirements still apply to these patients, including the washouts for prior therapy noted above in this section, the time restrictions outlined, and the eligibility criteria for the intended subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients with brain metastases or primary brain tumors must have completed treatment, surgery or radiation therapy &gt;= 4 weeks prior to start of treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have discontinued steroids &gt;= 1 week prior to registration to Step 0 and remain off steroids thereafter, except as permitted; patients with glioblastoma (GBM) must have been on stable dose of steroids, or be off steroids, for one week prior to registration to treatment (Step 1, 3, 5, 7) * NOTE: The following steroids are permitted (low dose steroid use is defined as prednisone 10 mg daily or less, or bioequivalent dose of other corticosteroid): ** Temporary steroid use: e.g. for CT imaging in setting of contrast allergy ** Low dose steroid use for appetite ** Chronic inhaled steroid use ** Steroid injections for joint disease ** Stable dose of replacement steroid for adrenal insufficiency or low doses for non-malignant disease ** Topical steroid ** Steroids required to manage toxicity related to study treatment, as described in the subprotocols ** Steroids required as pre- or post-chemotherapy medication for acceptable intervening chemotherapy *** NOTE: Steroids must be completed alongside last dose of chemotherapy</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Leukocytes &gt;= 3,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Absolute neutrophil count (ANC) &gt;= 1,500/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Platelets &gt;= 100,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: Patients with documented bone marrow involvement by lymphoma are not required to meet the above hematologic parameters, but must have a platelet count of at least 75,000/mcL and neutrophil count of at least 1,000/mcL</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Total bilirubin =&lt; 1.5 x institutional upper limit of normal (ULN) (unless documented Gilbert’s syndrome, for which bilirubin =&lt; 3 x institutional ULN is permitted) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =&lt; 2.5 x institutional ULN (up to 5 times ULN in presence of liver metastases) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Creatinine clearance &gt;= 45 mL/min/1.73 m^2 for patients with creatinine levels above institutional ULN * As defined by the Cockcroft-Gault equation (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have an electrocardiogram (ECG) within 8 weeks prior to registration to screening step and must meet the following cardiac criteria: * Resting corrected QT interval (QTc) =&lt; 480 msec ** NOTE: If the first recorded QTc exceeds 480 msec, two additional, consecutive ECGs are required and must result in a mean resting QTc =&lt; 480 msec; it is recommended that there are 10-minute (+/- 5 minutes) breaks between the ECGs * The following only need to be assessed if the mean QTc &gt; 480 msec ** Check potassium and magnesium serum levels ** Correct any identified hypokalemia and/or hypomagnesemia and may repeat ECG to confirm exclusion of patient due to QTc ** For patients with heart rate (HR) 60-100 beats per minute (bpm), no manual read of QTc is required ** For patients with baseline HR &lt; 60 or &gt; 100 bpm, manual read of QT by trained personnel is required, with Fridericia correction applied to determine QTc ** Patient must not have hypokalemia (value &lt; institutional lower limit of normal) * No factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age or any concomitant medication known to prolong the QT interval ** NOTE: Patient must be taken off prohibited medication prior to registration to the screening step (Step 0, 2, 4, 6) and remain off these medications thereafter, unless permitted on a subprotocol for the management of treatment related toxicity; patient must be off the drug for at least 5 half-lives prior to registration to the treatment step (Step 1, 3, 5, 7); the medication half-life can be found in the package insert for Food and Drug Administration (FDA) approved drugs</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FIRST TREATMENT (STEP 1)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: For patients entering step 0 with assay results from outside laboratories, no systemic treatment is allowed after step 0 registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>As MATCH is designed to add additional subprotocols, implement limited expansions of accrual for certain subprotocols, and/or amend existing arm-specific eligibility criteria, some patients entering under the original screening method may be eligible to have their results rerun in MATCHbox, even if they did not match to a treatment initially or did not receive a treatment assignment due to a lack of available assignment slots; patients whose sequence results will be rerun through MATCHbox must also meet the following criteria: * Samples must have been collected within 5 months of the activation of the addendum, as there is an additional month needed to get the patients on trial * Patient has not had treatment within the 5 months that resulted in a PR or better after the performance of the screening assessment * Patient must meet eligibility criteria, including performance status 1 or better and life expectancy of at least 3 months * Patients must meet the eligibility requirements with the following exceptions: ** Patients may have received other non-targeted, immunotherapy or targeted treatment, which could be stopped in favor of returning to MATCH, if no response to the interim treatment has occurred and no further benefit is expected from this interim treatment, per the treating physician&#39;s discretion; documentation of a lack of response to the interim treatment is not required in these cases; however, the following restrictions apply: *** Enrollment onto another investigational therapeutic study is not permitted *** Patient cannot be responding to interim treatment, since the benefit of the MATCH treatment is unknown and may deprive patient of an effective treatment if it were given when a patient is responding to another treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 results will be re-interrogated to determine if another treatment is available</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND SCREENING (STEP 2)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on Step 1 treatment or patient could not tolerate assigned treatment * NOTE: PATIENTS ENTERING STEP 1 WITH A “RARE VARIANT” FROM AN “OUTSIDE” LAB ARE NOT ELIGIBLE FOR STEP 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 1 treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance; only aMOIs detected by the MATCH assay may be used for the determination of eligibility to a relevant subprotocol OR</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Progression (or inability to tolerate further treatment) occurred after a (1) response OR (2) after &gt;= 6 months from start of step 1 treatment; patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspirate for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest (aMOI); archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not have been assigned to step 1 treatment based on a “rare variant” determined by a designated outside laboratory</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND TREATMENT (STEP 3)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy samples were submitted during step 2, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 3; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 2; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD SCREENING (STEP 4)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 3 treatment or patient could not tolerate assigned treatment * Patient must meet one of the following criteria: ** No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 3 (second) treatment AND a biopsy was performed at step 2 screening *** NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their latest MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance OR ** Progression (or inability to tolerate further treatment) occurred on step 3 treatment and a biopsy was not performed at step 2 screening (due to presence of additional aMOIs at that stage); patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspiration for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest; biopsy must not be considered to be more than minimal risk to the patient; archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: A patient may have a maximum of 2 screening biopsies (not including re-biopsy due to assay failure), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD TREATMENT (STEP 5)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy was submitted on step 4, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 5; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 4; the therapy cannot be an arm in the MATCH trial; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FOURTH SCREENING (STEP 6)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 5 protocol treatment or patient could not tolerate assigned treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have had no response, and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 5 treatment AND a biopsy was performed at step 4 screening * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, based on their 2nd biopsy, their results will be interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: For Step 6, biopsies to collect material for screening assay will NOT be performed; a patient may have a maximum of 2 successful screening assessments of submitted tissue (steps 0 and 2 OR steps 0 and 4), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY FOR FOURTH TREATMENT (STEP 7)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eligibility requirements for registration onto step 7 are outlined in the agent-specific subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR RESEARCH BIOPSY AND CIRCULATING TUMOR DNA COLLECTION (STEP 8)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ALL PATIENTS SHOULD BE ENCOURAGED TO PARTICIPATE IN STEP 8, IF SAFE; IF BIOPSY IS REFUSED OR INADVISABLE, ENCOURAGE COLLECTION OF WHOLE BLOOD FOR CIRCULATING TUMOR DNA As a reminder, the submission of the step 8 samples requires additional patient consent, as well as registration to step 8 * NOTE: Patients who entered the study (step 0) with a “rare variant” determined by an outside assay ARE potentially eligible and encouraged to participate in step 8</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient has completed their most recent MATCH study treatment, will not undergo an additional screening biopsies, and will receive no additional treatment on MATCH * NOTE: If a 2nd Screening Biopsy was performed and showed no study-actionable abnormalities, and blood samples were submitted with the screening biopsy, no additional end of treatment specimens are requested</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>For patients who consent to undergo the optional research biopsy, patient’s disease responded to the most recent MATCH study treatment and then progressed (or unable to tolerate further treatment) OR the disease progression (or inability to tolerate further treatment) occurs &gt; 6 months since the last screening biopsy * NOTE: Performance of a biopsy to collect tumor tissue for research is strongly encouraged but not required; it is acceptable to submit only the optional blood specimens * NOTE: If a biopsy will be performed solely to collect tumor specimens for research, the patient must be willing and able to undergo a tumor biopsy or bone marrow aspirate (for applicable multiple myeloma), for the collection and submission of tissue for research</li> 												</ul> 						</div> 										 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE: </p><p class='ctrp'>I. To evaluate the proportion of patients with objective response (OR) to targeted study agent(s) in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES: </p><p class='ctrp'>I. To evaluate the proportion of patients alive and progression free at 6 months of treatment with targeted study agent in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'>II. To evaluate time until death or disease progression.</p><p class='ctrp'>III. To identify potential predictive biomarkers beyond the genomic alteration by which treatment is assigned or resistance mechanisms using additional genomic, ribonucleic acid (RNA), protein and imaging-based assessment platforms.</p><p class='ctrp'>IV. To assess whether radiomic phenotypes obtained from pre-treatment imaging and changes from pre- through post-therapy imaging can predict objective response and progression free survival and to evaluate the association between pre-treatment radiomic phenotypes and targeted gene mutation patterns of tumor biopsy specimens.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE:</p><p class='ctrp'>STEP 0 (Screening): Patients undergo biopsy along with molecular characterization of the biopsy material for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing and immunohistochemistry. Consenting patients also undergo collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>STEPS 1, 3, 5, 7 (Treatment): Patients are assigned to 1 of 38 treatment subprotocols based on molecularly-defined subgroup. (See Arms Section) </p><p class='ctrp'></p><p class='ctrp'>STEPS 2, 4, 6 (Screening): Patients experiencing disease progression on the prior Step treatment or who could not tolerate the assigned treatment undergo review of their previous biopsy results to determine if another treatment is available or undergo another biopsy. Patients may have a maximum of 2 screening biopsies and 2 treatments per biopsy. </p><p class='ctrp'></p><p class='ctrp'>STEP 8 (Optional Research): Consenting patients undergo end-of-treatment biopsy and collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>Additionally, patients may undergo a computed tomography (CT) scan, magnetic resonance imaging, and/or radionuclide imaging throughout the trial. </p><p class='ctrp'></p><p class='ctrp'>After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 1 year.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>ECOG-ACRIN Cancer Research Group</div> 													<div>Principal Investigator: Keith Thomas Flaherty</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT02465060"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>California</h4>                           <h5 class=""locationCity"">Vacaville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sutter Cancer Centers Radiation Oncology Services-Vacaville</strong>     <br>Contact: Site Public Contact <br>Phone: 415-209-2683 <br>Email: <a href=""mailto:hempell@sutterhealth.org"">hempell@sutterhealth.org</a>   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Boulder</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Boulder Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:jbloomfield@co-cancerresearch.org"">jbloomfield@co-cancerresearch.org</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Gynecologic Oncology LLC</strong>     <br>Contact: Gregory Andrew Masters <br>Phone: 302-733-6227   </span> </div>                                   <h4>Florida</h4>                           <h5 class=""locationCity"">Fort Lauderdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Holy Cross Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 954-267-7748   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">Syracuse</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">SUNY Upstate Medical Center-Community Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 315-464-5476   </span> </div>                                   <h4>North Carolina</h4>                           <h5 class=""locationCity"">Hendersonville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hendersonville Hematology and Oncology at Pardee</strong>     <br>Contact: James Earl Radford <br>Phone: 828-696-4716   </span> </div>                                       <h5 class=""locationCity"">Mooresville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Cancer Institute - Mooresville</strong>     <br>Contact: Site Public Contact <br>Phone: 704-384-8920 <br>Email: <a href=""mailto:nnechiporchik@novanthealth.org"">nnechiporchik@novanthealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Winston-Salem</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Oncology Specialists</strong>     <br>Contact: Site Public Contact <br>Phone: 336-718-8335 <br>Email: <a href=""mailto:asmarrs@novanthealth.org"">asmarrs@novanthealth.org</a>   </span> </div>                                   <h4>North Dakota</h4>                           <h5 class=""locationCity"">Fargo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Clinic North-Fargo</strong>     <br>Contact: Preston D. Steen <br>Phone: 712-252-0088   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hematology and Oncology Associates Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 330-453-9993   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Pittsburgh</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Association</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Tennessee</h4>                           <h5 class=""locationCity"">Memphis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Family Cancer Center-Memphis</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Bellevue</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Cancer Institute-Eastside Oncology Hematology</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:CancerResearch@swedish.org"">CancerResearch@swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bremerton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Harrison HealthPartners Hematology and Oncology-Bremerton</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Green Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology at Saint Vincent Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology Limited at Saint Mary's Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Marinette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Marinette</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:Christy.Gilchrist@hshs.org"">Christy.Gilchrist@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sturgeon Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology - Sturgeon Bay</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Weston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Diagnostic and Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 888-799-3989 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                           			</div> 		</div> 					</div> 			</div> 		</div> 	</div>      <script id=""print-script"">         const subject = ""Clinical Trials from the National Cancer Institute's Website"";         const body = `Print-Friendly Clinical Trial Descriptions  ${document.location}  Please note that the URL will expire after 90 days.  You can find educational materials about clinical trials on NCI's Web site at http://www.cancer.gov/clinicaltrials. NCI's Web site, www.cancer.gov, contains comprehensive information about cancer causes and prevention, screening and diagnosis, treatment and survivorship; clinical trials; statistics; funding, training and employment opportunities; and the institute and its programs.  You can also get cancer information online through the LiveHelp instant messaging service at http://livehelp.cancer.gov. If you live in the United States, you may call the NCI's Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) for cancer information in English and Spanish.`;          let newLink = 'mailto:?subject=' + encodeURIComponent(subject) + '&body=' + encodeURIComponent(body);          const mailtoLink = document.getElementById(""ctl10_EmailResults"");         mailtoLink.attributes['href'].value = newLink;     </script>  	<!-- DTM PAGEBOTTOM TAG - DO NOT MODIFY --> 	<script type=""text/javascript"">_satellite.pageBottom();</script> </body> </html>"
250624D6-3245-EF11-A20D-005056B388D3,2024-07-18 14:23:32.520,NCI-2015-00054,[]," <!DOCTYPE html> <html lang=""en""> <head> 	 <meta name=""robots"" content=""noindex""> 	 <title>Clinical Trial Search Results</title> 	 <script src=""//assets.adobedtm.com/f1bfa9f7170c81b1a9a9ecdcc6c5215ee0b03c84/satelliteLib-5b3dcf1f2676c378b518a1583ef5355acd83cd3d.js""></script> 	 <script src=""https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js""></script> 	 <script src=""/CTS.Print-js/BasicCTSPrintPage.js"" type=""text/javascript""></script>  	 <link rel=""stylesheet"" id=""gFonts"" href=""https://fonts.googleapis.com/css?family=Noto+Sans:400,400i,700,700i"" /> 	 <link href=""/CTS.Print-styles/nvcg.css"" rel=""stylesheet"" /> 	 <link href=""/CTS.Print-styles/BasicCTSPrintPage.css"" rel=""stylesheet"" /> 	 <meta name=""dcterms.subject"" content=""Clinical Trials Print Results Page"" />      <meta name=""Generator"" content=""CTS.Print"" /> </head> <body> 	<div class=""wa-data-element hide"" data-prop3=""/"" data-prop6=""Comprehensive Cancer Information"" data-prop16=""Comprehensive Cancer Information"" data-prop25=""01/01/1980"" data-prop44=""Clinical Trials"" data-prop62=""Clinical Trials: Print Results Page"" data-evar44=""Clinical Trials"" data-evar62=""Clinical Trials: Print Results Page"" ></div> 	<div id=""cgovContainer""> 		<div id=""CT-results-print-banner""><img id=""NCILogo"" src=""https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/logos/nci-logo-full.svg"" alt=""NCI Logo""/></div> 		<div id=""cgvBody""> 			<div id=""bodyHeading""> 				<div id=""headingWrapper""> 					<h1 id=""ctPrintBodyHeading"">Your Clinical Trials Search Results</h1> 					<div id=""bodyHeadingLinks""> 						<a id=""printPage"" href=""javascript:window.print();"">Print</a> | 						<a id=""ctl10_EmailResults"" href=""/CTS.Print/Display?printid={0}"" target=""_blank"">E-Mail These Results</a> | 						<a id=""newSearch"" href=""/about-cancer/treatment/clinical-trials/search/advanced"">New Search</a> 					</div> 				</div> 			</div> 				<div id=""clinical-trials-print"">  					 	        		                     <p class=""printIntroText"">Here are the trials you selected from your search on 7/18/2024.</p> 					<p class=""printIntroText"">You will be able to access this page for approximately 90 days. Since trial information is updated regularly, you should check for updates to see the most current information on any of the trials below.</p>   				<div> 								<div class=""trialContainer""> 			<h2 class=""hangingIndent"">1. Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?t=C3208&st=C3471&a=24&loc=1&z=20850&zp=100&rl=2&id=NCI-2015-00054""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase II</td> 					<td>Screening</td> 					<td>Closed to Accrual</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> EAY131<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2015-00054<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/study/NCT02465060"" target=""_blank"">NCT02465060</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple myelomas that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and does not respond to treatment (refractory). Patients must have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic material (genes) of patients&#39; tumor cells. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit more from treatment which targets their tumor&#39;s particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors, lymphomas, or multiple myeloma.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SCREENING BIOPSY (STEP 0)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be &gt;= 18 years of age. Because no dosing or adverse event data are currently available on the use of study investigational agents in patients &lt; 18 years of age, children are excluded from this study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to registration; patients that are pregnant or breast feeding are excluded; a patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:  * Has achieved menarche at some point  * Has not undergone a hysterectomy or bilateral oophorectomy; or  * Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse prior to study entry, for the duration of study participation, and for 4 months after completion of study; should a patient or partner of the patient become pregnant or suspect a pregnancy while participating in this study, the treating physician should be informed immediately</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have histologically documented solid tumors or histologically confirmed diagnosis of lymphoma or multiple myeloma requiring therapy and meet one of the following criteria: * Patients must have progressed following at least one line of standard systemic therapy and there must not be other approval/standard therapy available that has been shown to prolong overall survival (i.e. in a randomized trial against another standard treatment or by comparison to historical controls); patients who cannot receive other standard therapy that has been shown to prolong overall survival due to medical issues will be eligible, if other eligibility criteria are met; if the patient is currently receiving therapy, the clinician must have assessed that the current therapy is no longer benefitting the patient prior to enrolling on MATCH, regardless of whether it is considered standard OR * Patients for whose disease no standard treatment exists that has been shown to prolong overall survival * NOTE: No other prior malignancy is allowed except for the following: * Adequately treated basal cell or squamous cell skin cancer * In situ cervical cancer * Adequately treated stage I or II cancer from which the patient is currently in complete remission * Any other cancer from which the patient has been disease-free for 5 years</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have measurable disease</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet the criteria below * Tumor tissue for the confirmation of “rare variant” by the MATCH assay is to be submitted, preferably from the same time of collection as that used to determine patient candidacy for treatment arm assignment ** Registration to Step 0 must occur after stopping prior systemic anti-cancer therapy. There is no specific duration for which patients must be off treatment prior to registration to Step 0, as long as all eligibility criteria are met ** Patients may have received other non-targeted, immunotherapy or targeted treatment between the prior genetic testing at the outside lab and registration to Step 0. The decision to stop such treatment in favor of participation in MATCH, if no further clinical benefit is expected, is per the treating physician&#39;s discretion. Documentation of a lack of response to the prior treatment is not required in these cases ** Patients with an applicable “rare variant” must be able to meet the eligibility criteria for the appropriate subprotocols within 4 weeks following notification of treatment assignment ** Patient meets one of the following criteria: *** Patient is a candidate for Z1M based on local Clinical Laboratory Improvement Act (CLIA) assessment of mismatch repair deficiency (MMRd) by immunohistochemistry (IHC) or microsatellite instability (MSI) status by polymerase chain reaction (PCR), adequate tumor tissue is available for submission for mandatory central screening IHC and the patient will be able to meet the eligibility criteria for Z1M within 4 weeks following notification of treatment assignment OR *** The sites have received results from one of the designated outside laboratories indicating a “rare variant” that is an actionable Mutation of Interest (aMOI) for specific select subprotocols * NOTE: There is no particular window of time after receiving the sequencing report notification of potential eligibility from an outside lab in which the patient must be registered to Step 0, but treatment slots will be assigned on a first come, first serve basis to those who do register to Step 0, and are not held for those notified of potential eligibility who do not register to Step 0 * NOTE: Treatment assignment (and the start of the associated deadline for Step 1 registration) may occur shortly after Step 0 registration. Note that certain “rare variant” arms require submission of archival tissue for central IHC testing to determine treatment assignment. For those arms, adequate tissue for the central IHC is required to be available for submission * NOTE: Other potential aMOIs that would be eligibility criteria for “NON RARE” arms, as determined by the designated laboratories, are not applicable for this process in MATCH</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not require the use of full dose coumarin-derivative anticoagulants such as warfarin; low molecular weight heparin is permitted for prophylactic or therapeutic use; factor X inhibitors are permitted * NOTE: Warfarin may not be started while enrolled in the EAY131 study * Stopping the anticoagulation for biopsy should be per site standard operating procedure (SOP)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =&lt; 1 and a life expectancy of at least 3 months</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not currently be receiving any other investigational agents</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not have any uncontrolled intercurrent illness including, but not limited to: * Symptomatic congestive heart failure (New York Heart Association [NYHA] classification of III/IV) * Unstable angina pectoris or coronary angioplasty, or stenting within 6 months prior to registration to Step 0, 2, 4, 6 * Cardiac arrhythmia (ongoing cardiac dysrhythmias of National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version [v]4 grade &gt;= 2) * Psychiatric illness/social situations that would limit compliance with study requirements * Intra-cardiac defibrillators * Known cardiac metastases * Abnormal cardiac valve morphology (&gt;= grade 2) documented by echocardiogram (ECHO) (as clinically indicated); (subjects with grade 1 abnormalities [i.e., mild regurgitation/stenosis] can be entered on study); subjects with moderate valvular thickening should not be entered on study * NOTE: To receive an agent, patient must not have any uncontrolled intercurrent illness such as ongoing or active infection; patients with infections unlikely to be resolved within 2 weeks following screening should not be considered for the trial</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be able to swallow tablets or capsules; a patient with any gastrointestinal disease that would impair ability to swallow, retain, or absorb drug is not eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients who are human immunodeficiency virus (HIV)-positive are eligible if:  * CD4+ cell count greater or equal to 250 cells/mm^3 * If patient is on antiretroviral therapy, there must be minimal interactions or overlapping toxicity of the antiretroviral therapy with the experimental cancer treatment; for experimental cancer therapeutics with CYP3A/4 interactions, protease inhibitor therapy is disallowed; suggested regimens to replace protease inhibitor therapy include dolutegravir given with tenofovir/emtricitabine; raltegravir given with tenofovir and emtricitabine; once daily combinations that use pharmacologic boosters may not be used * No history of non-malignancy acquired immune deficiency syndrome (AIDS)-defining conditions other than historical low CD4+ cell counts * Probable long-term survival with HIV if cancer were not present</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Any prior therapy, radiotherapy (except palliative radiation therapy of 30 gray [Gy] or less), or major surgery must have been completed &gt;= 4 weeks prior to start of treatment; all adverse events due to prior therapy have resolved to a grade 1 or better (except alopecia and lymphopenia) by start of treatment; palliative radiation therapy must have been completed at least 2 weeks prior to start of treatment; the radiotherapy must not be to a lesion that is included as measurable disease * NOTE: Prostate cancer patients may continue their luteinizing hormone-releasing hormone (LHRH) agonist * NOTE: For patients entering the study via the original screening process, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results; however, lack of response must be documented prior to registration to Step 1; new non-protocol treatment will NOT be permitted as intervening therapy after registration to Step 0; the only intervening treatment permitted is prior therapy that the patient already received prior to Step 0 registration; the decision to stop the intervening non-protocol treatment will be left up to the treating physician if patient has an aMOI; however, patients will need to be off such therapy for at least 4 weeks before receiving any MATCH protocol treatment * NOTE: For patients entering the study via a designated outside laboratory, no intervening systemic non-protocol treatment is permitted after Step 0 registration; all other eligibility requirements still apply to these patients, including the washouts for prior therapy noted above in this section, the time restrictions outlined, and the eligibility criteria for the intended subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients with brain metastases or primary brain tumors must have completed treatment, surgery or radiation therapy &gt;= 4 weeks prior to start of treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have discontinued steroids &gt;= 1 week prior to registration to Step 0 and remain off steroids thereafter, except as permitted; patients with glioblastoma (GBM) must have been on stable dose of steroids, or be off steroids, for one week prior to registration to treatment (Step 1, 3, 5, 7) * NOTE: The following steroids are permitted (low dose steroid use is defined as prednisone 10 mg daily or less, or bioequivalent dose of other corticosteroid): ** Temporary steroid use: e.g. for CT imaging in setting of contrast allergy ** Low dose steroid use for appetite ** Chronic inhaled steroid use ** Steroid injections for joint disease ** Stable dose of replacement steroid for adrenal insufficiency or low doses for non-malignant disease ** Topical steroid ** Steroids required to manage toxicity related to study treatment, as described in the subprotocols ** Steroids required as pre- or post-chemotherapy medication for acceptable intervening chemotherapy *** NOTE: Steroids must be completed alongside last dose of chemotherapy</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Leukocytes &gt;= 3,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Absolute neutrophil count (ANC) &gt;= 1,500/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Platelets &gt;= 100,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: Patients with documented bone marrow involvement by lymphoma are not required to meet the above hematologic parameters, but must have a platelet count of at least 75,000/mcL and neutrophil count of at least 1,000/mcL</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Total bilirubin =&lt; 1.5 x institutional upper limit of normal (ULN) (unless documented Gilbert’s syndrome, for which bilirubin =&lt; 3 x institutional ULN is permitted) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =&lt; 2.5 x institutional ULN (up to 5 times ULN in presence of liver metastases) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Creatinine clearance &gt;= 45 mL/min/1.73 m^2 for patients with creatinine levels above institutional ULN * As defined by the Cockcroft-Gault equation (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have an electrocardiogram (ECG) within 8 weeks prior to registration to screening step and must meet the following cardiac criteria: * Resting corrected QT interval (QTc) =&lt; 480 msec ** NOTE: If the first recorded QTc exceeds 480 msec, two additional, consecutive ECGs are required and must result in a mean resting QTc =&lt; 480 msec; it is recommended that there are 10-minute (+/- 5 minutes) breaks between the ECGs * The following only need to be assessed if the mean QTc &gt; 480 msec ** Check potassium and magnesium serum levels ** Correct any identified hypokalemia and/or hypomagnesemia and may repeat ECG to confirm exclusion of patient due to QTc ** For patients with heart rate (HR) 60-100 beats per minute (bpm), no manual read of QTc is required ** For patients with baseline HR &lt; 60 or &gt; 100 bpm, manual read of QT by trained personnel is required, with Fridericia correction applied to determine QTc ** Patient must not have hypokalemia (value &lt; institutional lower limit of normal) * No factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age or any concomitant medication known to prolong the QT interval ** NOTE: Patient must be taken off prohibited medication prior to registration to the screening step (Step 0, 2, 4, 6) and remain off these medications thereafter, unless permitted on a subprotocol for the management of treatment related toxicity; patient must be off the drug for at least 5 half-lives prior to registration to the treatment step (Step 1, 3, 5, 7); the medication half-life can be found in the package insert for Food and Drug Administration (FDA) approved drugs</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FIRST TREATMENT (STEP 1)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: For patients entering step 0 with assay results from outside laboratories, no systemic treatment is allowed after step 0 registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>As MATCH is designed to add additional subprotocols, implement limited expansions of accrual for certain subprotocols, and/or amend existing arm-specific eligibility criteria, some patients entering under the original screening method may be eligible to have their results rerun in MATCHbox, even if they did not match to a treatment initially or did not receive a treatment assignment due to a lack of available assignment slots; patients whose sequence results will be rerun through MATCHbox must also meet the following criteria: * Samples must have been collected within 5 months of the activation of the addendum, as there is an additional month needed to get the patients on trial * Patient has not had treatment within the 5 months that resulted in a PR or better after the performance of the screening assessment * Patient must meet eligibility criteria, including performance status 1 or better and life expectancy of at least 3 months * Patients must meet the eligibility requirements with the following exceptions: ** Patients may have received other non-targeted, immunotherapy or targeted treatment, which could be stopped in favor of returning to MATCH, if no response to the interim treatment has occurred and no further benefit is expected from this interim treatment, per the treating physician&#39;s discretion; documentation of a lack of response to the interim treatment is not required in these cases; however, the following restrictions apply: *** Enrollment onto another investigational therapeutic study is not permitted *** Patient cannot be responding to interim treatment, since the benefit of the MATCH treatment is unknown and may deprive patient of an effective treatment if it were given when a patient is responding to another treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 results will be re-interrogated to determine if another treatment is available</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND SCREENING (STEP 2)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on Step 1 treatment or patient could not tolerate assigned treatment * NOTE: PATIENTS ENTERING STEP 1 WITH A “RARE VARIANT” FROM AN “OUTSIDE” LAB ARE NOT ELIGIBLE FOR STEP 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 1 treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance; only aMOIs detected by the MATCH assay may be used for the determination of eligibility to a relevant subprotocol OR</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Progression (or inability to tolerate further treatment) occurred after a (1) response OR (2) after &gt;= 6 months from start of step 1 treatment; patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspirate for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest (aMOI); archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not have been assigned to step 1 treatment based on a “rare variant” determined by a designated outside laboratory</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND TREATMENT (STEP 3)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy samples were submitted during step 2, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 3; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 2; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD SCREENING (STEP 4)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 3 treatment or patient could not tolerate assigned treatment * Patient must meet one of the following criteria: ** No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 3 (second) treatment AND a biopsy was performed at step 2 screening *** NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their latest MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance OR ** Progression (or inability to tolerate further treatment) occurred on step 3 treatment and a biopsy was not performed at step 2 screening (due to presence of additional aMOIs at that stage); patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspiration for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest; biopsy must not be considered to be more than minimal risk to the patient; archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: A patient may have a maximum of 2 screening biopsies (not including re-biopsy due to assay failure), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD TREATMENT (STEP 5)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy was submitted on step 4, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 5; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 4; the therapy cannot be an arm in the MATCH trial; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FOURTH SCREENING (STEP 6)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 5 protocol treatment or patient could not tolerate assigned treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have had no response, and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 5 treatment AND a biopsy was performed at step 4 screening * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, based on their 2nd biopsy, their results will be interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: For Step 6, biopsies to collect material for screening assay will NOT be performed; a patient may have a maximum of 2 successful screening assessments of submitted tissue (steps 0 and 2 OR steps 0 and 4), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY FOR FOURTH TREATMENT (STEP 7)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eligibility requirements for registration onto step 7 are outlined in the agent-specific subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR RESEARCH BIOPSY AND CIRCULATING TUMOR DNA COLLECTION (STEP 8)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ALL PATIENTS SHOULD BE ENCOURAGED TO PARTICIPATE IN STEP 8, IF SAFE; IF BIOPSY IS REFUSED OR INADVISABLE, ENCOURAGE COLLECTION OF WHOLE BLOOD FOR CIRCULATING TUMOR DNA As a reminder, the submission of the step 8 samples requires additional patient consent, as well as registration to step 8 * NOTE: Patients who entered the study (step 0) with a “rare variant” determined by an outside assay ARE potentially eligible and encouraged to participate in step 8</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient has completed their most recent MATCH study treatment, will not undergo an additional screening biopsies, and will receive no additional treatment on MATCH * NOTE: If a 2nd Screening Biopsy was performed and showed no study-actionable abnormalities, and blood samples were submitted with the screening biopsy, no additional end of treatment specimens are requested</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>For patients who consent to undergo the optional research biopsy, patient’s disease responded to the most recent MATCH study treatment and then progressed (or unable to tolerate further treatment) OR the disease progression (or inability to tolerate further treatment) occurs &gt; 6 months since the last screening biopsy * NOTE: Performance of a biopsy to collect tumor tissue for research is strongly encouraged but not required; it is acceptable to submit only the optional blood specimens * NOTE: If a biopsy will be performed solely to collect tumor specimens for research, the patient must be willing and able to undergo a tumor biopsy or bone marrow aspirate (for applicable multiple myeloma), for the collection and submission of tissue for research</li> 												</ul> 						</div> 										 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE: </p><p class='ctrp'>I. To evaluate the proportion of patients with objective response (OR) to targeted study agent(s) in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES: </p><p class='ctrp'>I. To evaluate the proportion of patients alive and progression free at 6 months of treatment with targeted study agent in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'>II. To evaluate time until death or disease progression.</p><p class='ctrp'>III. To identify potential predictive biomarkers beyond the genomic alteration by which treatment is assigned or resistance mechanisms using additional genomic, ribonucleic acid (RNA), protein and imaging-based assessment platforms.</p><p class='ctrp'>IV. To assess whether radiomic phenotypes obtained from pre-treatment imaging and changes from pre- through post-therapy imaging can predict objective response and progression free survival and to evaluate the association between pre-treatment radiomic phenotypes and targeted gene mutation patterns of tumor biopsy specimens.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE:</p><p class='ctrp'>STEP 0 (Screening): Patients undergo biopsy along with molecular characterization of the biopsy material for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing and immunohistochemistry. Consenting patients also undergo collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>STEPS 1, 3, 5, 7 (Treatment): Patients are assigned to 1 of 38 treatment subprotocols based on molecularly-defined subgroup. (See Arms Section) </p><p class='ctrp'></p><p class='ctrp'>STEPS 2, 4, 6 (Screening): Patients experiencing disease progression on the prior Step treatment or who could not tolerate the assigned treatment undergo review of their previous biopsy results to determine if another treatment is available or undergo another biopsy. Patients may have a maximum of 2 screening biopsies and 2 treatments per biopsy. </p><p class='ctrp'></p><p class='ctrp'>STEP 8 (Optional Research): Consenting patients undergo end-of-treatment biopsy and collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>Additionally, patients may undergo a computed tomography (CT) scan, magnetic resonance imaging, and/or radionuclide imaging throughout the trial. </p><p class='ctrp'></p><p class='ctrp'>After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 1 year.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>ECOG-ACRIN Cancer Research Group</div> 													<div>Principal Investigator: Keith Thomas Flaherty</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT02465060"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>California</h4>                           <h5 class=""locationCity"">Vacaville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sutter Cancer Centers Radiation Oncology Services-Vacaville</strong>     <br>Contact: Site Public Contact <br>Phone: 415-209-2683 <br>Email: <a href=""mailto:hempell@sutterhealth.org"">hempell@sutterhealth.org</a>   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Boulder</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Boulder Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:jbloomfield@co-cancerresearch.org"">jbloomfield@co-cancerresearch.org</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Gynecologic Oncology LLC</strong>     <br>Contact: Gregory Andrew Masters <br>Phone: 302-733-6227   </span> </div>                                   <h4>Florida</h4>                           <h5 class=""locationCity"">Fort Lauderdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Holy Cross Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 954-267-7748   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">Syracuse</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">SUNY Upstate Medical Center-Community Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 315-464-5476   </span> </div>                                   <h4>North Carolina</h4>                           <h5 class=""locationCity"">Hendersonville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hendersonville Hematology and Oncology at Pardee</strong>     <br>Contact: James Earl Radford <br>Phone: 828-696-4716   </span> </div>                                       <h5 class=""locationCity"">Mooresville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Cancer Institute - Mooresville</strong>     <br>Contact: Site Public Contact <br>Phone: 704-384-8920 <br>Email: <a href=""mailto:nnechiporchik@novanthealth.org"">nnechiporchik@novanthealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Winston-Salem</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Oncology Specialists</strong>     <br>Contact: Site Public Contact <br>Phone: 336-718-8335 <br>Email: <a href=""mailto:asmarrs@novanthealth.org"">asmarrs@novanthealth.org</a>   </span> </div>                                   <h4>North Dakota</h4>                           <h5 class=""locationCity"">Fargo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Clinic North-Fargo</strong>     <br>Contact: Preston D. Steen <br>Phone: 712-252-0088   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hematology and Oncology Associates Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 330-453-9993   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Pittsburgh</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Association</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Tennessee</h4>                           <h5 class=""locationCity"">Memphis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Family Cancer Center-Memphis</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Bellevue</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Cancer Institute-Eastside Oncology Hematology</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:CancerResearch@swedish.org"">CancerResearch@swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bremerton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Harrison HealthPartners Hematology and Oncology-Bremerton</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Green Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology at Saint Vincent Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology Limited at Saint Mary's Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Marinette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Marinette</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:Christy.Gilchrist@hshs.org"">Christy.Gilchrist@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sturgeon Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology - Sturgeon Bay</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Weston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Diagnostic and Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 888-799-3989 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                           			</div> 		</div> 					</div> 			</div> 		</div> 	</div>      <script id=""print-script"">         const subject = ""Clinical Trials from the National Cancer Institute's Website"";         const body = `Print-Friendly Clinical Trial Descriptions  ${document.location}  Please note that the URL will expire after 90 days.  You can find educational materials about clinical trials on NCI's Web site at http://www.cancer.gov/clinicaltrials. NCI's Web site, www.cancer.gov, contains comprehensive information about cancer causes and prevention, screening and diagnosis, treatment and survivorship; clinical trials; statistics; funding, training and employment opportunities; and the institute and its programs.  You can also get cancer information online through the LiveHelp instant messaging service at http://livehelp.cancer.gov. If you live in the United States, you may call the NCI's Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) for cancer information in English and Spanish.`;          let newLink = 'mailto:?subject=' + encodeURIComponent(subject) + '&body=' + encodeURIComponent(body);          const mailtoLink = document.getElementById(""ctl10_EmailResults"");         mailtoLink.attributes['href'].value = newLink;     </script>  	<!-- DTM PAGEBOTTOM TAG - DO NOT MODIFY --> 	<script type=""text/javascript"">_satellite.pageBottom();</script> </body> </html>"
FD50685F-3345-EF11-A20D-005056B388D3,2024-07-18 14:27:22.807,NCI-2015-00054,[]," <!DOCTYPE html> <html lang=""en""> <head> 	 <meta name=""robots"" content=""noindex""> 	 <title>Clinical Trial Search Results</title> 	 <script src=""//assets.adobedtm.com/f1bfa9f7170c81b1a9a9ecdcc6c5215ee0b03c84/satelliteLib-5b3dcf1f2676c378b518a1583ef5355acd83cd3d.js""></script> 	 <script src=""https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js""></script> 	 <script src=""/CTS.Print-js/BasicCTSPrintPage.js"" type=""text/javascript""></script>  	 <link rel=""stylesheet"" id=""gFonts"" href=""https://fonts.googleapis.com/css?family=Noto+Sans:400,400i,700,700i"" /> 	 <link href=""/CTS.Print-styles/nvcg.css"" rel=""stylesheet"" /> 	 <link href=""/CTS.Print-styles/BasicCTSPrintPage.css"" rel=""stylesheet"" /> 	 <meta name=""dcterms.subject"" content=""Clinical Trials Print Results Page"" />      <meta name=""Generator"" content=""CTS.Print"" /> </head> <body> 	<div class=""wa-data-element hide"" data-prop3=""/"" data-prop6=""Comprehensive Cancer Information"" data-prop16=""Comprehensive Cancer Information"" data-prop25=""01/01/1980"" data-prop44=""Clinical Trials"" data-prop62=""Clinical Trials: Print Results Page"" data-evar44=""Clinical Trials"" data-evar62=""Clinical Trials: Print Results Page"" ></div> 	<div id=""cgovContainer""> 		<div id=""CT-results-print-banner""><img id=""NCILogo"" src=""https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/logos/nci-logo-full.svg"" alt=""NCI Logo""/></div> 		<div id=""cgvBody""> 			<div id=""bodyHeading""> 				<div id=""headingWrapper""> 					<h1 id=""ctPrintBodyHeading"">Your Clinical Trials Search Results</h1> 					<div id=""bodyHeadingLinks""> 						<a id=""printPage"" href=""javascript:window.print();"">Print</a> | 						<a id=""ctl10_EmailResults"" href=""/CTS.Print/Display?printid={0}"" target=""_blank"">E-Mail These Results</a> | 						<a id=""newSearch"" href=""/about-cancer/treatment/clinical-trials/search/advanced"">New Search</a> 					</div> 				</div> 			</div> 				<div id=""clinical-trials-print"">  					 	        		                     <p class=""printIntroText"">Here are the trials you selected from your search on 7/18/2024.</p> 					<p class=""printIntroText"">You will be able to access this page for approximately 90 days. Since trial information is updated regularly, you should check for updates to see the most current information on any of the trials below.</p>   				<div> 								<div class=""trialContainer""> 			<h2 class=""hangingIndent"">1. Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?t=C3208&st=C3471&a=24&loc=1&z=20850&zp=100&rl=2&id=NCI-2015-00054""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase II</td> 					<td>Screening</td> 					<td>Closed to Accrual</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> EAY131<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2015-00054<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/study/NCT02465060"" target=""_blank"">NCT02465060</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple myelomas that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and does not respond to treatment (refractory). Patients must have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic material (genes) of patients&#39; tumor cells. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit more from treatment which targets their tumor&#39;s particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors, lymphomas, or multiple myeloma.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SCREENING BIOPSY (STEP 0)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be &gt;= 18 years of age. Because no dosing or adverse event data are currently available on the use of study investigational agents in patients &lt; 18 years of age, children are excluded from this study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to registration; patients that are pregnant or breast feeding are excluded; a patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:  * Has achieved menarche at some point  * Has not undergone a hysterectomy or bilateral oophorectomy; or  * Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse prior to study entry, for the duration of study participation, and for 4 months after completion of study; should a patient or partner of the patient become pregnant or suspect a pregnancy while participating in this study, the treating physician should be informed immediately</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have histologically documented solid tumors or histologically confirmed diagnosis of lymphoma or multiple myeloma requiring therapy and meet one of the following criteria: * Patients must have progressed following at least one line of standard systemic therapy and there must not be other approval/standard therapy available that has been shown to prolong overall survival (i.e. in a randomized trial against another standard treatment or by comparison to historical controls); patients who cannot receive other standard therapy that has been shown to prolong overall survival due to medical issues will be eligible, if other eligibility criteria are met; if the patient is currently receiving therapy, the clinician must have assessed that the current therapy is no longer benefitting the patient prior to enrolling on MATCH, regardless of whether it is considered standard OR * Patients for whose disease no standard treatment exists that has been shown to prolong overall survival * NOTE: No other prior malignancy is allowed except for the following: * Adequately treated basal cell or squamous cell skin cancer * In situ cervical cancer * Adequately treated stage I or II cancer from which the patient is currently in complete remission * Any other cancer from which the patient has been disease-free for 5 years</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have measurable disease</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet the criteria below * Tumor tissue for the confirmation of “rare variant” by the MATCH assay is to be submitted, preferably from the same time of collection as that used to determine patient candidacy for treatment arm assignment ** Registration to Step 0 must occur after stopping prior systemic anti-cancer therapy. There is no specific duration for which patients must be off treatment prior to registration to Step 0, as long as all eligibility criteria are met ** Patients may have received other non-targeted, immunotherapy or targeted treatment between the prior genetic testing at the outside lab and registration to Step 0. The decision to stop such treatment in favor of participation in MATCH, if no further clinical benefit is expected, is per the treating physician&#39;s discretion. Documentation of a lack of response to the prior treatment is not required in these cases ** Patients with an applicable “rare variant” must be able to meet the eligibility criteria for the appropriate subprotocols within 4 weeks following notification of treatment assignment ** Patient meets one of the following criteria: *** Patient is a candidate for Z1M based on local Clinical Laboratory Improvement Act (CLIA) assessment of mismatch repair deficiency (MMRd) by immunohistochemistry (IHC) or microsatellite instability (MSI) status by polymerase chain reaction (PCR), adequate tumor tissue is available for submission for mandatory central screening IHC and the patient will be able to meet the eligibility criteria for Z1M within 4 weeks following notification of treatment assignment OR *** The sites have received results from one of the designated outside laboratories indicating a “rare variant” that is an actionable Mutation of Interest (aMOI) for specific select subprotocols * NOTE: There is no particular window of time after receiving the sequencing report notification of potential eligibility from an outside lab in which the patient must be registered to Step 0, but treatment slots will be assigned on a first come, first serve basis to those who do register to Step 0, and are not held for those notified of potential eligibility who do not register to Step 0 * NOTE: Treatment assignment (and the start of the associated deadline for Step 1 registration) may occur shortly after Step 0 registration. Note that certain “rare variant” arms require submission of archival tissue for central IHC testing to determine treatment assignment. For those arms, adequate tissue for the central IHC is required to be available for submission * NOTE: Other potential aMOIs that would be eligibility criteria for “NON RARE” arms, as determined by the designated laboratories, are not applicable for this process in MATCH</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not require the use of full dose coumarin-derivative anticoagulants such as warfarin; low molecular weight heparin is permitted for prophylactic or therapeutic use; factor X inhibitors are permitted * NOTE: Warfarin may not be started while enrolled in the EAY131 study * Stopping the anticoagulation for biopsy should be per site standard operating procedure (SOP)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =&lt; 1 and a life expectancy of at least 3 months</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not currently be receiving any other investigational agents</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not have any uncontrolled intercurrent illness including, but not limited to: * Symptomatic congestive heart failure (New York Heart Association [NYHA] classification of III/IV) * Unstable angina pectoris or coronary angioplasty, or stenting within 6 months prior to registration to Step 0, 2, 4, 6 * Cardiac arrhythmia (ongoing cardiac dysrhythmias of National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version [v]4 grade &gt;= 2) * Psychiatric illness/social situations that would limit compliance with study requirements * Intra-cardiac defibrillators * Known cardiac metastases * Abnormal cardiac valve morphology (&gt;= grade 2) documented by echocardiogram (ECHO) (as clinically indicated); (subjects with grade 1 abnormalities [i.e., mild regurgitation/stenosis] can be entered on study); subjects with moderate valvular thickening should not be entered on study * NOTE: To receive an agent, patient must not have any uncontrolled intercurrent illness such as ongoing or active infection; patients with infections unlikely to be resolved within 2 weeks following screening should not be considered for the trial</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be able to swallow tablets or capsules; a patient with any gastrointestinal disease that would impair ability to swallow, retain, or absorb drug is not eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients who are human immunodeficiency virus (HIV)-positive are eligible if:  * CD4+ cell count greater or equal to 250 cells/mm^3 * If patient is on antiretroviral therapy, there must be minimal interactions or overlapping toxicity of the antiretroviral therapy with the experimental cancer treatment; for experimental cancer therapeutics with CYP3A/4 interactions, protease inhibitor therapy is disallowed; suggested regimens to replace protease inhibitor therapy include dolutegravir given with tenofovir/emtricitabine; raltegravir given with tenofovir and emtricitabine; once daily combinations that use pharmacologic boosters may not be used * No history of non-malignancy acquired immune deficiency syndrome (AIDS)-defining conditions other than historical low CD4+ cell counts * Probable long-term survival with HIV if cancer were not present</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Any prior therapy, radiotherapy (except palliative radiation therapy of 30 gray [Gy] or less), or major surgery must have been completed &gt;= 4 weeks prior to start of treatment; all adverse events due to prior therapy have resolved to a grade 1 or better (except alopecia and lymphopenia) by start of treatment; palliative radiation therapy must have been completed at least 2 weeks prior to start of treatment; the radiotherapy must not be to a lesion that is included as measurable disease * NOTE: Prostate cancer patients may continue their luteinizing hormone-releasing hormone (LHRH) agonist * NOTE: For patients entering the study via the original screening process, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results; however, lack of response must be documented prior to registration to Step 1; new non-protocol treatment will NOT be permitted as intervening therapy after registration to Step 0; the only intervening treatment permitted is prior therapy that the patient already received prior to Step 0 registration; the decision to stop the intervening non-protocol treatment will be left up to the treating physician if patient has an aMOI; however, patients will need to be off such therapy for at least 4 weeks before receiving any MATCH protocol treatment * NOTE: For patients entering the study via a designated outside laboratory, no intervening systemic non-protocol treatment is permitted after Step 0 registration; all other eligibility requirements still apply to these patients, including the washouts for prior therapy noted above in this section, the time restrictions outlined, and the eligibility criteria for the intended subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients with brain metastases or primary brain tumors must have completed treatment, surgery or radiation therapy &gt;= 4 weeks prior to start of treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have discontinued steroids &gt;= 1 week prior to registration to Step 0 and remain off steroids thereafter, except as permitted; patients with glioblastoma (GBM) must have been on stable dose of steroids, or be off steroids, for one week prior to registration to treatment (Step 1, 3, 5, 7) * NOTE: The following steroids are permitted (low dose steroid use is defined as prednisone 10 mg daily or less, or bioequivalent dose of other corticosteroid): ** Temporary steroid use: e.g. for CT imaging in setting of contrast allergy ** Low dose steroid use for appetite ** Chronic inhaled steroid use ** Steroid injections for joint disease ** Stable dose of replacement steroid for adrenal insufficiency or low doses for non-malignant disease ** Topical steroid ** Steroids required to manage toxicity related to study treatment, as described in the subprotocols ** Steroids required as pre- or post-chemotherapy medication for acceptable intervening chemotherapy *** NOTE: Steroids must be completed alongside last dose of chemotherapy</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Leukocytes &gt;= 3,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Absolute neutrophil count (ANC) &gt;= 1,500/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Platelets &gt;= 100,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: Patients with documented bone marrow involvement by lymphoma are not required to meet the above hematologic parameters, but must have a platelet count of at least 75,000/mcL and neutrophil count of at least 1,000/mcL</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Total bilirubin =&lt; 1.5 x institutional upper limit of normal (ULN) (unless documented Gilbert’s syndrome, for which bilirubin =&lt; 3 x institutional ULN is permitted) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =&lt; 2.5 x institutional ULN (up to 5 times ULN in presence of liver metastases) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Creatinine clearance &gt;= 45 mL/min/1.73 m^2 for patients with creatinine levels above institutional ULN * As defined by the Cockcroft-Gault equation (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have an electrocardiogram (ECG) within 8 weeks prior to registration to screening step and must meet the following cardiac criteria: * Resting corrected QT interval (QTc) =&lt; 480 msec ** NOTE: If the first recorded QTc exceeds 480 msec, two additional, consecutive ECGs are required and must result in a mean resting QTc =&lt; 480 msec; it is recommended that there are 10-minute (+/- 5 minutes) breaks between the ECGs * The following only need to be assessed if the mean QTc &gt; 480 msec ** Check potassium and magnesium serum levels ** Correct any identified hypokalemia and/or hypomagnesemia and may repeat ECG to confirm exclusion of patient due to QTc ** For patients with heart rate (HR) 60-100 beats per minute (bpm), no manual read of QTc is required ** For patients with baseline HR &lt; 60 or &gt; 100 bpm, manual read of QT by trained personnel is required, with Fridericia correction applied to determine QTc ** Patient must not have hypokalemia (value &lt; institutional lower limit of normal) * No factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age or any concomitant medication known to prolong the QT interval ** NOTE: Patient must be taken off prohibited medication prior to registration to the screening step (Step 0, 2, 4, 6) and remain off these medications thereafter, unless permitted on a subprotocol for the management of treatment related toxicity; patient must be off the drug for at least 5 half-lives prior to registration to the treatment step (Step 1, 3, 5, 7); the medication half-life can be found in the package insert for Food and Drug Administration (FDA) approved drugs</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FIRST TREATMENT (STEP 1)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: For patients entering step 0 with assay results from outside laboratories, no systemic treatment is allowed after step 0 registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>As MATCH is designed to add additional subprotocols, implement limited expansions of accrual for certain subprotocols, and/or amend existing arm-specific eligibility criteria, some patients entering under the original screening method may be eligible to have their results rerun in MATCHbox, even if they did not match to a treatment initially or did not receive a treatment assignment due to a lack of available assignment slots; patients whose sequence results will be rerun through MATCHbox must also meet the following criteria: * Samples must have been collected within 5 months of the activation of the addendum, as there is an additional month needed to get the patients on trial * Patient has not had treatment within the 5 months that resulted in a PR or better after the performance of the screening assessment * Patient must meet eligibility criteria, including performance status 1 or better and life expectancy of at least 3 months * Patients must meet the eligibility requirements with the following exceptions: ** Patients may have received other non-targeted, immunotherapy or targeted treatment, which could be stopped in favor of returning to MATCH, if no response to the interim treatment has occurred and no further benefit is expected from this interim treatment, per the treating physician&#39;s discretion; documentation of a lack of response to the interim treatment is not required in these cases; however, the following restrictions apply: *** Enrollment onto another investigational therapeutic study is not permitted *** Patient cannot be responding to interim treatment, since the benefit of the MATCH treatment is unknown and may deprive patient of an effective treatment if it were given when a patient is responding to another treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 results will be re-interrogated to determine if another treatment is available</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND SCREENING (STEP 2)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on Step 1 treatment or patient could not tolerate assigned treatment * NOTE: PATIENTS ENTERING STEP 1 WITH A “RARE VARIANT” FROM AN “OUTSIDE” LAB ARE NOT ELIGIBLE FOR STEP 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 1 treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance; only aMOIs detected by the MATCH assay may be used for the determination of eligibility to a relevant subprotocol OR</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Progression (or inability to tolerate further treatment) occurred after a (1) response OR (2) after &gt;= 6 months from start of step 1 treatment; patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspirate for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest (aMOI); archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not have been assigned to step 1 treatment based on a “rare variant” determined by a designated outside laboratory</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND TREATMENT (STEP 3)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy samples were submitted during step 2, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 3; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 2; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD SCREENING (STEP 4)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 3 treatment or patient could not tolerate assigned treatment * Patient must meet one of the following criteria: ** No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 3 (second) treatment AND a biopsy was performed at step 2 screening *** NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their latest MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance OR ** Progression (or inability to tolerate further treatment) occurred on step 3 treatment and a biopsy was not performed at step 2 screening (due to presence of additional aMOIs at that stage); patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspiration for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest; biopsy must not be considered to be more than minimal risk to the patient; archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: A patient may have a maximum of 2 screening biopsies (not including re-biopsy due to assay failure), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD TREATMENT (STEP 5)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy was submitted on step 4, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 5; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 4; the therapy cannot be an arm in the MATCH trial; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FOURTH SCREENING (STEP 6)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 5 protocol treatment or patient could not tolerate assigned treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have had no response, and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 5 treatment AND a biopsy was performed at step 4 screening * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, based on their 2nd biopsy, their results will be interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: For Step 6, biopsies to collect material for screening assay will NOT be performed; a patient may have a maximum of 2 successful screening assessments of submitted tissue (steps 0 and 2 OR steps 0 and 4), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY FOR FOURTH TREATMENT (STEP 7)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eligibility requirements for registration onto step 7 are outlined in the agent-specific subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR RESEARCH BIOPSY AND CIRCULATING TUMOR DNA COLLECTION (STEP 8)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ALL PATIENTS SHOULD BE ENCOURAGED TO PARTICIPATE IN STEP 8, IF SAFE; IF BIOPSY IS REFUSED OR INADVISABLE, ENCOURAGE COLLECTION OF WHOLE BLOOD FOR CIRCULATING TUMOR DNA As a reminder, the submission of the step 8 samples requires additional patient consent, as well as registration to step 8 * NOTE: Patients who entered the study (step 0) with a “rare variant” determined by an outside assay ARE potentially eligible and encouraged to participate in step 8</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient has completed their most recent MATCH study treatment, will not undergo an additional screening biopsies, and will receive no additional treatment on MATCH * NOTE: If a 2nd Screening Biopsy was performed and showed no study-actionable abnormalities, and blood samples were submitted with the screening biopsy, no additional end of treatment specimens are requested</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>For patients who consent to undergo the optional research biopsy, patient’s disease responded to the most recent MATCH study treatment and then progressed (or unable to tolerate further treatment) OR the disease progression (or inability to tolerate further treatment) occurs &gt; 6 months since the last screening biopsy * NOTE: Performance of a biopsy to collect tumor tissue for research is strongly encouraged but not required; it is acceptable to submit only the optional blood specimens * NOTE: If a biopsy will be performed solely to collect tumor specimens for research, the patient must be willing and able to undergo a tumor biopsy or bone marrow aspirate (for applicable multiple myeloma), for the collection and submission of tissue for research</li> 												</ul> 						</div> 										 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE: </p><p class='ctrp'>I. To evaluate the proportion of patients with objective response (OR) to targeted study agent(s) in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES: </p><p class='ctrp'>I. To evaluate the proportion of patients alive and progression free at 6 months of treatment with targeted study agent in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'>II. To evaluate time until death or disease progression.</p><p class='ctrp'>III. To identify potential predictive biomarkers beyond the genomic alteration by which treatment is assigned or resistance mechanisms using additional genomic, ribonucleic acid (RNA), protein and imaging-based assessment platforms.</p><p class='ctrp'>IV. To assess whether radiomic phenotypes obtained from pre-treatment imaging and changes from pre- through post-therapy imaging can predict objective response and progression free survival and to evaluate the association between pre-treatment radiomic phenotypes and targeted gene mutation patterns of tumor biopsy specimens.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE:</p><p class='ctrp'>STEP 0 (Screening): Patients undergo biopsy along with molecular characterization of the biopsy material for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing and immunohistochemistry. Consenting patients also undergo collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>STEPS 1, 3, 5, 7 (Treatment): Patients are assigned to 1 of 38 treatment subprotocols based on molecularly-defined subgroup. (See Arms Section) </p><p class='ctrp'></p><p class='ctrp'>STEPS 2, 4, 6 (Screening): Patients experiencing disease progression on the prior Step treatment or who could not tolerate the assigned treatment undergo review of their previous biopsy results to determine if another treatment is available or undergo another biopsy. Patients may have a maximum of 2 screening biopsies and 2 treatments per biopsy. </p><p class='ctrp'></p><p class='ctrp'>STEP 8 (Optional Research): Consenting patients undergo end-of-treatment biopsy and collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>Additionally, patients may undergo a computed tomography (CT) scan, magnetic resonance imaging, and/or radionuclide imaging throughout the trial. </p><p class='ctrp'></p><p class='ctrp'>After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 1 year.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>ECOG-ACRIN Cancer Research Group</div> 													<div>Principal Investigator: Keith Thomas Flaherty</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT02465060"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>California</h4>                           <h5 class=""locationCity"">Vacaville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sutter Cancer Centers Radiation Oncology Services-Vacaville</strong>     <br>Contact: Site Public Contact <br>Phone: 415-209-2683 <br>Email: <a href=""mailto:hempell@sutterhealth.org"">hempell@sutterhealth.org</a>   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Boulder</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Boulder Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:jbloomfield@co-cancerresearch.org"">jbloomfield@co-cancerresearch.org</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Gynecologic Oncology LLC</strong>     <br>Contact: Gregory Andrew Masters <br>Phone: 302-733-6227   </span> </div>                                   <h4>Florida</h4>                           <h5 class=""locationCity"">Fort Lauderdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Holy Cross Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 954-267-7748   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">Syracuse</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">SUNY Upstate Medical Center-Community Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 315-464-5476   </span> </div>                                   <h4>North Carolina</h4>                           <h5 class=""locationCity"">Hendersonville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hendersonville Hematology and Oncology at Pardee</strong>     <br>Contact: James Earl Radford <br>Phone: 828-696-4716   </span> </div>                                       <h5 class=""locationCity"">Mooresville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Cancer Institute - Mooresville</strong>     <br>Contact: Site Public Contact <br>Phone: 704-384-8920 <br>Email: <a href=""mailto:nnechiporchik@novanthealth.org"">nnechiporchik@novanthealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Winston-Salem</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Oncology Specialists</strong>     <br>Contact: Site Public Contact <br>Phone: 336-718-8335 <br>Email: <a href=""mailto:asmarrs@novanthealth.org"">asmarrs@novanthealth.org</a>   </span> </div>                                   <h4>North Dakota</h4>                           <h5 class=""locationCity"">Fargo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Clinic North-Fargo</strong>     <br>Contact: Preston D. Steen <br>Phone: 712-252-0088   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hematology and Oncology Associates Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 330-453-9993   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Pittsburgh</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Association</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Tennessee</h4>                           <h5 class=""locationCity"">Memphis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Family Cancer Center-Memphis</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Bellevue</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Cancer Institute-Eastside Oncology Hematology</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:CancerResearch@swedish.org"">CancerResearch@swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bremerton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Harrison HealthPartners Hematology and Oncology-Bremerton</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Green Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology at Saint Vincent Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology Limited at Saint Mary's Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Marinette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Marinette</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:Christy.Gilchrist@hshs.org"">Christy.Gilchrist@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sturgeon Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology - Sturgeon Bay</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Weston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Diagnostic and Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 888-799-3989 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                           			</div> 		</div> 					</div> 			</div> 		</div> 	</div>      <script id=""print-script"">         const subject = ""Clinical Trials from the National Cancer Institute's Website"";         const body = `Print-Friendly Clinical Trial Descriptions  ${document.location}  Please note that the URL will expire after 90 days.  You can find educational materials about clinical trials on NCI's Web site at http://www.cancer.gov/clinicaltrials. NCI's Web site, www.cancer.gov, contains comprehensive information about cancer causes and prevention, screening and diagnosis, treatment and survivorship; clinical trials; statistics; funding, training and employment opportunities; and the institute and its programs.  You can also get cancer information online through the LiveHelp instant messaging service at http://livehelp.cancer.gov. If you live in the United States, you may call the NCI's Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) for cancer information in English and Spanish.`;          let newLink = 'mailto:?subject=' + encodeURIComponent(subject) + '&body=' + encodeURIComponent(body);          const mailtoLink = document.getElementById(""ctl10_EmailResults"");         mailtoLink.attributes['href'].value = newLink;     </script>  	<!-- DTM PAGEBOTTOM TAG - DO NOT MODIFY --> 	<script type=""text/javascript"">_satellite.pageBottom();</script> </body> </html>"
DDD38DCF-3345-EF11-A20D-005056B388D3,2024-07-18 14:30:30.960,NCI-2015-00054,[]," <!DOCTYPE html> <html lang=""en""> <head> 	 <meta name=""robots"" content=""noindex""> 	 <title>Clinical Trial Search Results</title> 	 <script src=""//assets.adobedtm.com/f1bfa9f7170c81b1a9a9ecdcc6c5215ee0b03c84/satelliteLib-5b3dcf1f2676c378b518a1583ef5355acd83cd3d.js""></script> 	 <script src=""https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js""></script> 	 <script src=""/CTS.Print-js/BasicCTSPrintPage.js"" type=""text/javascript""></script>  	 <link rel=""stylesheet"" id=""gFonts"" href=""https://fonts.googleapis.com/css?family=Noto+Sans:400,400i,700,700i"" /> 	 <link href=""/CTS.Print-styles/nvcg.css"" rel=""stylesheet"" /> 	 <link href=""/CTS.Print-styles/BasicCTSPrintPage.css"" rel=""stylesheet"" /> 	 <meta name=""dcterms.subject"" content=""Clinical Trials Print Results Page"" />      <meta name=""Generator"" content=""CTS.Print"" /> </head> <body> 	<div class=""wa-data-element hide"" data-prop3=""/"" data-prop6=""Comprehensive Cancer Information"" data-prop16=""Comprehensive Cancer Information"" data-prop25=""01/01/1980"" data-prop44=""Clinical Trials"" data-prop62=""Clinical Trials: Print Results Page"" data-evar44=""Clinical Trials"" data-evar62=""Clinical Trials: Print Results Page"" ></div> 	<div id=""cgovContainer""> 		<div id=""CT-results-print-banner""><img id=""NCILogo"" src=""https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/logos/nci-logo-full.svg"" alt=""NCI Logo""/></div> 		<div id=""cgvBody""> 			<div id=""bodyHeading""> 				<div id=""headingWrapper""> 					<h1 id=""ctPrintBodyHeading"">Your Clinical Trials Search Results</h1> 					<div id=""bodyHeadingLinks""> 						<a id=""printPage"" href=""javascript:window.print();"">Print</a> | 						<a id=""ctl10_EmailResults"" href=""/CTS.Print/Display?printid={0}"" target=""_blank"">E-Mail These Results</a> | 						<a id=""newSearch"" href=""/about-cancer/treatment/clinical-trials/search/advanced"">New Search</a> 					</div> 				</div> 			</div> 				<div id=""clinical-trials-print"">  					 	        		                     <p class=""printIntroText"">Here are the trials you selected from your search on 7/18/2024.</p> 					<p class=""printIntroText"">You will be able to access this page for approximately 90 days. Since trial information is updated regularly, you should check for updates to see the most current information on any of the trials below.</p>   				<div> 								<div class=""trialContainer""> 			<h2 class=""hangingIndent"">1. Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?t=C3208&st=C3471&a=24&loc=1&z=20850&zp=100&rl=2&id=NCI-2015-00054""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase II</td> 					<td>Screening</td> 					<td>Closed to Accrual</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> EAY131<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2015-00054<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/study/NCT02465060"" target=""_blank"">NCT02465060</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple myelomas that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and does not respond to treatment (refractory). Patients must have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic material (genes) of patients&#39; tumor cells. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit more from treatment which targets their tumor&#39;s particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors, lymphomas, or multiple myeloma.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SCREENING BIOPSY (STEP 0)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be &gt;= 18 years of age. Because no dosing or adverse event data are currently available on the use of study investigational agents in patients &lt; 18 years of age, children are excluded from this study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to registration; patients that are pregnant or breast feeding are excluded; a patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:  * Has achieved menarche at some point  * Has not undergone a hysterectomy or bilateral oophorectomy; or  * Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse prior to study entry, for the duration of study participation, and for 4 months after completion of study; should a patient or partner of the patient become pregnant or suspect a pregnancy while participating in this study, the treating physician should be informed immediately</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have histologically documented solid tumors or histologically confirmed diagnosis of lymphoma or multiple myeloma requiring therapy and meet one of the following criteria: * Patients must have progressed following at least one line of standard systemic therapy and there must not be other approval/standard therapy available that has been shown to prolong overall survival (i.e. in a randomized trial against another standard treatment or by comparison to historical controls); patients who cannot receive other standard therapy that has been shown to prolong overall survival due to medical issues will be eligible, if other eligibility criteria are met; if the patient is currently receiving therapy, the clinician must have assessed that the current therapy is no longer benefitting the patient prior to enrolling on MATCH, regardless of whether it is considered standard OR * Patients for whose disease no standard treatment exists that has been shown to prolong overall survival * NOTE: No other prior malignancy is allowed except for the following: * Adequately treated basal cell or squamous cell skin cancer * In situ cervical cancer * Adequately treated stage I or II cancer from which the patient is currently in complete remission * Any other cancer from which the patient has been disease-free for 5 years</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have measurable disease</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet the criteria below * Tumor tissue for the confirmation of “rare variant” by the MATCH assay is to be submitted, preferably from the same time of collection as that used to determine patient candidacy for treatment arm assignment ** Registration to Step 0 must occur after stopping prior systemic anti-cancer therapy. There is no specific duration for which patients must be off treatment prior to registration to Step 0, as long as all eligibility criteria are met ** Patients may have received other non-targeted, immunotherapy or targeted treatment between the prior genetic testing at the outside lab and registration to Step 0. The decision to stop such treatment in favor of participation in MATCH, if no further clinical benefit is expected, is per the treating physician&#39;s discretion. Documentation of a lack of response to the prior treatment is not required in these cases ** Patients with an applicable “rare variant” must be able to meet the eligibility criteria for the appropriate subprotocols within 4 weeks following notification of treatment assignment ** Patient meets one of the following criteria: *** Patient is a candidate for Z1M based on local Clinical Laboratory Improvement Act (CLIA) assessment of mismatch repair deficiency (MMRd) by immunohistochemistry (IHC) or microsatellite instability (MSI) status by polymerase chain reaction (PCR), adequate tumor tissue is available for submission for mandatory central screening IHC and the patient will be able to meet the eligibility criteria for Z1M within 4 weeks following notification of treatment assignment OR *** The sites have received results from one of the designated outside laboratories indicating a “rare variant” that is an actionable Mutation of Interest (aMOI) for specific select subprotocols * NOTE: There is no particular window of time after receiving the sequencing report notification of potential eligibility from an outside lab in which the patient must be registered to Step 0, but treatment slots will be assigned on a first come, first serve basis to those who do register to Step 0, and are not held for those notified of potential eligibility who do not register to Step 0 * NOTE: Treatment assignment (and the start of the associated deadline for Step 1 registration) may occur shortly after Step 0 registration. Note that certain “rare variant” arms require submission of archival tissue for central IHC testing to determine treatment assignment. For those arms, adequate tissue for the central IHC is required to be available for submission * NOTE: Other potential aMOIs that would be eligibility criteria for “NON RARE” arms, as determined by the designated laboratories, are not applicable for this process in MATCH</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not require the use of full dose coumarin-derivative anticoagulants such as warfarin; low molecular weight heparin is permitted for prophylactic or therapeutic use; factor X inhibitors are permitted * NOTE: Warfarin may not be started while enrolled in the EAY131 study * Stopping the anticoagulation for biopsy should be per site standard operating procedure (SOP)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =&lt; 1 and a life expectancy of at least 3 months</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not currently be receiving any other investigational agents</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not have any uncontrolled intercurrent illness including, but not limited to: * Symptomatic congestive heart failure (New York Heart Association [NYHA] classification of III/IV) * Unstable angina pectoris or coronary angioplasty, or stenting within 6 months prior to registration to Step 0, 2, 4, 6 * Cardiac arrhythmia (ongoing cardiac dysrhythmias of National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version [v]4 grade &gt;= 2) * Psychiatric illness/social situations that would limit compliance with study requirements * Intra-cardiac defibrillators * Known cardiac metastases * Abnormal cardiac valve morphology (&gt;= grade 2) documented by echocardiogram (ECHO) (as clinically indicated); (subjects with grade 1 abnormalities [i.e., mild regurgitation/stenosis] can be entered on study); subjects with moderate valvular thickening should not be entered on study * NOTE: To receive an agent, patient must not have any uncontrolled intercurrent illness such as ongoing or active infection; patients with infections unlikely to be resolved within 2 weeks following screening should not be considered for the trial</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be able to swallow tablets or capsules; a patient with any gastrointestinal disease that would impair ability to swallow, retain, or absorb drug is not eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients who are human immunodeficiency virus (HIV)-positive are eligible if:  * CD4+ cell count greater or equal to 250 cells/mm^3 * If patient is on antiretroviral therapy, there must be minimal interactions or overlapping toxicity of the antiretroviral therapy with the experimental cancer treatment; for experimental cancer therapeutics with CYP3A/4 interactions, protease inhibitor therapy is disallowed; suggested regimens to replace protease inhibitor therapy include dolutegravir given with tenofovir/emtricitabine; raltegravir given with tenofovir and emtricitabine; once daily combinations that use pharmacologic boosters may not be used * No history of non-malignancy acquired immune deficiency syndrome (AIDS)-defining conditions other than historical low CD4+ cell counts * Probable long-term survival with HIV if cancer were not present</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Any prior therapy, radiotherapy (except palliative radiation therapy of 30 gray [Gy] or less), or major surgery must have been completed &gt;= 4 weeks prior to start of treatment; all adverse events due to prior therapy have resolved to a grade 1 or better (except alopecia and lymphopenia) by start of treatment; palliative radiation therapy must have been completed at least 2 weeks prior to start of treatment; the radiotherapy must not be to a lesion that is included as measurable disease * NOTE: Prostate cancer patients may continue their luteinizing hormone-releasing hormone (LHRH) agonist * NOTE: For patients entering the study via the original screening process, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results; however, lack of response must be documented prior to registration to Step 1; new non-protocol treatment will NOT be permitted as intervening therapy after registration to Step 0; the only intervening treatment permitted is prior therapy that the patient already received prior to Step 0 registration; the decision to stop the intervening non-protocol treatment will be left up to the treating physician if patient has an aMOI; however, patients will need to be off such therapy for at least 4 weeks before receiving any MATCH protocol treatment * NOTE: For patients entering the study via a designated outside laboratory, no intervening systemic non-protocol treatment is permitted after Step 0 registration; all other eligibility requirements still apply to these patients, including the washouts for prior therapy noted above in this section, the time restrictions outlined, and the eligibility criteria for the intended subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients with brain metastases or primary brain tumors must have completed treatment, surgery or radiation therapy &gt;= 4 weeks prior to start of treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have discontinued steroids &gt;= 1 week prior to registration to Step 0 and remain off steroids thereafter, except as permitted; patients with glioblastoma (GBM) must have been on stable dose of steroids, or be off steroids, for one week prior to registration to treatment (Step 1, 3, 5, 7) * NOTE: The following steroids are permitted (low dose steroid use is defined as prednisone 10 mg daily or less, or bioequivalent dose of other corticosteroid): ** Temporary steroid use: e.g. for CT imaging in setting of contrast allergy ** Low dose steroid use for appetite ** Chronic inhaled steroid use ** Steroid injections for joint disease ** Stable dose of replacement steroid for adrenal insufficiency or low doses for non-malignant disease ** Topical steroid ** Steroids required to manage toxicity related to study treatment, as described in the subprotocols ** Steroids required as pre- or post-chemotherapy medication for acceptable intervening chemotherapy *** NOTE: Steroids must be completed alongside last dose of chemotherapy</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Leukocytes &gt;= 3,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Absolute neutrophil count (ANC) &gt;= 1,500/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Platelets &gt;= 100,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: Patients with documented bone marrow involvement by lymphoma are not required to meet the above hematologic parameters, but must have a platelet count of at least 75,000/mcL and neutrophil count of at least 1,000/mcL</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Total bilirubin =&lt; 1.5 x institutional upper limit of normal (ULN) (unless documented Gilbert’s syndrome, for which bilirubin =&lt; 3 x institutional ULN is permitted) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =&lt; 2.5 x institutional ULN (up to 5 times ULN in presence of liver metastases) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Creatinine clearance &gt;= 45 mL/min/1.73 m^2 for patients with creatinine levels above institutional ULN * As defined by the Cockcroft-Gault equation (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have an electrocardiogram (ECG) within 8 weeks prior to registration to screening step and must meet the following cardiac criteria: * Resting corrected QT interval (QTc) =&lt; 480 msec ** NOTE: If the first recorded QTc exceeds 480 msec, two additional, consecutive ECGs are required and must result in a mean resting QTc =&lt; 480 msec; it is recommended that there are 10-minute (+/- 5 minutes) breaks between the ECGs * The following only need to be assessed if the mean QTc &gt; 480 msec ** Check potassium and magnesium serum levels ** Correct any identified hypokalemia and/or hypomagnesemia and may repeat ECG to confirm exclusion of patient due to QTc ** For patients with heart rate (HR) 60-100 beats per minute (bpm), no manual read of QTc is required ** For patients with baseline HR &lt; 60 or &gt; 100 bpm, manual read of QT by trained personnel is required, with Fridericia correction applied to determine QTc ** Patient must not have hypokalemia (value &lt; institutional lower limit of normal) * No factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age or any concomitant medication known to prolong the QT interval ** NOTE: Patient must be taken off prohibited medication prior to registration to the screening step (Step 0, 2, 4, 6) and remain off these medications thereafter, unless permitted on a subprotocol for the management of treatment related toxicity; patient must be off the drug for at least 5 half-lives prior to registration to the treatment step (Step 1, 3, 5, 7); the medication half-life can be found in the package insert for Food and Drug Administration (FDA) approved drugs</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FIRST TREATMENT (STEP 1)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: For patients entering step 0 with assay results from outside laboratories, no systemic treatment is allowed after step 0 registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>As MATCH is designed to add additional subprotocols, implement limited expansions of accrual for certain subprotocols, and/or amend existing arm-specific eligibility criteria, some patients entering under the original screening method may be eligible to have their results rerun in MATCHbox, even if they did not match to a treatment initially or did not receive a treatment assignment due to a lack of available assignment slots; patients whose sequence results will be rerun through MATCHbox must also meet the following criteria: * Samples must have been collected within 5 months of the activation of the addendum, as there is an additional month needed to get the patients on trial * Patient has not had treatment within the 5 months that resulted in a PR or better after the performance of the screening assessment * Patient must meet eligibility criteria, including performance status 1 or better and life expectancy of at least 3 months * Patients must meet the eligibility requirements with the following exceptions: ** Patients may have received other non-targeted, immunotherapy or targeted treatment, which could be stopped in favor of returning to MATCH, if no response to the interim treatment has occurred and no further benefit is expected from this interim treatment, per the treating physician&#39;s discretion; documentation of a lack of response to the interim treatment is not required in these cases; however, the following restrictions apply: *** Enrollment onto another investigational therapeutic study is not permitted *** Patient cannot be responding to interim treatment, since the benefit of the MATCH treatment is unknown and may deprive patient of an effective treatment if it were given when a patient is responding to another treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 results will be re-interrogated to determine if another treatment is available</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND SCREENING (STEP 2)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on Step 1 treatment or patient could not tolerate assigned treatment * NOTE: PATIENTS ENTERING STEP 1 WITH A “RARE VARIANT” FROM AN “OUTSIDE” LAB ARE NOT ELIGIBLE FOR STEP 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 1 treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance; only aMOIs detected by the MATCH assay may be used for the determination of eligibility to a relevant subprotocol OR</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Progression (or inability to tolerate further treatment) occurred after a (1) response OR (2) after &gt;= 6 months from start of step 1 treatment; patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspirate for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest (aMOI); archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not have been assigned to step 1 treatment based on a “rare variant” determined by a designated outside laboratory</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND TREATMENT (STEP 3)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy samples were submitted during step 2, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 3; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 2; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD SCREENING (STEP 4)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 3 treatment or patient could not tolerate assigned treatment * Patient must meet one of the following criteria: ** No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 3 (second) treatment AND a biopsy was performed at step 2 screening *** NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their latest MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance OR ** Progression (or inability to tolerate further treatment) occurred on step 3 treatment and a biopsy was not performed at step 2 screening (due to presence of additional aMOIs at that stage); patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspiration for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest; biopsy must not be considered to be more than minimal risk to the patient; archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: A patient may have a maximum of 2 screening biopsies (not including re-biopsy due to assay failure), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD TREATMENT (STEP 5)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy was submitted on step 4, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 5; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 4; the therapy cannot be an arm in the MATCH trial; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FOURTH SCREENING (STEP 6)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 5 protocol treatment or patient could not tolerate assigned treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have had no response, and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 5 treatment AND a biopsy was performed at step 4 screening * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, based on their 2nd biopsy, their results will be interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: For Step 6, biopsies to collect material for screening assay will NOT be performed; a patient may have a maximum of 2 successful screening assessments of submitted tissue (steps 0 and 2 OR steps 0 and 4), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY FOR FOURTH TREATMENT (STEP 7)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eligibility requirements for registration onto step 7 are outlined in the agent-specific subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR RESEARCH BIOPSY AND CIRCULATING TUMOR DNA COLLECTION (STEP 8)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ALL PATIENTS SHOULD BE ENCOURAGED TO PARTICIPATE IN STEP 8, IF SAFE; IF BIOPSY IS REFUSED OR INADVISABLE, ENCOURAGE COLLECTION OF WHOLE BLOOD FOR CIRCULATING TUMOR DNA As a reminder, the submission of the step 8 samples requires additional patient consent, as well as registration to step 8 * NOTE: Patients who entered the study (step 0) with a “rare variant” determined by an outside assay ARE potentially eligible and encouraged to participate in step 8</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient has completed their most recent MATCH study treatment, will not undergo an additional screening biopsies, and will receive no additional treatment on MATCH * NOTE: If a 2nd Screening Biopsy was performed and showed no study-actionable abnormalities, and blood samples were submitted with the screening biopsy, no additional end of treatment specimens are requested</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>For patients who consent to undergo the optional research biopsy, patient’s disease responded to the most recent MATCH study treatment and then progressed (or unable to tolerate further treatment) OR the disease progression (or inability to tolerate further treatment) occurs &gt; 6 months since the last screening biopsy * NOTE: Performance of a biopsy to collect tumor tissue for research is strongly encouraged but not required; it is acceptable to submit only the optional blood specimens * NOTE: If a biopsy will be performed solely to collect tumor specimens for research, the patient must be willing and able to undergo a tumor biopsy or bone marrow aspirate (for applicable multiple myeloma), for the collection and submission of tissue for research</li> 												</ul> 						</div> 										 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE: </p><p class='ctrp'>I. To evaluate the proportion of patients with objective response (OR) to targeted study agent(s) in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES: </p><p class='ctrp'>I. To evaluate the proportion of patients alive and progression free at 6 months of treatment with targeted study agent in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'>II. To evaluate time until death or disease progression.</p><p class='ctrp'>III. To identify potential predictive biomarkers beyond the genomic alteration by which treatment is assigned or resistance mechanisms using additional genomic, ribonucleic acid (RNA), protein and imaging-based assessment platforms.</p><p class='ctrp'>IV. To assess whether radiomic phenotypes obtained from pre-treatment imaging and changes from pre- through post-therapy imaging can predict objective response and progression free survival and to evaluate the association between pre-treatment radiomic phenotypes and targeted gene mutation patterns of tumor biopsy specimens.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE:</p><p class='ctrp'>STEP 0 (Screening): Patients undergo biopsy along with molecular characterization of the biopsy material for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing and immunohistochemistry. Consenting patients also undergo collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>STEPS 1, 3, 5, 7 (Treatment): Patients are assigned to 1 of 38 treatment subprotocols based on molecularly-defined subgroup. (See Arms Section) </p><p class='ctrp'></p><p class='ctrp'>STEPS 2, 4, 6 (Screening): Patients experiencing disease progression on the prior Step treatment or who could not tolerate the assigned treatment undergo review of their previous biopsy results to determine if another treatment is available or undergo another biopsy. Patients may have a maximum of 2 screening biopsies and 2 treatments per biopsy. </p><p class='ctrp'></p><p class='ctrp'>STEP 8 (Optional Research): Consenting patients undergo end-of-treatment biopsy and collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>Additionally, patients may undergo a computed tomography (CT) scan, magnetic resonance imaging, and/or radionuclide imaging throughout the trial. </p><p class='ctrp'></p><p class='ctrp'>After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 1 year.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>ECOG-ACRIN Cancer Research Group</div> 													<div>Principal Investigator: Keith Thomas Flaherty</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT02465060"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>California</h4>                           <h5 class=""locationCity"">Vacaville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sutter Cancer Centers Radiation Oncology Services-Vacaville</strong>     <br>Contact: Site Public Contact <br>Phone: 415-209-2683 <br>Email: <a href=""mailto:hempell@sutterhealth.org"">hempell@sutterhealth.org</a>   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Boulder</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Boulder Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:jbloomfield@co-cancerresearch.org"">jbloomfield@co-cancerresearch.org</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Gynecologic Oncology LLC</strong>     <br>Contact: Gregory Andrew Masters <br>Phone: 302-733-6227   </span> </div>                                   <h4>Florida</h4>                           <h5 class=""locationCity"">Fort Lauderdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Holy Cross Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 954-267-7748   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">Syracuse</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">SUNY Upstate Medical Center-Community Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 315-464-5476   </span> </div>                                   <h4>North Carolina</h4>                           <h5 class=""locationCity"">Hendersonville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hendersonville Hematology and Oncology at Pardee</strong>     <br>Contact: James Earl Radford <br>Phone: 828-696-4716   </span> </div>                                       <h5 class=""locationCity"">Mooresville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Cancer Institute - Mooresville</strong>     <br>Contact: Site Public Contact <br>Phone: 704-384-8920 <br>Email: <a href=""mailto:nnechiporchik@novanthealth.org"">nnechiporchik@novanthealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Winston-Salem</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Oncology Specialists</strong>     <br>Contact: Site Public Contact <br>Phone: 336-718-8335 <br>Email: <a href=""mailto:asmarrs@novanthealth.org"">asmarrs@novanthealth.org</a>   </span> </div>                                   <h4>North Dakota</h4>                           <h5 class=""locationCity"">Fargo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Clinic North-Fargo</strong>     <br>Contact: Preston D. Steen <br>Phone: 712-252-0088   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hematology and Oncology Associates Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 330-453-9993   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Pittsburgh</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Association</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Tennessee</h4>                           <h5 class=""locationCity"">Memphis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Family Cancer Center-Memphis</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Bellevue</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Cancer Institute-Eastside Oncology Hematology</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:CancerResearch@swedish.org"">CancerResearch@swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bremerton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Harrison HealthPartners Hematology and Oncology-Bremerton</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Green Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology at Saint Vincent Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology Limited at Saint Mary's Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Marinette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Marinette</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:Christy.Gilchrist@hshs.org"">Christy.Gilchrist@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sturgeon Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology - Sturgeon Bay</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Weston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Diagnostic and Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 888-799-3989 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                           			</div> 		</div> 					</div> 			</div> 		</div> 	</div>      <script id=""print-script"">         const subject = ""Clinical Trials from the National Cancer Institute's Website"";         const body = `Print-Friendly Clinical Trial Descriptions  ${document.location}  Please note that the URL will expire after 90 days.  You can find educational materials about clinical trials on NCI's Web site at http://www.cancer.gov/clinicaltrials. NCI's Web site, www.cancer.gov, contains comprehensive information about cancer causes and prevention, screening and diagnosis, treatment and survivorship; clinical trials; statistics; funding, training and employment opportunities; and the institute and its programs.  You can also get cancer information online through the LiveHelp instant messaging service at http://livehelp.cancer.gov. If you live in the United States, you may call the NCI's Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) for cancer information in English and Spanish.`;          let newLink = 'mailto:?subject=' + encodeURIComponent(subject) + '&body=' + encodeURIComponent(body);          const mailtoLink = document.getElementById(""ctl10_EmailResults"");         mailtoLink.attributes['href'].value = newLink;     </script>  	<!-- DTM PAGEBOTTOM TAG - DO NOT MODIFY --> 	<script type=""text/javascript"">_satellite.pageBottom();</script> </body> </html>"
54320ED9-3345-EF11-A20D-005056B388D3,2024-07-18 14:30:46.907,NCI-2015-00054,[]," <!DOCTYPE html> <html lang=""en""> <head> 	 <meta name=""robots"" content=""noindex""> 	 <title>Clinical Trial Search Results</title> 	 <script src=""//assets.adobedtm.com/f1bfa9f7170c81b1a9a9ecdcc6c5215ee0b03c84/satelliteLib-5b3dcf1f2676c378b518a1583ef5355acd83cd3d.js""></script> 	 <script src=""https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js""></script> 	 <script src=""/CTS.Print-js/BasicCTSPrintPage.js"" type=""text/javascript""></script>  	 <link rel=""stylesheet"" id=""gFonts"" href=""https://fonts.googleapis.com/css?family=Noto+Sans:400,400i,700,700i"" /> 	 <link href=""/CTS.Print-styles/nvcg.css"" rel=""stylesheet"" /> 	 <link href=""/CTS.Print-styles/BasicCTSPrintPage.css"" rel=""stylesheet"" /> 	 <meta name=""dcterms.subject"" content=""Clinical Trials Print Results Page"" />      <meta name=""Generator"" content=""CTS.Print"" /> </head> <body> 	<div class=""wa-data-element hide"" data-prop3=""/"" data-prop6=""Comprehensive Cancer Information"" data-prop16=""Comprehensive Cancer Information"" data-prop25=""01/01/1980"" data-prop44=""Clinical Trials"" data-prop62=""Clinical Trials: Print Results Page"" data-evar44=""Clinical Trials"" data-evar62=""Clinical Trials: Print Results Page"" ></div> 	<div id=""cgovContainer""> 		<div id=""CT-results-print-banner""><img id=""NCILogo"" src=""https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/logos/nci-logo-full.svg"" alt=""NCI Logo""/></div> 		<div id=""cgvBody""> 			<div id=""bodyHeading""> 				<div id=""headingWrapper""> 					<h1 id=""ctPrintBodyHeading"">Your Clinical Trials Search Results</h1> 					<div id=""bodyHeadingLinks""> 						<a id=""printPage"" href=""javascript:window.print();"">Print</a> | 						<a id=""ctl10_EmailResults"" href=""/CTS.Print/Display?printid={0}"" target=""_blank"">E-Mail These Results</a> | 						<a id=""newSearch"" href=""/about-cancer/treatment/clinical-trials/search/advanced"">New Search</a> 					</div> 				</div> 			</div> 				<div id=""clinical-trials-print"">  					 	        		                     <p class=""printIntroText"">Here are the trials you selected from your search on 7/18/2024.</p> 					<p class=""printIntroText"">You will be able to access this page for approximately 90 days. Since trial information is updated regularly, you should check for updates to see the most current information on any of the trials below.</p>   				<div> 								<div class=""trialContainer""> 			<h2 class=""hangingIndent"">1. Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?t=C3208&st=C3471&a=24&loc=1&z=20850&zp=100&rl=2&id=NCI-2015-00054""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase II</td> 					<td>Screening</td> 					<td>Closed to Accrual</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> EAY131<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2015-00054<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/study/NCT02465060"" target=""_blank"">NCT02465060</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple myelomas that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and does not respond to treatment (refractory). Patients must have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic material (genes) of patients&#39; tumor cells. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit more from treatment which targets their tumor&#39;s particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors, lymphomas, or multiple myeloma.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SCREENING BIOPSY (STEP 0)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be &gt;= 18 years of age. Because no dosing or adverse event data are currently available on the use of study investigational agents in patients &lt; 18 years of age, children are excluded from this study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to registration; patients that are pregnant or breast feeding are excluded; a patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:  * Has achieved menarche at some point  * Has not undergone a hysterectomy or bilateral oophorectomy; or  * Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse prior to study entry, for the duration of study participation, and for 4 months after completion of study; should a patient or partner of the patient become pregnant or suspect a pregnancy while participating in this study, the treating physician should be informed immediately</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have histologically documented solid tumors or histologically confirmed diagnosis of lymphoma or multiple myeloma requiring therapy and meet one of the following criteria: * Patients must have progressed following at least one line of standard systemic therapy and there must not be other approval/standard therapy available that has been shown to prolong overall survival (i.e. in a randomized trial against another standard treatment or by comparison to historical controls); patients who cannot receive other standard therapy that has been shown to prolong overall survival due to medical issues will be eligible, if other eligibility criteria are met; if the patient is currently receiving therapy, the clinician must have assessed that the current therapy is no longer benefitting the patient prior to enrolling on MATCH, regardless of whether it is considered standard OR * Patients for whose disease no standard treatment exists that has been shown to prolong overall survival * NOTE: No other prior malignancy is allowed except for the following: * Adequately treated basal cell or squamous cell skin cancer * In situ cervical cancer * Adequately treated stage I or II cancer from which the patient is currently in complete remission * Any other cancer from which the patient has been disease-free for 5 years</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have measurable disease</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet the criteria below * Tumor tissue for the confirmation of “rare variant” by the MATCH assay is to be submitted, preferably from the same time of collection as that used to determine patient candidacy for treatment arm assignment ** Registration to Step 0 must occur after stopping prior systemic anti-cancer therapy. There is no specific duration for which patients must be off treatment prior to registration to Step 0, as long as all eligibility criteria are met ** Patients may have received other non-targeted, immunotherapy or targeted treatment between the prior genetic testing at the outside lab and registration to Step 0. The decision to stop such treatment in favor of participation in MATCH, if no further clinical benefit is expected, is per the treating physician&#39;s discretion. Documentation of a lack of response to the prior treatment is not required in these cases ** Patients with an applicable “rare variant” must be able to meet the eligibility criteria for the appropriate subprotocols within 4 weeks following notification of treatment assignment ** Patient meets one of the following criteria: *** Patient is a candidate for Z1M based on local Clinical Laboratory Improvement Act (CLIA) assessment of mismatch repair deficiency (MMRd) by immunohistochemistry (IHC) or microsatellite instability (MSI) status by polymerase chain reaction (PCR), adequate tumor tissue is available for submission for mandatory central screening IHC and the patient will be able to meet the eligibility criteria for Z1M within 4 weeks following notification of treatment assignment OR *** The sites have received results from one of the designated outside laboratories indicating a “rare variant” that is an actionable Mutation of Interest (aMOI) for specific select subprotocols * NOTE: There is no particular window of time after receiving the sequencing report notification of potential eligibility from an outside lab in which the patient must be registered to Step 0, but treatment slots will be assigned on a first come, first serve basis to those who do register to Step 0, and are not held for those notified of potential eligibility who do not register to Step 0 * NOTE: Treatment assignment (and the start of the associated deadline for Step 1 registration) may occur shortly after Step 0 registration. Note that certain “rare variant” arms require submission of archival tissue for central IHC testing to determine treatment assignment. For those arms, adequate tissue for the central IHC is required to be available for submission * NOTE: Other potential aMOIs that would be eligibility criteria for “NON RARE” arms, as determined by the designated laboratories, are not applicable for this process in MATCH</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not require the use of full dose coumarin-derivative anticoagulants such as warfarin; low molecular weight heparin is permitted for prophylactic or therapeutic use; factor X inhibitors are permitted * NOTE: Warfarin may not be started while enrolled in the EAY131 study * Stopping the anticoagulation for biopsy should be per site standard operating procedure (SOP)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =&lt; 1 and a life expectancy of at least 3 months</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not currently be receiving any other investigational agents</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not have any uncontrolled intercurrent illness including, but not limited to: * Symptomatic congestive heart failure (New York Heart Association [NYHA] classification of III/IV) * Unstable angina pectoris or coronary angioplasty, or stenting within 6 months prior to registration to Step 0, 2, 4, 6 * Cardiac arrhythmia (ongoing cardiac dysrhythmias of National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version [v]4 grade &gt;= 2) * Psychiatric illness/social situations that would limit compliance with study requirements * Intra-cardiac defibrillators * Known cardiac metastases * Abnormal cardiac valve morphology (&gt;= grade 2) documented by echocardiogram (ECHO) (as clinically indicated); (subjects with grade 1 abnormalities [i.e., mild regurgitation/stenosis] can be entered on study); subjects with moderate valvular thickening should not be entered on study * NOTE: To receive an agent, patient must not have any uncontrolled intercurrent illness such as ongoing or active infection; patients with infections unlikely to be resolved within 2 weeks following screening should not be considered for the trial</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be able to swallow tablets or capsules; a patient with any gastrointestinal disease that would impair ability to swallow, retain, or absorb drug is not eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients who are human immunodeficiency virus (HIV)-positive are eligible if:  * CD4+ cell count greater or equal to 250 cells/mm^3 * If patient is on antiretroviral therapy, there must be minimal interactions or overlapping toxicity of the antiretroviral therapy with the experimental cancer treatment; for experimental cancer therapeutics with CYP3A/4 interactions, protease inhibitor therapy is disallowed; suggested regimens to replace protease inhibitor therapy include dolutegravir given with tenofovir/emtricitabine; raltegravir given with tenofovir and emtricitabine; once daily combinations that use pharmacologic boosters may not be used * No history of non-malignancy acquired immune deficiency syndrome (AIDS)-defining conditions other than historical low CD4+ cell counts * Probable long-term survival with HIV if cancer were not present</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Any prior therapy, radiotherapy (except palliative radiation therapy of 30 gray [Gy] or less), or major surgery must have been completed &gt;= 4 weeks prior to start of treatment; all adverse events due to prior therapy have resolved to a grade 1 or better (except alopecia and lymphopenia) by start of treatment; palliative radiation therapy must have been completed at least 2 weeks prior to start of treatment; the radiotherapy must not be to a lesion that is included as measurable disease * NOTE: Prostate cancer patients may continue their luteinizing hormone-releasing hormone (LHRH) agonist * NOTE: For patients entering the study via the original screening process, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results; however, lack of response must be documented prior to registration to Step 1; new non-protocol treatment will NOT be permitted as intervening therapy after registration to Step 0; the only intervening treatment permitted is prior therapy that the patient already received prior to Step 0 registration; the decision to stop the intervening non-protocol treatment will be left up to the treating physician if patient has an aMOI; however, patients will need to be off such therapy for at least 4 weeks before receiving any MATCH protocol treatment * NOTE: For patients entering the study via a designated outside laboratory, no intervening systemic non-protocol treatment is permitted after Step 0 registration; all other eligibility requirements still apply to these patients, including the washouts for prior therapy noted above in this section, the time restrictions outlined, and the eligibility criteria for the intended subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients with brain metastases or primary brain tumors must have completed treatment, surgery or radiation therapy &gt;= 4 weeks prior to start of treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have discontinued steroids &gt;= 1 week prior to registration to Step 0 and remain off steroids thereafter, except as permitted; patients with glioblastoma (GBM) must have been on stable dose of steroids, or be off steroids, for one week prior to registration to treatment (Step 1, 3, 5, 7) * NOTE: The following steroids are permitted (low dose steroid use is defined as prednisone 10 mg daily or less, or bioequivalent dose of other corticosteroid): ** Temporary steroid use: e.g. for CT imaging in setting of contrast allergy ** Low dose steroid use for appetite ** Chronic inhaled steroid use ** Steroid injections for joint disease ** Stable dose of replacement steroid for adrenal insufficiency or low doses for non-malignant disease ** Topical steroid ** Steroids required to manage toxicity related to study treatment, as described in the subprotocols ** Steroids required as pre- or post-chemotherapy medication for acceptable intervening chemotherapy *** NOTE: Steroids must be completed alongside last dose of chemotherapy</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Leukocytes &gt;= 3,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Absolute neutrophil count (ANC) &gt;= 1,500/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Platelets &gt;= 100,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: Patients with documented bone marrow involvement by lymphoma are not required to meet the above hematologic parameters, but must have a platelet count of at least 75,000/mcL and neutrophil count of at least 1,000/mcL</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Total bilirubin =&lt; 1.5 x institutional upper limit of normal (ULN) (unless documented Gilbert’s syndrome, for which bilirubin =&lt; 3 x institutional ULN is permitted) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =&lt; 2.5 x institutional ULN (up to 5 times ULN in presence of liver metastases) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Creatinine clearance &gt;= 45 mL/min/1.73 m^2 for patients with creatinine levels above institutional ULN * As defined by the Cockcroft-Gault equation (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have an electrocardiogram (ECG) within 8 weeks prior to registration to screening step and must meet the following cardiac criteria: * Resting corrected QT interval (QTc) =&lt; 480 msec ** NOTE: If the first recorded QTc exceeds 480 msec, two additional, consecutive ECGs are required and must result in a mean resting QTc =&lt; 480 msec; it is recommended that there are 10-minute (+/- 5 minutes) breaks between the ECGs * The following only need to be assessed if the mean QTc &gt; 480 msec ** Check potassium and magnesium serum levels ** Correct any identified hypokalemia and/or hypomagnesemia and may repeat ECG to confirm exclusion of patient due to QTc ** For patients with heart rate (HR) 60-100 beats per minute (bpm), no manual read of QTc is required ** For patients with baseline HR &lt; 60 or &gt; 100 bpm, manual read of QT by trained personnel is required, with Fridericia correction applied to determine QTc ** Patient must not have hypokalemia (value &lt; institutional lower limit of normal) * No factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age or any concomitant medication known to prolong the QT interval ** NOTE: Patient must be taken off prohibited medication prior to registration to the screening step (Step 0, 2, 4, 6) and remain off these medications thereafter, unless permitted on a subprotocol for the management of treatment related toxicity; patient must be off the drug for at least 5 half-lives prior to registration to the treatment step (Step 1, 3, 5, 7); the medication half-life can be found in the package insert for Food and Drug Administration (FDA) approved drugs</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FIRST TREATMENT (STEP 1)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: For patients entering step 0 with assay results from outside laboratories, no systemic treatment is allowed after step 0 registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>As MATCH is designed to add additional subprotocols, implement limited expansions of accrual for certain subprotocols, and/or amend existing arm-specific eligibility criteria, some patients entering under the original screening method may be eligible to have their results rerun in MATCHbox, even if they did not match to a treatment initially or did not receive a treatment assignment due to a lack of available assignment slots; patients whose sequence results will be rerun through MATCHbox must also meet the following criteria: * Samples must have been collected within 5 months of the activation of the addendum, as there is an additional month needed to get the patients on trial * Patient has not had treatment within the 5 months that resulted in a PR or better after the performance of the screening assessment * Patient must meet eligibility criteria, including performance status 1 or better and life expectancy of at least 3 months * Patients must meet the eligibility requirements with the following exceptions: ** Patients may have received other non-targeted, immunotherapy or targeted treatment, which could be stopped in favor of returning to MATCH, if no response to the interim treatment has occurred and no further benefit is expected from this interim treatment, per the treating physician&#39;s discretion; documentation of a lack of response to the interim treatment is not required in these cases; however, the following restrictions apply: *** Enrollment onto another investigational therapeutic study is not permitted *** Patient cannot be responding to interim treatment, since the benefit of the MATCH treatment is unknown and may deprive patient of an effective treatment if it were given when a patient is responding to another treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 results will be re-interrogated to determine if another treatment is available</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND SCREENING (STEP 2)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on Step 1 treatment or patient could not tolerate assigned treatment * NOTE: PATIENTS ENTERING STEP 1 WITH A “RARE VARIANT” FROM AN “OUTSIDE” LAB ARE NOT ELIGIBLE FOR STEP 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 1 treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance; only aMOIs detected by the MATCH assay may be used for the determination of eligibility to a relevant subprotocol OR</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Progression (or inability to tolerate further treatment) occurred after a (1) response OR (2) after &gt;= 6 months from start of step 1 treatment; patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspirate for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest (aMOI); archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not have been assigned to step 1 treatment based on a “rare variant” determined by a designated outside laboratory</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND TREATMENT (STEP 3)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy samples were submitted during step 2, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 3; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 2; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD SCREENING (STEP 4)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 3 treatment or patient could not tolerate assigned treatment * Patient must meet one of the following criteria: ** No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 3 (second) treatment AND a biopsy was performed at step 2 screening *** NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their latest MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance OR ** Progression (or inability to tolerate further treatment) occurred on step 3 treatment and a biopsy was not performed at step 2 screening (due to presence of additional aMOIs at that stage); patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspiration for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest; biopsy must not be considered to be more than minimal risk to the patient; archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: A patient may have a maximum of 2 screening biopsies (not including re-biopsy due to assay failure), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD TREATMENT (STEP 5)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy was submitted on step 4, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 5; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 4; the therapy cannot be an arm in the MATCH trial; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FOURTH SCREENING (STEP 6)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 5 protocol treatment or patient could not tolerate assigned treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have had no response, and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 5 treatment AND a biopsy was performed at step 4 screening * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, based on their 2nd biopsy, their results will be interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: For Step 6, biopsies to collect material for screening assay will NOT be performed; a patient may have a maximum of 2 successful screening assessments of submitted tissue (steps 0 and 2 OR steps 0 and 4), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY FOR FOURTH TREATMENT (STEP 7)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eligibility requirements for registration onto step 7 are outlined in the agent-specific subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR RESEARCH BIOPSY AND CIRCULATING TUMOR DNA COLLECTION (STEP 8)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ALL PATIENTS SHOULD BE ENCOURAGED TO PARTICIPATE IN STEP 8, IF SAFE; IF BIOPSY IS REFUSED OR INADVISABLE, ENCOURAGE COLLECTION OF WHOLE BLOOD FOR CIRCULATING TUMOR DNA As a reminder, the submission of the step 8 samples requires additional patient consent, as well as registration to step 8 * NOTE: Patients who entered the study (step 0) with a “rare variant” determined by an outside assay ARE potentially eligible and encouraged to participate in step 8</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient has completed their most recent MATCH study treatment, will not undergo an additional screening biopsies, and will receive no additional treatment on MATCH * NOTE: If a 2nd Screening Biopsy was performed and showed no study-actionable abnormalities, and blood samples were submitted with the screening biopsy, no additional end of treatment specimens are requested</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>For patients who consent to undergo the optional research biopsy, patient’s disease responded to the most recent MATCH study treatment and then progressed (or unable to tolerate further treatment) OR the disease progression (or inability to tolerate further treatment) occurs &gt; 6 months since the last screening biopsy * NOTE: Performance of a biopsy to collect tumor tissue for research is strongly encouraged but not required; it is acceptable to submit only the optional blood specimens * NOTE: If a biopsy will be performed solely to collect tumor specimens for research, the patient must be willing and able to undergo a tumor biopsy or bone marrow aspirate (for applicable multiple myeloma), for the collection and submission of tissue for research</li> 												</ul> 						</div> 										 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE: </p><p class='ctrp'>I. To evaluate the proportion of patients with objective response (OR) to targeted study agent(s) in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES: </p><p class='ctrp'>I. To evaluate the proportion of patients alive and progression free at 6 months of treatment with targeted study agent in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'>II. To evaluate time until death or disease progression.</p><p class='ctrp'>III. To identify potential predictive biomarkers beyond the genomic alteration by which treatment is assigned or resistance mechanisms using additional genomic, ribonucleic acid (RNA), protein and imaging-based assessment platforms.</p><p class='ctrp'>IV. To assess whether radiomic phenotypes obtained from pre-treatment imaging and changes from pre- through post-therapy imaging can predict objective response and progression free survival and to evaluate the association between pre-treatment radiomic phenotypes and targeted gene mutation patterns of tumor biopsy specimens.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE:</p><p class='ctrp'>STEP 0 (Screening): Patients undergo biopsy along with molecular characterization of the biopsy material for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing and immunohistochemistry. Consenting patients also undergo collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>STEPS 1, 3, 5, 7 (Treatment): Patients are assigned to 1 of 38 treatment subprotocols based on molecularly-defined subgroup. (See Arms Section) </p><p class='ctrp'></p><p class='ctrp'>STEPS 2, 4, 6 (Screening): Patients experiencing disease progression on the prior Step treatment or who could not tolerate the assigned treatment undergo review of their previous biopsy results to determine if another treatment is available or undergo another biopsy. Patients may have a maximum of 2 screening biopsies and 2 treatments per biopsy. </p><p class='ctrp'></p><p class='ctrp'>STEP 8 (Optional Research): Consenting patients undergo end-of-treatment biopsy and collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>Additionally, patients may undergo a computed tomography (CT) scan, magnetic resonance imaging, and/or radionuclide imaging throughout the trial. </p><p class='ctrp'></p><p class='ctrp'>After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 1 year.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>ECOG-ACRIN Cancer Research Group</div> 													<div>Principal Investigator: Keith Thomas Flaherty</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT02465060"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>California</h4>                           <h5 class=""locationCity"">Vacaville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sutter Cancer Centers Radiation Oncology Services-Vacaville</strong>     <br>Contact: Site Public Contact <br>Phone: 415-209-2683 <br>Email: <a href=""mailto:hempell@sutterhealth.org"">hempell@sutterhealth.org</a>   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Boulder</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Boulder Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:jbloomfield@co-cancerresearch.org"">jbloomfield@co-cancerresearch.org</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Gynecologic Oncology LLC</strong>     <br>Contact: Gregory Andrew Masters <br>Phone: 302-733-6227   </span> </div>                                   <h4>Florida</h4>                           <h5 class=""locationCity"">Fort Lauderdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Holy Cross Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 954-267-7748   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">Syracuse</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">SUNY Upstate Medical Center-Community Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 315-464-5476   </span> </div>                                   <h4>North Carolina</h4>                           <h5 class=""locationCity"">Hendersonville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hendersonville Hematology and Oncology at Pardee</strong>     <br>Contact: James Earl Radford <br>Phone: 828-696-4716   </span> </div>                                       <h5 class=""locationCity"">Mooresville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Cancer Institute - Mooresville</strong>     <br>Contact: Site Public Contact <br>Phone: 704-384-8920 <br>Email: <a href=""mailto:nnechiporchik@novanthealth.org"">nnechiporchik@novanthealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Winston-Salem</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Oncology Specialists</strong>     <br>Contact: Site Public Contact <br>Phone: 336-718-8335 <br>Email: <a href=""mailto:asmarrs@novanthealth.org"">asmarrs@novanthealth.org</a>   </span> </div>                                   <h4>North Dakota</h4>                           <h5 class=""locationCity"">Fargo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Clinic North-Fargo</strong>     <br>Contact: Preston D. Steen <br>Phone: 712-252-0088   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hematology and Oncology Associates Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 330-453-9993   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Pittsburgh</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Association</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Tennessee</h4>                           <h5 class=""locationCity"">Memphis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Family Cancer Center-Memphis</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Bellevue</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Cancer Institute-Eastside Oncology Hematology</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:CancerResearch@swedish.org"">CancerResearch@swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bremerton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Harrison HealthPartners Hematology and Oncology-Bremerton</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Green Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology at Saint Vincent Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology Limited at Saint Mary's Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Marinette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Marinette</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:Christy.Gilchrist@hshs.org"">Christy.Gilchrist@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sturgeon Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology - Sturgeon Bay</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Weston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Diagnostic and Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 888-799-3989 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                           			</div> 		</div> 					</div> 			</div> 		</div> 	</div>      <script id=""print-script"">         const subject = ""Clinical Trials from the National Cancer Institute's Website"";         const body = `Print-Friendly Clinical Trial Descriptions  ${document.location}  Please note that the URL will expire after 90 days.  You can find educational materials about clinical trials on NCI's Web site at http://www.cancer.gov/clinicaltrials. NCI's Web site, www.cancer.gov, contains comprehensive information about cancer causes and prevention, screening and diagnosis, treatment and survivorship; clinical trials; statistics; funding, training and employment opportunities; and the institute and its programs.  You can also get cancer information online through the LiveHelp instant messaging service at http://livehelp.cancer.gov. If you live in the United States, you may call the NCI's Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) for cancer information in English and Spanish.`;          let newLink = 'mailto:?subject=' + encodeURIComponent(subject) + '&body=' + encodeURIComponent(body);          const mailtoLink = document.getElementById(""ctl10_EmailResults"");         mailtoLink.attributes['href'].value = newLink;     </script>  	<!-- DTM PAGEBOTTOM TAG - DO NOT MODIFY --> 	<script type=""text/javascript"">_satellite.pageBottom();</script> </body> </html>"
0DED7BF0-3645-EF11-A20D-005056B388D3,2024-07-18 14:52:54.697,NCI-2015-00054,[]," <!DOCTYPE html> <html lang=""en""> <head> 	 <meta name=""robots"" content=""noindex""> 	 <title>Clinical Trial Search Results</title> 	 <script src=""//assets.adobedtm.com/f1bfa9f7170c81b1a9a9ecdcc6c5215ee0b03c84/satelliteLib-5b3dcf1f2676c378b518a1583ef5355acd83cd3d.js""></script> 	 <script src=""https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js""></script> 	 <script src=""/CTS.Print-js/BasicCTSPrintPage.js"" type=""text/javascript""></script>  	 <link rel=""stylesheet"" id=""gFonts"" href=""https://fonts.googleapis.com/css?family=Noto+Sans:400,400i,700,700i"" /> 	 <link href=""/CTS.Print-styles/nvcg.css"" rel=""stylesheet"" /> 	 <link href=""/CTS.Print-styles/BasicCTSPrintPage.css"" rel=""stylesheet"" /> 	 <meta name=""dcterms.subject"" content=""Clinical Trials Print Results Page"" />      <meta name=""Generator"" content=""CTS.Print"" /> </head> <body> 	<div class=""wa-data-element hide"" data-prop3=""/"" data-prop6=""Comprehensive Cancer Information"" data-prop16=""Comprehensive Cancer Information"" data-prop25=""01/01/1980"" data-prop44=""Clinical Trials"" data-prop62=""Clinical Trials: Print Results Page"" data-evar44=""Clinical Trials"" data-evar62=""Clinical Trials: Print Results Page"" ></div> 	<div id=""cgovContainer""> 		<div id=""CT-results-print-banner""><img id=""NCILogo"" src=""https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/logos/nci-logo-full.svg"" alt=""NCI Logo""/></div> 		<div id=""cgvBody""> 			<div id=""bodyHeading""> 				<div id=""headingWrapper""> 					<h1 id=""ctPrintBodyHeading"">Your Clinical Trials Search Results</h1> 					<div id=""bodyHeadingLinks""> 						<a id=""printPage"" href=""javascript:window.print();"">Print</a> | 						<a id=""ctl10_EmailResults"" href=""/CTS.Print/Display?printid=1ec84473-1c79-4137-b1ae-a6422a869dec"" target=""_blank"">E-Mail These Results</a> | 						<a id=""newSearch"" href=""/about-cancer/treatment/clinical-trials/search/advanced"">New Search</a> 					</div> 				</div> 			</div> 				<div id=""clinical-trials-print"">  					 	        		                     <p class=""printIntroText"">Here are the trials you selected from your search on 7/18/2024.</p> 					<p class=""printIntroText"">You will be able to access this page for approximately 90 days. Since trial information is updated regularly, you should check for updates to see the most current information on any of the trials below.</p>   				<div> 								<div class=""trialContainer""> 			<h2 class=""hangingIndent"">1. Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?t=C3208&st=C3471&a=24&loc=1&z=20850&zp=100&rl=2&id=NCI-2015-00054""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase II</td> 					<td>Screening</td> 					<td>Closed to Accrual</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> EAY131<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2015-00054<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/study/NCT02465060"" target=""_blank"">NCT02465060</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple myelomas that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and does not respond to treatment (refractory). Patients must have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic material (genes) of patients&#39; tumor cells. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit more from treatment which targets their tumor&#39;s particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors, lymphomas, or multiple myeloma.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SCREENING BIOPSY (STEP 0)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be &gt;= 18 years of age. Because no dosing or adverse event data are currently available on the use of study investigational agents in patients &lt; 18 years of age, children are excluded from this study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to registration; patients that are pregnant or breast feeding are excluded; a patient of childbearing potential is anyone, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:  * Has achieved menarche at some point  * Has not undergone a hysterectomy or bilateral oophorectomy; or  * Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse prior to study entry, for the duration of study participation, and for 4 months after completion of study; should a patient or partner of the patient become pregnant or suspect a pregnancy while participating in this study, the treating physician should be informed immediately</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have histologically documented solid tumors or histologically confirmed diagnosis of lymphoma or multiple myeloma requiring therapy and meet one of the following criteria: * Patients must have progressed following at least one line of standard systemic therapy and there must not be other approval/standard therapy available that has been shown to prolong overall survival (i.e. in a randomized trial against another standard treatment or by comparison to historical controls); patients who cannot receive other standard therapy that has been shown to prolong overall survival due to medical issues will be eligible, if other eligibility criteria are met; if the patient is currently receiving therapy, the clinician must have assessed that the current therapy is no longer benefitting the patient prior to enrolling on MATCH, regardless of whether it is considered standard OR * Patients for whose disease no standard treatment exists that has been shown to prolong overall survival * NOTE: No other prior malignancy is allowed except for the following: * Adequately treated basal cell or squamous cell skin cancer * In situ cervical cancer * Adequately treated stage I or II cancer from which the patient is currently in complete remission * Any other cancer from which the patient has been disease-free for 5 years</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have measurable disease</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet the criteria below * Tumor tissue for the confirmation of “rare variant” by the MATCH assay is to be submitted, preferably from the same time of collection as that used to determine patient candidacy for treatment arm assignment ** Registration to Step 0 must occur after stopping prior systemic anti-cancer therapy. There is no specific duration for which patients must be off treatment prior to registration to Step 0, as long as all eligibility criteria are met ** Patients may have received other non-targeted, immunotherapy or targeted treatment between the prior genetic testing at the outside lab and registration to Step 0. The decision to stop such treatment in favor of participation in MATCH, if no further clinical benefit is expected, is per the treating physician&#39;s discretion. Documentation of a lack of response to the prior treatment is not required in these cases ** Patients with an applicable “rare variant” must be able to meet the eligibility criteria for the appropriate subprotocols within 4 weeks following notification of treatment assignment ** Patient meets one of the following criteria: *** Patient is a candidate for Z1M based on local Clinical Laboratory Improvement Act (CLIA) assessment of mismatch repair deficiency (MMRd) by immunohistochemistry (IHC) or microsatellite instability (MSI) status by polymerase chain reaction (PCR), adequate tumor tissue is available for submission for mandatory central screening IHC and the patient will be able to meet the eligibility criteria for Z1M within 4 weeks following notification of treatment assignment OR *** The sites have received results from one of the designated outside laboratories indicating a “rare variant” that is an actionable Mutation of Interest (aMOI) for specific select subprotocols * NOTE: There is no particular window of time after receiving the sequencing report notification of potential eligibility from an outside lab in which the patient must be registered to Step 0, but treatment slots will be assigned on a first come, first serve basis to those who do register to Step 0, and are not held for those notified of potential eligibility who do not register to Step 0 * NOTE: Treatment assignment (and the start of the associated deadline for Step 1 registration) may occur shortly after Step 0 registration. Note that certain “rare variant” arms require submission of archival tissue for central IHC testing to determine treatment assignment. For those arms, adequate tissue for the central IHC is required to be available for submission * NOTE: Other potential aMOIs that would be eligibility criteria for “NON RARE” arms, as determined by the designated laboratories, are not applicable for this process in MATCH</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not require the use of full dose coumarin-derivative anticoagulants such as warfarin; low molecular weight heparin is permitted for prophylactic or therapeutic use; factor X inhibitors are permitted * NOTE: Warfarin may not be started while enrolled in the EAY131 study * Stopping the anticoagulation for biopsy should be per site standard operating procedure (SOP)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =&lt; 1 and a life expectancy of at least 3 months</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not currently be receiving any other investigational agents</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not have any uncontrolled intercurrent illness including, but not limited to: * Symptomatic congestive heart failure (New York Heart Association [NYHA] classification of III/IV) * Unstable angina pectoris or coronary angioplasty, or stenting within 6 months prior to registration to Step 0, 2, 4, 6 * Cardiac arrhythmia (ongoing cardiac dysrhythmias of National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version [v]4 grade &gt;= 2) * Psychiatric illness/social situations that would limit compliance with study requirements * Intra-cardiac defibrillators * Known cardiac metastases * Abnormal cardiac valve morphology (&gt;= grade 2) documented by echocardiogram (ECHO) (as clinically indicated); (subjects with grade 1 abnormalities [i.e., mild regurgitation/stenosis] can be entered on study); subjects with moderate valvular thickening should not be entered on study * NOTE: To receive an agent, patient must not have any uncontrolled intercurrent illness such as ongoing or active infection; patients with infections unlikely to be resolved within 2 weeks following screening should not be considered for the trial</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be able to swallow tablets or capsules; a patient with any gastrointestinal disease that would impair ability to swallow, retain, or absorb drug is not eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients who are human immunodeficiency virus (HIV)-positive are eligible if:  * CD4+ cell count greater or equal to 250 cells/mm^3 * If patient is on antiretroviral therapy, there must be minimal interactions or overlapping toxicity of the antiretroviral therapy with the experimental cancer treatment; for experimental cancer therapeutics with CYP3A/4 interactions, protease inhibitor therapy is disallowed; suggested regimens to replace protease inhibitor therapy include dolutegravir given with tenofovir/emtricitabine; raltegravir given with tenofovir and emtricitabine; once daily combinations that use pharmacologic boosters may not be used * No history of non-malignancy acquired immune deficiency syndrome (AIDS)-defining conditions other than historical low CD4+ cell counts * Probable long-term survival with HIV if cancer were not present</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Any prior therapy, radiotherapy (except palliative radiation therapy of 30 gray [Gy] or less), or major surgery must have been completed &gt;= 4 weeks prior to start of treatment; all adverse events due to prior therapy have resolved to a grade 1 or better (except alopecia and lymphopenia) by start of treatment; palliative radiation therapy must have been completed at least 2 weeks prior to start of treatment; the radiotherapy must not be to a lesion that is included as measurable disease * NOTE: Prostate cancer patients may continue their luteinizing hormone-releasing hormone (LHRH) agonist * NOTE: For patients entering the study via the original screening process, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results; however, lack of response must be documented prior to registration to Step 1; new non-protocol treatment will NOT be permitted as intervening therapy after registration to Step 0; the only intervening treatment permitted is prior therapy that the patient already received prior to Step 0 registration; the decision to stop the intervening non-protocol treatment will be left up to the treating physician if patient has an aMOI; however, patients will need to be off such therapy for at least 4 weeks before receiving any MATCH protocol treatment * NOTE: For patients entering the study via a designated outside laboratory, no intervening systemic non-protocol treatment is permitted after Step 0 registration; all other eligibility requirements still apply to these patients, including the washouts for prior therapy noted above in this section, the time restrictions outlined, and the eligibility criteria for the intended subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients with brain metastases or primary brain tumors must have completed treatment, surgery or radiation therapy &gt;= 4 weeks prior to start of treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have discontinued steroids &gt;= 1 week prior to registration to Step 0 and remain off steroids thereafter, except as permitted; patients with glioblastoma (GBM) must have been on stable dose of steroids, or be off steroids, for one week prior to registration to treatment (Step 1, 3, 5, 7) * NOTE: The following steroids are permitted (low dose steroid use is defined as prednisone 10 mg daily or less, or bioequivalent dose of other corticosteroid): ** Temporary steroid use: e.g. for CT imaging in setting of contrast allergy ** Low dose steroid use for appetite ** Chronic inhaled steroid use ** Steroid injections for joint disease ** Stable dose of replacement steroid for adrenal insufficiency or low doses for non-malignant disease ** Topical steroid ** Steroids required to manage toxicity related to study treatment, as described in the subprotocols ** Steroids required as pre- or post-chemotherapy medication for acceptable intervening chemotherapy *** NOTE: Steroids must be completed alongside last dose of chemotherapy</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Leukocytes &gt;= 3,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Absolute neutrophil count (ANC) &gt;= 1,500/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Platelets &gt;= 100,000/mcL (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: Patients with documented bone marrow involvement by lymphoma are not required to meet the above hematologic parameters, but must have a platelet count of at least 75,000/mcL and neutrophil count of at least 1,000/mcL</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Total bilirubin =&lt; 1.5 x institutional upper limit of normal (ULN) (unless documented Gilbert’s syndrome, for which bilirubin =&lt; 3 x institutional ULN is permitted) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =&lt; 2.5 x institutional ULN (up to 5 times ULN in presence of liver metastases) (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Creatinine clearance &gt;= 45 mL/min/1.73 m^2 for patients with creatinine levels above institutional ULN * As defined by the Cockcroft-Gault equation (within 2 weeks prior to screening step registration and within 4 weeks prior to treatment step registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have an electrocardiogram (ECG) within 8 weeks prior to registration to screening step and must meet the following cardiac criteria: * Resting corrected QT interval (QTc) =&lt; 480 msec ** NOTE: If the first recorded QTc exceeds 480 msec, two additional, consecutive ECGs are required and must result in a mean resting QTc =&lt; 480 msec; it is recommended that there are 10-minute (+/- 5 minutes) breaks between the ECGs * The following only need to be assessed if the mean QTc &gt; 480 msec ** Check potassium and magnesium serum levels ** Correct any identified hypokalemia and/or hypomagnesemia and may repeat ECG to confirm exclusion of patient due to QTc ** For patients with heart rate (HR) 60-100 beats per minute (bpm), no manual read of QTc is required ** For patients with baseline HR &lt; 60 or &gt; 100 bpm, manual read of QT by trained personnel is required, with Fridericia correction applied to determine QTc ** Patient must not have hypokalemia (value &lt; institutional lower limit of normal) * No factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age or any concomitant medication known to prolong the QT interval ** NOTE: Patient must be taken off prohibited medication prior to registration to the screening step (Step 0, 2, 4, 6) and remain off these medications thereafter, unless permitted on a subprotocol for the management of treatment related toxicity; patient must be off the drug for at least 5 half-lives prior to registration to the treatment step (Step 1, 3, 5, 7); the medication half-life can be found in the package insert for Food and Drug Administration (FDA) approved drugs</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FIRST TREATMENT (STEP 1)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: For patients entering step 0 with assay results from outside laboratories, no systemic treatment is allowed after step 0 registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>As MATCH is designed to add additional subprotocols, implement limited expansions of accrual for certain subprotocols, and/or amend existing arm-specific eligibility criteria, some patients entering under the original screening method may be eligible to have their results rerun in MATCHbox, even if they did not match to a treatment initially or did not receive a treatment assignment due to a lack of available assignment slots; patients whose sequence results will be rerun through MATCHbox must also meet the following criteria: * Samples must have been collected within 5 months of the activation of the addendum, as there is an additional month needed to get the patients on trial * Patient has not had treatment within the 5 months that resulted in a PR or better after the performance of the screening assessment * Patient must meet eligibility criteria, including performance status 1 or better and life expectancy of at least 3 months * Patients must meet the eligibility requirements with the following exceptions: ** Patients may have received other non-targeted, immunotherapy or targeted treatment, which could be stopped in favor of returning to MATCH, if no response to the interim treatment has occurred and no further benefit is expected from this interim treatment, per the treating physician&#39;s discretion; documentation of a lack of response to the interim treatment is not required in these cases; however, the following restrictions apply: *** Enrollment onto another investigational therapeutic study is not permitted *** Patient cannot be responding to interim treatment, since the benefit of the MATCH treatment is unknown and may deprive patient of an effective treatment if it were given when a patient is responding to another treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 results will be re-interrogated to determine if another treatment is available</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND SCREENING (STEP 2)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on Step 1 treatment or patient could not tolerate assigned treatment * NOTE: PATIENTS ENTERING STEP 1 WITH A “RARE VARIANT” FROM AN “OUTSIDE” LAB ARE NOT ELIGIBLE FOR STEP 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 1 treatment * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their step 0 MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance; only aMOIs detected by the MATCH assay may be used for the determination of eligibility to a relevant subprotocol OR</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Progression (or inability to tolerate further treatment) occurred after a (1) response OR (2) after &gt;= 6 months from start of step 1 treatment; patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspirate for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest (aMOI); archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not have been assigned to step 1 treatment based on a “rare variant” determined by a designated outside laboratory</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR SECOND TREATMENT (STEP 3)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy samples were submitted during step 2, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 3; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 2; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD SCREENING (STEP 4)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 3 treatment or patient could not tolerate assigned treatment * Patient must meet one of the following criteria: ** No response and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 3 (second) treatment AND a biopsy was performed at step 2 screening *** NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, their latest MATCH assay results will be re-interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance OR ** Progression (or inability to tolerate further treatment) occurred on step 3 treatment and a biopsy was not performed at step 2 screening (due to presence of additional aMOIs at that stage); patient must have tumor amenable to percutaneous biopsy and be willing and able to undergo a tumor biopsy or bone marrow aspiration for collection and submission of tumor tissue OR patient will be undergoing a procedure due to medical necessity during which the tissue may be collected for the central determination of the presence of one or more of the specific “actionable” mutations/amplifications of interest; biopsy must not be considered to be more than minimal risk to the patient; archived specimens cannot be accepted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: A patient may have a maximum of 2 screening biopsies (not including re-biopsy due to assay failure), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR THIRD TREATMENT (STEP 5)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: If screening biopsy was submitted on step 4, patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results however, lack of response must be documented prior to registration to step 5; new non-protocol treatment will NOT be permitted as intervening therapy after registration to step 4; the therapy cannot be an arm in the MATCH trial; the decision to stop the intervening nonprotocol treatment will be left up to the treating physician if patient has an aMOI; waiting periods as described will apply</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR FOURTH SCREENING (STEP 6)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient’s disease has progressed on step 5 protocol treatment or patient could not tolerate assigned treatment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have had no response, and progression (or inability to tolerate further treatment) occurred &lt; 6 months from start of step 5 treatment AND a biopsy was performed at step 4 screening * NOTE: Patients meeting these criteria will NOT be biopsied at this time point; instead, based on their 2nd biopsy, their results will be interrogated to determine if another treatment is available upon registration to this study step; it is not necessary to confirm the availability of another potential treatment assignment in advance</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must meet eligibility criteria as defined in step 0 * NOTE: For Step 6, biopsies to collect material for screening assay will NOT be performed; a patient may have a maximum of 2 successful screening assessments of submitted tissue (steps 0 and 2 OR steps 0 and 4), and 2 MATCH treatments per biopsy (if &gt; 1 aMOI)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY FOR FOURTH TREATMENT (STEP 7)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eligibility requirements for registration onto step 7 are outlined in the agent-specific subprotocol</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA FOR RESEARCH BIOPSY AND CIRCULATING TUMOR DNA COLLECTION (STEP 8)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ALL PATIENTS SHOULD BE ENCOURAGED TO PARTICIPATE IN STEP 8, IF SAFE; IF BIOPSY IS REFUSED OR INADVISABLE, ENCOURAGE COLLECTION OF WHOLE BLOOD FOR CIRCULATING TUMOR DNA As a reminder, the submission of the step 8 samples requires additional patient consent, as well as registration to step 8 * NOTE: Patients who entered the study (step 0) with a “rare variant” determined by an outside assay ARE potentially eligible and encouraged to participate in step 8</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient has completed their most recent MATCH study treatment, will not undergo an additional screening biopsies, and will receive no additional treatment on MATCH * NOTE: If a 2nd Screening Biopsy was performed and showed no study-actionable abnormalities, and blood samples were submitted with the screening biopsy, no additional end of treatment specimens are requested</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>For patients who consent to undergo the optional research biopsy, patient’s disease responded to the most recent MATCH study treatment and then progressed (or unable to tolerate further treatment) OR the disease progression (or inability to tolerate further treatment) occurs &gt; 6 months since the last screening biopsy * NOTE: Performance of a biopsy to collect tumor tissue for research is strongly encouraged but not required; it is acceptable to submit only the optional blood specimens * NOTE: If a biopsy will be performed solely to collect tumor specimens for research, the patient must be willing and able to undergo a tumor biopsy or bone marrow aspirate (for applicable multiple myeloma), for the collection and submission of tissue for research</li> 												</ul> 						</div> 										 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE: </p><p class='ctrp'>I. To evaluate the proportion of patients with objective response (OR) to targeted study agent(s) in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES: </p><p class='ctrp'>I. To evaluate the proportion of patients alive and progression free at 6 months of treatment with targeted study agent in patients with advanced refractory cancers/lymphomas/multiple myeloma.</p><p class='ctrp'>II. To evaluate time until death or disease progression.</p><p class='ctrp'>III. To identify potential predictive biomarkers beyond the genomic alteration by which treatment is assigned or resistance mechanisms using additional genomic, ribonucleic acid (RNA), protein and imaging-based assessment platforms.</p><p class='ctrp'>IV. To assess whether radiomic phenotypes obtained from pre-treatment imaging and changes from pre- through post-therapy imaging can predict objective response and progression free survival and to evaluate the association between pre-treatment radiomic phenotypes and targeted gene mutation patterns of tumor biopsy specimens.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE:</p><p class='ctrp'>STEP 0 (Screening): Patients undergo biopsy along with molecular characterization of the biopsy material for specific, pre-defined mutations, amplifications, or translocations of interest via tumor sequencing and immunohistochemistry. Consenting patients also undergo collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>STEPS 1, 3, 5, 7 (Treatment): Patients are assigned to 1 of 38 treatment subprotocols based on molecularly-defined subgroup. (See Arms Section) </p><p class='ctrp'></p><p class='ctrp'>STEPS 2, 4, 6 (Screening): Patients experiencing disease progression on the prior Step treatment or who could not tolerate the assigned treatment undergo review of their previous biopsy results to determine if another treatment is available or undergo another biopsy. Patients may have a maximum of 2 screening biopsies and 2 treatments per biopsy. </p><p class='ctrp'></p><p class='ctrp'>STEP 8 (Optional Research): Consenting patients undergo end-of-treatment biopsy and collection of blood samples for research purposes.</p><p class='ctrp'></p><p class='ctrp'>Additionally, patients may undergo a computed tomography (CT) scan, magnetic resonance imaging, and/or radionuclide imaging throughout the trial. </p><p class='ctrp'></p><p class='ctrp'>After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 1 year.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>ECOG-ACRIN Cancer Research Group</div> 													<div>Principal Investigator: Keith Thomas Flaherty</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT02465060"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>California</h4>                           <h5 class=""locationCity"">Vacaville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sutter Cancer Centers Radiation Oncology Services-Vacaville</strong>     <br>Contact: Site Public Contact <br>Phone: 415-209-2683 <br>Email: <a href=""mailto:hempell@sutterhealth.org"">hempell@sutterhealth.org</a>   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Boulder</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Boulder Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:jbloomfield@co-cancerresearch.org"">jbloomfield@co-cancerresearch.org</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Gynecologic Oncology LLC</strong>     <br>Contact: Gregory Andrew Masters <br>Phone: 302-733-6227   </span> </div>                                   <h4>Florida</h4>                           <h5 class=""locationCity"">Fort Lauderdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Holy Cross Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 954-267-7748   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">Syracuse</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">SUNY Upstate Medical Center-Community Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 315-464-5476   </span> </div>                                   <h4>North Carolina</h4>                           <h5 class=""locationCity"">Hendersonville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hendersonville Hematology and Oncology at Pardee</strong>     <br>Contact: James Earl Radford <br>Phone: 828-696-4716   </span> </div>                                       <h5 class=""locationCity"">Mooresville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Cancer Institute - Mooresville</strong>     <br>Contact: Site Public Contact <br>Phone: 704-384-8920 <br>Email: <a href=""mailto:nnechiporchik@novanthealth.org"">nnechiporchik@novanthealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Winston-Salem</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Novant Health Oncology Specialists</strong>     <br>Contact: Site Public Contact <br>Phone: 336-718-8335 <br>Email: <a href=""mailto:asmarrs@novanthealth.org"">asmarrs@novanthealth.org</a>   </span> </div>                                   <h4>North Dakota</h4>                           <h5 class=""locationCity"">Fargo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Clinic North-Fargo</strong>     <br>Contact: Preston D. Steen <br>Phone: 712-252-0088   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hematology and Oncology Associates Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 330-453-9993   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Pittsburgh</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Association</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Tennessee</h4>                           <h5 class=""locationCity"">Memphis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Family Cancer Center-Memphis</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Bellevue</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Cancer Institute-Eastside Oncology Hematology</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:CancerResearch@swedish.org"">CancerResearch@swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bremerton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Harrison HealthPartners Hematology and Oncology-Bremerton</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Green Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology at Saint Vincent Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology Limited at Saint Mary's Hospital</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Marinette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Marinette</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:Christy.Gilchrist@hshs.org"">Christy.Gilchrist@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sturgeon Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Green Bay Oncology - Sturgeon Bay</strong>     <br>Contact: Brian Leslie Burnette <br>Phone: 920-433-8889   </span> </div>                                       <h5 class=""locationCity"">Weston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Diagnostic and Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 888-799-3989 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                           			</div> 		</div> 					</div> 			</div> 		</div> 	</div>      <script id=""print-script"">         const subject = ""Clinical Trials from the National Cancer Institute's Website"";         const body = `Print-Friendly Clinical Trial Descriptions  ${document.location}  Please note that the URL will expire after 90 days.  You can find educational materials about clinical trials on NCI's Web site at http://www.cancer.gov/clinicaltrials. NCI's Web site, www.cancer.gov, contains comprehensive information about cancer causes and prevention, screening and diagnosis, treatment and survivorship; clinical trials; statistics; funding, training and employment opportunities; and the institute and its programs.  You can also get cancer information online through the LiveHelp instant messaging service at http://livehelp.cancer.gov. If you live in the United States, you may call the NCI's Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) for cancer information in English and Spanish.`;          let newLink = 'mailto:?subject=' + encodeURIComponent(subject) + '&body=' + encodeURIComponent(body);          const mailtoLink = document.getElementById(""ctl10_EmailResults"");         mailtoLink.attributes['href'].value = newLink;     </script>  	<!-- DTM PAGEBOTTOM TAG - DO NOT MODIFY --> 	<script type=""text/javascript"">_satellite.pageBottom();</script> </body> </html>"
AB561B48-B860-EF11-A20E-005056B388D3,2024-08-22 14:56:48.177,"NCI-2019-04727,NCI-2019-01528,NCI-2017-00902,NCI-2021-07529,NCI-2015-01548,NCI-2016-01047,NCI-2021-03303,NCI-2018-01807,NCI-2020-11651,NCI-2020-07169","[{""Label"":""Trial Type"",""Value"":""Supportive Care, Health Services Research, Basic Science""}]"," <!DOCTYPE html> <html lang=""en""> <head> 	 <meta name=""robots"" content=""noindex""> 	 <title>Clinical Trial Search Results</title> 	 <script src=""//assets.adobedtm.com/f1bfa9f7170c81b1a9a9ecdcc6c5215ee0b03c84/satelliteLib-5b3dcf1f2676c378b518a1583ef5355acd83cd3d.js""></script> 	 <script src=""https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js""></script> 	 <script src=""/CTS.Print-js/BasicCTSPrintPage.js"" type=""text/javascript""></script>  	 <link rel=""stylesheet"" id=""gFonts"" href=""https://fonts.googleapis.com/css?family=Noto+Sans:400,400i,700,700i"" /> 	 <link href=""/CTS.Print-styles/nvcg.css"" rel=""stylesheet"" /> 	 <link href=""/CTS.Print-styles/BasicCTSPrintPage.css"" rel=""stylesheet"" /> 	 <meta name=""dcterms.subject"" content=""Clinical Trials Print Results Page"" />      <meta name=""Generator"" content=""CTS.Print"" /> </head> <body> 	<div class=""wa-data-element hide"" data-prop3=""/"" data-prop6=""Comprehensive Cancer Information"" data-prop16=""Comprehensive Cancer Information"" data-prop25=""01/01/1980"" data-prop44=""Clinical Trials"" data-prop62=""Clinical Trials: Print Results Page"" data-evar44=""Clinical Trials"" data-evar62=""Clinical Trials: Print Results Page"" ></div> 	<div id=""cgovContainer""> 		<div id=""CT-results-print-banner""><img id=""NCILogo"" src=""https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/logos/nci-logo-full.svg"" alt=""NCI Logo""/></div> 		<div id=""cgvBody""> 			<div id=""bodyHeading""> 				<div id=""headingWrapper""> 					<h1 id=""ctPrintBodyHeading"">Your Clinical Trials Search Results</h1> 					<div id=""bodyHeadingLinks""> 						<a id=""printPage"" href=""javascript:window.print();"">Print</a> | 						<a id=""ctl10_EmailResults"" href=""${generatePrintURL}"" target=""_blank"">E-Mail These Results</a> | 						<a id=""newSearch"" href=""/about-cancer/treatment/clinical-trials/search/advanced"">New Search</a> 					</div> 				</div> 			</div> 				<div id=""clinical-trials-print"">  					 	        								     <a href=""#"" class=""ctscb"" id=""ctscb"">Show Search Criteria</a>     <div class=""search-criteria-box"" aria-expanded=""false"" aria-labelledby=""ctscb"">       <div class=""clinicaltrials-results-criteria-display"">         <h3>Your Search Criteria</h3>         <table class=""table no-auto-enlarge"" style=""width: 100%;"">             <thead>                 <tr>                   <th class=""hdrlft"" scope=""col""><h3>Category</h3></th>                   <th class=""hdrrt"" scope=""col""><h3>Your Selection</h3></th>                 </tr>             </thead>             <tbody>                                                     <tr>                         <td class=""hdrlft""><strong>Trial Type:</strong></td>                         <td>Supportive Care, Health Services Research, Basic Science</td>                     </tr>                             </tbody>         </table>       </div>     </div> 					                     <p class=""printIntroText"">Here are the trials you selected from your search on 8/22/2024.</p> 					<p class=""printIntroText"">You will be able to access this page for approximately 90 days. Since trial information is updated regularly, you should check for updates to see the most current information on any of the trials below.</p>   				<div> 								<div class=""trialContainer""> 			<h2 class=""hangingIndent"">1. Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?loc=0&rl=2&tt=supportive_care&tt=health_services_research&tt=basic_science&id=NCI-2019-04727""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase II/III</td> 					<td>Supportive care</td> 					<td>Closed to Accrual</td> 					<td>25 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> A221805<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2019-04727<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT04137107"" target=""_blank"">NCT04137107</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase II/III trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, numbness, and muscle weakness (peripheral neuropathy) caused by treatment with oxaliplatin in patients with stage II-III colorectal cancer. Duloxetine increases the amount of certain chemicals in the brain that help relieve depression and pain. Giving duloxetine in patients undergoing treatment with oxaliplatin for colorectal cancer may help prevent peripheral neuropathy.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																								<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>Stage II-III colorectal cancer patients scheduled to receive oxaliplatin via one of the following treatment regimens: * FOLFOX (3-month): 510 mg/m^2 (total planned maximum cumulative dose) over 12 weeks (6 cycles), in which patients are scheduled to receive oxaliplatin 85 mg/m^2 every 2 week * FOLFOX (6-month): 1020 mg/m^2 (total planned maximum cumulative dose) over 24 weeks (12 cycles) in which patients are scheduled to receive oxaliplatin 85 mg/m^2 every 2 weeks * CAPOX (3-month): 520 mg/m^2 (total planned maximum cumulative dose) over 12 weeks (4 cycles) in which patients are scheduled to receive oxaliplatin 130 mg/m^2 every 3 weeks</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No prior neurotoxic chemotherapy</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No pre-existing clinical or pre-clinical peripheral neuropathy from any cause</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients with the following comorbid conditions are not eligible: * History of seizure disorder * Narrow-angle glaucoma * History of suicidal thoughts * Symptoms of or a history of schizophrenia, bipolar disease, and/or a major depression * A serious eating disorder such as bulimia or anorexia * Known diagnosis of ethanol (ETOH) addiction/dependence within the past 10 years</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Concomitant medications: * No concomitant use of other adjuvant pharmacologic interventions (e.g., gabapentin, pregabalin, venlafaxine) with known or hypothesized efficacy for peripheral neuropathy. Must be discontinued at least 7 days prior to start of protocol treatment * No concomitant use of non-pharmacologic interventions (known or hypothesized) for CIPN (e.g., cryotherapy, acupuncture) * No anticipated or concurrent use of warfarin or heparin products while patients are receiving study drug. No anticipated or concurrent use of any antidepressant or serotonin-altering agent or other potent CYP2D6 inhibitors (e.g. paroxetine, fluoxetine, quinidine) known to interact with duloxetine, due to concern regarding cumulative toxicity and potential drug interactions. Use of an monoamine oxidase inhibitor (MAOI) or other antidepressants must be discontinued at least 14 days prior to start of protocol treatment * Chronic concomitant treatment with drugs that are extensively metabolized by CYP2D6 and that have a narrow therapeutic index, including certain antidepressants, phenothiazines, and Type 1C antiarrhythmics should be approached with caution ** Concomitant administration of duloxetine and thioridazine should be avoided * Chronic concomitant treatment with strong CYP1A2 inhibitors should be avoided during this trial due to concern regarding cumulative toxicity and potential drug interactions</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Not pregnant and not nursing, because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown. Therefore, for women of childbearing potential, a negative pregnancy test done =&lt; 7 days prior to registration is required</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Age &gt;= 25 years. Duloxetine black box warnings indicate an increased risk of suicide in patients &lt; 25 years of age</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eastern Cooperative Oncology Group (ECOG) performance status 0-2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>In order to complete the mandatory patient-completed measure, patients must be able to speak and read English</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Calculated creatinine clearance &gt; 30 mL/min</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Aspartate aminotransferases (AST)/serum glutamic-oxaloacetic transaminase (SGOT) =&lt; 3 x upper limit of normal (ULN)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ePRO-E ELIGIBILITY CRITERIA * Registration to A221805-SI1 (OPEN Step 2) is closed to accrual as of 09/15/2022</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Must be enrolled in A221805</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Participant must own a smartphone or tablet computer, and have access to Wi-Fi</li> 												</ul> 						</div> 										 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVES:</p><p class='ctrp'>I. To determine the dosage of duloxetine hydrochloride (duloxetine) (30 mg or 60 mg daily) that appears most promising in preventing oxaliplatin-induced peripheral neuropathy (OIPN), as assessed on day 1 of each oxaliplatin treatment cycle as well as 2 weeks (14 days) after day 1/cycle 4 (capecitabine and oxaliplatin [CAPOX]) or day 1/cycle 6 (5-fluorouracil, oxaliplatin, and leucovorin calcium [FOLFOX]), regardless of the oxaliplatin treatment regimen received (3- or 6- month FOLFOX or 3-month CAPOX). (Phase II)</p><p class='ctrp'>II. To demonstrate that the most promising dosage of duloxetine identified in the Phase II component is more effective than placebo at preventing OIPN sensory symptoms, as assessed on day 1 of each oxaliplatin treatment cycle as well as 2 weeks (14 days) after day 1/cycle 4 (CAPOX) or day 1/cycle 6 (FOLFOX), regardless of the oxaliplatin treatment regimen received (3-or 6-month FOLFOX or 3-month CAPOX). (Phase III)</p><p class='ctrp'>III. To demonstrate that the most promising dosage of duloxetine identified in the Phase II component is more effective than placebo at preventing oxaliplatin-induced chronic neuropathic pain. (Phase III)</p><p class='ctrp'>IV. Compare electronic pateint-reported outcome (ePRO) uptake in patients who do and do not have access to ePRO-E. (Correlative study)</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES:</p><p class='ctrp'>I. To characterize toxicity in each arm, including duloxetine side effects of nausea, dry mouth, dizziness, somnolence, fatigue, and insomnia using Common Terminology Criteria for Adverse Events (CTCAE) version (v) 5.0 as well as characterizing the toxicity profile within the two distinct patient cohorts: those receiving 3- or 6-month oxaliplatin regimens. (Phase II)</p><p class='ctrp'>II. To compare the serially measured OIPN total sensory neuropathy scores calculated from the six individual Quality of Life Questionnaire (QLQ)-Chemotherapy-Induced Peripheral Neuropathy (CIPN) 20 questions that quantify numbness, tingling, and pain in the fingers (or hands) and toes (or feet), assessed on day 1 of each oxaliplatin treatment cycle as well as 2 weeks (14 days) after day 1/cycle 4 (CAPOX) or day 1/cycle 6 (FOLFOX) regardless of oxaliplatin treatment regimen received (3- or 6- month FOLFOX or 3-month CAPOX) between the most promising dosage of duloxetine identified in the Phase II component and placebo. (Phase III)</p><p class='ctrp'>III. To characterize toxicity in each arm, including duloxetine side effects of nausea, dry mouth, dizziness, somnolence, fatigue, and insomnia using the CTCAE v 5.0 as well as characterizing the toxicity profile within the two distinct patient cohorts: those receiving 3- or 6-month oxaliplatin regimens. (Phase III)</p><p class='ctrp'>IV. Compare ePRO data submission patterns in patients who do and do not have access to ePRO-E. (Correlative study)</p><p class='ctrp'></p><p class='ctrp'>EXPLORATORY OBJECTIVES:</p><p class='ctrp'>I. To explore differences in the response profile by arm of the patient-reported outcomes obtained from the QLQ-CIPN20, Brief Pain Inventory - short form (BPI-SF), including the BPI-SF interference subscale, and the 7-day average of chronic (worse and average) neuropathic pain obtained from the 7-day chronic neuropathy pain diary, measured through 18 months post-oxaliplatin treatment, in two separate patient cohorts: those receiving 3- and 6-month oxaliplatin regimens, separately. (Phase III)</p><p class='ctrp'>II. To explore between-arm differences in the time to initial onset of sensory OIPN (numbness [N], tingling [T], and pain) in two separate patient cohorts: those receiving 3- and 6-month oxaliplatin regimens, separately. (Phase III)</p><p class='ctrp'>III. To explore between-arm differences in the pattern of acute, more transient neuropathy symptoms reported with oxaliplatin therapy, in two separate patient cohorts: those receiving 3- and 6-month oxaliplatin regimens, separately. (Phase III)</p><p class='ctrp'>IV. To explore between-arm differences in the percentages of patients receiving full planned oxaliplatin doses per cycle, in two separate patient cohorts: those receiving 3- and 6-month oxaliplatin regimens, separately. (Phase III)</p><p class='ctrp'>V. To characterize the frequency and severity of patient-reported pain, numbness, and tingling as measured by the Patient Reported Outcomes (PRO)-CTCAE, measured through 18 months post oxaliplatin treatment, in patients receiving 3- and 6-month oxaliplatin regimens, separately. (Phase III)</p><p class='ctrp'>VI. To document the reasons why a patient chose not to use the electronic patient-reported outcome (ePRO) tool to complete the study questionnaires. (Phase III)</p><p class='ctrp'>VII. Using a quantitative and qualitative data collection methods, describe the demographic and clinical characteristics, and technology attitudes and experiences of all A221805 participants (control and intervention group patients) who do and do not elect to use ePRO as their preferred method for submitting PRO study questionnaires. (Correlative study)</p><p class='ctrp'></p><p class='ctrp'>OUTLINE: This is a phase II study followed by a phase III study.</p><p class='ctrp'></p><p class='ctrp'>PHASE II: Patients are randomized to 1 of 3 arms.</p><p class='ctrp'></p><p class='ctrp'>ARM I: Patients receive duloxetine hydrochloride orally (PO) once daily (QD) during week 1, duloxetine hydrochloride PO QD and placebo PO QD during weeks 2-16, followed by duloxetine hydrochloride PO QD during week 17 in the absence of unacceptable toxicity. Patients also receive standard of care (SOC) oxaliplatin during weeks 1-12.</p><p class='ctrp'></p><p class='ctrp'>ARM II: Patients receive duloxetine hydrochloride PO QD during weeks 1-17 in the absence of unacceptable toxicity. Patients also receive SOC oxaliplatin during weeks 1-12.</p><p class='ctrp'></p><p class='ctrp'>ARM III: Patients receive placebo PO QD during weeks 1-17 in the absence of unacceptable toxicity. Patients also receive SOC oxaliplatin during weeks 1-12.</p><p class='ctrp'></p><p class='ctrp'>PHASE III: Patients are randomized to 1 of 2 arms.</p><p class='ctrp'></p><p class='ctrp'>ARM I: Patients receive most promising dose of duloxetine hydrochloride from Phase II PO QD during weeks 1-16 in the absence of unacceptable toxicity. Patients also receive SOC oxaliplatin during weeks 1-12.</p><p class='ctrp'></p><p class='ctrp'>ARM II: Patients receive placebo PO QD during weeks 1-16 in the absence of unacceptable toxicity. Patients also receive SOC oxaliplatin during weeks 1-12.</p><p class='ctrp'></p><p class='ctrp'>After completion of study, patients are followed up at 30 days and at 3, 6, 12, and 18 months after last oxaliplatin treatment.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>Alliance for Clinical Trials in Oncology</div> 													<div>Principal Investigator: Ellen M. Lavoie Smith</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT04137107"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>Nebraska</h4>                           <h5 class=""locationCity"">Lincoln</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Partners of Nebraska - Pine Lake</strong>     <br>Contact: Site Public Contact <br>Phone: 402-327-7363 <br>Email: <a href=""mailto:research@cancerpartners.com"">research@cancerpartners.com</a>   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Greenville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Associates</strong>     <br>Contact: Site Public Contact <br>Phone: 773-702-9171 <br>Email: <a href=""mailto:protocols@AllianceNCTN.org"">protocols@AllianceNCTN.org</a>   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Bremerton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Harrison HealthPartners Hematology and Oncology-Bremerton</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                           			</div> 		</div> 			<div class=""trialContainer""> 			<h2 class=""hangingIndent"">2. Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?loc=0&rl=2&tt=supportive_care&tt=health_services_research&tt=basic_science&id=NCI-2019-01528""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase III</td> 					<td>Supportive care</td> 					<td>Active</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> URCC-18007<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2019-01528<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT03996265"" target=""_blank"">NCT03996265</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase III trial studies how well bupropion works in reducing cancer related fatigue in cancer survivors. Cancer and its treatment can cause fatigue. Bupropion is a drug that is used to treat depression, as well as to help people quit smoking. It belongs to the family of drugs called antidepressants and works by increasing certain types of activity in the brain. Bupropion may reduce cancer-related fatigue by causing changes in inflammation and stress hormones. Giving bupropion may improve cancer related fatigue in cancer survivors.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																						<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>Be at least 18 years of age</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Be diagnosed with cancer</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Have stable disease or no evidence of disease</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Report WORST level of fatigue in the past week as moderate to severe (i.e., a score &gt;= 4 on a 0-10 scale, screening measures, question 1)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Have completed surgery, radiation, and/or systemic intravenous anticancer therapy (e.g., chemotherapy, targeted therapy, immunotherapy) 2 or more months prior to enrollment. Participants currently receiving oral maintenance, targeted, or hormonal therapy are eligible. Participants receiving intravenous supportive therapy (e.g., bisphosphonates) are eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Able to read and speak English</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Currently not pregnant or breastfeeding. Women of child-bearing potential must agree to use adequate contraception, i.e, abstinence, IUD (intrauterine device), hormonal contraceptive (birth control pills) or barrier method (condoms) prior to study entry and for the duration of study participation</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Be capable of providing written informed consent</li> 												</ul> 						</div> 														<h4>Exclusion Criteria</h4> 										<div> 							<ul> 																<li>Be receiving intravenous anti-cancer therapy (e.g., intravenous immune checkpoint inhibitor therapy, targeted therapy)</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Be currently taking any medications that contain bupropion (e.g., Wellbutrin, Forfivo, Aplenzin, or Zyban)</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Be taking an monoamine oxidase inhibitor (MAOI), linezolid, or methylene blue within two weeks prior to enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Be taking any anti-psychotic medications within a week prior to enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have a history of renal impairment (i.e., glomerular filtration rate &lt; 45)</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have a history of cirrhosis (i.e., Child-Pugh score &gt;= 5)</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have a history of seizures</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have a history of bulimia or anorexia nervosa</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Report a history of sensitivity to bupropion</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Report an allergy to lactose</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have psychiatric or neurological disorder(s) that would interfere with study participation per physician or physician’s designee</li> 												</ul> 						</div> 							 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE:</p><p class='ctrp'>I. To determine the efficacy of bupropion hydrochloride controlled-release (bupropion) versus placebo in reducing fatigue in a double-blinded, placebo-controlled, randomized clinical trial of cancer survivors with fatigue.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES:</p><p class='ctrp'>I. To assess the efficacy of bupropion versus placebo on depression and quality of life in cancer survivors with fatigue.</p><p class='ctrp'>II. To assess the tolerability of bupropion in cancer survivors with fatigue.</p><p class='ctrp'></p><p class='ctrp'>EXPLORATORY OBJECTIVES:</p><p class='ctrp'>I. To assess the efficacy of bupropion versus placebo on symptomatology and cognition in cancer survivors with fatigue.</p><p class='ctrp'>II. To explore the effects of bupropion on putative mechanisms of cancer-related fatigue.</p><p class='ctrp'>III. To explore associations of CYP2B6 genotype with bupropion metabolism and changes in fatigue.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE: Patients are randomized to 1 of 2 arms.</p><p class='ctrp'></p><p class='ctrp'>ARM I: Patients receive bupropion hydrochloride controlled-release orally (PO) once daily (QD) for up to 13 weeks in the absence of unacceptable toxicity. Patients also undergo blood sample collection throughout study.</p><p class='ctrp'></p><p class='ctrp'>ARM II: Patients receive placebo PO QD for up to 13 weeks in the absence of unacceptable toxicity.  Patients also undergo blood sample collection throughout study.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>University of Rochester NCORP Research Base</div> 													<div>Principal Investigator: Heather S.L. Jim</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT03996265"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>Alaska</h4>                           <h5 class=""locationCity"">Anchorage</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alaska Breast Care and Surgery LLC</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alaska Oncology and Hematology LLC</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alaska Women's Cancer Care</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Anchorage Associates in Radiation Medicine</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Anchorage Oncology Centre</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Anchorage Radiation Therapy Center</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Katmai Oncology Group</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Alaska Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Fairbanks</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairbanks Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 907-458-3043 <br>Email: <a href=""mailto:Veronica.Stevenson@foundationhealth.org"">Veronica.Stevenson@foundationhealth.org</a>   </span> </div>                                   <h4>Arizona</h4>                           <h5 class=""locationCity"">Kingman</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kingman Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                   <h4>Arkansas</h4>                           <h5 class=""locationCity"">Ft. Smith</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Fort Smith</strong>     <br>Contact: Site Public Contact <br>Phone: 800-378-9373   </span> </div>                                       <h5 class=""locationCity"">Little Rock</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CARTI Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 501-906-4199 <br>Email: <a href=""mailto:Research@CARTI.com"">Research@CARTI.com</a>   </span> </div>                                   <h4>California</h4>                           <h5 class=""locationCity"">Antioch</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Deer Valley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Arroyo Grande</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">PCR Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Burbank</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Saint Joseph Medical Center/Disney Family Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 818-847-4793 <br>Email: <a href=""mailto:Najee.Boucher@providence.org"">Najee.Boucher@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Dublin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente Dublin</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691   </span> </div>                                       <h5 class=""locationCity"">Fremont</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Fremont</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Fresno</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fresno Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Fresno</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Martinez</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Contra Costa Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 925-957-5400   </span> </div>                                       <h5 class=""locationCity"">Modesto</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Modesto</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Oakland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente Oakland-Broadway</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Oakland</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rancho Cordova</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Rancho Cordova Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Redwood City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente- Marshall Medical Offices</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Redwood City</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Richmond</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Richmond</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rohnert Park</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rohnert Park Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Roseville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Roseville</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Permanente Medical Group-Roseville Radiation Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sacramento</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente Downtown Commons</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:kpoct@kp.org"">kpoct@kp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-South Sacramento</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">South Sacramento Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">San Francisco</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-San Francisco</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">San Jose</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Santa Teresa-San Jose</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">San Leandro</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente San Leandro</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">San Rafael</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser San Rafael-Gallinas</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Santa Clara</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente Medical Center - Santa Clara</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Santa Rosa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Santa Rosa</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">South San Francisco</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente Cancer Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-South San Francisco</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Stockton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Stockton</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Vacaville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente Medical Center-Vacaville</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Vallejo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Vallejo</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Walnut Creek</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">BASS Medical Group - Lennon</strong>     <br>Contact: Site Public Contact <br>Phone: 307-760-7636 <br>Email: <a href=""mailto:brenna.lindsey@bassmedicalgroup.com"">brenna.lindsey@bassmedicalgroup.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Walnut Creek</strong>     <br>Contact: Site Public Contact <br>Phone: 877-642-4691 <br>Email: <a href=""mailto:Kpoct@kp.org"">Kpoct@kp.org</a>   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Aurora</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Aurora</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Boulder</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Boulder Community Foothills Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Boulder</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Centennial</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers - Centennial</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Denver</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Colorado Blood Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Franklin</strong>     <br>Contact: Site Public Contact <br>Phone: 303-720-2685 <br>Email: <a href=""mailto:kristi.m.bronkan@kp.org"">kristi.m.bronkan@kp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Midtown</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Rose</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Women's Imaging Center</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Englewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers - Swedish</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Melanoma and Skin Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ryan.weight@theskincancerinstitute.com"">ryan.weight@theskincancerinstitute.com</a>   </span> </div>                                       <h5 class=""locationCity"">Lafayette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Rock Creek</strong>     <br>Contact: Site Public Contact <br>Phone: 303-720-2685 <br>Email: <a href=""mailto:kristi.m.bronkan@kp.org"">kristi.m.bronkan@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lakewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Lakewood</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Littleton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Littleton</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lone Tree</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Lone Tree</strong>     <br>Contact: Site Public Contact <br>Phone: 303-720-2685 <br>Email: <a href=""mailto:kristi.m.bronkan@kp.org"">kristi.m.bronkan@kp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Sky Ridge</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Longmont</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Longmont</strong>     <br>Contact: Site Public Contact <br>Phone: 719-776-6550 <br>Email: <a href=""mailto:ResearchTracking@Centura.Org"">ResearchTracking@Centura.Org</a>   </span> </div>                                       <h5 class=""locationCity"">Thornton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Thornton</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Lewes</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Millville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe South Coastal Health Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Christiana Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delaware Clinical and Laboratory Physicians PA</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:mhayden@christianacare.org"">mhayden@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Helen F Graham Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Medical Oncology Hematology Consultants PA</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rehoboth Beach</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe Health Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Seaford</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">TidalHealth Nanticoke / Allen Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 410-543-7019 <br>Email: <a href=""mailto:anna-maria.howard@peninsula.org"">anna-maria.howard@peninsula.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wilmington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Wilmington Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                   <h4>Florida</h4>                           <h5 class=""locationCity"">Fort Lauderdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Holy Cross Hospital</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:eileen.georgi@holy-cross.com"">eileen.georgi@holy-cross.com</a>   </span> </div>                                   <h4>Georgia</h4>                           <h5 class=""locationCity"">Atlanta</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northside Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 404-303-3355 <br>Email: <a href=""mailto:ClinicalTrials@northside.com"">ClinicalTrials@northside.com</a>   </span> </div>                                       <h5 class=""locationCity"">Duluth</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northside Hospital - Duluth</strong>     <br>Contact: Site Public Contact <br>Phone: 404-303-3355 <br>Email: <a href=""mailto:Clinical.trials@northside.com"">Clinical.trials@northside.com</a>   </span> </div>                                       <h5 class=""locationCity"">Lawrenceville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northside Hospital - Gwinnett</strong>     <br>Contact: Site Public Contact <br>Phone: 404-303-3355 <br>Email: <a href=""mailto:Clinical.trials@northside.com"">Clinical.trials@northside.com</a>   </span> </div>                                   <h4>Hawaii</h4>                           <h5 class=""locationCity"">Aiea</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hawaii Cancer Care - Westridge</strong>     <br>Contact: Jeffrey L. Berenberg <br>Phone: 808-586-2979 <br>Email: <a href=""mailto:jeffrey.l.Berenberg.civ@mail.mil"">jeffrey.l.Berenberg.civ@mail.mil</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Pali Momi Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 808-486-6000   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Queen's Cancer Center - Pearlridge</strong>     <br>Contact: Site Public Contact <br>Phone: 808-487-7447   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Cancer Center of Hawaii-Pali Momi</strong>     <br>Contact: Site Public Contact <br>Phone: 808-678-9000   </span> </div>                                       <h5 class=""locationCity"">Ewa Beach</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Queen's Medical Center - West Oahu</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:rohta@queens.org"">rohta@queens.org</a>   </span> </div>                                       <h5 class=""locationCity"">Hilo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Island Urology-Hilo</strong>     <br>Contact: Site Public Contact <br>Phone: 808-536-2306   </span> </div>                                       <h5 class=""locationCity"">Honolulu</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hawaii Cancer Care Inc - Waterfront Plaza</strong>     <br>Contact: Jeffrey L. Berenberg <br>Phone: 808-586-2979 <br>Email: <a href=""mailto:jeffrey.l.Berenberg.civ@mail.mil"">jeffrey.l.Berenberg.civ@mail.mil</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hawaii Cancer Care Inc-Liliha</strong>     <br>Contact: Jeffrey L. Berenberg <br>Phone: 808-586-2979 <br>Email: <a href=""mailto:jeffrey.l.Berenberg.civ@mail.mil"">jeffrey.l.Berenberg.civ@mail.mil</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hawaii Diagnostic Radiology Services LLC</strong>     <br>Contact: Site Public Contact <br>Phone: 808-792-7897 <br>Email: <a href=""mailto:mmiyoshi@hawaiidrs.com"">mmiyoshi@hawaiidrs.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Island Urology</strong>     <br>Contact: Site Public Contact <br>Phone: 808-536-2306 <br>Email: <a href=""mailto:virginia@cc.hawaii.edu"">virginia@cc.hawaii.edu</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente Moanalua Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 808-432-5195 <br>Email: <a href=""mailto:shelley.a.clark@kp.org"">shelley.a.clark@kp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kapiolani Medical Center for Women and Children</strong>     <br>Contact: Jeffrey L. Berenberg <br>Phone: 808-586-2979 <br>Email: <a href=""mailto:jeffrey.l.Berenberg.civ@mail.mil"">jeffrey.l.Berenberg.civ@mail.mil</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kuakini Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 808-547-9816   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Queen's Cancer Cenrer - POB I</strong>     <br>Contact: Jeffrey L. Berenberg <br>Phone: 808-586-2979 <br>Email: <a href=""mailto:jeffrey.l.Berenberg.civ@mail.miL"">jeffrey.l.Berenberg.civ@mail.miL</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Queen's Cancer Center - Kuakini</strong>     <br>Contact: Jeffrey L. Berenberg <br>Phone: 808-586-2979 <br>Email: <a href=""mailto:jeffrey.l.Berenberg.civ@mail.mil"">jeffrey.l.Berenberg.civ@mail.mil</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Queen's Medical Center</strong>     <br>Contact: Jeffrey L. Berenberg <br>Phone: 808-586-2979 <br>Email: <a href=""mailto:Jeffrey.l.Berenberg.civ@mail.mil"">Jeffrey.l.Berenberg.civ@mail.mil</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Straub Clinic and Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 808-522-4333   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Cancer Center of Hawaii-Liliha</strong>     <br>Contact: Site Public Contact <br>Phone: 808-547-6881   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Hawaii Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 808-586-2979   </span> </div>                                       <h5 class=""locationCity"">Kahului</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Straub Medical Center - Kahului Clinic</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:lori.kam@hawaiipacifichealth.org"">lori.kam@hawaiipacifichealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Kailua</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Castle Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 888-823-5923 <br>Email: <a href=""mailto:ctsucontact@westat.com"">ctsucontact@westat.com</a>   </span> </div>                                       <h5 class=""locationCity"">Lihue</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Wilcox Memorial Hospital and Kauai Medical Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 808-535-7960   </span> </div>                                   <h4>Idaho</h4>                           <h5 class=""locationCity"">Boise</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Cancer Institute - Boise</strong>     <br>Contact: Site Public Contact <br>Phone: 208-381-2774 <br>Email: <a href=""mailto:eslinget@slhs.org"">eslinget@slhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Fruitland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Cancer Institute - Fruitland</strong>     <br>Contact: Site Public Contact <br>Phone: 208-381-2774 <br>Email: <a href=""mailto:eslinget@slhs.org"">eslinget@slhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Meridian</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Cancer Institute - Meridian</strong>     <br>Contact: Site Public Contact <br>Phone: 208-381-2774 <br>Email: <a href=""mailto:eslinget@slhs.org"">eslinget@slhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Nampa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Cancer Institute - Nampa</strong>     <br>Contact: Site Public Contact <br>Phone: 208-381-2774 <br>Email: <a href=""mailto:eslinget@slhs.org"">eslinget@slhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Twin Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Cancer Institute - Twin Falls</strong>     <br>Contact: Site Public Contact <br>Phone: 208-381-2774 <br>Email: <a href=""mailto:eslinget@slhs.org"">eslinget@slhs.org</a>   </span> </div>                                   <h4>Illinois</h4>                           <h5 class=""locationCity"">Alton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Anthony's Health</strong>     <br>Contact: Site Public Contact <br>Phone: 618-463-5623   </span> </div>                                       <h5 class=""locationCity"">Aurora</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rush - Copley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 630-978-6212 <br>Email: <a href=""mailto:Cancer.Research@rushcopley.com"">Cancer.Research@rushcopley.com</a>   </span> </div>                                       <h5 class=""locationCity"">Bloomington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bromenn Lifecare Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Bloomington</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Carbondale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Hospital of Carbondale</strong>     <br>Contact: Site Public Contact <br>Phone: 618-457-5200 <br>Email: <a href=""mailto:clinical.research@sih.net"">clinical.research@sih.net</a>   </span> </div>                                       <h5 class=""locationCity"">Carterville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">SIH Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 618-985-3333 <br>Email: <a href=""mailto:clinical.research@sih.net"">clinical.research@sih.net</a>   </span> </div>                                       <h5 class=""locationCity"">Carthage</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Carthage</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Centralia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Centralia Oncology Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 888-823-5923 <br>Email: <a href=""mailto:ctsucontact@westat.com"">ctsucontact@westat.com</a>   </span> </div>                                       <h5 class=""locationCity"">Danville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle at The Riverfront</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Decatur</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Specialists of Illinois - Decatur</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Decatur Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Dixon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Dixon</strong>     <br>Contact: Site Public Contact <br>Phone: 815-285-7800   </span> </div>                                       <h5 class=""locationCity"">Effingham</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Physician Group-Effingham</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Crossroads Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Eureka</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Eureka</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Galesburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Galesburg</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Western Illinois Cancer Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 309-344-2831   </span> </div>                                       <h5 class=""locationCity"">Kewanee</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Kewanee Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Macomb</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Macomb</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Mattoon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Physician Group-Mattoon/Charleston</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Mount Vernon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Good Samaritan Regional Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 618-242-4600   </span> </div>                                       <h5 class=""locationCity"">Normal</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bromenn Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Cancer Institute Normal</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">O'Fallon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Center of O'Fallon</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">HSHS Saint Elizabeth's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Ottawa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Ottawa Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Pekin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Pekin</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Peoria</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Peoria</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Methodist Medical Center of Illinois</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Peru</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Peru</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Valley Radiation Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 815-664-4141   </span> </div>                                       <h5 class=""locationCity"">Princeton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Princeton</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Springfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 217-528-7541 <br>Email: <a href=""mailto:pallante.beth@mhsil.com"">pallante.beth@mhsil.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southern Illinois University School of Medicine</strong>     <br>Contact: Site Public Contact <br>Phone: 217-545-7929   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Springfield Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 800-444-7541   </span> </div>                                       <h5 class=""locationCity"">Swansea</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southwest Illinois Health Services LLP</strong>     <br>Contact: Site Public Contact <br>Phone: 618-236-1000 <br>Email: <a href=""mailto:lynns@thecancercenter.com"">lynns@thecancercenter.com</a>   </span> </div>                                       <h5 class=""locationCity"">Urbana</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Carle Foundation Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Washington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare - Washington</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Yorkville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rush-Copley Healthcare Center</strong>     <br>Contact: Site Public Contact <br>Phone: 630-978-6212 <br>Email: <a href=""mailto:Cancer.Research@rushcopley.com"">Cancer.Research@rushcopley.com</a>   </span> </div>                                   <h4>Indiana</h4>                           <h5 class=""locationCity"">Crown Point</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwest Cancer Center - Main Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 219-310-2550   </span> </div>                                       <h5 class=""locationCity"">Dyer</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwest Oncology LLC</strong>     <br>Contact: Site Public Contact <br>Phone: 219-924-8178   </span> </div>                                       <h5 class=""locationCity"">Hobart</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwest Cancer Center - Hobart</strong>     <br>Contact: Site Public Contact <br>Phone: 219-947-1795   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 219-836-6875 <br>Email: <a href=""mailto:CancerResearch@COMHS.org"">CancerResearch@COMHS.org</a>   </span> </div>                                       <h5 class=""locationCity"">Indianapolis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Catherine Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 888-823-5923 <br>Email: <a href=""mailto:ctsucontact@westat.com"">ctsucontact@westat.com</a>   </span> </div>                                       <h5 class=""locationCity"">Munster</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 219-836-3349   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Women's Diagnostic Center - Munster</strong>     <br>Contact: Site Public Contact <br>Phone: 219-934-8869 <br>Email: <a href=""mailto:mnicholson@comhs.org"">mnicholson@comhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Richmond</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Reid Health</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Valparaiso</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwest Cancer Center - Valparaiso</strong>     <br>Contact: Site Public Contact <br>Phone: 219-836-6875 <br>Email: <a href=""mailto:CancerResearch@COMHS.org"">CancerResearch@COMHS.org</a>   </span> </div>                                   <h4>Iowa</h4>                           <h5 class=""locationCity"">Cedar Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Physicians' Clinic of Iowa PC</strong>     <br>Contact: Site Public Contact <br>Phone: 319-297-2900   </span> </div>                                   <h4>Kansas</h4>                           <h5 class=""locationCity"">Garden City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Care Cancer Center - Garden City</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Great Bend</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Care Cancer Center - Great Bend</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lenexa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kansas Institute of Medicine Cancer and Blood Center</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Minimally Invasive Surgery Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Overland Park</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Menorah Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                   <h4>Kentucky</h4>                           <h5 class=""locationCity"">Paducah</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health - Paducah Medical Oncology and Hematology</strong>     <br>Contact: Site Public Contact <br>Phone: 270-538-5632 <br>Email: <a href=""mailto:BJWarner@mercy.com"">BJWarner@mercy.com</a>   </span> </div>                                   <h4>Louisiana</h4>                           <h5 class=""locationCity"">Houma</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Center of The South Incorporated</strong>     <br>Contact: Site Public Contact <br>Phone: 225-215-1353 <br>Email: <a href=""mailto:clinicalresearch@marybird.com"">clinicalresearch@marybird.com</a>   </span> </div>                                   <h4>Maryland</h4>                           <h5 class=""locationCity"">Elkton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care - Union Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 410-443-1360 <br>Email: <a href=""mailto:frank.crum@christianacare.org"">frank.crum@christianacare.org</a>   </span> </div>                                   <h4>Massachusetts</h4>                           <h5 class=""locationCity"">Springfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 413-748-9234   </span> </div>                                   <h4>Michigan</h4>                           <h5 class=""locationCity"">Ann Arbor</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Saint Joseph Mercy Hospital Ann Arbor</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Battle Creek</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bronson Battle Creek</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Brighton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Brighton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Medical Center - Brighton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Medical Center - Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Caro</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Caro Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chelsea</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Chelsea Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Chelsea Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Clarkston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hematology Oncology Consultants-Clarkston</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Newland Medical Associates-Clarkston</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Detroit</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Saint John Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">East China</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Doctors Park</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Flint</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesee Cancer and Blood Disease Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesee Hematology Oncology PC</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesys Hurley Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hurley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grand Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Grand Rapids Hospitals - Butterworth Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-267-1925 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Grand Rapids Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grosse Pointe Woods</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Academic Hematology Oncology Specialists</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Van Elslander Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Michigan Breast Specialists-Grosse Pointe Woods</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Kalamazoo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Borgess Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Borgess Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bronson Methodist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">West Michigan Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lansing</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Michigan Health - Sparrow Lansing</strong>     <br>Contact: Site Public Contact <br>Phone: 517-364-3712 <br>Email: <a href=""mailto:harsha.trivedi@umhsparrow.org"">harsha.trivedi@umhsparrow.org</a>   </span> </div>                                       <h5 class=""locationCity"">Livonia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hope Cancer Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-3671 <br>Email: <a href=""mailto:stephanie.couch@stjoeshealth.org"">stephanie.couch@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Saint Mary Mercy Livonia Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Macomb Township</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Macomb Medical Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Michigan Breast Specialists-Macomb Township</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Marlette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary's Oncology/Hematology Associates of Marlette</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Muskegon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Muskegon Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Niles</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Lakeland Hospitals - Niles Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230   </span> </div>                                       <h5 class=""locationCity"">Norton Shores</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer and Hematology Centers of Western Michigan - Norton Shores</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:connie.szczepanek@crcwm.org"">connie.szczepanek@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Pontiac</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hope Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Michigan Healthcare Professionals Pontiac</strong>     <br>Contact: Site Public Contact <br>Phone: 248-858-6215 <br>Email: <a href=""mailto:Emily.Crofts@trinity-health.org"">Emily.Crofts@trinity-health.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Newland Medical Associates-Pontiac</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Saint Joseph Mercy Oakland Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Port Huron</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Huron Medical Center PC</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lake Huron Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Reed City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Reed City Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rochester Hills</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Rochester Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-3671 <br>Email: <a href=""mailto:stephanie.couch@stjoeshealth.org"">stephanie.couch@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Saginaw</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MyMichigan Medical Center Saginaw</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Associates of Saginaw Valley PC</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Joseph</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Lakeland Hospitals - Saint Joseph Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sterling Heights</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bhadresh Nayak MD PC-Sterling Heights</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Tawas City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MyMichigan Medical Center Tawas</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Traverse City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Munson Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Warren</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Advanced Breast Care Center PLLC</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Macomb Professional Building</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Macomb Hematology Oncology PC</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Michigan Breast Specialists-Warren</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint John Macomb-Oakland Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">West Branch</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary's Oncology/Hematology Associates of West Branch</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wyoming</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Michigan Health - West</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Ypsilanti</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Huron Gastroenterology PC</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology  Ann Arbor Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                   <h4>Minnesota</h4>                           <h5 class=""locationCity"">Burnsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Ridges Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Minnesota Oncology - Burnsville</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Cambridge</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cambridge Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Coon Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Edina</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Southdale Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Maple Grove</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Clinics and Surgery Center Maple Grove</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Maplewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Minnesota Oncology Hematology PA-Maplewood</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint John's Hospital - Healtheast</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Minneapolis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Abbott-Northwestern Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Health Partners Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hennepin County Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Monticello</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Monticello Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">New Ulm</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">New Ulm Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Princeton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Northland Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Robbinsdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">North Memorial Medical Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Louis Park</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Park Nicollet Clinic - Saint Louis Park</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Paul</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Regions Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">United Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Shakopee</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Stillwater</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lakeview Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Waconia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ridgeview Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Willmar</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rice Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Woodbury</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Minnesota Oncology Hematology PA-Woodbury</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Wyoming</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Lakes Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                   <h4>Missouri</h4>                           <h5 class=""locationCity"">Ballwin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Louis Cancer and Breast Institute-Ballwin</strong>     <br>Contact: Site Public Contact <br>Phone: 314-251-7058   </span> </div>                                       <h5 class=""locationCity"">Bolivar</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Care Cancer Center - Bolivar</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bonne Terre</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Parkland Health Center-Bonne Terre</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Branson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cox Cancer Center Branson</strong>     <br>Contact: Site Public Contact <br>Phone: 417-269-4520   </span> </div>                                       <h5 class=""locationCity"">Cape Girardeau</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-334-2230 <br>Email: <a href=""mailto:sfmc@sfmc.net"">sfmc@sfmc.net</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southeast Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-651-5550   </span> </div>                                       <h5 class=""locationCity"">Farmington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Parkland Health Center - Farmington</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Independence</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Centerpoint Medical Center LLC</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Jefferson City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MU Health Care Goldschmidt Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-632-4851 <br>Email: <a href=""mailto:amy.franken@health.missouri.edu"">amy.franken@health.missouri.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Joplin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Freeman Health System</strong>     <br>Contact: Site Public Contact <br>Phone: 417-347-4030 <br>Email: <a href=""mailto:LJCrockett@freemanhealth.com"">LJCrockett@freemanhealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Joplin</strong>     <br>Contact: Site Public Contact <br>Phone: 417-556-3074 <br>Email: <a href=""mailto:esmeralda.carrillo@mercy.net"">esmeralda.carrillo@mercy.net</a>   </span> </div>                                       <h5 class=""locationCity"">Kansas City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Research Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Osage Beach</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lake Regional Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 573-302-2768 <br>Email: <a href=""mailto:clinicaltrials@lakeregional.com"">clinicaltrials@lakeregional.com</a>   </span> </div>                                       <h5 class=""locationCity"">Rolla</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delbert Day Cancer Institute at PCRMC</strong>     <br>Contact: Site Public Contact <br>Phone: 573-458-7504 <br>Email: <a href=""mailto:research@phelpshealth.org"">research@phelpshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Clinic-Rolla-Cancer and Hematology</strong>     <br>Contact: Site Public Contact <br>Phone: 573-458-6379   </span> </div>                                       <h5 class=""locationCity"">Saint Joseph</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Heartland Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 816-271-7937 <br>Email: <a href=""mailto:linda.schumacher@mymlc.com"">linda.schumacher@mymlc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Louis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Saint Louis</strong>     <br>Contact: Site Public Contact <br>Phone: 314-251-7066   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital South</strong>     <br>Contact: Site Public Contact <br>Phone: 314-525-6042 <br>Email: <a href=""mailto:Danielle.Werle@mercy.net"">Danielle.Werle@mercy.net</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Missouri Baptist Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Louis Cancer and Breast Institute-South City</strong>     <br>Contact: Site Public Contact <br>Phone: 314-353-1870   </span> </div>                                       <h5 class=""locationCity"">Sainte Genevieve</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sainte Genevieve County Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Springfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CoxHealth South Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 417-269-4520   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Springfield</strong>     <br>Contact: Site Public Contact <br>Phone: 417-269-4520   </span> </div>                                       <h5 class=""locationCity"">Sullivan</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Missouri Baptist Sullivan Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Sunset Hills</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">BJC Outpatient Center at Sunset Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Washington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Washington</strong>     <br>Contact: Site Public Contact <br>Phone: 636-390-1600   </span> </div>                                   <h4>Montana</h4>                           <h5 class=""locationCity"">Missoula</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Patrick Hospital - Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 406-327-3118 <br>Email: <a href=""mailto:amy.hanneman@providence.org"">amy.hanneman@providence.org</a>   </span> </div>                                   <h4>Nevada</h4>                           <h5 class=""locationCity"">Carson City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carson Tahoe Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Henderson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer and Blood Specialists-Henderson</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada - Henderson</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada-Horizon Ridge</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada-Southeast Henderson</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">GenesisCare USA - Henderson</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Cancer Center-Henderson</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Green Valley</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Pebble</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at Seven Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Urology Specialists of Nevada - Green Valley</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Las Vegas</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alliance for Childhood Diseases/Cure 4 the Kids Foundation</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ann M Wierman MD LTD</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer and Blood Specialists-Shadow</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer and Blood Specialists-Tenaya</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada - Central Valley</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada - Northwest</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada - Town Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada-Summerlin</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Desert West Surgery</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">GenesisCare USA - Fort Apache</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">GenesisCare USA - Las Vegas</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">GenesisCare USA - Vegas Tenaya</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">HealthCare Partners Medical Group Oncology/Hematology-San Martin</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">HealthCare Partners Medical Group Oncology/Hematology-Tenaya</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hope Cancer Care of Nevada</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Cancer Center-Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Prostate Cancer Center</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Cathedral Rock</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Pecos</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Smoke Ranch</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@smcrf.org"">research@smcrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Sunset</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at Charleston</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at Fort Apache</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at MountainView</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Radiation Oncology Centers of Nevada Central</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Radiation Oncology Centers of Nevada Southeast</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Summerlin Hospital Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sunrise Hospital and Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University Medical Center of Southern Nevada</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Urology Specialists of Nevada - Central</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Urology Specialists of Nevada - Northwest</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Urology Specialists of Nevada - Southwest</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Pahrump</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hope Cancer Care of Nevada-Pahrump</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Reno</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Radiation Oncology Associates</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Renown Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary's Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">Greenlawn</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwell Health Cancer Institute at Huntington</strong>     <br>Contact: Site Public Contact <br>Phone: 516-734-8896   </span> </div>                                   <h4>North Carolina</h4>                           <h5 class=""locationCity"">Asheboro</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cone Health Cancer Center at Asheboro</strong>     <br>Contact: Site Public Contact <br>Phone: 336-832-0836   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Randolph Health Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 336-832-0836 <br>Email: <a href=""mailto:stacey.phelps@conehealth.com"">stacey.phelps@conehealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Randolph Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 333-328-3333   </span> </div>                                       <h5 class=""locationCity"">Burlington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cone Health Cancer Center at Alamance Regional</strong>     <br>Contact: Site Public Contact <br>Phone: 336-832-0836 <br>Email: <a href=""mailto:stacey.phelps@conehealth.com"">stacey.phelps@conehealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Gastonia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CaroMont Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 704-834-2810 <br>Email: <a href=""mailto:tammy.cozad@caromonthealth.org"">tammy.cozad@caromonthealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Greensboro</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cone Health Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 336-832-0836 <br>Email: <a href=""mailto:stacey.phelps@conehealth.com"">stacey.phelps@conehealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cone Health Cancer Center at Drawbridge Parkway</strong>     <br>Contact: Site Public Contact <br>Phone: 336-832-0836 <br>Email: <a href=""mailto:stacey.phelps@conehealth.com"">stacey.phelps@conehealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Nags Head</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Outer Banks Hospital</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@vidanthealth.com"">research@vidanthealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Reidsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Annie Penn Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 336-832-0836 <br>Email: <a href=""mailto:stacey.phelps@conehealth.com"">stacey.phelps@conehealth.com</a>   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Beavercreek</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Indu and Raj Soin Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Belpre</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Strecker Cancer Center-Belpre</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Boardman</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Elizabeth Boardman Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Centerville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Dayton Physicians LLC-Miami Valley South</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Miami Valley Hospital South</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chillicothe</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Adena Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-779-7585 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Cincinnati</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Care Inc-Kenwood</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Columbus</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Columbus Oncology and Hematology Associates Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Doctors Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Grant Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mount Carmel East Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mount Carmel Health Center West</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Riverside Methodist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Mark H Zangmeister Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Dayton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Dayton Physician LLC - Englewood</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Good Samaritan Hospital - Dayton</strong>     <br>Contact: Site Public Contact <br>Phone: 937-416-9270 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Miami Valley Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Miami Valley Hospital North</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Delaware</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delaware Health Center-Grady Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Grady Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Dublin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Columbus Oncology and Hematology Associates</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Dublin Methodist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Findlay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Armes Family Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Blanchard Valley Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Orion Cancer Care</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Franklin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Atrium Medical Center-Middletown Regional Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Dayton Physicians LLC-Atrium</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Gahanna</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Ohio Breast and Endocrine Surgery</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Greenville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Dayton Physicians LLC-Wayne</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Wayne Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grove City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mount Carmel Grove City Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Zangmeister Center Grove City</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Kettering</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">First Dayton Cancer Care</strong>     <br>Contact: Site Public Contact <br>Phone: 937-416-9270 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Greater Dayton Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kettering Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lancaster</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairfield Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lima</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Rita's Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Mansfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OhioHealth Mansfield Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Marietta</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Marietta Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Marion</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OhioHealth Marion General Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Marysville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Mount Vernon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Knox Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">New Albany</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mount Carmel New Albany Surgical Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Licking Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Newark Radiation Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Perrysburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health Perrysburg Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Portsmouth</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southern Ohio Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Springfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Springfield Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Springfield Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Toledo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health - Saint Anne Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health - Saint Vincent Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health  Sylvania Radiation Oncology Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Troy</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Dayton Physicians LLC - Troy</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Upper Valley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Warren</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Joseph Warren Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Westerville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Ann's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wilmington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Clinton Memorial Hospital/Foster J Boyd Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">WPAFB</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Wright-Patterson Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Youngstown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Elizabeth Youngstown Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 937-528-2900 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Zanesville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesis Healthcare System Cancer Care Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                   <h4>Oklahoma</h4>                           <h5 class=""locationCity"">Oklahoma City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Oklahoma City</strong>     <br>Contact: Site Public Contact <br>Phone: 405-752-3402   </span> </div>                                   <h4>Oregon</h4>                           <h5 class=""locationCity"">Bend</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Charles Health System</strong>     <br>Contact: Site Public Contact <br>Phone: 541-706-2909 <br>Email: <a href=""mailto:nosall@stcharleshealthcare.org"">nosall@stcharleshealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Clackamas</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Clackamas Radiation Oncology Center</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Cancer Institute Clackamas Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Coos Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bay Area Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 541-269-8392 <br>Email: <a href=""mailto:cherie.cox@bayareahospital.org"">cherie.cox@bayareahospital.org</a>   </span> </div>                                       <h5 class=""locationCity"">Newberg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Newberg Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Oregon City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Willamette Falls Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Portland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Portland Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Saint Vincent Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Redmond</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Charles Health System-Redmond</strong>     <br>Contact: Site Public Contact <br>Phone: 541-706-2909   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Allentown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lehigh Valley Hospital-Cedar Crest</strong>     <br>Contact: Site Public Contact <br>Phone: 610-402-9543 <br>Email: <a href=""mailto:Morgan_M.Horton@lvhn.org"">Morgan_M.Horton@lvhn.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bethlehem</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lehigh Valley Hospital - Muhlenberg</strong>     <br>Contact: Site Public Contact <br>Phone: 610-402-9543 <br>Email: <a href=""mailto:Morgan_M.Horton@lvhn.org"">Morgan_M.Horton@lvhn.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chadds Ford</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Concord Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Danville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-271-5251 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">East Stroudsburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Pocono Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 610-402-9543 <br>Email: <a href=""mailto:Morgan_M.Horton@lvhn.org"">Morgan_M.Horton@lvhn.org</a>   </span> </div>                                       <h5 class=""locationCity"">Hazleton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Center-Cancer Center Hazleton</strong>     <br>Contact: Site Public Contact <br>Phone: 570-459-2901 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lehigh Valley Hospital-Hazleton</strong>     <br>Contact: Site Public Contact <br>Phone: 610-402-9543 <br>Email: <a href=""mailto:Morgan_M.Horton@lvhn.org"">Morgan_M.Horton@lvhn.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lewisburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Oncology-Lewisburg</strong>     <br>Contact: Site Public Contact <br>Phone: 570-374-8555 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Lewistown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lewistown Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 717-242-7703 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Pottsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Cancer Services-Pottsville</strong>     <br>Contact: Site Public Contact <br>Phone: 800-275-6401 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Scranton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Community Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-703-4768 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Selinsgrove</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Oncology-Selinsgrove</strong>     <br>Contact: Site Public Contact <br>Phone: 570-374-8555 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">State College</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Group</strong>     <br>Contact: Site Public Contact <br>Phone: 570-271-5251 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Wilkes-Barre</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Wyoming Valley/Henry Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-271-5251 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                   <h4>South Carolina</h4>                           <h5 class=""locationCity"">Boiling Springs</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Spartanburg</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Easley</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Easley</strong>     <br>Contact: Site Public Contact <br>Phone: 864-522-2066 <br>Email: <a href=""mailto:Kim.Williams3@prismahealth.org"">Kim.Williams3@prismahealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Gaffney</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Gibbs Cancer Center-Gaffney</strong>     <br>Contact: Site Public Contact <br>Phone: 864-560-6104 <br>Email: <a href=""mailto:kmertz-rivera@gibbscc.org"">kmertz-rivera@gibbscc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Greenville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Butternut</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Eastside</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Faris</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Greenville Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Greer</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Gibbs Cancer Center-Pelham</strong>     <br>Contact: Site Public Contact <br>Phone: 864-560-6104 <br>Email: <a href=""mailto:kmertz-rivera@gibbscc.org"">kmertz-rivera@gibbscc.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Greer</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Seneca</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Seneca</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Spartanburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Spartanburg Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 864-560-6104 <br>Email: <a href=""mailto:kmertz-rivera@gibbscc.org"">kmertz-rivera@gibbscc.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Spartanburg Medical Center - Mary Black Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 864-560-6812   </span> </div>                                       <h5 class=""locationCity"">Union</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MGC Hematology Oncology-Union</strong>     <br>Contact: Site Public Contact <br>Phone: 864-560-6104 <br>Email: <a href=""mailto:kmertz-rivera@gibbscc.org"">kmertz-rivera@gibbscc.org</a>   </span> </div>                                   <h4>Tennessee</h4>                           <h5 class=""locationCity"">Cookeville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cookeville Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 931-783-2714   </span> </div>                                   <h4>Virginia</h4>                           <h5 class=""locationCity"">Chesapeake</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Chesapeake Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:CancerCare@ChesapeakeRegional.com"">CancerCare@ChesapeakeRegional.com</a>   </span> </div>                                       <h5 class=""locationCity"">Martinsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sovah Health Martinsville</strong>     <br>Contact: Site Public Contact <br>Phone: 276-666-7489 <br>Email: <a href=""mailto:sharon.hubbard@lpnt.net"">sharon.hubbard@lpnt.net</a>   </span> </div>                                       <h5 class=""locationCity"">Mechanicsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bon Secours Memorial Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 804-893-8978 <br>Email: <a href=""mailto:anne_carmellat@bshsi.org"">anne_carmellat@bshsi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Midlothian</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bon Secours Saint Francis Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 804-893-8978 <br>Email: <a href=""mailto:anne_carmellat@bshsi.org"">anne_carmellat@bshsi.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bon Secours Westchester Emergency Center</strong>     <br>Contact: Site Public Contact <br>Phone: 804-893-8978 <br>Email: <a href=""mailto:anne_carmellat@bshsi.org"">anne_carmellat@bshsi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Norfolk</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bon Secours DePaul Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 757-278-2170 <br>Email: <a href=""mailto:Marylou_Anton@bshsi.org"">Marylou_Anton@bshsi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Portsmouth</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bon Secours Maryview Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 757-278-2170 <br>Email: <a href=""mailto:Marylou_Anton@bshsi.org"">Marylou_Anton@bshsi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Richmond</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bon Secours Cancer Institute at Reynolds Crossing</strong>     <br>Contact: Site Public Contact <br>Phone: 804-893-8978 <br>Email: <a href=""mailto:Anne_caramella@bshsi.org"">Anne_caramella@bshsi.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bon Secours Richmond Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 804-893-8978 <br>Email: <a href=""mailto:anne_carmellat@bshsi.org"">anne_carmellat@bshsi.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bon Secours Saint Mary's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 804-893-8978 <br>Email: <a href=""mailto:anne_carmellat@bshsi.org"">anne_carmellat@bshsi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Suffolk</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bon Secours Health Center at Harbour View</strong>     <br>Contact: Site Public Contact <br>Phone: 757-278-2170 <br>Email: <a href=""mailto:Marylou_Anton@bshsi.org"">Marylou_Anton@bshsi.org</a>   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Aberdeen</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer System-Aberdeen</strong>     <br>Contact: Site Public Contact <br>Phone: 360-412-8958 <br>Email: <a href=""mailto:deidre.dillon@providence.org"">deidre.dillon@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bellevue</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Overlake Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 425-688-5407 <br>Email: <a href=""mailto:OHMCResearch@overlakehospital.org"">OHMCResearch@overlakehospital.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bellingham</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">PeaceHealth Saint Joseph Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 360-788-8223   </span> </div>                                       <h5 class=""locationCity"">Centralia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer System-Centralia</strong>     <br>Contact: Site Public Contact <br>Phone: 360-412-8958 <br>Email: <a href=""mailto:deidre.dillon@providence.org"">deidre.dillon@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Edmonds</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Cancer Institute-Edmonds</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Everett</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer Partnership</strong>     <br>Contact: Site Public Contact <br>Phone: 425-261-3529 <br>Email: <a href=""mailto:marilyn.birchman@providence.org"">marilyn.birchman@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Issaquah</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Cancer Institute-Issaquah</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Kennewick</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kadlec Clinic Hematology and Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 509-783-4637 <br>Email: <a href=""mailto:research@kadlecmed.org"">research@kadlecmed.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lacey</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer System-Lacey</strong>     <br>Contact: Site Public Contact <br>Phone: 360-412-8958 <br>Email: <a href=""mailto:deidre.dillon@providence.org"">deidre.dillon@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Longview</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">PeaceHealth Saint John Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 360-514-2016 <br>Email: <a href=""mailto:kmakin-bond@peacehealth.org"">kmakin-bond@peacehealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Mount Vernon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Skagit Regional Health Cancer Care Center</strong>     <br>Contact: Site Public Contact <br>Phone: 360-814-2182 <br>Email: <a href=""mailto:rcccclinicalresearch@skagitvalleyhospital.org"">rcccclinicalresearch@skagitvalleyhospital.org</a>   </span> </div>                                       <h5 class=""locationCity"">Port Townsend</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Jefferson Healthcare</strong>     <br>Contact: Site Public Contact <br>Phone: 360-344-3091   </span> </div>                                       <h5 class=""locationCity"">Renton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Valley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 425-228-3440 <br>Email: <a href=""mailto:research@valleymed.org"">research@valleymed.org</a>   </span> </div>                                       <h5 class=""locationCity"">Seattle</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Pacific Gynecology Specialists</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Medical Center-Ballard Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Medical Center-Cherry Hill</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Medical Center-First Hill</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sedro-Woolley</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">PeaceHealth United General Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 360-788-8238 <br>Email: <a href=""mailto:lkey@peacehealth.org"">lkey@peacehealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Shelton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer System-Shelton</strong>     <br>Contact: Site Public Contact <br>Phone: 360-412-8958 <br>Email: <a href=""mailto:deidre.dillon@providence.org"">deidre.dillon@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Vancouver</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">PeaceHealth Southwest Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 360-514-3940 <br>Email: <a href=""mailto:kmakin-bond@peacehealth.org"">kmakin-bond@peacehealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Walla Walla</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Saint Mary Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 509-897-5993 <br>Email: <a href=""mailto:Cheryl.Dodd@providence.org"">Cheryl.Dodd@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Yakima</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">North Star Lodge Cancer Center at Yakima Valley Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 509-574-3535 <br>Email: <a href=""mailto:Memorial-ClinicalTrials@yvmh.org"">Memorial-ClinicalTrials@yvmh.org</a>   </span> </div>                                       <h5 class=""locationCity"">Yelm</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer System-Yelm</strong>     <br>Contact: Site Public Contact <br>Phone: 360-412-8958 <br>Email: <a href=""mailto:deidre.dillon@providence.org"">deidre.dillon@providence.org</a>   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Antigo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Langlade Hospital and Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 715-623-9869 <br>Email: <a href=""mailto:Juli.Alford@aspirus.org"">Juli.Alford@aspirus.org</a>   </span> </div>                                       <h5 class=""locationCity"">Appleton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Saint Elizabeth Hospital</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.inquiry@ascension.org"">AWRI.inquiry@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">ThedaCare Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 920-364-3604 <br>Email: <a href=""mailto:ResearchDept@thedacare.org"">ResearchDept@thedacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Brookfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Southeast Wisconsin Hospital - Elmbrook Campus</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.Inquiry@Ascension.org"">AWRI.Inquiry@Ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chilton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Calumet Hospital</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.inquiry@ascension.org"">AWRI.inquiry@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Eau Claire</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">HSHS Sacred Heart Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:ewd_research_admin@hshs.org"">ewd_research_admin@hshs.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Marshfield Medical Center-EC Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-782-8581 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                                       <h5 class=""locationCity"">Franklin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Saint Francis - Reiman Cancer Center</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.Inquiry@Ascension.org"">AWRI.Inquiry@Ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Southeast Wisconsin Hospital - Franklin</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.Inquiry@Ascension.org"">AWRI.Inquiry@Ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Green Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Saint Mary's</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:ewd_research_admin@hshs.org"">ewd_research_admin@hshs.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center Green Bay</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:ewd_research_admin@hshs.org"">ewd_research_admin@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Marshfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Marshfield Medical Center-Marshfield</strong>     <br>Contact: Site Public Contact <br>Phone: 800-782-8581 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                                       <h5 class=""locationCity"">Medford</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Aspirus Medford Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 715-847-2353 <br>Email: <a href=""mailto:Beth.Knetter@aspirus.org"">Beth.Knetter@aspirus.org</a>   </span> </div>                                       <h5 class=""locationCity"">Mequon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Columbia Saint Mary's Hospital Ozaukee</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.Inquiry@Ascension.org"">AWRI.Inquiry@Ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Milwaukee</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Columbia Saint Mary's Hospital - Milwaukee</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.Inquiry@Ascension.org"">AWRI.Inquiry@Ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Saint Francis Hospital</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.Inquiry@Ascension.org"">AWRI.Inquiry@Ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Southeast Wisconsin Hospital - Saint Joseph Campus</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.Inquiry@Ascension.org"">AWRI.Inquiry@Ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Minocqua</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Marshfield Clinic-Minocqua Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-782-8581 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                                       <h5 class=""locationCity"">New Richmond</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Center of Western Wisconsin</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Oshkosh</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Mercy Hospital</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.inquiry@ascension.org"">AWRI.inquiry@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Racine</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension All Saints Hospital</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.Inquiry@Ascension.org"">AWRI.Inquiry@Ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rhinelander</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Saint Mary's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 715-847-2353 <br>Email: <a href=""mailto:Beth.Knetter@aspirus.org"">Beth.Knetter@aspirus.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rice Lake</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Marshfield Medical Center-Rice Lake</strong>     <br>Contact: Site Public Contact <br>Phone: 800-782-8581 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                                       <h5 class=""locationCity"">Stevens Point</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Saint Michael's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 715-847-2353 <br>Email: <a href=""mailto:Beth.Knetter@aspirus.org"">Beth.Knetter@aspirus.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Marshfield Medical Center-River Region at Stevens Point</strong>     <br>Contact: Site Public Contact <br>Phone: 800-782-8581 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wausau</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Aspirus Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-405-6866   </span> </div>                                       <h5 class=""locationCity"">Wauwatosa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Medical Group Southeast Wisconsin - Mayfair Road</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:AWRI.Inquiry@Ascension.org"">AWRI.Inquiry@Ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Weston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Marshfield Medical Center - Weston</strong>     <br>Contact: Site Public Contact <br>Phone: 800-782-8581 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wisconsin Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Aspirus Cancer Care - Wisconsin Rapids</strong>     <br>Contact: Site Public Contact <br>Phone: 715-422-7718   </span> </div>                           			</div> 		</div> 			<div class=""trialContainer""> 			<h2 class=""hangingIndent"">3. Netupitant/Palonosetron Hydrochloride and Dexamethasone with or without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients with Breast Cancer</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?loc=0&rl=2&tt=supportive_care&tt=health_services_research&tt=basic_science&id=NCI-2017-00902""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase III</td> 					<td>Supportive care</td> 					<td>Closed to Accrual and Intervention</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> URCC16070<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> URCC-16070, NCI-2017-00902<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT03367572"" target=""_blank"">NCT03367572</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This randomized phase III trial studies how well netupitant/palonosetron hydrochloride and dexamethasone with or without prochlorperazine or olanzapine work in improving chemotherapy-induced nausea and vomiting in patients with breast cancer. Antiemetic drugs, such as prochlorperazine and olanzapine, may help lessen nausea and vomiting in patients with breast cancer treated with chemotherapy.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>INCLUSION CRITERIA FOR PARTICIPATION IN THE CYCLE 1 PORTION OF THE STUDY</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Have a diagnosis of breast cancer and be chemotherapy naive; NOTE: prior methotrexate for non-cancerous conditions is allowed</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Be scheduled to receive a single-day chemotherapy regimen that contains doxorubicin and/or cyclophosphamide and/or carboplatin; Herceptin (trastuzumab) and other chemotherapy agents will be allowed with any of these regimens</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Be scheduled to receive an antiemetic regimen that does not contain Akynzeo * For chemotherapy regimens with a high emetic risk, the antiemetic regimen must include an natural killer (NK)-1 antagonist receptor, a 5HT3 receptor antagonist and dexamethasone; other antiemetics, including additional dexamethasone and olanzapine, may also be included at cycle one * For chemotherapy regimens with a moderate emetic risk, the antiemetic regimen must include a 5HT3 receptor antagonist and dexamethasone; other antiemetics, including additional dexamethasone and olanzapine, may also be included at cycle one</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Be able to read English; materials will not be provided in Spanish because validated translations of most of the study measures are not available in Spanish, and Spanish translating capacity is not available at all affiliate sites</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Have the ability to give written informed consent</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Be at least 18 years of age</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Be female</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Have Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: Because the National Comprehensive Cancer Network (NCCN) antiemetic guidelines state that olanzapine should be used with caution in elderly patients, patients 80 years of age or older must have approval from an oncologist or their designee to participate in this study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>NOTE: Because aprepitant can lower international normalized ratio (INR) levels if taken concurrently with warfarin, patients currently receiving warfarin must have approval from an oncologist or their designee to participate in this study.</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control, or abstinence) for the duration of the study and have a negative pregnancy test within 10 days prior to the initiation of chemotherapy; should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her study physician immediately</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>CYCLE II PORTION ONLY: Only participants with a nausea score &gt;= 3 at least once on the 4-day home record from cycle 1 can be randomized for cycle 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>CYCLE II PORTION ONLY: Participants must be scheduled to receive the same chemotherapy regimen as received at cycle 1</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>CYCLE II PORTION ONLY: Because quinolone antibiotic therapy can increase the level or effect of olanzapine by altering drug metabolism and thereby potentially increase risk of side effects, patients currently receiving quinolone antibiotic therapy must have approval from an oncologist or their designee to participate in the cycle 2 portion of the study</li> 												</ul> 						</div> 														<h4>Exclusion Criteria</h4> 										<div> 							<ul> 																<li>PARTICIPATION IN THE CYCLE I PORTION OF THE STUDY</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have clinical evidence of current or impending bowel obstruction</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have a known history of central nervous system disease (e.g., brain metastases or a seizure disorder)</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have dementia</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have uncontrolled diabetes mellitus or uncontrolled hyperglycemia</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have severe hepatic impairment, severe renal impairment, or end-stage renal disease as determined by the treating physician</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have had long-term treatment (&gt; 5 days within the past 30 days) with an antipsychotic agent such as risperidone, quetiapine, clozapine, a phenothiazine, or a butyrophenone within 30 days before enrollment or plans for such treatment during the study period; Note: Participants could have received prochlorperazine and other phenothiazines as antiemetic therapy on a short term basis (i.e., =&lt; 5 days)</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have a known cardiac arrhythmia, uncontrolled congestive heart failure, or acute myocardial infarction within the previous 6 months</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Be taking benzodiazepines regularly (&gt; 5 days within the past 30 days); pro re nata (PRN) use (=&lt; 5 days) for the short-term relief of the symptoms of anxiety, anxiety associated with depressive symptoms, or as a rescue medication for breakthrough CINV is allowed</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Be taking anticholinergic medications</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Be receiving quinolone antibiotic therapy</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Be taking amifostine (Ethiofos)</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Have a known hypersensitivity to olanzapine or to phenothiazines</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>CYCLE II PORTION ONLY: Must not have received Akynzeo at cycle 1</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>CYCLE II PORTION ONLY: Must still meet all the exclusion criteria for cycle 1</li> 												</ul> 						</div> 							 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE:</p><p class='ctrp'>I. To determine if control of nausea at cycle 2 in participants who experienced chemotherapy-induced nausea and vomiting (CINV) at cycle 1 is improved by the addition of either prochlorperazine or olanzapine to the control arm of netupitant, palonosetron and dexamethasone.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES:</p><p class='ctrp'>I. To determine if olanzapine is more effective than prochlorperazine in controlling nausea at cycle 2 in participants who experienced CINV at cycle 1 when used in combination with netupitant, palonosetron and dexamethasone.</p><p class='ctrp'>II. To determine if control of vomiting at cycle 2 in patients who experienced CINV at cycle 1 is improved by the addition of either prochlorperazine or olanzapine to the control arm of netupitant, palonosetron and dexamethasone.</p><p class='ctrp'>III. To determine if olanzapine is more effective than prochlorperazine in controlling vomiting at cycle 2 in participants who experienced CINV at cycle 1 when used in combination with netupitant, palonosetron and dexamethasone. </p><p class='ctrp'></p><p class='ctrp'>EXPLORATORY OBJECTIVES:</p><p class='ctrp'>I. To create an empirically-based algorithm predicting nausea from breast cancer chemotherapy regimens that takes into account not only state-of-the-art anti-emetic regimens but also participant factors such as age, race, education, ethnicity, quality of life (QOL), alcohol consumption, susceptibility to nausea, expectancy, anxiety, level of nausea on the day prior to treatment, and prior history of nausea.</p><p class='ctrp'>II. To compare the effects of the interventions on QOL, as assessed by the Functional Assessment of Cancer Therapy- General (FACT-G), by following the same procedures described under the primary aim and the first secondary aim, using change in the FACT-G scores as the response.</p><p class='ctrp'>III. To provide preliminary data on the frequency and severity of sleep disturbance, fatigue, anxiety, and dizziness, across treatment conditions. </p><p class='ctrp'>IV. To provide preliminary data on biological factors (e.g. glutathione [GSH] recycling, genetic markers) that may help identify a subgroup of participants at high risk for development of cancer-related or treatment-related side effects, or response to treatment.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE: </p><p class='ctrp'>PART I: Patients receive 1 cycle of standard of care chemotherapy.</p><p class='ctrp'></p><p class='ctrp'>PART II: Patients with a nausea score &gt;= 3 at least once on the diary at cycle 1 chemotherapy are randomized into 1 of 3 groups at cycle 2.</p><p class='ctrp'></p><p class='ctrp'>GROUP I: Within 1 hour prior to chemotherapy, patients receive netupitant/palonosetron hydrochloride orally (PO) on day 1. Within 30 minutes prior to chemotherapy, patients also receive dexamethasone PO on days 1-4. Patients also receive placebo PO with chemotherapy every 8 hours (Q8H) on days 1-4.</p><p class='ctrp'></p><p class='ctrp'>GROUP II: Patients receive netupitant/palonosetron hydrochloride and dexamethasone as in Group I. Patients also receive prochlorperazine PO Q8H and placebo PO with chemotherapy on days 1-4.</p><p class='ctrp'></p><p class='ctrp'>GROUP III: Patients receive netupitant/palonosetron hydrochloride and dexamethasone as in Group I. Patients also receive olanzapine PO and placebo PO Q8H with chemotherapy on days 1-4.</p><p class='ctrp'></p><p class='ctrp'>Patients undergo blood sample collection at screening.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>University of Rochester NCORP Research Base</div> 													<div>Principal Investigator: Luke Joseph Peppone</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT03367572"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								     			</div> 		</div> 			<div class=""trialContainer""> 			<h2 class=""hangingIndent"">4. Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?loc=0&rl=2&tt=supportive_care&tt=health_services_research&tt=basic_science&id=NCI-2021-07529""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase NA</td> 					<td>Supportive care</td> 					<td>Temporarily Closed to Accrual</td> 					<td>18 													to 39 years 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> EAQ202<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> ECOG-ACRIN-EAQ202, NCI-2021-07529<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT05108298"" target=""_blank"">NCT05108298</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This clinical trial gathers information about adolescents and young adults (AYA) and patient reported outcomes data in Eastern Cooperative Oncology Group (ECOG)-American College of Radiology Imaging Network (ACRIN) trials to improve the collection of AYA patient reported outcomes. This study may help doctors understand the needs of adolescent and young adult cancer patients.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																								<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>Patient must be &gt;= 18 years and =&lt; 39 years of age at registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have a histologically confirmed diagnosis of primary cancer of any stage within 12 weeks (84 days) at registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must not have a recurrence or second primary cancer</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not have basal cell skin carcinoma</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have received, be currently receiving or planning to receive treatment for cancer, including surgery and/or chemotherapy and/or radiation therapy</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status 0-3</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have a life expectancy &gt; 24 months</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must be able to complete questionnaires in English or in Spanish</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have internet access through computer, tablet, or smartphone</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have an email address</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must have a mobile phone able with text messaging capabilities</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must be able to accurately provide self-report data (e.g. per clinical judgment, cognitive function is intact)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must be able to provide informed consent</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Participation in clinical trials is not an exclusionary criterion in EAQ202. Patients may be dually enrolled in EAQ202 as well as in therapeutic trials, including those involving checkpoint inhibitors * NOTE: We understand that some therapeutic trials may also collect PRO data (e.g., the cross-National Clinical Trials Network [NCTN] S1826 study in which ECOG-ACRIN is participating), thus creating a potential for overburdening patients. We will be attentive to informing all patients of this potential overburdening as they consider a voluntary decision to register for EAQ202. We will coordinate with the PRO chair(s) of the therapeutic studies to ensure that the integrity of the PRO analyses be preserved</li> 												</ul> 						</div> 										 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE:</p><p class='ctrp'>I. To evaluate feasibility and acceptability of completing patient reported outcomes (PROs) among AYAs randomized to Choice PRO versus (vs) Fixed PRO.</p><p class='ctrp'></p><p class='ctrp'>EXPLORATORY OBJECTIVES:</p><p class='ctrp'>I. To evaluate AYAs’ health-related quality of life (HRQOL) priorities and HRQOL PRO trajectories.</p><p class='ctrp'>II. To evaluate access to and utilization of psychosocial and financial resources using items from the Consumer-Based Cancer Care Value Index (CCVI).</p><p class='ctrp'>III. To summarize AYAs’ preferences for how their PRO data should be shared with them, their families, and/or their providers.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE: Patients are randomized to 1 of 2 arms.</p><p class='ctrp'></p><p class='ctrp'>ARM I (CHOICE PRO): Patients rank 15 HRQOL domains from most important to least important and choose 5 HRQOL domains to complete over 13-18 minutes at baseline, 1, 3, 6 and 12 months.</p><p class='ctrp'></p><p class='ctrp'>ARM II (FIXED PRO): Patients rank 15 HRQOL domains from most important to least important and complete 5 pre-selected HRQOL domains over 13-18 minutes at baseline, 1, 3, 6 and 12 months.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>ECOG-ACRIN Cancer Research Group</div> 													<div>Principal Investigator: John M Salsman</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT05108298"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>Alaska</h4>                           <h5 class=""locationCity"">Fairbanks</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairbanks Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 907-458-3043 <br>Email: <a href=""mailto:Veronica.Stevenson@foundationhealth.org"">Veronica.Stevenson@foundationhealth.org</a>   </span> </div>                                   <h4>Arizona</h4>                           <h5 class=""locationCity"">Kingman</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kingman Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                   <h4>Arkansas</h4>                           <h5 class=""locationCity"">Ft. Smith</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Fort Smith</strong>     <br>Contact: Site Public Contact <br>Phone: 800-378-9373   </span> </div>                                       <h5 class=""locationCity"">Hot Springs</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CHI Saint Vincent Cancer Center Hot Springs</strong>     <br>Contact: Site Public Contact <br>Phone: 855-313-2409 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Little Rock</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CARTI Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 501-906-4199 <br>Email: <a href=""mailto:Research@CARTI.com"">Research@CARTI.com</a>   </span> </div>                                   <h4>California</h4>                           <h5 class=""locationCity"">Arroyo Grande</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">PCR Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Dublin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Epic Care-Dublin</strong>     <br>Contact: Site Public Contact <br>Phone: 925-875-1677   </span> </div>                                       <h5 class=""locationCity"">Emeryville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bay Area Breast Surgeons Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 510-835-9900   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Epic Care Partners in Cancer Care</strong>     <br>Contact: Site Public Contact <br>Phone: 510-629-6682   </span> </div>                                       <h5 class=""locationCity"">Martinez</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Contra Costa Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 925-957-5400   </span> </div>                                       <h5 class=""locationCity"">Oakland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bay Area Tumor Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 510-465-2242 <br>Email: <a href=""mailto:lradke@bati.org"">lradke@bati.org</a>   </span> </div>                                       <h5 class=""locationCity"">Walnut Creek</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Epic Care Cyberknife Center</strong>     <br>Contact: Site Public Contact <br>Phone: 510-465-8016 <br>Email: <a href=""mailto:somega@bati.org"">somega@bati.org</a>   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Aurora</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Aurora</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Medical Center of Aurora</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Boulder</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Boulder Community Foothills Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Boulder</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Centennial</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers - Centennial</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Denver</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Colorado Blood Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Porter Adventist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 719-776-6550 <br>Email: <a href=""mailto:ResearchTracking@Centura.Org"">ResearchTracking@Centura.Org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Presbyterian - Saint Lukes Medical Center - Health One</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Midtown</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Rose</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rose Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:ccrp@co-cancerresearch.org"">ccrp@co-cancerresearch.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Women's Imaging Center</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Western Surgical Care</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663   </span> </div>                                       <h5 class=""locationCity"">Englewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mountain Blue Cancer Care Center - Swedish</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers - Swedish</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Melanoma and Skin Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ryan.weight@theskincancerinstitute.com"">ryan.weight@theskincancerinstitute.com</a>   </span> </div>                                       <h5 class=""locationCity"">Greeley</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Banner North Colorado Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 970-810-3046 <br>Email: <a href=""mailto:BMDACCResearchCOMailbox@bannerhealth.com"">BMDACCResearchCOMailbox@bannerhealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Lakewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Lakewood</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Littleton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Littleton Adventist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 719-776-6550 <br>Email: <a href=""mailto:ResearchTracking@Centura.Org"">ResearchTracking@Centura.Org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Littleton</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lone Tree</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Sky Ridge</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sky Ridge Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Longmont</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Longmont</strong>     <br>Contact: Site Public Contact <br>Phone: 719-776-6550 <br>Email: <a href=""mailto:ResearchTracking@Centura.Org"">ResearchTracking@Centura.Org</a>   </span> </div>                                       <h5 class=""locationCity"">Loveland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Banner McKee Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 970-810-3046 <br>Email: <a href=""mailto:BMDACCResearchCOMailbox@bannerhealth.com"">BMDACCResearchCOMailbox@bannerhealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Parker</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Parker Adventist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 719-776-6550 <br>Email: <a href=""mailto:ResearchTracking@Centura.Org"">ResearchTracking@Centura.Org</a>   </span> </div>                                       <h5 class=""locationCity"">Thornton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Thornton</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Lewes</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Millville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe South Coastal Health Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Christiana Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delaware Clinical and Laboratory Physicians PA</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:mhayden@christianacare.org"">mhayden@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Helen F Graham Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Medical Oncology Hematology Consultants PA</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rehoboth Beach</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe Health Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wilmington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Wilmington Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                   <h4>Georgia</h4>                           <h5 class=""locationCity"">Savannah</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lewis Cancer and Research Pavilion at Saint Joseph's/Candler</strong>     <br>Contact: Site Public Contact <br>Phone: 912-819-5704 <br>Email: <a href=""mailto:underberga@sjchs.org"">underberga@sjchs.org</a>   </span> </div>                                   <h4>Illinois</h4>                           <h5 class=""locationCity"">Alton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Anthony's Health</strong>     <br>Contact: Site Public Contact <br>Phone: 618-463-5623   </span> </div>                                       <h5 class=""locationCity"">Aurora</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rush - Copley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 630-978-6212 <br>Email: <a href=""mailto:Cancer.Research@rushcopley.com"">Cancer.Research@rushcopley.com</a>   </span> </div>                                       <h5 class=""locationCity"">Bloomington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bromenn Lifecare Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Bloomington</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Carbondale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Hospital of Carbondale</strong>     <br>Contact: Site Public Contact <br>Phone: 618-457-5200 <br>Email: <a href=""mailto:clinical.research@sih.net"">clinical.research@sih.net</a>   </span> </div>                                       <h5 class=""locationCity"">Carterville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">SIH Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 618-985-3333 <br>Email: <a href=""mailto:clinical.research@sih.net"">clinical.research@sih.net</a>   </span> </div>                                       <h5 class=""locationCity"">Carthage</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Carthage</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Centralia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Centralia Oncology Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Danville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle at The Riverfront</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Decatur</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Specialists of Illinois - Decatur</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Decatur Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Dixon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Dixon</strong>     <br>Contact: Site Public Contact <br>Phone: 815-285-7800   </span> </div>                                       <h5 class=""locationCity"">Effingham</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Physician Group-Effingham</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Crossroads Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Eureka</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Eureka</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Galesburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Galesburg</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Western Illinois Cancer Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 309-344-2831   </span> </div>                                       <h5 class=""locationCity"">Kewanee</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Kewanee Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Macomb</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Macomb</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Mattoon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Physician Group-Mattoon/Charleston</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Mount Vernon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Good Samaritan Regional Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 618-242-4600   </span> </div>                                       <h5 class=""locationCity"">Normal</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bromenn Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Cancer Institute Normal</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">O'Fallon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Center of O'Fallon</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Ottawa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Ottawa Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Pekin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Pekin</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Peoria</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Peoria</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Methodist Medical Center of Illinois</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Peru</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Peru</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Valley Radiation Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 815-664-4141   </span> </div>                                       <h5 class=""locationCity"">Princeton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Princeton</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Springfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 217-528-7541 <br>Email: <a href=""mailto:pallante.beth@mhsil.com"">pallante.beth@mhsil.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southern Illinois University School of Medicine</strong>     <br>Contact: Site Public Contact <br>Phone: 217-545-7929   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Springfield Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 800-444-7541   </span> </div>                                       <h5 class=""locationCity"">Urbana</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Carle Foundation Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Washington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare - Washington</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Yorkville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rush-Copley Healthcare Center</strong>     <br>Contact: Site Public Contact <br>Phone: 630-978-6212 <br>Email: <a href=""mailto:Cancer.Research@rushcopley.com"">Cancer.Research@rushcopley.com</a>   </span> </div>                                   <h4>Iowa</h4>                           <h5 class=""locationCity"">Ames</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mary Greeley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Ames</strong>     <br>Contact: Site Public Contact <br>Phone: 515-239-4734 <br>Email: <a href=""mailto:ksoder@mcfarlandclinic.com"">ksoder@mcfarlandclinic.com</a>   </span> </div>                                       <h5 class=""locationCity"">Ankeny</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mission Cancer and Blood - Ankeny</strong>     <br>Contact: Site Public Contact <br>Phone: 515-282-2921   </span> </div>                                       <h5 class=""locationCity"">Boone</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Boone</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                       <h5 class=""locationCity"">Carroll</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Anthony Regional Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 515-689-7658 <br>Email: <a href=""mailto:sbenson@iora.org"">sbenson@iora.org</a>   </span> </div>                                       <h5 class=""locationCity"">Cedar Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 319-365-4673   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Associates at Mercy Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 319-363-2690   </span> </div>                                       <h5 class=""locationCity"">Clive</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Cancer Center-West Lakes</strong>     <br>Contact: Site Public Contact <br>Phone: 515-358-6613 <br>Email: <a href=""mailto:cancerresearch@mercydesmoines.org"">cancerresearch@mercydesmoines.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mission Cancer and Blood - West Des Moines</strong>     <br>Contact: Site Public Contact <br>Phone: 515-241-3305   </span> </div>                                       <h5 class=""locationCity"">Creston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Greater Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 515-358-6613 <br>Email: <a href=""mailto:cancerresearch@mercydesmoines.org"">cancerresearch@mercydesmoines.org</a>   </span> </div>                                       <h5 class=""locationCity"">Des Moines</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Broadlawns Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 515-282-2200   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Iowa Lutheran Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 515-241-8704   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Iowa Methodist Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 515-241-6727   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Medical Center - Des Moines</strong>     <br>Contact: Site Public Contact <br>Phone: 515-358-6613 <br>Email: <a href=""mailto:cancerresearch@mercydesmoines.org"">cancerresearch@mercydesmoines.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mission Cancer and Blood - Des Moines</strong>     <br>Contact: Site Public Contact <br>Phone: 515-241-3305   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mission Cancer and Blood - Laurel</strong>     <br>Contact: Site Public Contact <br>Phone: 515-241-3305   </span> </div>                                       <h5 class=""locationCity"">Fort Dodge</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Trinity Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 515-574-8302   </span> </div>                                       <h5 class=""locationCity"">Jefferson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Jefferson</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                       <h5 class=""locationCity"">Marshalltown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Marshalltown</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                       <h5 class=""locationCity"">West Des Moines</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Medical Center-West Lakes</strong>     <br>Contact: Site Public Contact <br>Phone: 515-358-6613 <br>Email: <a href=""mailto:cancerresearch@mercydesmoines.org"">cancerresearch@mercydesmoines.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Methodist West Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 515-343-1000   </span> </div>                                   <h4>Kansas</h4>                           <h5 class=""locationCity"">Garden City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Care Cancer Center - Garden City</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Great Bend</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Care Cancer Center - Great Bend</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                   <h4>Kentucky</h4>                           <h5 class=""locationCity"">Louisville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Jewish Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 859-629-7169 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saints Mary and Elizabeth Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 859-629-7169 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UofL Health Medical Center Northeast</strong>     <br>Contact: Site Public Contact <br>Phone: 502-852-2755 <br>Email: <a href=""mailto:ctoinfo@louisville.edu"">ctoinfo@louisville.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Paducah</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health - Paducah Medical Oncology and Hematology</strong>     <br>Contact: Site Public Contact <br>Phone: 270-538-5632 <br>Email: <a href=""mailto:BJWarner@mercy.com"">BJWarner@mercy.com</a>   </span> </div>                                   <h4>Maryland</h4>                           <h5 class=""locationCity"">Elkton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care - Union Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 410-443-1360 <br>Email: <a href=""mailto:frank.crum@christianacare.org"">frank.crum@christianacare.org</a>   </span> </div>                                   <h4>Massachusetts</h4>                           <h5 class=""locationCity"">Boston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Tufts Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 617-636-5000 <br>Email: <a href=""mailto:ContactUsCancerCenter@TuftsMedicalCenter.org"">ContactUsCancerCenter@TuftsMedicalCenter.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lowell</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lowell General Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 978-788-7084 <br>Email: <a href=""mailto:ghincks@lowellgeneral.org"">ghincks@lowellgeneral.org</a>   </span> </div>                                   <h4>Minnesota</h4>                           <h5 class=""locationCity"">Burnsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Ridges Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Minnesota Oncology - Burnsville</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Cambridge</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cambridge Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Coon Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Edina</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Southdale Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Maple Grove</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Clinics and Surgery Center Maple Grove</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Maplewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Minnesota Oncology Hematology PA-Maplewood</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint John's Hospital - Healtheast</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Minneapolis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Abbott-Northwestern Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Health Partners Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hennepin County Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Monticello</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Monticello Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">New Ulm</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">New Ulm Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Princeton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Northland Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Robbinsdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">North Memorial Medical Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Rochester</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mayo Clinic in Rochester</strong>     <br>Contact: Site Public Contact <br>Phone: 855-776-0015   </span> </div>                                       <h5 class=""locationCity"">Saint Louis Park</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Park Nicollet Clinic - Saint Louis Park</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Paul</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Regions Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">United Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Shakopee</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Stillwater</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lakeview Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Waconia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ridgeview Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Willmar</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rice Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Woodbury</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Minnesota Oncology Hematology PA-Woodbury</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Wyoming</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Lakes Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                   <h4>Missouri</h4>                           <h5 class=""locationCity"">Ballwin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Louis Cancer and Breast Institute-Ballwin</strong>     <br>Contact: Site Public Contact <br>Phone: 314-251-7058   </span> </div>                                       <h5 class=""locationCity"">Bolivar</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Care Cancer Center - Bolivar</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Branson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cox Cancer Center Branson</strong>     <br>Contact: Site Public Contact <br>Phone: 417-269-4520   </span> </div>                                       <h5 class=""locationCity"">Cape Girardeau</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-334-2230 <br>Email: <a href=""mailto:sfmc@sfmc.net"">sfmc@sfmc.net</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southeast Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-651-5550   </span> </div>                                       <h5 class=""locationCity"">Farmington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Parkland Health Center - Farmington</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Jefferson City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MU Health Care Goldschmidt Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-632-4851 <br>Email: <a href=""mailto:amy.franken@health.missouri.edu"">amy.franken@health.missouri.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Joplin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Freeman Health System</strong>     <br>Contact: Site Public Contact <br>Phone: 417-347-4030 <br>Email: <a href=""mailto:LJCrockett@freemanhealth.com"">LJCrockett@freemanhealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Joplin</strong>     <br>Contact: Site Public Contact <br>Phone: 417-556-3074 <br>Email: <a href=""mailto:esmeralda.carrillo@mercy.net"">esmeralda.carrillo@mercy.net</a>   </span> </div>                                       <h5 class=""locationCity"">Osage Beach</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lake Regional Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 573-302-2768 <br>Email: <a href=""mailto:clinicaltrials@lakeregional.com"">clinicaltrials@lakeregional.com</a>   </span> </div>                                       <h5 class=""locationCity"">Rolla</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delbert Day Cancer Institute at PCRMC</strong>     <br>Contact: Site Public Contact <br>Phone: 573-458-7504 <br>Email: <a href=""mailto:research@phelpshealth.org"">research@phelpshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Clinic-Rolla-Cancer and Hematology</strong>     <br>Contact: Site Public Contact <br>Phone: 573-458-6379   </span> </div>                                       <h5 class=""locationCity"">Saint Joseph</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Heartland Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 816-271-7937 <br>Email: <a href=""mailto:linda.schumacher@mymlc.com"">linda.schumacher@mymlc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Louis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Saint Louis</strong>     <br>Contact: Site Public Contact <br>Phone: 314-251-7066   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital South</strong>     <br>Contact: Site Public Contact <br>Phone: 314-525-6042 <br>Email: <a href=""mailto:Danielle.Werle@mercy.net"">Danielle.Werle@mercy.net</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Missouri Baptist Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Louis Cancer and Breast Institute-South City</strong>     <br>Contact: Site Public Contact <br>Phone: 314-353-1870   </span> </div>                                       <h5 class=""locationCity"">Sainte Genevieve</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sainte Genevieve County Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Springfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CoxHealth South Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 417-269-4520   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Springfield</strong>     <br>Contact: Site Public Contact <br>Phone: 417-269-4520   </span> </div>                                       <h5 class=""locationCity"">Sullivan</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Missouri Baptist Sullivan Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Sunset Hills</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">BJC Outpatient Center at Sunset Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Washington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Washington</strong>     <br>Contact: Site Public Contact <br>Phone: 636-390-1600   </span> </div>                                   <h4>Nebraska</h4>                           <h5 class=""locationCity"">Grand Island</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Nebraska Cancer Specialists/Oncology Hematology West PC</strong>     <br>Contact: Site Public Contact <br>Phone: 402-334-4773   </span> </div>                                   <h4>Nevada</h4>                           <h5 class=""locationCity"">Carson City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carson Tahoe Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Henderson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada - Henderson</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada-Horizon Ridge</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada-Southeast Henderson</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">GenesisCare USA - Henderson</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Cancer Center-Henderson</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Green Valley</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Pebble</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at Seven Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Urology Specialists of Nevada - Green Valley</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Las Vegas</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alliance for Childhood Diseases/Cure 4 the Kids Foundation</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ann M Wierman MD LTD</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada - Central Valley</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada - Northwest</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada - Town Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada-Summerlin</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Desert West Surgery</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">GenesisCare USA - Fort Apache</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">GenesisCare USA - Las Vegas</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">GenesisCare USA - Vegas Tenaya</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Cancer Center-Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Prostate Cancer Center</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Cathedral Rock</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Pecos</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Smoke Ranch</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@smcrf.org"">research@smcrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Las Vegas Urology - Sunset</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at Charleston</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at Fort Apache</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at MountainView</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Radiation Oncology Centers of Nevada Central</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Radiation Oncology Centers of Nevada Southeast</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Summerlin Hospital Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Urology Specialists of Nevada - Central</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Urology Specialists of Nevada - Northwest</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Urology Specialists of Nevada - Southwest</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Reno</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Specialists - Reno</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Renown Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary's Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Nevada at Reno Veterans Affairs Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                   <h4>New Jersey</h4>                           <h5 class=""locationCity"">Teaneck</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Holy Name Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 201-833-6312   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">Bronx</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Children's Hospital at Montefiore</strong>     <br>Contact: Site Public Contact <br>Phone: 718-379-6866 <br>Email: <a href=""mailto:aaraiza@montefiore.org"">aaraiza@montefiore.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Montefiore Medical Center - Moses Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 718-379-6866 <br>Email: <a href=""mailto:eskwak@montefiore.org"">eskwak@montefiore.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Montefiore Medical Center-Einstein Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 718-379-6866 <br>Email: <a href=""mailto:eskwak@montefiore.org"">eskwak@montefiore.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Montefiore Medical Center-Weiler Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 718-379-6866 <br>Email: <a href=""mailto:eskwak@montefiore.org"">eskwak@montefiore.org</a>   </span> </div>                                   <h4>North Carolina</h4>                           <h5 class=""locationCity"">Gastonia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CaroMont Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 704-834-2810 <br>Email: <a href=""mailto:tammy.cozad@caromonthealth.org"">tammy.cozad@caromonthealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lincolnton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CaroMont Health - Lincoln Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 704-671-7031   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Belpre</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Strecker Cancer Center-Belpre</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chillicothe</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Adena Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-779-7585 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Columbus</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Columbus Oncology and Hematology Associates Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Doctors Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Grant Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mount Carmel East Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mount Carmel Health Center West</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Riverside Methodist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Mark H Zangmeister Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Delaware</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delaware Health Center-Grady Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Grady Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Dublin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Columbus Oncology and Hematology Associates</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Dublin Methodist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Gahanna</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Ohio Breast and Endocrine Surgery</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grove City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mount Carmel Grove City Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lancaster</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairfield Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lima</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Rita's Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Mansfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OhioHealth Mansfield Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Marietta</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Marietta Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Marion</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OhioHealth Marion General Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Marysville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Mount Vernon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Knox Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">New Albany</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mount Carmel New Albany Surgical Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Licking Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Newark Radiation Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Perrysburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health Perrysburg Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Portsmouth</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southern Ohio Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Toledo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health - Saint Anne Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health - Saint Vincent Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health  Sylvania Radiation Oncology Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Westerville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Ann's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wilmington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Clinton Memorial Hospital/Foster J Boyd Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Zanesville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesis Healthcare System Cancer Care Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                   <h4>Oklahoma</h4>                           <h5 class=""locationCity"">Oklahoma City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Oklahoma City</strong>     <br>Contact: Site Public Contact <br>Phone: 405-752-3402   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Chadds Ford</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Concord Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Danville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-271-5251 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">East Norriton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fox Chase Cancer Center - East Norriton Hospital Outpatient Center</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ecog.rss@jimmy.harvard.edu"">ecog.rss@jimmy.harvard.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Hazleton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Center-Cancer Center Hazleton</strong>     <br>Contact: Site Public Contact <br>Phone: 570-459-2901 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Lewisburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Oncology-Lewisburg</strong>     <br>Contact: Site Public Contact <br>Phone: 570-374-8555 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Philadelphia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fox Chase Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 215-728-4790   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Temple University Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 215-728-2983   </span> </div>                                       <h5 class=""locationCity"">Pottsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Cancer Services-Pottsville</strong>     <br>Contact: Site Public Contact <br>Phone: 800-275-6401 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Scranton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Community Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-703-4768 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Wilkes-Barre</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Wyoming Valley/Henry Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-271-5251 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                   <h4>South Carolina</h4>                           <h5 class=""locationCity"">Anderson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">AnMed Health Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 864-512-4651 <br>Email: <a href=""mailto:rhonda.ballew@anmedhealth.org"">rhonda.ballew@anmedhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bluffton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Joseph's/Candler - Bluffton Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 912-819-5704 <br>Email: <a href=""mailto:underberga@sjchs.org"">underberga@sjchs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Boiling Springs</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Spartanburg</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Easley</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Easley</strong>     <br>Contact: Site Public Contact <br>Phone: 864-522-2066 <br>Email: <a href=""mailto:Kim.Williams3@prismahealth.org"">Kim.Williams3@prismahealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Gaffney</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Gibbs Cancer Center-Gaffney</strong>     <br>Contact: Site Public Contact <br>Phone: 864-560-6104 <br>Email: <a href=""mailto:kmertz-rivera@gibbscc.org"">kmertz-rivera@gibbscc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Greenville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Butternut</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Eastside</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Faris</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Greenville Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 864-603-6213 <br>Email: <a href=""mailto:melissa_beckman@bshsi.org"">melissa_beckman@bshsi.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 864-603-6213 <br>Email: <a href=""mailto:melissa_beckman@bshsi.org"">melissa_beckman@bshsi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Greer</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Gibbs Cancer Center-Pelham</strong>     <br>Contact: Site Public Contact <br>Phone: 864-560-6104 <br>Email: <a href=""mailto:kmertz-rivera@gibbscc.org"">kmertz-rivera@gibbscc.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Greer</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Seneca</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Seneca</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Spartanburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Spartanburg Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 864-560-6104 <br>Email: <a href=""mailto:kmertz-rivera@gibbscc.org"">kmertz-rivera@gibbscc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Union</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MGC Hematology Oncology-Union</strong>     <br>Contact: Site Public Contact <br>Phone: 864-560-6104 <br>Email: <a href=""mailto:kmertz-rivera@gibbscc.org"">kmertz-rivera@gibbscc.org</a>   </span> </div>                                   <h4>Tennessee</h4>                           <h5 class=""locationCity"">Bristol</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bristol Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 423-578-8538 <br>Email: <a href=""mailto:justin.reynolds@wellmont.org"">justin.reynolds@wellmont.org</a>   </span> </div>                                       <h5 class=""locationCity"">Kingsport</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ballad Health Cancer Care – Kingsport</strong>     <br>Contact: Site Public Contact <br>Phone: 423-578-8538 <br>Email: <a href=""mailto:Justin.reynolds@balladhealth.org"">Justin.reynolds@balladhealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Wellmont Holston Valley Hospital and Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 423-578-8538 <br>Email: <a href=""mailto:justin.reynolds@wellmont.org"">justin.reynolds@wellmont.org</a>   </span> </div>                                   <h4>Texas</h4>                           <h5 class=""locationCity"">San Antonio</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Texas Health Science Center at San Antonio</strong>     <br>Contact: Site Public Contact <br>Phone: 210-450-3800 <br>Email: <a href=""mailto:phoresearchoffice@uthscsa.edu"">phoresearchoffice@uthscsa.edu</a>   </span> </div>                                   <h4>Virginia</h4>                           <h5 class=""locationCity"">Bristol</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Wellmont Medical Associates-Bristol</strong>     <br>Contact: Site Public Contact <br>Phone: 423-578-8538 <br>Email: <a href=""mailto:justin.reynolds@wellmont.org"">justin.reynolds@wellmont.org</a>   </span> </div>                                       <h5 class=""locationCity"">Norton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southwest VA Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 423-578-8538 <br>Email: <a href=""mailto:justin.reynolds@wellmont.org"">justin.reynolds@wellmont.org</a>   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Bellevue</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Overlake Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 425-688-5407 <br>Email: <a href=""mailto:OHMCResearch@overlakehospital.org"">OHMCResearch@overlakehospital.org</a>   </span> </div>                                       <h5 class=""locationCity"">Port Townsend</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Jefferson Healthcare</strong>     <br>Contact: Site Public Contact <br>Phone: 360-344-3091   </span> </div>                                       <h5 class=""locationCity"">Renton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Valley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 425-228-3440 <br>Email: <a href=""mailto:research@valleymed.org"">research@valleymed.org</a>   </span> </div>                                       <h5 class=""locationCity"">Yakima</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">North Star Lodge Cancer Center at Yakima Valley Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 509-574-3535 <br>Email: <a href=""mailto:Memorial-ClinicalTrials@yvmh.org"">Memorial-ClinicalTrials@yvmh.org</a>   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Green Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Saint Mary's</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:ewd_research_admin@hshs.org"">ewd_research_admin@hshs.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center Green Bay</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:ewd_research_admin@hshs.org"">ewd_research_admin@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">La Crosse</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Gundersen Lutheran Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 608-775-2385 <br>Email: <a href=""mailto:cancerctr@gundersenhealth.org"">cancerctr@gundersenhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">New Richmond</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Center of Western Wisconsin</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Oconto Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Oconto Falls</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:ewd_research_admin@hshs.org"">ewd_research_admin@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sturgeon Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Sturgeon Bay</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:ewd_research_admin@hshs.org"">ewd_research_admin@hshs.org</a>   </span> </div>                                   <h4>Wyoming</h4>                           <h5 class=""locationCity"">Cheyenne</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cheyenne Regional Medical Center-West</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:ccrp@co-cancerresearch.org"">ccrp@co-cancerresearch.org</a>   </span> </div>                           			</div> 		</div> 			<div class=""trialContainer""> 			<h2 class=""hangingIndent"">5. Testing Whether Avoiding the Hippocampus During Whole-Brain Radiation Therapy Prevents Cognitive Side Effects in Patients with Small Cell Lung Cancer</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?loc=0&rl=2&tt=supportive_care&tt=health_services_research&tt=basic_science&id=NCI-2015-01548""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase II/III</td> 					<td>Supportive care</td> 					<td>Closed to Accrual and Intervention</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> NRG-CC003<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2015-01548<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT02635009"" target=""_blank"">NCT02635009</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase II/III trial studies whether avoiding the hippocampus during whole-brain radiation therapy prevents cognitive side effects in patients with small cell lung cancer that is found in one lung, the tissues between the lungs, and nearby lymph nodes only (limited stage) or has spread outside of the lung in which it began or to other parts of the body (extensive stage). Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. The hippocampus is part of the brain that is important for memory. Avoiding the hippocampus during whole-brain radiation could decrease the chance of side effects on memory and thinking. It is not yet known whether giving whole-brain radiation therapy is more effective with or without hippocampal avoidance in treating patients with small cell lung cancer.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>PRIOR TO STEP 1 REGISTRATION</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Histologic proof or unequivocal cytologic proof (fine needle aspiration, biopsy or two positive sputa) of SCLC within 250 days prior to Step 1 registration; * High-grade neuroendocrine carcinoma or combined SCLC and non-small cell lung cancer (NSCLC) is permitted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be registered to Step 1 registration no earlier than 7 days and no later than 56 days after completing chemotherapy, Note: * Post-chemotherapy restaging imaging must be completed no more than 56 days prior to Step 1 registration * For patients with extensive-stage small cell lung cancer who are being considered for consolidative thoracic radiotherapy after chemotherapy, concomitant administration of consolidative thoracic radiotherapy and protocol-specified prophylactic cranial irradiation with or without hippocampal avoidance is permitted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have a gadolinium contrast-enhanced three-dimensional (3D), spoiled gradient (SPGR), magnetization-prepared rapid gradient echo (MP-RAGE), or turbo field echo (TFE) magnetic resonance imaging (MRI) scan; to yield acceptable image quality, the gadolinium contrast-enhanced three-dimensional SPGR, MP-RAGE or TFE axial MRI scan must use the smallest possible axial slice thickness not exceeding 1.5 mm; sites may contact the Imaging Co-Chairs for further information or assistance if needed * This MRI must be obtained within 56 days prior to Step 1 registration. * Note: the MRI study is mandatory irrespective of randomization to the experimental or control arm of this study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Prior to chemotherapy +/- or thoracic radiotherapy, patients must be defined as limited-stage or extensive-stage SCLC after clinical staging evaluation involving the following: * History/physical examination; * Computed tomography (CT) of the chest and abdomen with contrast (does not have to be done if the patient has had a positron emission tomography [PET]/CT scan prior to initiating chemotherapy or thoracic radiotherapy) * MRI of the brain with contrast or diagnostic head CT with contrast * For patients without evidence of extensive-stage SCLC on chest and abdomen CT and brain MRI or head CT, a PET/CT or bone scan is required to confirm limited-stage SCLC</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>After chemotherapy, patients must be restaged prior Step 1 registration using the same diagnostic work-up as required pre-chemotherapy; repeat PET/CT or bone scan is not required; patients must have: * History/physical examination within 30 days of Step 1 registration * No central nervous system (CNS) metastases (repeat MRI required) within 56 days prior to Step 1 registration * No progression in any site * Radiographic partial or complete response to chemotherapy in at least one disease site within 56 days prior to Step 1 registration ** If PET/CT was obtained prior to chemotherapy, either a repeat PET/CT or CT of the chest and abdomen with contrast can be obtained for response assessment ** Patients who underwent resection for limited-stage SCLC prior to chemotherapy and have no radiographically evident disease for response assessment remain eligible if post-chemotherapy imaging demonstrates no progression</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Zubrod performance status 0-2 within 30 days prior to Step 1 registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Age &gt;= 18</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Women of childbearing potential must have a negative qualitative serum pregnancy test =&lt; 14 days prior to Step 1 registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients who are primary English or French speakers are eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must sign a study-specific informed consent prior to study entry</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>PRIOR TO STEP 2 REGISTRATION</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>The following baseline neurocognitive assessments must be completed and uploaded within 10 calendar days after or at the time of Step 1 registration: HVLT-R (recall, delayed recall, and recognition), TMT (parts A and B), and COWA; the neurocognitive assessments will be uploaded into the National Surgical Adjuvant Breast and Bowel Project, Radiation Therapy Oncology Group, and Gynecologic Oncology Group (NRG) Oncology RAVE system for evaluation by Dr. Wefel; once the upload is complete, within 3 business days, a notification will be sent to the site to proceed to Step 2 registration; at minimum, the HVLT-R delayed recall must be able to be scored (i.e. completed without error) in order to be eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have a baseline raw score greater than 2 on the HVLT-R delayed recall. as determined by central assessment by the Neurocognitive Co-Chair, Dr. Wefel</li> 												</ul> 						</div> 														<h4>Exclusion Criteria</h4> 										<div> 							<ul> 																<li>Prior radiotherapy to the head or neck (except for T1 glottic cancer), resulting in overlap of radiation fields</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Radiographic evidence of CNS metastases</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Radiographic evidence of hydrocephalus or other architectural distortion of the ventricular system, including placement of external ventricular drain or ventriculoperitoneal shunt</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Planned concurrent chemotherapy during PCI * Concurrent atezolizumab permitted</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Concomitant invasive malignancy or invasive malignancy within the past five years other than non-melanomatous skin cancer; history of in situ carcinoma (e.g. ductal carcinoma in situ of breast, in situ carcinoma of the cervix, vulva or larynx) is permitted</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Contraindication to MR imaging, such as implanted metal devices or foreign bodies or severe claustrophobia</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Severe, active comorbidity, defined as follows: * Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months * Transmural myocardial infarction within the last 6 months * Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration * Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects * Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration * Uncontrolled, clinically significant cardiac arrhythmias * Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD)4 count &lt; 200 cells/microliter ** Note: patients who are HIV positive are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count &gt;= 200 cells/microliter within 30 days prior to Step 1 registration ** Note: HIV testing is not required for eligibility for this protocol</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Pregnant or lactating women or women of childbearing potential and male participants who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the radiation treatment involved in this study may be significantly teratogenic.</li> 												</ul> 						</div> 							 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVES:</p><p class='ctrp'>I. Determine whether the 12-month intracranial relapse rate following hippocampal avoidance (HA)-prophylactic cranial irradiation (PCI) is non-inferior to the rate following PCI for patients with small cell lung cancer (SCLC). (Randomized Phase II Component [Non-Inferiority])</p><p class='ctrp'>II. Determine whether HA-PCI reduces the likelihood of 6-month deterioration from baseline in Hopkins Verbal Learning Test (HVLT)-Revised (R) delayed recall compared to PCI for patients with SCLC. (Phase III Component [Efficacy])</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES:</p><p class='ctrp'>I. Compare time to cognitive failure, as measured by a battery of tests (HVLT-R, Controlled Oral Word Association [COWA] test, and Trail Making Test [TMT] parts A and B), after PCI versus HA-PCI in SCLC.</p><p class='ctrp'>II. Compare time to cognitive failure as separately measured by each test (HVLT-R for Total Recall and Delayed Recognition, COWA test, and TMT parts A and B), after PCI versus HA-PCI for SCLC.</p><p class='ctrp'>III. Compare patient-reported cognitive functioning and other quality of life domains (assessed by the European Organization for Research and Treatment of Cancer [EORTC] Quality of Life Questionnaire [QLQ]-Core [C]30 and Brain Cancer Module [BN] 20) between PCI versus HA-PCI for patients with SCLC.</p><p class='ctrp'>IV. Compare overall survival after PCI versus HA-PCI for patients with SCLC.</p><p class='ctrp'>V. Compare 12-month intracranial relapse rate (at completion of phase III) and time to intracranial relapse after PCI versus HA-PCI for patients with SCLC.</p><p class='ctrp'>VI. Evaluate adverse events according to Common Terminology Criteria for Adverse Events (CTCAE) criteria.</p><p class='ctrp'>VII. Correlate changes in health-related quality of life (HRQOL) domains with changes in cognitive testing outcomes following PCI versus HA-PCI for patients with SCLC.</p><p class='ctrp'>VIII. Assess cost-effectiveness of HA-PCI (modulated radiation therapy [MRT]) and PCI (3-dimensional conformal radiation therapy [3DCRT]) using the EuroQOL-5 dimension (D) health state classification (EQ-5D-5L).</p><p class='ctrp'>IX. Correlate micro-ribonucleic acid (miRNA) signatures with cognitive failure in SCLC patients who received PCI and HA-PCI.</p><p class='ctrp'>X. Evaluate APOE genotyping as potential predictor of neurocognitive decline, hippocampal atrophy after brain irradiation and/or differential benefit from hippocampal avoidance.</p><p class='ctrp'>XI. Evaluate baseline MR imaging biomarkers of white matter injury and hippocampal volumetry as potential predictors of cognitive decline and differential benefit from HA-PCI as compared to PCI.</p><p class='ctrp'></p><p class='ctrp'>EXPLORATORY OBJECTIVES:</p><p class='ctrp'>I. Collect serum and whole blood for future translational research analyses.</p><p class='ctrp'>II. Compare levels of hopefulness between PCI versus HA-PCI for patients with SCLC.</p><p class='ctrp'>III. Feasibility of remote neurocognitive testing.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE: Patients are randomized to 1 of 2 treatment arms.</p><p class='ctrp'></p><p class='ctrp'>ARM I: Patients undergo PCI using 3DCRT daily for 2 weeks.</p><p class='ctrp'></p><p class='ctrp'>ARM II: Patients undergo PCI with HA using IMRT daily for 2 weeks.</p><p class='ctrp'></p><p class='ctrp'>After completion of study treatment, patients are followed every 3 months for 1 year, then every 6 months until 3 years and then annually until death.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>NRG Oncology</div> 													<div>Principal Investigator: Vinai Gondi</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT02635009"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>Maryland</h4>                           <h5 class=""locationCity"">Baltimore</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Maryland Medical Center</strong>     <br>Contact: Minesh P. Mehta <br>Phone: 410-328-6921 <br>Email: <a href=""mailto:mmehta@umm.edu"">mmehta@umm.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Glen Burnie</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UM Baltimore Washington Medical Center/Tate Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 410-553-8100   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Weston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Diagnostic and Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 888-799-3989 <br>Email: <a href=""mailto:oncology.clinical.trials@marshfieldresearch.org"">oncology.clinical.trials@marshfieldresearch.org</a>   </span> </div>                                 <h3 class=""locationCountryLabel"">Canada</h3>               <h4>Quebec</h4>                           <h5 class=""locationCity"">Montreal</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CHUM - Hopital Notre-Dame</strong>     <br>Contact: Anne Dagnault <br>Phone: 418-649-5593 <br>Email: <a href=""mailto:jbegin@uresp.ulaval.ca"">jbegin@uresp.ulaval.ca</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McGill University Department of Oncology</strong>     <br>Contact: Anne Dagnault <br>Email: <a href=""mailto:rechclinique@crchuq.ulaval.ca"">rechclinique@crchuq.ulaval.ca</a>   </span> </div>                                       <h5 class=""locationCity"">Sherbrooke</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Centre Hospitalier Universitaire de Sherbrooke-Fleurimont</strong>     <br>Contact: Site Public Contact <br>Phone: 819-820-6480 <br>Email: <a href=""mailto:crcinformation.chus@ssss.gouv.qc.ca"">crcinformation.chus@ssss.gouv.qc.ca</a>   </span> </div>                           			</div> 		</div> 			<div class=""trialContainer""> 			<h2 class=""hangingIndent"">6. Testing the Addition of a Blood Pressure Medication, Carvedilol, to HER-2 Targeted Therapy for Metastatic Breast Cancer to Prevent Cardiac Toxicity</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?loc=0&rl=2&tt=supportive_care&tt=health_services_research&tt=basic_science&id=NCI-2016-01047""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase III</td> 					<td>Supportive care</td> 					<td>Temporarily Closed to Accrual</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> S1501<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> SWOG-S1501, NCI-2016-01047<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT03418961"" target=""_blank"">NCT03418961</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase III trial studies compares prophylactic beta blocker therapy with carvedilol versus no prophylaxis in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic). A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may protect the heart from the side effects of chemotherapy.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>STEP 1 REGISTRATION</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have metastatic breast cancer and be initiating within 11 calendar days of step 1 registration or be continuing trastuzumab–based HER-2 targeted therapy without concurrent anthracyclines and be receiving the trastuzumab-based HER-2 targeted therapy for metastatic disease in first, second, third, or fourth line setting; patients may have brain metastasis; there is no limit for number of doses of HER-2 targeted therapy prior to registration; examples of eligible HER-2 targeted therapy: * Trastuzumab or a trastuzumab biosimilar * Trastuzumab + chemotherapy or hormonal therapy * Trastuzumab + other HER-2 targeted agent with or without chemotherapy (such as pertuzumab, lapatinib, and tucatinib) * Ado-trastuzumab (Kadcyla [registered trademark]) * Fam-trastuzumab deruxtecan (Enhertu) ** NOTE: Patients on lapatinib without trastuzumab are not eligible; planned treatment with concurrent HER-2 targeted therapy and anthracyclines is not permitted</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be at increased risk for cardiotoxicity defined by at least one of the following: * Previous anthracycline exposure, OR * 1 or more of the following risk factors for heart disease: ** Left ventricular ejection fraction (LVEF) 50-54% by local echocardiography (ECHO) read ** Age &gt;= 65 ** Body mass index (BMI) &gt;= 30 kg/m^2 ** Current or prior anti-hypertensive therapy ** Diagnosis of coronary artery disease (CAD) ** Diagnosis of diabetes mellitus ** Diagnosis of atrial fibrillation/flutter *** ECHO can be performed at any time prior to registration. If the participant has multiple ECHOs prior to registration, they may be eligible as long as any one of those ECHOS shows an LVEF reading within the allowable range</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not have taken within 21 days prior to step 1 registration, be currently taking at the time of step 1 registration, or planning to take once registered to step 1 a beta blocker, ARB, or ACE inhibitor in order to be randomized (Arms 1 and 2) * Patients currently taking a beta blocker, ARB, or ACE inhibitor at the time of step 1 registration are eligible to register for the non-randomized observational cohort (Arm 3)  ** Arm 3 is permanently closed to accrual; therefore, participants who previously would have been eligible based on beta blocker, ARB, or ACE inhibitor usage will not be eligible for enrollment after the closure of Arm 3. Participants enrolled prior to that closure remain eligible and may continue study participation</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not be currently taking or planning to take the following medications during study treatment or observation: * B2 agonists (except rescue inhalers) * Bosutinib * Ceritinib * Floctafenine * Methacholine * Pazopanib * Rivastigmine * Vincristine * Silodosin</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have a Zubrod performance status of 0-2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be at &gt;= 18 years of age</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have a complete physical examination and medical history within 28 days prior to registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have LVEF &gt;= 50% by 2-dimensional (D) echocardiogram within 28 days prior to registration; the echocardiogram must be obtained from the site&#39;s approved S1501 validated ECHO laboratory (lab) and submitted for central review by the S1501 ECHO core lab; an ECHO should not be submitted for central read until patient has been registered; Participants must be planning on having ECHO’s completed and submitted every 12 weeks</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Serum bilirubin &lt; 3.0 x institutional upper limit of normal (IULN) (within 28 days prior to registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Serum glutamic oxaloacetic transaminase (SGOT)/aspartate aminotransferase (AST) and serum glutamic pyruvic transaminase (SGPT)/alanine aminotransferase (ALT) &lt; 5.0 x IULN (within 28 days prior to registration)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must have a systolic blood pressure &gt;= 80 mm Hg within 14 days prior to registration * NOTE: Patients enrolled at sites in Korea must have a systolic blood pressure &gt;= 90 mm Hg within 14 days prior to registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not be dialysis dependent</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be able to swallow tablets</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not have uncontrolled asthma; patients may use a steroid inhaler or other treatment, but patients must not require use of B2 agonists more than once weekly</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, prostate cancer on active surveillance, adequately treated stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for five years</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not be pregnant or nursing due to potential fetal or nursing infant harm; women/men of reproductive potential must have agreed to use an effective contraceptive method, a woman is considered to be of &quot;reproductive potential&quot; if she has had menses at any time in the preceding 12 consecutive months; in addition to routine contraceptive methods, &quot;effective contraception&quot; also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation; however, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be willing to submit blood specimens</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Sites must seek additional patient consent for the future use of specimens</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution&#39;s identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>STEP 2 REGISTRATION (Randomization)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must not be registered to step 2 until confirming via RAVE electronic data capture (EDC) that the patient’s LVEF by echocardiogram was &gt;= 50% by central review; patients must be registered within 11 calendar days of submission of the ECHO study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Site must verify that there is no known change in the step 1 eligibility since initial registration</li> 												</ul> 						</div> 										 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE:</p><p class='ctrp'>I. To assess whether prophylactic beta blocker therapy with carvedilol compared with no prophylaxis reduces the risk of subsequent cardiac dysfunction in patients with metastatic breast cancer receiving trastuzumab–based HER-2 targeted therapy.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES:</p><p class='ctrp'>I. To assess whether prophylactic beta blocker therapy with carvedilol compared with no prophylaxis reduces the risk of predefined subsequent cardiac events in patients with metastatic breast cancer receiving trastuzumab–based HER-2 targeted therapy.</p><p class='ctrp'>II. To evaluate if prophylactic carvedilol compared with no prophylaxis results in a longer time to first interruption of trastuzumab–based HER-2 targeted therapy due to either cardiac dysfunction or events.</p><p class='ctrp'>III. To assess whether prophylactic beta blocker therapy with carvedilol compared with no prophylaxis reduces the risk of subsequent cardiac dysfunction OR events in this population.</p><p class='ctrp'>IV. To establish and prospectively collect a predefined panel of baseline core cardiovascular measures and develop a predictive model of cardiac dysfunction.</p><p class='ctrp'>V. To evaluate the rate of cardiac dysfunction in an observational arm consisting of individuals otherwise eligible for the study except for use of beta blockers, angiotensin receptor blocker (ARB), or angiotensin converting enzyme (ACE) inhibitors for other medical reasons.</p><p class='ctrp'>VI. To compare the local and central reads of left ventricular ejection fraction (LVEF) and strain and assess if strain changes can predict drop in ejection fraction.</p><p class='ctrp'>VII. Assess if strain can be used in the community as a marker of cardiotoxicity.</p><p class='ctrp'></p><p class='ctrp'>TRANSLATIONAL OBJECTIVES:</p><p class='ctrp'>I. To evaluate the isoleucine (lle) 655 valine (Val) and alanine (Ala)ll70 proline (Pro) single nucleotide polymorphisms (SNPs) of the HER-2 gene as a predictive biomarker of study-defined cardiac dysfunction.</p><p class='ctrp'>II. To evaluate plasma neuregulin-1 at baseline and over study time as a predictive biomarker of study-defined cardiac dysfunction.</p><p class='ctrp'>III. To evaluate the feasibility of local labs performing serial left ventricular strain in a National Clinical Trials Network (NCTN) group setting, with the goal of 75% of patients contributing both a baseline and at least one follow-up strain measurement.</p><p class='ctrp'>IV. To bank blood for future translational medicine studies such as brain natriuretic peptide (BNP), additional SNPs, and high sensitivity troponin.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE: Patients are randomized to 1 of 2 arms. Patients taking beta blocker, ARB, or ACE inhibitor at registration are assigned to Arm III. </p><p class='ctrp'></p><p class='ctrp'>ARM I: Patients not taking beta blocker, ARB, or ACE inhibitor at registration receive carvedilol orally (PO) twice daily (BID) on study. Cycles repeat every 12 weeks for 108 weeks in the absence of disease progression or unacceptable toxicity. Patients also undergo echocardiography (ECHO) and blood sample collection throughout the study.</p><p class='ctrp'></p><p class='ctrp'>ARM II: Patients not taking beta blocker, ARB, or ACE inhibitor at registration receive no study intervention for up to 108 weeks on study. Patients also undergo ECHO and blood sample collection throughout the study.</p><p class='ctrp'></p><p class='ctrp'>ARM III (CLOSED TO ACCRUAL 7/7/21): Patients undergo observation for up to 108 weeks on study. Patients also undergo ECHO and blood sample collection throughout the study.</p><p class='ctrp'></p><p class='ctrp'>After completion of study, patients are followed up every 12 weeks for up to 108 weeks.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>SWOG</div> 													<div>Principal Investigator: Justin D. Floyd</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT03418961"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>Alaska</h4>                           <h5 class=""locationCity"">Anchorage</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alaska Breast Care and Surgery LLC</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alaska Oncology and Hematology LLC</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alaska Women's Cancer Care</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Anchorage Associates in Radiation Medicine</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Anchorage Oncology Centre</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Katmai Oncology Group</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Alaska Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 907-212-6871 <br>Email: <a href=""mailto:AKPAMC.OncologyResearchSupport@providence.org"">AKPAMC.OncologyResearchSupport@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Fairbanks</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairbanks Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 907-458-3043 <br>Email: <a href=""mailto:Veronica.Stevenson@foundationhealth.org"">Veronica.Stevenson@foundationhealth.org</a>   </span> </div>                                   <h4>Arkansas</h4>                           <h5 class=""locationCity"">Hot Springs</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CHI Saint Vincent Cancer Center Hot Springs</strong>     <br>Contact: Site Public Contact <br>Phone: 855-313-2409 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                   <h4>California</h4>                           <h5 class=""locationCity"">Burbank</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Saint Joseph Medical Center/Disney Family Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 818-847-4793 <br>Email: <a href=""mailto:Najee.Boucher@providence.org"">Najee.Boucher@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Dublin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Epic Care-Dublin</strong>     <br>Contact: Site Public Contact <br>Phone: 925-875-1677   </span> </div>                                       <h5 class=""locationCity"">Emeryville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bay Area Breast Surgeons Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 510-835-9900   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Epic Care Partners in Cancer Care</strong>     <br>Contact: Site Public Contact <br>Phone: 510-629-6682   </span> </div>                                       <h5 class=""locationCity"">Los Angeles</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">USC / Norris Comprehensive Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 323-865-0451   </span> </div>                                       <h5 class=""locationCity"">Martinez</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Contra Costa Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 925-957-5400   </span> </div>                                       <h5 class=""locationCity"">Mission Hills</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">City of Hope Mission Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 800-826-4673 <br>Email: <a href=""mailto:becomingapatient@coh.org"">becomingapatient@coh.org</a>   </span> </div>                                       <h5 class=""locationCity"">Newport Beach</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">City of Hope Newport Beach</strong>     <br>Contact: Site Public Contact <br>Phone: 877-467-3411   </span> </div>                                       <h5 class=""locationCity"">Oakland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bay Area Tumor Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 510-465-2242 <br>Email: <a href=""mailto:lradke@bati.org"">lradke@bati.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sacramento</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of California Davis Comprehensive Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 916-734-3089   </span> </div>                                       <h5 class=""locationCity"">South Pasadena</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">City of Hope South Pasadena</strong>     <br>Contact: Site Public Contact <br>Phone: 800-826-4673 <br>Email: <a href=""mailto:becomingapatient@coh.org"">becomingapatient@coh.org</a>   </span> </div>                                       <h5 class=""locationCity"">Torrance</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">City of Hope South Bay</strong>     <br>Contact: Site Public Contact <br>Phone: 877-467-3411   </span> </div>                                       <h5 class=""locationCity"">Upland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">City of Hope Upland</strong>     <br>Contact: Site Public Contact <br>Phone: 800-826-4673 <br>Email: <a href=""mailto:becomingapatient@coh.org"">becomingapatient@coh.org</a>   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Colorado Springs</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Penrose-Saint Francis Healthcare</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Penrose</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Denver</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Franklin</strong>     <br>Contact: Site Public Contact <br>Phone: 303-720-2685 <br>Email: <a href=""mailto:kristi.m.bronkan@kp.org"">kristi.m.bronkan@kp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Porter Adventist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 719-776-6550 <br>Email: <a href=""mailto:ResearchTracking@Centura.Org"">ResearchTracking@Centura.Org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">SCL Health Saint Joseph Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 303-318-3413 <br>Email: <a href=""mailto:alan.franklin@sclhealth.org"">alan.franklin@sclhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Durango</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southwest Oncology PC</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Golden</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mountain Blue Cancer Care Center</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lafayette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Good Samaritan Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 303-673-1622   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Rock Creek</strong>     <br>Contact: Site Public Contact <br>Phone: 303-720-2685 <br>Email: <a href=""mailto:kristi.m.bronkan@kp.org"">kristi.m.bronkan@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lakewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Lakewood</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Anthony Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Littleton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Littleton Adventist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 719-776-6550 <br>Email: <a href=""mailto:ResearchTracking@Centura.Org"">ResearchTracking@Centura.Org</a>   </span> </div>                                       <h5 class=""locationCity"">Lone Tree</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente-Lone Tree</strong>     <br>Contact: Site Public Contact <br>Phone: 303-720-2685 <br>Email: <a href=""mailto:kristi.m.bronkan@kp.org"">kristi.m.bronkan@kp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Longmont</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Longmont United Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Longmont</strong>     <br>Contact: Site Public Contact <br>Phone: 719-776-6550 <br>Email: <a href=""mailto:ResearchTracking@Centura.Org"">ResearchTracking@Centura.Org</a>   </span> </div>                                       <h5 class=""locationCity"">Parker</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Parker Adventist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 719-776-6550 <br>Email: <a href=""mailto:ResearchTracking@Centura.Org"">ResearchTracking@Centura.Org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Parker</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Pueblo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers - Pueblo</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary Corwin Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Thornton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Thornton</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                   <h4>Connecticut</h4>                           <h5 class=""locationCity"">Middletown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Middlesex Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 860-358-2058 <br>Email: <a href=""mailto:beth_slifer@midhosp.org"">beth_slifer@midhosp.org</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Dover</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bayhealth Hospital Kent Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 302-674-4401 <br>Email: <a href=""mailto:clinical_trials@bayhealth.org"">clinical_trials@bayhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lewes</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Millville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe South Coastal Health Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Christiana Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delaware Clinical and Laboratory Physicians PA</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:mhayden@christianacare.org"">mhayden@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Helen F Graham Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Medical Oncology Hematology Consultants PA</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rehoboth Beach</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe Health Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Seaford</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">TidalHealth Nanticoke / Allen Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 410-543-7019 <br>Email: <a href=""mailto:anna-maria.howard@peninsula.org"">anna-maria.howard@peninsula.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wilmington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Wilmington Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                   <h4>Florida</h4>                           <h5 class=""locationCity"">Tampa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Moffitt Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-679-0775 <br>Email: <a href=""mailto:ClinicalTrials@moffitt.org"">ClinicalTrials@moffitt.org</a>   </span> </div>                                       <h5 class=""locationCity"">Weston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cleveland Clinic-Weston</strong>     <br>Contact: Site Public Contact <br>Phone: 954-659-5705 <br>Email: <a href=""mailto:CancerAnswer@ccf.org"">CancerAnswer@ccf.org</a>   </span> </div>                                   <h4>Georgia</h4>                           <h5 class=""locationCity"">Atlanta</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Emory Saint Joseph's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 404-851-7115   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Emory University Hospital Midtown</strong>     <br>Contact: Site Public Contact <br>Phone: 888-946-7447   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Emory University Hospital/Winship Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 404-778-1868   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northside Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 404-303-3355 <br>Email: <a href=""mailto:ClinicalTrials@northside.com"">ClinicalTrials@northside.com</a>   </span> </div>                                       <h5 class=""locationCity"">Gainesville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northeast Georgia Medical Center-Gainesville</strong>     <br>Contact: Site Public Contact <br>Phone: 770-219-8800 <br>Email: <a href=""mailto:cancerpatient.navigator@nghs.com"">cancerpatient.navigator@nghs.com</a>   </span> </div>                                       <h5 class=""locationCity"">Savannah</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lewis Cancer and Research Pavilion at Saint Joseph's/Candler</strong>     <br>Contact: Site Public Contact <br>Phone: 912-819-5704 <br>Email: <a href=""mailto:underberga@sjchs.org"">underberga@sjchs.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Low Country Cancer Care</strong>     <br>Contact: Site Public Contact <br>Phone: 912-350-7887 <br>Email: <a href=""mailto:Lorraine.OHara@hcahealthcare.com"">Lorraine.OHara@hcahealthcare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Summit Cancer Care-Candler</strong>     <br>Contact: Site Public Contact <br>Phone: 912-800-6560   </span> </div>                                       <h5 class=""locationCity"">Thomasville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lewis Hall Singletary Oncology Center</strong>     <br>Contact: Site Public Contact <br>Phone: 888-823-5923 <br>Email: <a href=""mailto:ctsucontact@westat.com"">ctsucontact@westat.com</a>   </span> </div>                                   <h4>Idaho</h4>                           <h5 class=""locationCity"">Boise</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Alphonsus Cancer Care Center-Boise</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-3671 <br>Email: <a href=""mailto:stephanie.couch@stjoeshealth.org"">stephanie.couch@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Cancer Institute - Boise</strong>     <br>Contact: Site Public Contact <br>Phone: 208-381-2774 <br>Email: <a href=""mailto:eslinget@slhs.org"">eslinget@slhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Caldwell</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Alphonsus Cancer Care Center-Caldwell</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-3671 <br>Email: <a href=""mailto:stephanie.couch@stjoeshealth.org"">stephanie.couch@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Coeur D'Alene</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kootenai Health - Coeur d'Alene</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Emmett</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Walter Knox Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-3671 <br>Email: <a href=""mailto:stephanie.couch@stjoeshealth.org"">stephanie.couch@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Fruitland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Cancer Institute - Fruitland</strong>     <br>Contact: Site Public Contact <br>Phone: 208-381-2774 <br>Email: <a href=""mailto:eslinget@slhs.org"">eslinget@slhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Meridian</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Idaho Urologic Institute-Meridian</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-3671 <br>Email: <a href=""mailto:stephanie.couch@stjoeshealth.org"">stephanie.couch@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Cancer Institute - Meridian</strong>     <br>Contact: Site Public Contact <br>Phone: 208-381-2774 <br>Email: <a href=""mailto:eslinget@slhs.org"">eslinget@slhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Nampa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Alphonsus Cancer Care Center-Nampa</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Cancer Institute - Nampa</strong>     <br>Contact: Site Public Contact <br>Phone: 208-381-2774 <br>Email: <a href=""mailto:eslinget@slhs.org"">eslinget@slhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Post Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kootenai Clinic Cancer Services - Post Falls</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sandpoint</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kootenai Clinic Cancer Services - Sandpoint</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Twin Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Cancer Institute - Twin Falls</strong>     <br>Contact: Site Public Contact <br>Phone: 208-381-2774 <br>Email: <a href=""mailto:eslinget@slhs.org"">eslinget@slhs.org</a>   </span> </div>                                   <h4>Illinois</h4>                           <h5 class=""locationCity"">Aurora</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rush - Copley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 630-978-6212 <br>Email: <a href=""mailto:Cancer.Research@rushcopley.com"">Cancer.Research@rushcopley.com</a>   </span> </div>                                       <h5 class=""locationCity"">Bloomington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Bloomington</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Carbondale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Hospital of Carbondale</strong>     <br>Contact: Site Public Contact <br>Phone: 618-457-5200 <br>Email: <a href=""mailto:clinical.research@sih.net"">clinical.research@sih.net</a>   </span> </div>                                       <h5 class=""locationCity"">Carterville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">SIH Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 618-985-3333 <br>Email: <a href=""mailto:clinical.research@sih.net"">clinical.research@sih.net</a>   </span> </div>                                       <h5 class=""locationCity"">Carthage</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Carthage</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Centralia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Centralia Oncology Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Chicago</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">John H Stroger Jr Hospital of Cook County</strong>     <br>Contact: Site Public Contact <br>Phone: 312-864-5204   </span> </div>                                       <h5 class=""locationCity"">Danville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle at The Riverfront</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Decatur</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Specialists of Illinois - Decatur</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Decatur Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Effingham</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Physician Group-Effingham</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Crossroads Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Eureka</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Eureka</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Galesburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Galesburg</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Western Illinois Cancer Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 309-344-2831   </span> </div>                                       <h5 class=""locationCity"">Kewanee</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Kewanee Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Macomb</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Macomb</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Mattoon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Physician Group-Mattoon/Charleston</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Maywood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Loyola University Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 708-226-4357   </span> </div>                                       <h5 class=""locationCity"">Mount Vernon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Good Samaritan Regional Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 618-242-4600   </span> </div>                                       <h5 class=""locationCity"">O'Fallon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Center of O'Fallon</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Ottawa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Ottawa Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Pekin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Pekin</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OSF Saint Francis Radiation Oncology at Pekin</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Peoria</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Peoria</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Methodist Medical Center of Illinois</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OSF Saint Francis Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OSF Saint Francis Radiation Oncology at Peoria Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Peru</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Peru</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Valley Radiation Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 815-664-4141   </span> </div>                                       <h5 class=""locationCity"">Princeton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Princeton</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Springfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 217-528-7541 <br>Email: <a href=""mailto:pallante.beth@mhsil.com"">pallante.beth@mhsil.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southern Illinois University School of Medicine</strong>     <br>Contact: Site Public Contact <br>Phone: 217-545-7929   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Springfield Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 800-444-7541   </span> </div>                                       <h5 class=""locationCity"">Swansea</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southwest Illinois Health Services LLP</strong>     <br>Contact: Site Public Contact <br>Phone: 618-236-1000 <br>Email: <a href=""mailto:lynns@thecancercenter.com"">lynns@thecancercenter.com</a>   </span> </div>                                       <h5 class=""locationCity"">Urbana</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Carle Foundation Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Yorkville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rush-Copley Healthcare Center</strong>     <br>Contact: Site Public Contact <br>Phone: 630-978-6212 <br>Email: <a href=""mailto:Cancer.Research@rushcopley.com"">Cancer.Research@rushcopley.com</a>   </span> </div>                                   <h4>Indiana</h4>                           <h5 class=""locationCity"">Indianapolis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Franciscan Health Indianapolis</strong>     <br>Contact: Site Public Contact <br>Phone: 317-528-7060   </span> </div>                                       <h5 class=""locationCity"">Lafayette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Franciscan Saint Elizabeth Health - Lafayette East</strong>     <br>Contact: Site Public Contact <br>Phone: 888-823-5923 <br>Email: <a href=""mailto:ctsucontact@westat.com"">ctsucontact@westat.com</a>   </span> </div>                                       <h5 class=""locationCity"">Mooresville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Franciscan Health Mooresville</strong>     <br>Contact: Site Public Contact <br>Phone: 317-834-3603   </span> </div>                                       <h5 class=""locationCity"">Terre Haute</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Union Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 812-238-7394   </span> </div>                                   <h4>Iowa</h4>                           <h5 class=""locationCity"">Council Bluffs</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alegent Health Mercy Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 402-717-1510 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                   <h4>Kansas</h4>                           <h5 class=""locationCity"">Coffeyville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Coffeyville Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 620-252-1606   </span> </div>                                       <h5 class=""locationCity"">Garden City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Care Cancer Center - Garden City</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Catherine Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 800-592-5110 <br>Email: <a href=""mailto:info@cccancer.com"">info@cccancer.com</a>   </span> </div>                                       <h5 class=""locationCity"">Great Bend</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Care Cancer Center - Great Bend</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Hays</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">HaysMed</strong>     <br>Contact: Site Public Contact <br>Phone: 785-623-5774   </span> </div>                                       <h5 class=""locationCity"">Kansas City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Kansas Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 913-588-3671 <br>Email: <a href=""mailto:KUCC_Navigation@kumc.edu"">KUCC_Navigation@kumc.edu</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Kansas Cancer Center-West</strong>     <br>Contact: Site Public Contact <br>Phone: 913-588-3671 <br>Email: <a href=""mailto:KUCC_Navigation@kumc.edu"">KUCC_Navigation@kumc.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Olathe</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Olathe Health Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 913-355-3943 <br>Email: <a href=""mailto:atheCCResearch@kumc.edu"">atheCCResearch@kumc.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Overland Park</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Kansas Cancer Center-Overland Park</strong>     <br>Contact: Site Public Contact <br>Phone: 913-588-3671 <br>Email: <a href=""mailto:KUCC_Navigation@kumc.edu"">KUCC_Navigation@kumc.edu</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Kansas Hospital-Indian Creek Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 913-588-3671 <br>Email: <a href=""mailto:KUCC_Navigation@kumc.edu"">KUCC_Navigation@kumc.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Pittsburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Via Christi - Pittsburg</strong>     <br>Contact: Site Public Contact <br>Phone: 620-235-7900 <br>Email: <a href=""mailto:jennifer.jameson@ascension.org"">jennifer.jameson@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Salina</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Salina Regional Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 785-452-7038 <br>Email: <a href=""mailto:mleepers@srhc.com"">mleepers@srhc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Topeka</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Kansas Health System Saint Francis Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 785-295-8000   </span> </div>                                       <h5 class=""locationCity"">Westwood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Kansas Hospital-Westwood Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 913-588-3671 <br>Email: <a href=""mailto:KUCC_Navigation@kumc.edu"">KUCC_Navigation@kumc.edu</a>   </span> </div>                                   <h4>Kentucky</h4>                           <h5 class=""locationCity"">Bardstown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Flaget Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Corbin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Commonwealth Cancer Center-Corbin</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lexington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Joseph Hospital East</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Joseph Radiation Oncology Resource Center</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">London</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Joseph London</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Louisville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Jewish Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 859-629-7169 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saints Mary and Elizabeth Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 859-629-7169 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UofL Health Medical Center Northeast</strong>     <br>Contact: Site Public Contact <br>Phone: 502-852-2755 <br>Email: <a href=""mailto:ctoinfo@louisville.edu"">ctoinfo@louisville.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Shepherdsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Jewish Hospital Medical Center South</strong>     <br>Contact: Site Public Contact <br>Phone: 859-629-7169 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                   <h4>Louisiana</h4>                           <h5 class=""locationCity"">Baton Rouge</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Louisiana Hematology Oncology Associates</strong>     <br>Contact: Site Public Contact <br>Phone: 225-215-1353 <br>Email: <a href=""mailto:clinicalresearch@marybird.com"">clinicalresearch@marybird.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Louisiana Hematology Oncology Associates LLC</strong>     <br>Contact: Site Public Contact <br>Phone: 225-215-1353 <br>Email: <a href=""mailto:clinicalresearch@marybird.com"">clinicalresearch@marybird.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">LSU Health Baton Rouge-North Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 225-765-7659 <br>Email: <a href=""mailto:research@ololrmc.com"">research@ololrmc.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mary Bird Perkins Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 225-215-1353 <br>Email: <a href=""mailto:clinicalresearch@marybird.com"">clinicalresearch@marybird.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Our Lady of the Lake Medical Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 225-765-7659 <br>Email: <a href=""mailto:research@ololrmc.com"">research@ololrmc.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Our Lady of the Lake Physician Group</strong>     <br>Contact: Site Public Contact <br>Phone: 225-765-7659 <br>Email: <a href=""mailto:research@ololrmc.com"">research@ololrmc.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Woman's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 225-215-1353 <br>Email: <a href=""mailto:Clinicalreserach@marybird.com"">Clinicalreserach@marybird.com</a>   </span> </div>                                   <h4>Maryland</h4>                           <h5 class=""locationCity"">Bel Air</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UM Upper Chesapeake Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 443-643-3010   </span> </div>                                   <h4>Massachusetts</h4>                           <h5 class=""locationCity"">Burlington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lahey Hospital and Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 781-744-3421 <br>Email: <a href=""mailto:lhmc-cancer-clinical-trials@lahey.org"">lhmc-cancer-clinical-trials@lahey.org</a>   </span> </div>                                       <h5 class=""locationCity"">Winchester</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Winchester Hospital</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:protocols@swog.org"">protocols@swog.org</a>   </span> </div>                                   <h4>Michigan</h4>                           <h5 class=""locationCity"">Ann Arbor</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Saint Joseph Mercy Hospital Ann Arbor</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Michigan Comprehensive Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-865-1125   </span> </div>                                       <h5 class=""locationCity"">Battle Creek</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bronson Battle Creek</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bay City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McLaren Cancer Institute-Bay City</strong>     <br>Contact: Site Public Contact <br>Phone: 313-576-9790 <br>Email: <a href=""mailto:ctoadmin@karmanos.org"">ctoadmin@karmanos.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bloomfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McLaren Cancer Institute-Bloomfield</strong>     <br>Contact: Site Public Contact <br>Phone: 313-576-9790 <br>Email: <a href=""mailto:ctoadmin@karmanos.org"">ctoadmin@karmanos.org</a>   </span> </div>                                       <h5 class=""locationCity"">Brighton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Brighton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Medical Center - Brighton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Brownstown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Henry Ford Cancer Institute-Downriver</strong>     <br>Contact: Site Public Contact <br>Phone: 313-916-3721 <br>Email: <a href=""mailto:CTOResearch@hfhs.org"">CTOResearch@hfhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Medical Center - Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Caro</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Caro Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chelsea</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Chelsea Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Chelsea Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Clarkston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hematology Oncology Consultants-Clarkston</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McLaren Cancer Institute-Clarkston</strong>     <br>Contact: Site Public Contact <br>Phone: 313-576-9790 <br>Email: <a href=""mailto:ctoadmin@karmanos.org"">ctoadmin@karmanos.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Newland Medical Associates-Clarkston</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Clinton Township</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Henry Ford Macomb Hospital-Clinton Township</strong>     <br>Contact: Site Public Contact <br>Phone: 313-916-3721 <br>Email: <a href=""mailto:CTOResearch@hfhs.org"">CTOResearch@hfhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Dearborn</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Henry Ford Medical Center-Fairlane</strong>     <br>Contact: Site Public Contact <br>Phone: 313-916-3721 <br>Email: <a href=""mailto:CTOResearch@hfhs.org"">CTOResearch@hfhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Detroit</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Saint John Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Henry Ford Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 313-916-3721 <br>Email: <a href=""mailto:CTOResearch@hfhs.org"">CTOResearch@hfhs.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Wayne State University/Karmanos Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 313-576-9790 <br>Email: <a href=""mailto:ctoadmin@karmanos.org"">ctoadmin@karmanos.org</a>   </span> </div>                                       <h5 class=""locationCity"">East China</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Doctors Park</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Flint</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesee Cancer and Blood Disease Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesee Hematology Oncology PC</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesys Hurley Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hurley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McLaren Cancer Institute-Flint</strong>     <br>Contact: Site Public Contact <br>Phone: 313-576-9790 <br>Email: <a href=""mailto:ctoadmin@karmanos.org"">ctoadmin@karmanos.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Singh and Arora Hematology Oncology PC</strong>     <br>Contact: Site Public Contact <br>Phone: 313-576-9790 <br>Email: <a href=""mailto:ctoadmin@karmanos.org"">ctoadmin@karmanos.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grand Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Grand Rapids Hospitals - Butterworth Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Grand Rapids Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grosse Pointe Woods</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Academic Hematology Oncology Specialists</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Van Elslander Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Michigan Breast Specialists-Grosse Pointe Woods</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Jackson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Allegiance Health</strong>     <br>Contact: Site Public Contact <br>Phone: 313-916-3721 <br>Email: <a href=""mailto:CTOResearch@hfhs.org"">CTOResearch@hfhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Kalamazoo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Borgess Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bronson Methodist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">West Michigan Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lansing</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Karmanos Cancer Institute at McLaren Greater Lansing</strong>     <br>Contact: Site Public Contact <br>Phone: 313-576-9790 <br>Email: <a href=""mailto:ctoadmin@karmanos.org"">ctoadmin@karmanos.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Michigan Health - Sparrow Lansing</strong>     <br>Contact: Site Public Contact <br>Phone: 517-364-3712 <br>Email: <a href=""mailto:harsha.trivedi@umhsparrow.org"">harsha.trivedi@umhsparrow.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lapeer</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McLaren Cancer Institute-Lapeer Region</strong>     <br>Contact: Site Public Contact <br>Phone: 313-576-9790 <br>Email: <a href=""mailto:ctoadmin@karmanos.org"">ctoadmin@karmanos.org</a>   </span> </div>                                       <h5 class=""locationCity"">Livonia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hope Cancer Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-3671 <br>Email: <a href=""mailto:stephanie.couch@stjoeshealth.org"">stephanie.couch@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Saint Mary Mercy Livonia Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Macomb Township</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Macomb Medical Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Michigan Breast Specialists-Macomb Township</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Marlette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary's Oncology/Hematology Associates of Marlette</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Mount Clemens</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McLaren Cancer Institute-Macomb</strong>     <br>Contact: Site Public Contact <br>Phone: 313-576-9790 <br>Email: <a href=""mailto:ctoadmin@karmanos.org"">ctoadmin@karmanos.org</a>   </span> </div>                                       <h5 class=""locationCity"">Muskegon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Muskegon Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Niles</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Lakeland Hospitals - Niles Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230   </span> </div>                                       <h5 class=""locationCity"">Novi</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Providence Hospitals - Novi</strong>     <br>Contact: Site Public Contact <br>Phone: 248-849-5332 <br>Email: <a href=""mailto:karen.fife@ascension.org"">karen.fife@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Henry Ford Medical Center-Columbus</strong>     <br>Contact: Site Public Contact <br>Phone: 313-916-3721 <br>Email: <a href=""mailto:CTOResearch@hfhs.org"">CTOResearch@hfhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Pontiac</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hope Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Michigan Healthcare Professionals Pontiac</strong>     <br>Contact: Site Public Contact <br>Phone: 248-858-6215 <br>Email: <a href=""mailto:Emily.Crofts@trinity-health.org"">Emily.Crofts@trinity-health.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Newland Medical Associates-Pontiac</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Saint Joseph Mercy Oakland Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Reed City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Reed City Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rochester Hills</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Rochester Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-3671 <br>Email: <a href=""mailto:stephanie.couch@stjoeshealth.org"">stephanie.couch@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Saginaw</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MyMichigan Medical Center Saginaw</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Associates of Saginaw Valley PC</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Joseph</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Corewell Health Lakeland Hospitals - Saint Joseph Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Southfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Providence Hospitals - Southfield</strong>     <br>Contact: Site Public Contact <br>Phone: 248-849-5332 <br>Email: <a href=""mailto:karen.fife@ascension.org"">karen.fife@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sterling Heights</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bhadresh Nayak MD PC-Sterling Heights</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Tawas City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MyMichigan Medical Center Tawas</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Traverse City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Munson Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Warren</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Advanced Breast Care Center PLLC</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Macomb Professional Building</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Macomb Hematology Oncology PC</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Michigan Breast Specialists-Warren</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint John Macomb-Oakland Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">West Bloomfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Henry Ford West Bloomfield Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 313-916-3721 <br>Email: <a href=""mailto:CTOResearch@hfhs.org"">CTOResearch@hfhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">West Branch</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary's Oncology/Hematology Associates of West Branch</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wyoming</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Michigan Health - West</strong>     <br>Contact: Site Public Contact <br>Phone: 616-391-1230 <br>Email: <a href=""mailto:crcwm-regulatory@crcwm.org"">crcwm-regulatory@crcwm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Ypsilanti</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Huron Gastroenterology PC</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology  Ann Arbor Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                   <h4>Minnesota</h4>                           <h5 class=""locationCity"">Burnsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Ridges Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Coon Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Edina</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Southdale Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Maple Grove</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Clinics and Surgery Center Maple Grove</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Maplewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Minnesota Oncology Hematology PA-Maplewood</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint John's Hospital - Healtheast</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Minneapolis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Abbott-Northwestern Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Health Partners Inc</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hennepin County Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Monticello</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Monticello Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">New Ulm</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">New Ulm Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Robbinsdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">North Memorial Medical Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Louis Park</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Park Nicollet Clinic - Saint Louis Park</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Paul</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Regions Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">United Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Shakopee</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Stillwater</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lakeview Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Waconia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ridgeview Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Willmar</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rice Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Woodbury</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Minnesota Oncology Hematology PA-Woodbury</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Wyoming</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Lakes Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                   <h4>Mississippi</h4>                           <h5 class=""locationCity"">Columbus</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Golden Triangle</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grenada</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Cancer Center-Grenada</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Jackson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Mississippi Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 601-815-6700   </span> </div>                                       <h5 class=""locationCity"">New Albany</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Union County</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Oxford</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Oxford</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Southhaven</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Desoto</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                   <h4>Missouri</h4>                           <h5 class=""locationCity"">Ballwin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Louis Cancer and Breast Institute-Ballwin</strong>     <br>Contact: Site Public Contact <br>Phone: 314-251-7058   </span> </div>                                       <h5 class=""locationCity"">Bolivar</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Care Cancer Center - Bolivar</strong>     <br>Contact: Site Public Contact <br>Phone: 913-948-5588 <br>Email: <a href=""mailto:aroland@kccop.org"">aroland@kccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bonne Terre</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Parkland Health Center-Bonne Terre</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Branson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cox Cancer Center Branson</strong>     <br>Contact: Site Public Contact <br>Phone: 417-269-4520   </span> </div>                                       <h5 class=""locationCity"">Cape Girardeau</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-334-2230 <br>Email: <a href=""mailto:sfmc@sfmc.net"">sfmc@sfmc.net</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southeast Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-651-5550   </span> </div>                                       <h5 class=""locationCity"">Columbia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MU Health - University Hospital/Ellis Fischel Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-882-7440   </span> </div>                                       <h5 class=""locationCity"">Jefferson City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MU Health Care Goldschmidt Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-632-4851 <br>Email: <a href=""mailto:amy.franken@health.missouri.edu"">amy.franken@health.missouri.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Joplin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Freeman Health System</strong>     <br>Contact: Site Public Contact <br>Phone: 417-347-4030 <br>Email: <a href=""mailto:LJCrockett@freemanhealth.com"">LJCrockett@freemanhealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Joplin</strong>     <br>Contact: Site Public Contact <br>Phone: 417-556-3074 <br>Email: <a href=""mailto:esmeralda.carrillo@mercy.net"">esmeralda.carrillo@mercy.net</a>   </span> </div>                                       <h5 class=""locationCity"">Kansas City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University Health Truman Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 816-404-4375   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Kansas Cancer Center - North</strong>     <br>Contact: Site Public Contact <br>Phone: 913-588-3671 <br>Email: <a href=""mailto:KUCC_Navigation@kumc.edu"">KUCC_Navigation@kumc.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Lee's Summit</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Kansas Cancer Center - Lee's Summit</strong>     <br>Contact: Site Public Contact <br>Phone: 913-588-3671 <br>Email: <a href=""mailto:KUCC_Navigation@kumc.edu"">KUCC_Navigation@kumc.edu</a>   </span> </div>                                       <h5 class=""locationCity"">North Kansas City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Kansas Cancer Center at North Kansas City Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 913-588-3671 <br>Email: <a href=""mailto:KUCC_Navigation@kumc.edu"">KUCC_Navigation@kumc.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Rolla</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delbert Day Cancer Institute at PCRMC</strong>     <br>Contact: Site Public Contact <br>Phone: 573-458-7504 <br>Email: <a href=""mailto:research@phelpshealth.org"">research@phelpshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Clinic-Rolla-Cancer and Hematology</strong>     <br>Contact: Site Public Contact <br>Phone: 573-458-6379   </span> </div>                                       <h5 class=""locationCity"">Saint Joseph</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Heartland Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 816-271-7937 <br>Email: <a href=""mailto:linda.schumacher@mymlc.com"">linda.schumacher@mymlc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Louis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Saint Louis</strong>     <br>Contact: Site Public Contact <br>Phone: 314-251-7066   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital South</strong>     <br>Contact: Site Public Contact <br>Phone: 314-525-6042 <br>Email: <a href=""mailto:Danielle.Werle@mercy.net"">Danielle.Werle@mercy.net</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Missouri Baptist Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Louis Cancer and Breast Institute-South City</strong>     <br>Contact: Site Public Contact <br>Phone: 314-353-1870   </span> </div>                                       <h5 class=""locationCity"">Sainte Genevieve</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sainte Genevieve County Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Springfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CoxHealth South Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 417-269-4520   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Springfield</strong>     <br>Contact: Site Public Contact <br>Phone: 417-269-4520   </span> </div>                                       <h5 class=""locationCity"">Sullivan</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Missouri Baptist Sullivan Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Sunset Hills</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">BJC Outpatient Center at Sunset Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Washington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Washington</strong>     <br>Contact: Site Public Contact <br>Phone: 636-390-1600   </span> </div>                                   <h4>Montana</h4>                           <h5 class=""locationCity"">Anaconda</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Community Hospital of Anaconda</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Billings</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Billings Clinic Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-996-2663 <br>Email: <a href=""mailto:research@billingsclinic.org"">research@billingsclinic.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bozeman</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bozeman Health Deaconess Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Great Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Benefis Sletten Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Falls Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Helena</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Peter's Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Kalispell</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kalispell Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Missoula</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Community Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Patrick Hospital - Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 406-327-3118 <br>Email: <a href=""mailto:amy.hanneman@providence.org"">amy.hanneman@providence.org</a>   </span> </div>                                   <h4>Nebraska</h4>                           <h5 class=""locationCity"">Grand Island</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Nebraska Cancer Specialists/Oncology Hematology West PC</strong>     <br>Contact: Site Public Contact <br>Phone: 402-334-4773   </span> </div>                                       <h5 class=""locationCity"">Kearney</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CHI Health Good Samaritan</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Heartland Hematology and Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 308-865-2303   </span> </div>                                       <h5 class=""locationCity"">Lincoln</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Elizabeth Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 855-313-2409 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Omaha</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alegent Health Bergan Mercy Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alegent Health Immanuel Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Alegent Health Lakeside Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Creighton University Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hematology and Oncology Consultants PC</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Papillion</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Midlands Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 402-717-1510 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                   <h4>New Jersey</h4>                           <h5 class=""locationCity"">Morristown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Morristown Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 973-971-5900   </span> </div>                                       <h5 class=""locationCity"">Newton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Newton Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 973-971-5990   </span> </div>                                       <h5 class=""locationCity"">Summit</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Overlook Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 908-522-2043   </span> </div>                                       <h5 class=""locationCity"">Teaneck</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Holy Name Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 201-833-6312   </span> </div>                                   <h4>New Mexico</h4>                           <h5 class=""locationCity"">Albuquerque</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of New Mexico Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 505-925-0348 <br>Email: <a href=""mailto:HSC-ClinicalTrialInfo@salud.unm.edu"">HSC-ClinicalTrialInfo@salud.unm.edu</a>   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">New York</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 212-342-5162 <br>Email: <a href=""mailto:cancerclinicaltrials@cumc.columbia.edu"">cancerclinicaltrials@cumc.columbia.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Nyack</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Nyack Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 845-348-8507   </span> </div>                                       <h5 class=""locationCity"">White Plains</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Dickstein Cancer Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 914-849-7582 <br>Email: <a href=""mailto:mcortese@wphospital.org"">mcortese@wphospital.org</a>   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Akron</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cleveland Clinic Akron General</strong>     <br>Contact: Site Public Contact <br>Phone: 866-223-8100 <br>Email: <a href=""mailto:CancerAnswer@ccf.org"">CancerAnswer@ccf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Aultman Health Foundation</strong>     <br>Contact: Site Public Contact <br>Phone: 330-363-7274 <br>Email: <a href=""mailto:ClinicalReserachDept@aultman.com"">ClinicalReserachDept@aultman.com</a>   </span> </div>                                       <h5 class=""locationCity"">Cincinnati</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bethesda North Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Good Samaritan Hospital - Cincinnati</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Christ Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 513-585-0844   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">TriHealth Cancer Institute-Anderson</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">TriHealth Cancer Institute-Westside</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Cleveland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cleveland Clinic Cancer Center/Fairview Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 866-223-8100 <br>Email: <a href=""mailto:TaussigResearch@ccf.org"">TaussigResearch@ccf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cleveland Clinic Foundation</strong>     <br>Contact: Site Public Contact <br>Phone: 866-223-8100 <br>Email: <a href=""mailto:TaussigResearch@ccf.org"">TaussigResearch@ccf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Dayton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Good Samaritan Hospital - Dayton</strong>     <br>Contact: Site Public Contact <br>Phone: 937-416-9270 <br>Email: <a href=""mailto:clinical.trials@daytonncorp.org"">clinical.trials@daytonncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Elyria</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Cancer Center-Elyria</strong>     <br>Contact: Site Public Contact <br>Phone: 800-641-2422 <br>Email: <a href=""mailto:CTUReferral@UHhospitals.org"">CTUReferral@UHhospitals.org</a>   </span> </div>                                       <h5 class=""locationCity"">Independence</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cleveland Clinic Cancer Center Independence</strong>     <br>Contact: Site Public Contact <br>Phone: 866-223-8100 <br>Email: <a href=""mailto:TaussigResearch@ccf.org"">TaussigResearch@ccf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Mansfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cleveland Clinic Cancer Center Mansfield</strong>     <br>Contact: Site Public Contact <br>Phone: 866-223-8100 <br>Email: <a href=""mailto:TaussigResearch@ccf.org"">TaussigResearch@ccf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Mayfield Heights</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hillcrest Hospital Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 866-223-8100 <br>Email: <a href=""mailto:TaussigResearch@ccf.org"">TaussigResearch@ccf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sandusky</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">North Coast Cancer Care</strong>     <br>Contact: Site Public Contact <br>Phone: 866-223-8100 <br>Email: <a href=""mailto:TaussigResearch@ccf.org"">TaussigResearch@ccf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Strongsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cleveland Clinic Cancer Center Strongsville</strong>     <br>Contact: Site Public Contact <br>Phone: 866-223-8100 <br>Email: <a href=""mailto:TaussigResearch@ccf.org"">TaussigResearch@ccf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Warrensville Heights</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">South Pointe Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 866-223-8100 <br>Email: <a href=""mailto:TaussigResearch@ccf.org"">TaussigResearch@ccf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wooster</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cleveland Clinic Wooster Family Health and Surgery Center</strong>     <br>Contact: Site Public Contact <br>Phone: 866-223-8100 <br>Email: <a href=""mailto:TaussigResearch@ccf.org"">TaussigResearch@ccf.org</a>   </span> </div>                                   <h4>Oklahoma</h4>                           <h5 class=""locationCity"">Oklahoma City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Oklahoma City</strong>     <br>Contact: Site Public Contact <br>Phone: 405-752-3402   </span> </div>                                   <h4>Oregon</h4>                           <h5 class=""locationCity"">Baker City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Alphonsus Cancer Care Center-Baker City</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bend</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Charles Health System</strong>     <br>Contact: Site Public Contact <br>Phone: 541-706-2909 <br>Email: <a href=""mailto:nosall@stcharleshealthcare.org"">nosall@stcharleshealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Clackamas</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Clackamas Radiation Oncology Center</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Cancer Institute Clackamas Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Coos Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bay Area Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 541-269-8392 <br>Email: <a href=""mailto:cherie.cox@bayareahospital.org"">cherie.cox@bayareahospital.org</a>   </span> </div>                                       <h5 class=""locationCity"">Newberg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Newberg Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Ontario</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Alphonsus Cancer Care Center-Ontario</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Portland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kaiser Permanente Northwest</strong>     <br>Contact: Site Public Contact <br>Phone: 503-335-2400 <br>Email: <a href=""mailto:information@kpchr.org"">information@kpchr.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oregon Health and Science University</strong>     <br>Contact: Site Public Contact <br>Phone: 503-494-1080 <br>Email: <a href=""mailto:trials@ohsu.edu"">trials@ohsu.edu</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Portland Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Saint Vincent Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 503-215-2614 <br>Email: <a href=""mailto:CanRsrchStudies@providence.org"">CanRsrchStudies@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Redmond</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Charles Health System-Redmond</strong>     <br>Contact: Site Public Contact <br>Phone: 541-706-2909   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Allentown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lehigh Valley Hospital-Cedar Crest</strong>     <br>Contact: Site Public Contact <br>Phone: 610-402-9543 <br>Email: <a href=""mailto:Morgan_M.Horton@lvhn.org"">Morgan_M.Horton@lvhn.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bethlehem</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lehigh Valley Hospital - Muhlenberg</strong>     <br>Contact: Site Public Contact <br>Phone: 610-402-9543 <br>Email: <a href=""mailto:Morgan_M.Horton@lvhn.org"">Morgan_M.Horton@lvhn.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chadds Ford</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Concord Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">East Stroudsburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Pocono Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 610-402-9543 <br>Email: <a href=""mailto:Morgan_M.Horton@lvhn.org"">Morgan_M.Horton@lvhn.org</a>   </span> </div>                                       <h5 class=""locationCity"">Hazleton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lehigh Valley Hospital-Hazleton</strong>     <br>Contact: Site Public Contact <br>Phone: 610-402-9543 <br>Email: <a href=""mailto:Morgan_M.Horton@lvhn.org"">Morgan_M.Horton@lvhn.org</a>   </span> </div>                                       <h5 class=""locationCity"">Hershey</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Penn State Milton S Hershey Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 717-531-3779 <br>Email: <a href=""mailto:CTO@hmc.psu.edu"">CTO@hmc.psu.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Phoenixville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Phoenixville Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 610-983-1800   </span> </div>                                       <h5 class=""locationCity"">Sayre</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Guthrie Medical Group PC-Robert Packer Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 800-836-0388   </span> </div>                                   <h4>South Carolina</h4>                           <h5 class=""locationCity"">Boiling Springs</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Spartanburg</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Charleston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Medical University of South Carolina</strong>     <br>Contact: Site Public Contact <br>Phone: 843-792-9321 <br>Email: <a href=""mailto:hcc-clinical-trials@musc.edu"">hcc-clinical-trials@musc.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Clinton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Laurens</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Easley</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Easley</strong>     <br>Contact: Site Public Contact <br>Phone: 864-522-2066 <br>Email: <a href=""mailto:Kim.Williams3@prismahealth.org"">Kim.Williams3@prismahealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Greenville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Butternut</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Eastside</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Faris</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Greenville Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Greenwood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Self Regional Healthcare</strong>     <br>Contact: Site Public Contact <br>Phone: 864-725-4771 <br>Email: <a href=""mailto:nmcgaha@selfregional.org"">nmcgaha@selfregional.org</a>   </span> </div>                                       <h5 class=""locationCity"">Greer</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Greer</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Seneca</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Seneca</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                   <h4>Tennessee</h4>                           <h5 class=""locationCity"">Chattanooga</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Collierville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Collierville</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Hixson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Pulmonary Medicine Center of Chattanooga-Hixson</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Memphis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Memphis</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital for Women</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Ooltewah</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial GYN Plus</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                   <h4>Texas</h4>                           <h5 class=""locationCity"">Bryan</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Joseph Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 855-313-2409 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Dallas</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UT Southwestern/Simmons Cancer Center-Dallas</strong>     <br>Contact: Site Public Contact <br>Phone: 214-648-7097 <br>Email: <a href=""mailto:canceranswerline@UTSouthwestern.edu"">canceranswerline@UTSouthwestern.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Fort Worth</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UT Southwestern/Simmons Cancer Center-Fort Worth</strong>     <br>Contact: Site Public Contact <br>Phone: 214-648-7097 <br>Email: <a href=""mailto:canceranswerline@UTSouthwestern.edu"">canceranswerline@UTSouthwestern.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Richardson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UT Southwestern Clinical Center at Richardson/Plano</strong>     <br>Contact: Site Public Contact <br>Phone: 972-669-7044 <br>Email: <a href=""mailto:Suzanne.cole@utsouthwestern.edu"">Suzanne.cole@utsouthwestern.edu</a>   </span> </div>                                   <h4>Virginia</h4>                           <h5 class=""locationCity"">Fishersville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Augusta Health Center for Cancer and Blood Disorders</strong>     <br>Contact: Site Public Contact <br>Phone: 540-332-5960   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Aberdeen</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer System-Aberdeen</strong>     <br>Contact: Site Public Contact <br>Phone: 360-412-8958 <br>Email: <a href=""mailto:deidre.dillon@providence.org"">deidre.dillon@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Auburn</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MultiCare Auburn Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 253-887-9333 <br>Email: <a href=""mailto:research@multicare.org"">research@multicare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bellevue</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Overlake Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 425-688-5407 <br>Email: <a href=""mailto:OHMCResearch@overlakehospital.org"">OHMCResearch@overlakehospital.org</a>   </span> </div>                                       <h5 class=""locationCity"">Bellingham</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">PeaceHealth Saint Joseph Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 360-788-8223   </span> </div>                                       <h5 class=""locationCity"">Bremerton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Harrison HealthPartners Hematology and Oncology-Bremerton</strong>     <br>Contact: Site Public Contact <br>Phone: 308-398-6518 <br>Email: <a href=""mailto:clinicaltrials@sfmc-gi.org"">clinicaltrials@sfmc-gi.org</a>   </span> </div>                                       <h5 class=""locationCity"">Burien</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Highline Medical Center-Main Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 253-426-6882 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Centralia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer System-Centralia</strong>     <br>Contact: Site Public Contact <br>Phone: 360-412-8958 <br>Email: <a href=""mailto:deidre.dillon@providence.org"">deidre.dillon@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Edmonds</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Cancer Institute-Edmonds</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Enumclaw</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Elizabeth Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 253-426-6882 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Everett</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer Partnership</strong>     <br>Contact: Site Public Contact <br>Phone: 425-261-3529 <br>Email: <a href=""mailto:marilyn.birchman@providence.org"">marilyn.birchman@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Federal Way</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 253-426-6882 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Gig Harbor</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MultiCare Gig Harbor Medical Park</strong>     <br>Contact: Site Public Contact <br>Phone: 253-403-2394 <br>Email: <a href=""mailto:research@multicare.org"">research@multicare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Issaquah</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Cancer Institute-Issaquah</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                       <h5 class=""locationCity"">Kennewick</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kadlec Clinic Hematology and Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 509-783-4637 <br>Email: <a href=""mailto:research@kadlecmed.org"">research@kadlecmed.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lacey</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer System-Lacey</strong>     <br>Contact: Site Public Contact <br>Phone: 360-412-8958 <br>Email: <a href=""mailto:deidre.dillon@providence.org"">deidre.dillon@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lakewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Clare Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 253-426-6882 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Longview</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">PeaceHealth Saint John Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 360-514-2016 <br>Email: <a href=""mailto:kmakin-bond@peacehealth.org"">kmakin-bond@peacehealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Port Townsend</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Jefferson Healthcare</strong>     <br>Contact: Site Public Contact <br>Phone: 360-344-3091   </span> </div>                                       <h5 class=""locationCity"">Renton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Valley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 425-228-3440 <br>Email: <a href=""mailto:research@valleymed.org"">research@valleymed.org</a>   </span> </div>                                       <h5 class=""locationCity"">Seattle</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">FHCC South Lake Union</strong>     <br>Contact: Site Public Contact <br>Phone: 800-804-8824   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fred Hutchinson Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-804-8824   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Pacific Gynecology Specialists</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Medical Center-Ballard Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Medical Center-Cherry Hill</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Swedish Medical Center-First Hill</strong>     <br>Contact: Site Public Contact <br>Phone: 206-215-3086 <br>Email: <a href=""mailto:PCRC-NCORP@Swedish.org"">PCRC-NCORP@Swedish.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Washington Medical Center - Montlake</strong>     <br>Contact: Site Public Contact <br>Phone: 800-804-8824   </span> </div>                                       <h5 class=""locationCity"">Sedro-Woolley</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">PeaceHealth United General Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 360-788-8238 <br>Email: <a href=""mailto:lkey@peacehealth.org"">lkey@peacehealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Shelton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer System-Shelton</strong>     <br>Contact: Site Public Contact <br>Phone: 360-412-8958 <br>Email: <a href=""mailto:deidre.dillon@providence.org"">deidre.dillon@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Silverdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Michael Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                       <h5 class=""locationCity"">Spokane</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MultiCare Deaconess Cancer and Blood Specialty Center - Downtown</strong>     <br>Contact: Site Public Contact <br>Phone: 253-403-7249 <br>Email: <a href=""mailto:research@multicare.org"">research@multicare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MultiCare Deaconess Cancer and Blood Specialty Center - North</strong>     <br>Contact: Site Public Contact <br>Phone: 253-402-7249 <br>Email: <a href=""mailto:research@multicare.org"">research@multicare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Spokane Valley</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MultiCare Deaconess Cancer and Blood Specialty Center - Valley</strong>     <br>Contact: Site Public Contact <br>Phone: 253-403-7249 <br>Email: <a href=""mailto:research@multicare.org"">research@multicare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Tacoma</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Franciscan Research Center-Northwest Medical Plaza</strong>     <br>Contact: Site Public Contact <br>Phone: 253-426-6882 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MultiCare Tacoma General Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 253-403-3229 <br>Email: <a href=""mailto:research@multicare.org"">research@multicare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwest Medical Specialties PLLC</strong>     <br>Contact: Site Public Contact <br>Phone: 253-306-0532 <br>Email: <a href=""mailto:research@southsoundcare.org"">research@southsoundcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Vancouver</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">PeaceHealth Southwest Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 360-514-3940 <br>Email: <a href=""mailto:kmakin-bond@peacehealth.org"">kmakin-bond@peacehealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Walla Walla</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Saint Mary Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 509-897-5993 <br>Email: <a href=""mailto:Cheryl.Dodd@providence.org"">Cheryl.Dodd@providence.org</a>   </span> </div>                                       <h5 class=""locationCity"">Yakima</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">North Star Lodge Cancer Center at Yakima Valley Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 509-574-3535 <br>Email: <a href=""mailto:Memorial-ClinicalTrials@yvmh.org"">Memorial-ClinicalTrials@yvmh.org</a>   </span> </div>                                       <h5 class=""locationCity"">Yelm</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Providence Regional Cancer System-Yelm</strong>     <br>Contact: Site Public Contact <br>Phone: 360-412-8958 <br>Email: <a href=""mailto:deidre.dillon@providence.org"">deidre.dillon@providence.org</a>   </span> </div>                                   <h4>West Virginia</h4>                           <h5 class=""locationCity"">Martinsburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">WVUH-Berkely Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 304-293-7374 <br>Email: <a href=""mailto:cancertrialsinfo@hsc.wvu.edu"">cancertrialsinfo@hsc.wvu.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Morgantown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">West Virginia University Healthcare</strong>     <br>Contact: Site Public Contact <br>Phone: 304-293-7374 <br>Email: <a href=""mailto:cancertrialsinfo@hsc.wvu.edu"">cancertrialsinfo@hsc.wvu.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Parkersburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Camden Clark Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 304-293-7374 <br>Email: <a href=""mailto:cancertrialsinfo@hsc.wvu.edu"">cancertrialsinfo@hsc.wvu.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Wheeling</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Wheeling Hospital/Schiffler Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 304-243-6442   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Green Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bellin Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 920-435-8326   </span> </div>                                       <h5 class=""locationCity"">New Richmond</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Center of Western Wisconsin</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                   <h4>Wyoming</h4>                           <h5 class=""locationCity"">Cody</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Billings Clinic-Cody</strong>     <br>Contact: Site Public Contact <br>Phone: 800-996-2663 <br>Email: <a href=""mailto:research@billingsclinic.org"">research@billingsclinic.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sheridan</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Welch Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                 <h3 class=""locationCountryLabel"">Other</h3>               <h4>Korea, Republic of</h4>                           <h5 class=""locationCity"">Goyang-si</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">National Cancer Center-Korea</strong>     <br>Contact: Site Public Contact <br>Phone:  82-31-920-1934   </span> </div>                           			</div> 		</div> 			<div class=""trialContainer""> 			<h2 class=""hangingIndent"">7. Olanzapine versus Megestrol Acetate for the Treatment of Loss of Appetite among Advanced Cancer Patients</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?loc=0&rl=2&tt=supportive_care&tt=health_services_research&tt=basic_science&id=NCI-2021-03303""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase III</td> 					<td>Supportive care</td> 					<td>Active</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> A222004<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2021-03303<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT04939090"" target=""_blank"">NCT04939090</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase III trial compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Olanzapine is studied in the treatment of nausea and vomiting caused by some cancer treatments and may stimulate and increase appetite. Megestrol acetate works by stimulating patients appetites in order to treat or prevent weight loss. This study is looking at the effect of olanzapine on appetite and weight loss in patients with advanced cancer and determining whether it is better or worse than megestrol acetate.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>Clinicians should be aware of drug interactions between the agents used in this study and drugs that can prolong the QT interval, that can induce or inhibit CYP1A2, or that can function as an anticholinergic. Clinicians should use their clinical judgment to decide whether the doses and duration of such agents is such that they can be used concurrently with the medications prescribed in this study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Women and men of reproductive potential should agree to use an appropriate method of birth control throughout their participation in this study due to the teratogenic potential of the therapy utilized in this trial. Appropriate methods of birth control include abstinence, oral contraceptives, implantable hormonal contraceptives or double barrier method (diaphragm plus condom)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Diagnosis of advanced cancer</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient-reported 2-month weight loss of at least 5 pounds (2.3 kilograms) and/or physician-estimated caloric intake of less than 20 calories/kilogram of body weight per day</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>The patient must perceive loss of appetite and/or weight as a problem; and have an appetite score of 4 or worse on the “Please rate your appetite….” question that requires a patient response on a 0-10 numeric rating scale</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Not receiving ongoing tube feedings or parenteral nutrition at the time of registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Not currently using systemic adrenal steroids (with the exception of short-term dexamethasone within 3 days of chemotherapy for control of chemotherapy side effects)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No use of androgens, progesterone analogs, or other appetite stimulants within the past month</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient should not have poorly controlled hypertension, defined as multiple blood pressure readings with systolic levels above 160 and diastolic levels above 100 or congestive heart failure at registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient should not have an obstruction of the alimentary canal, malabsorption, or intractable vomiting (defined as vomiting more than 3 times per day over the preceding week)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Not currently using olanzapine for another medical condition or had previously used olanzapine for chronic nausea or for any pre-existing psychotic disorder</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients with impaired decision-making capacity from any etiology (such as with a diagnosis of dementia or memory loss) are not eligible for this study</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No presence of a hormone-sensitive tumor, such as breast, endometrial, or prostate cancer (this exclusion criterion is intended to circumvent any confounding antineoplastic effects of megestrol acetate)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient should not have had a previous blood clot at any time in the past</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No history of poorly controlled diabetes</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No symptomatic leptomeningeal disease or known brain metastases as these patients may have difficulty taking oral medications</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No history of hypersensitivity to olanzapine or megestrol acetate</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No coronavirus disease 2019 (COVID-19) infection in the past that, in the opinion of the treating physician, had left patients with compromised taste, which has not resolved at the time of registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Not pregnant and not nursing, because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown. Therefore, for women of childbearing potential only, a negative urine or serum pregnancy test done =&lt; 14 days prior to registration is required</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Age &gt;= 18 years</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Estimated life expectancy of 3 months or longer</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Creatinine =&lt; 2.0 mg/dL</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) =&lt; 3 x upper limit of normal (ULN)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Glucose =&lt; 140 mg/dL</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Granulocytes &gt;= 1000/mm^3</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No treatment with another antipsychotic agent, such as risperidone, quetiapine, clozapine, butyrophenone within 30 days of enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>In order to complete the mandatory patient-completed measures, participants must be able to speak and/or read English or Spanish. Sites seeking to enroll Spanish-speaking patients should have access to Spanish speaking staff on site or through the use of a translation service to be able to conduct the informed consent discussion in Spanish, and to conduct the weekly phone calls</li> 												</ul> 						</div> 														<h4>Exclusion Criteria</h4> 										<div> 							<ul> 																<li>Medical condition such as uncontrolled infection (including human immunodeficiency virus [HIV]), uncontrolled diabetes mellitus or cardiac disease which, in the opinion of the treating physician, would make this protocol unreasonably hazardous for the patient</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Patients who cannot swallow oral formulations of the agents</li> 												</ul> 						</div> 							 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE:</p><p class='ctrp'>I. To determine whether olanzapine leads to greater appetite improvement from baseline in cancer patients suffering from anorexia compared to megestrol acetate using the 0-10 numerical rating scale (NRS).</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES:</p><p class='ctrp'>I. To determine whether olanzapine leads to a greater proportion of patients who report a 5% or greater weight gain from baseline compared to megestrol acetate.</p><p class='ctrp'>II. To compare change in cachexia/anorexia symptoms with olanzapine compared to megestrol acetate using the Functional Assessment of Anorexia/Cachexia Treatment (FAACT)-Anorexia/Cachexia Subscale (A/CS) instrument.</p><p class='ctrp'></p><p class='ctrp'>EXPLORATORY OBJECTIVES:</p><p class='ctrp'>I. To describe the trajectory of appetite scores from baseline to end of treatment by arm using the NRS.</p><p class='ctrp'>II. To describe the trajectory of weight from baseline to end of treatment by arm.</p><p class='ctrp'>III. To explore the difference in trajectory of nausea, vomiting, fatigue, pain, quality of sleep, anxiety/stress, and sense of taste and smell from baseline to end of treatment between olanzapine and to megestrol acetate.</p><p class='ctrp'>IV. To explore whether olanzapine will decrease the use of other antiemetic drugs compared to megestrol acetate.</p><p class='ctrp'>V. To describe the adverse event profiles of olanzapine versus megestrol acetate.</p><p class='ctrp'>VI. To report weekly appetite change by treatment and race/ethnicity.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE: Patient are randomized to 1 of 2 arms.</p><p class='ctrp'></p><p class='ctrp'>ARM I: Patients receive olanzapine orally (PO) once daily (QD) for up to 4 weeks in the absence of disease progression or unacceptable toxicity.</p><p class='ctrp'></p><p class='ctrp'>ARM II: Patients receive megestrol acetate PO QD for up to 4 weeks in the absence of disease progression or unacceptable toxicity.</p><p class='ctrp'></p><p class='ctrp'>Patients undergo blood sample collection at screening and may undergo additional blood sample collection on study.</p><p class='ctrp'></p><p class='ctrp'>At the end of the study intervention, patients are followed within 30 days.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>Alliance for Clinical Trials in Oncology</div> 													<div>Principal Investigator: Aminah Jatoi</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT04939090"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>Arizona</h4>                           <h5 class=""locationCity"">Gilbert</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Arizona Center for Cancer Care - Gilbert</strong>     <br>Contact: Site Public Contact <br>Phone: 480-278-8261 <br>Email: <a href=""mailto:penny.labriola@arizonaccc.com"">penny.labriola@arizonaccc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Goodyear</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CTCA at Western Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 623-207-3000   </span> </div>                                       <h5 class=""locationCity"">Peoria</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Arizona Center for Cancer Care-Peoria</strong>     <br>Contact: Site Public Contact <br>Phone: 623-773-2873   </span> </div>                                       <h5 class=""locationCity"">Phoenix</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Arizona Center for Cancer Care - Phoenix</strong>     <br>Contact: Site Public Contact <br>Phone: 480-278-8261 <br>Email: <a href=""mailto:penny.labriola@arizonaccc.com"">penny.labriola@arizonaccc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Scottsdale</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Arizona Center for Cancer Care - Osborn</strong>     <br>Contact: Site Public Contact <br>Phone: 480-278-8261 <br>Email: <a href=""mailto:penny.labriola@arizonaccc.com"">penny.labriola@arizonaccc.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Arizona Center for Cancer Care - Scottsdale</strong>     <br>Contact: Site Public Contact <br>Phone: 480-278-8261 <br>Email: <a href=""mailto:penny.labriola@arizonaccc.com"">penny.labriola@arizonaccc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Surprise</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Arizona Center for Cancer Care-Surprise</strong>     <br>Contact: Site Public Contact <br>Phone: 888-823-5923 <br>Email: <a href=""mailto:ctsucontact@westat.com"">ctsucontact@westat.com</a>   </span> </div>                                   <h4>Arkansas</h4>                           <h5 class=""locationCity"">Jonesboro</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro</strong>     <br>Contact: Site Public Contact <br>Phone: 870-936-7066 <br>Email: <a href=""mailto:Emily.Carvell@bmhcc.org"">Emily.Carvell@bmhcc.org</a>   </span> </div>                                   <h4>California</h4>                           <h5 class=""locationCity"">Martinez</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Contra Costa Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 925-957-5400   </span> </div>                                       <h5 class=""locationCity"">San Francisco</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Zuckerberg San Francisco General Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 415-476-4082 <br>Email: <a href=""mailto:Paul.Couey@ucsf.edu"">Paul.Couey@ucsf.edu</a>   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Aurora</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Aurora</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Boulder</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Boulder</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Centennial</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers - Centennial</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Denver</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Midtown</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Rose</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Englewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mountain Blue Cancer Care Center - Swedish</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers - Swedish</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grand Junction</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Grand Valley Oncology</strong>     <br>Contact: Site Public Contact <br>Phone: 970-644-4460 <br>Email: <a href=""mailto:gvoclinicaltrials@gjhosp.org"">gvoclinicaltrials@gjhosp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lakewood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Lakewood</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lone Tree</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Sky Ridge</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                       <h5 class=""locationCity"">Thornton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rocky Mountain Cancer Centers-Thornton</strong>     <br>Contact: Site Public Contact <br>Phone: 303-777-2663 <br>Email: <a href=""mailto:info@westernstatesncorp.org"">info@westernstatesncorp.org</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Millville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe South Coastal Health Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delaware Clinical and Laboratory Physicians PA</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:mhayden@christianacare.org"">mhayden@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Helen F Graham Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Medical Oncology Hematology Consultants PA</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rehoboth Beach</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe Health Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                   <h4>Florida</h4>                           <h5 class=""locationCity"">Clearwater</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Morton Plant Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 855-314-8646   </span> </div>                                       <h5 class=""locationCity"">Fort Myers</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Regional Cancer Center-Lee Memorial Health System</strong>     <br>Contact: Site Public Contact <br>Phone: 773-702-9171 <br>Email: <a href=""mailto:protocols@AllianceNCTN.org"">protocols@AllianceNCTN.org</a>   </span> </div>                                       <h5 class=""locationCity"">Plant City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">South Florida Baptist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 813-707-2155 <br>Email: <a href=""mailto:Claudia.Quinones@baycare.org"">Claudia.Quinones@baycare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Safety Harbor</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mease Countryside Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 813-870-4760 <br>Email: <a href=""mailto:research.cto@baycare.org"">research.cto@baycare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Petersburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Anthony's Hospital Cancer Care Center</strong>     <br>Contact: Site Public Contact <br>Phone: 727-825-1113 <br>Email: <a href=""mailto:Mindy.Thacker@baycare.org"">Mindy.Thacker@baycare.org</a>   </span> </div>                                   <h4>Georgia</h4>                           <h5 class=""locationCity"">Atlanta</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Piedmont Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 404-425-7943 <br>Email: <a href=""mailto:ORS@piedmont.org"">ORS@piedmont.org</a>   </span> </div>                                       <h5 class=""locationCity"">Fayetteville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Piedmont Fayette Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 888-823-5923 <br>Email: <a href=""mailto:ctsucontact@westat.com"">ctsucontact@westat.com</a>   </span> </div>                                       <h5 class=""locationCity"">Newnan</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Piedmont Newnan Hospital</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:ors@piedmont.org"">ors@piedmont.org</a>   </span> </div>                                       <h5 class=""locationCity"">Stockbridge</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Piedmont Henry Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 404-425-1800   </span> </div>                                   <h4>Hawaii</h4>                           <h5 class=""locationCity"">Aiea</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hawaii Cancer Care - Westridge</strong>     <br>Contact: Site Public Contact <br>Phone: 808-539-2273 <br>Email: <a href=""mailto:info@hawaiicancercare.com"">info@hawaiicancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Pali Momi Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 808-486-6000   </span> </div>                                       <h5 class=""locationCity"">Honolulu</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Hawaii Cancer Care Inc - Waterfront Plaza</strong>     <br>Contact: Site Public Contact <br>Phone: 808-524-6115 <br>Email: <a href=""mailto:i.webster@hawaiicancercare.com"">i.webster@hawaiicancercare.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kapiolani Medical Center for Women and Children</strong>     <br>Contact: Site Public Contact <br>Phone: 808-983-6090   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Queen's Cancer Cenrer - POB I</strong>     <br>Contact: Site Public Contact <br>Phone: 808-532-0315   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Queen's Cancer Center - Kuakini</strong>     <br>Contact: Site Public Contact <br>Phone: 808-531-8521   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Queen's Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 808-545-8548   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Straub Clinic and Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 808-522-4333   </span> </div>                                   <h4>Illinois</h4>                           <h5 class=""locationCity"">Aurora</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rush - Copley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 630-978-6212 <br>Email: <a href=""mailto:Cancer.Research@rushcopley.com"">Cancer.Research@rushcopley.com</a>   </span> </div>                                       <h5 class=""locationCity"">Bloomington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Bloomington</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Carthage</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Carthage</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Centralia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Centralia Oncology Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Chicago</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mount Sinai Hospital Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 773-257-5960 <br>Email: <a href=""mailto:suhi@sinai.org"">suhi@sinai.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern University</strong>     <br>Contact: Site Public Contact <br>Phone: 312-695-1301 <br>Email: <a href=""mailto:cancer@northwestern.edu"">cancer@northwestern.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Danville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle at The Riverfront</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Decatur</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Specialists of Illinois - Decatur</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">DeKalb</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern Medicine Cancer Center Kishwaukee</strong>     <br>Contact: Site Public Contact <br>Phone: 630-352-5360 <br>Email: <a href=""mailto:Donald.Smith3@nm.org"">Donald.Smith3@nm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Dixon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Dixon</strong>     <br>Contact: Site Public Contact <br>Phone: 815-285-7800   </span> </div>                                       <h5 class=""locationCity"">Effingham</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Crossroads Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Eureka</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Eureka</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Galesburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Galesburg</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Geneva</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern Medicine Cancer Center Delnor</strong>     <br>Contact: Site Public Contact <br>Phone: 630-352-5360 <br>Email: <a href=""mailto:Donald.Smith3@nm.org"">Donald.Smith3@nm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Glenview</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern Medicine Glenview Outpatient Center</strong>     <br>Contact: Site Public Contact <br>Phone: 312-695-1102   </span> </div>                                       <h5 class=""locationCity"">Grayslake</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern Medicine Grayslake Outpatient Center</strong>     <br>Contact: Site Public Contact <br>Phone: 312-695-1102   </span> </div>                                       <h5 class=""locationCity"">Kewanee</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Kewanee Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Lake Forest</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern Medicine Lake Forest Hospital</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:cancertrials@northwestern.edu"">cancertrials@northwestern.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Macomb</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Macomb</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Mattoon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Physician Group-Mattoon/Charleston</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">O'Fallon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Center of O'Fallon</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Orland Park</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern Medicine Orland Park</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:nctnprogram_rhlccc@northwestern.edu"">nctnprogram_rhlccc@northwestern.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Ottawa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Ottawa Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Pekin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Pekin</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Peoria</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Peoria</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Peru</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Peru</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Princeton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare-Princeton</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">River Forest</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">West Suburban Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 708-763-2707 <br>Email: <a href=""mailto:jkoch@rfcampus.com"">jkoch@rfcampus.com</a>   </span> </div>                                       <h5 class=""locationCity"">Springfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 217-528-7541 <br>Email: <a href=""mailto:pallante.beth@mhsil.com"">pallante.beth@mhsil.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southern Illinois University School of Medicine</strong>     <br>Contact: Site Public Contact <br>Phone: 217-545-7929   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Springfield Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 800-444-7541   </span> </div>                                       <h5 class=""locationCity"">Urbana</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Warrenville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern Medicine Cancer Center Warrenville</strong>     <br>Contact: Site Public Contact <br>Phone: 630-352-5360 <br>Email: <a href=""mailto:Donald.Smith3@nm.org"">Donald.Smith3@nm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Washington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Illinois CancerCare - Washington</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Yorkville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rush-Copley Healthcare Center</strong>     <br>Contact: Site Public Contact <br>Phone: 630-978-6212 <br>Email: <a href=""mailto:Cancer.Research@rushcopley.com"">Cancer.Research@rushcopley.com</a>   </span> </div>                                   <h4>Indiana</h4>                           <h5 class=""locationCity"">Crown Point</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwest Cancer Center - Main Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 219-310-2550   </span> </div>                                       <h5 class=""locationCity"">Dyer</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwest Oncology LLC</strong>     <br>Contact: Site Public Contact <br>Phone: 219-924-8178   </span> </div>                                       <h5 class=""locationCity"">Hobart</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwest Cancer Center - Hobart</strong>     <br>Contact: Site Public Contact <br>Phone: 219-947-1795   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 219-836-6875 <br>Email: <a href=""mailto:CancerResearch@COMHS.org"">CancerResearch@COMHS.org</a>   </span> </div>                                       <h5 class=""locationCity"">Indianapolis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Catherine Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 773-702-9171 <br>Email: <a href=""mailto:protocols@AllianceNCTN.org"">protocols@AllianceNCTN.org</a>   </span> </div>                                       <h5 class=""locationCity"">Munster</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Community Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 219-836-3349   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Women's Diagnostic Center - Munster</strong>     <br>Contact: Site Public Contact <br>Phone: 219-934-8869 <br>Email: <a href=""mailto:mnicholson@comhs.org"">mnicholson@comhs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Valparaiso</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwest Cancer Center - Valparaiso</strong>     <br>Contact: Site Public Contact <br>Phone: 219-836-6875 <br>Email: <a href=""mailto:CancerResearch@COMHS.org"">CancerResearch@COMHS.org</a>   </span> </div>                                   <h4>Iowa</h4>                           <h5 class=""locationCity"">Ames</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mary Greeley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Ames</strong>     <br>Contact: Site Public Contact <br>Phone: 515-239-4734 <br>Email: <a href=""mailto:ksoder@mcfarlandclinic.com"">ksoder@mcfarlandclinic.com</a>   </span> </div>                                       <h5 class=""locationCity"">Bettendorf</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Iowa Healthcare Cancer Services Quad Cities</strong>     <br>Contact: Site Public Contact <br>Phone: 563-355-7733 <br>Email: <a href=""mailto:kedaprile@rccqc.com"">kedaprile@rccqc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Boone</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Boone</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                       <h5 class=""locationCity"">Cedar Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Associates at Mercy Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 319-363-2690   </span> </div>                                       <h5 class=""locationCity"">Des Moines</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Iowa Methodist Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 515-241-6727   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Medical Center - Des Moines</strong>     <br>Contact: Site Public Contact <br>Phone: 515-358-6613 <br>Email: <a href=""mailto:cancerresearch@mercydesmoines.org"">cancerresearch@mercydesmoines.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mission Cancer and Blood - Des Moines</strong>     <br>Contact: Site Public Contact <br>Phone: 515-241-3305   </span> </div>                                       <h5 class=""locationCity"">Fort Dodge</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Trinity Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                       <h5 class=""locationCity"">Iowa City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Iowa/Holden Comprehensive Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-237-1225   </span> </div>                                       <h5 class=""locationCity"">Jefferson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Jefferson</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                       <h5 class=""locationCity"">Marshalltown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Marshalltown</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                   <h4>Kentucky</h4>                           <h5 class=""locationCity"">Lexington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Joseph Hospital East</strong>     <br>Contact: Site Public Contact <br>Phone: 720-874-1881 <br>Email: <a href=""mailto:ResearchInstituteInquiries@CommonSpirit.org"">ResearchInstituteInquiries@CommonSpirit.org</a>   </span> </div>                                   <h4>Maryland</h4>                           <h5 class=""locationCity"">Towson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UM Saint Joseph Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 410-337-4569 <br>Email: <a href=""mailto:Jeanmarie.downing@umm.edu"">Jeanmarie.downing@umm.edu</a>   </span> </div>                                   <h4>Massachusetts</h4>                           <h5 class=""locationCity"">Boston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Tufts Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 617-636-5000 <br>Email: <a href=""mailto:ContactUsCancerCenter@TuftsMedicalCenter.org"">ContactUsCancerCenter@TuftsMedicalCenter.org</a>   </span> </div>                                   <h4>Michigan</h4>                           <h5 class=""locationCity"">Ann Arbor</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Saint Joseph Mercy Hospital Ann Arbor</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Brighton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Brighton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Medical Center - Brighton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Medical Center - Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chelsea</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Chelsea Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Chelsea Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Detroit</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Saint John Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">East China</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Doctors Park</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Flint</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesee Cancer and Blood Disease Treatment Center</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesee Hematology Oncology PC</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Genesys Hurley Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 810-762-8038 <br>Email: <a href=""mailto:wstrong@ghci.org"">wstrong@ghci.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grosse Pointe Woods</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Van Elslander Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Livonia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Saint Mary Mercy Livonia Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Macomb Township</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Macomb Medical Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Saginaw</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MyMichigan Medical Center Saginaw</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sterling Heights</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Bhadresh Nayak MD PC-Sterling Heights</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Warren</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Great Lakes Cancer Management Specialists-Macomb Professional Building</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint John Macomb-Oakland Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 313-343-3166 <br>Email: <a href=""mailto:karen.forman@ascension.org"">karen.forman@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Ypsilanti</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Huron Gastroenterology PC</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology  Ann Arbor Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                   <h4>Minnesota</h4>                           <h5 class=""locationCity"">Bemidji</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Joe Lueken Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 218-333-5000 <br>Email: <a href=""mailto:OncologyClinicalTrialsFargo@sanfordhealth.org"">OncologyClinicalTrialsFargo@sanfordhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Brainerd</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health Saint Joseph's Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Coon Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Deer River</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health - Deer River Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Detroit Lakes</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health Saint Mary's - Detroit Lakes Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Duluth</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Hospital of Duluth</strong>     <br>Contact: Site Public Contact <br>Phone: 218-249-7825 <br>Email: <a href=""mailto:kdean@slhduluth.com"">kdean@slhduluth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Edina</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Southdale Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Fosston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health - Fosston</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Hibbing</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health Hibbing Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308   </span> </div>                                       <h5 class=""locationCity"">Minneapolis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Abbott-Northwestern Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Minneapolis VA Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 612-467-2800   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Minnesota/Masonic Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 612-624-2620   </span> </div>                                       <h5 class=""locationCity"">New Ulm</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">New Ulm Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Park Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health - Park Rapids</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Cloud</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Coborn Cancer Center at Saint Cloud Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 877-229-4907 <br>Email: <a href=""mailto:coborncancercenter@centracare.com"">coborncancercenter@centracare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Louis Park</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Park Nicollet Clinic - Saint Louis Park</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Paul</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Regions Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">United Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Sandstone</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health Sandstone</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Stillwater</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lakeview Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Thief River Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Thief River Falls Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 605-312-3320   </span> </div>                                       <h5 class=""locationCity"">Virginia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health Virginia Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Willmar</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rice Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Worthington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Cancer Center Worthington</strong>     <br>Contact: Site Public Contact <br>Phone: 605-312-3320   </span> </div>                                   <h4>Mississippi</h4>                           <h5 class=""locationCity"">Columbus</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Golden Triangle</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grenada</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Cancer Center-Grenada</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                       <h5 class=""locationCity"">New Albany</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Union County</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Southhaven</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Desoto</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                   <h4>Missouri</h4>                           <h5 class=""locationCity"">Cape Girardeau</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-334-2230 <br>Email: <a href=""mailto:sfmc@sfmc.net"">sfmc@sfmc.net</a>   </span> </div>                                       <h5 class=""locationCity"">Chesterfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-205-6936   </span> </div>                                       <h5 class=""locationCity"">Farmington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Parkland Health Center - Farmington</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Saint Louis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Saint Louis</strong>     <br>Contact: Site Public Contact <br>Phone: 314-251-7066   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Missouri Baptist Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Sainte Genevieve</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sainte Genevieve County Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Sullivan</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Missouri Baptist Sullivan Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Sunset Hills</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">BJC Outpatient Center at Sunset Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                   <h4>Montana</h4>                           <h5 class=""locationCity"">Billings</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Billings Clinic Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-996-2663 <br>Email: <a href=""mailto:research@billingsclinic.org"">research@billingsclinic.org</a>   </span> </div>                                       <h5 class=""locationCity"">Great Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Benefis Sletten Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                   <h4>Nevada</h4>                           <h5 class=""locationCity"">Henderson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at Seven Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                       <h5 class=""locationCity"">Las Vegas</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada - Central Valley</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Comprehensive Cancer Centers of Nevada - Town Center</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at Charleston</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OptumCare Cancer Care at Fort Apache</strong>     <br>Contact: Site Public Contact <br>Phone: 702-384-0013 <br>Email: <a href=""mailto:research@sncrf.org"">research@sncrf.org</a>   </span> </div>                                   <h4>New Hampshire</h4>                           <h5 class=""locationCity"">Exeter</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Exeter Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 800-439-3837   </span> </div>                                   <h4>New Mexico</h4>                           <h5 class=""locationCity"">Albuquerque</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of New Mexico Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 505-925-0348 <br>Email: <a href=""mailto:HSC-ClinicalTrialInfo@salud.unm.edu"">HSC-ClinicalTrialInfo@salud.unm.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Las Cruces</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Medical Center - Las Cruces</strong>     <br>Contact: Site Public Contact <br>Phone: 575-556-6545 <br>Email: <a href=""mailto:Kim.Hoffman@lpnt.net"">Kim.Hoffman@lpnt.net</a>   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">Bronx</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">James J Peters VA Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 718-584-9000 <br>Email: <a href=""mailto:kl2965@cumc.columbia.edu"">kl2965@cumc.columbia.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Glens Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Glens Falls Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 518-926-6700   </span> </div>                                       <h5 class=""locationCity"">Jamaica</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Queens Hospital Center</strong>     <br>Contact: Site Public Contact <br>Phone: 718-883-3000   </span> </div>                                   <h4>North Carolina</h4>                           <h5 class=""locationCity"">Charlotte</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Atrium Health Pineville/LCI-Pineville</strong>     <br>Contact: Site Public Contact <br>Phone: 980-442-2000   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Atrium Health University City/LCI-University</strong>     <br>Contact: Site Public Contact <br>Phone: 800-804-9376   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carolinas Medical Center/Levine Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 800-804-9376   </span> </div>                                       <h5 class=""locationCity"">Clinton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southeastern Medical Oncology Center-Clinton</strong>     <br>Contact: Site Public Contact <br>Phone: 919-587-9084 <br>Email: <a href=""mailto:jfields@cancersmoc.com"">jfields@cancersmoc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Concord</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Atrium Health Cabarrus/LCI-Concord</strong>     <br>Contact: Site Public Contact <br>Phone: 800-804-9376   </span> </div>                                       <h5 class=""locationCity"">Forest City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Levine Cancer Institute - Rutherford</strong>     <br>Contact: Site Public Contact <br>Phone: 800-804-9376   </span> </div>                                       <h5 class=""locationCity"">Gastonia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CaroMont Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 704-834-2810 <br>Email: <a href=""mailto:tammy.cozad@caromonthealth.org"">tammy.cozad@caromonthealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Levine Cancer Institute-Gaston</strong>     <br>Contact: Site Public Contact <br>Phone: 800-804-9376   </span> </div>                                       <h5 class=""locationCity"">Goldsboro</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southeastern Medical Oncology Center-Goldsboro</strong>     <br>Contact: Site Public Contact <br>Phone: 919-587-9084 <br>Email: <a href=""mailto:jfields@cancersmoc.com"">jfields@cancersmoc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Jacksonville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Southeastern Medical Oncology Center-Jacksonville</strong>     <br>Contact: Site Public Contact <br>Phone: 910-587-9084 <br>Email: <a href=""mailto:jfields@cancersmoc.com"">jfields@cancersmoc.com</a>   </span> </div>                                       <h5 class=""locationCity"">Monroe</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Atrium Health Union/LCI-Union</strong>     <br>Contact: Site Public Contact <br>Phone: 980-442-2000   </span> </div>                                       <h5 class=""locationCity"">Pinehurst</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">FirstHealth of the Carolinas-Moore Regional Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 910-715-3500 <br>Email: <a href=""mailto:jcwilliams@firsthealth.org"">jcwilliams@firsthealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Washington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Marion L Shepard Cancer Center - ECU Health Beaufort Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 252-975-4308 <br>Email: <a href=""mailto:research@ecuhealth.org"">research@ecuhealth.org</a>   </span> </div>                                   <h4>North Dakota</h4>                           <h5 class=""locationCity"">Bismarck</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Bismarck Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 701-323-5760 <br>Email: <a href=""mailto:OncologyClinicalTrialsFargo@sanfordhealth.org"">OncologyClinicalTrialsFargo@sanfordhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Fargo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health Cancer Center-South University Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Broadway Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 701-323-5760 <br>Email: <a href=""mailto:OncologyClinicalTrialsFargo@sanfordhealth.org"">OncologyClinicalTrialsFargo@sanfordhealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Roger Maris Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 701-234-6161 <br>Email: <a href=""mailto:OncologyClinicalTrialsFargo@sanfordhealth.org"">OncologyClinicalTrialsFargo@sanfordhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Grand Forks</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Altru Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 701-780-6520   </span> </div>                                       <h5 class=""locationCity"">Jamestown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Essentia Health - Jamestown Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Lima</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Rita's Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Danville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-271-5251 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Hazleton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Center-Cancer Center Hazleton</strong>     <br>Contact: Site Public Contact <br>Phone: 570-459-2901 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Lewisburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Oncology-Lewisburg</strong>     <br>Contact: Site Public Contact <br>Phone: 570-374-8555 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Pottsville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Cancer Services-Pottsville</strong>     <br>Contact: Site Public Contact <br>Phone: 800-275-6401 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Sayre</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Guthrie Medical Group PC-Robert Packer Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 800-836-0388   </span> </div>                                       <h5 class=""locationCity"">Scranton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Community Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-703-4768 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Wilkes-Barre</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Wyoming Valley/Henry Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-271-5251 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                   <h4>South Carolina</h4>                           <h5 class=""locationCity"">Boiling Springs</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Spartanburg</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Easley</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Easley</strong>     <br>Contact: Site Public Contact <br>Phone: 864-522-2066 <br>Email: <a href=""mailto:Kim.Williams3@prismahealth.org"">Kim.Williams3@prismahealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Georgetown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Tidelands Georgetown Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 843-545-5600 <br>Email: <a href=""mailto:broe@tidelandshealth.org"">broe@tidelandshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Greenville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Butternut</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Eastside</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Faris</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Greenville Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Greer</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Greer</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                       <h5 class=""locationCity"">Rock Hill</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Levine Cancer Institute-Rock Hill</strong>     <br>Contact: Site Public Contact <br>Phone: 800-804-9376   </span> </div>                                       <h5 class=""locationCity"">Seneca</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Prisma Health Cancer Institute - Seneca</strong>     <br>Contact: Site Public Contact <br>Phone: 864-241-6251   </span> </div>                                   <h4>South Dakota</h4>                           <h5 class=""locationCity"">Sioux Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Cancer Center Oncology Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 605-312-3320 <br>Email: <a href=""mailto:OncologyClinicTrialsSF@sanfordhealth.org"">OncologyClinicTrialsSF@sanfordhealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford USD Medical Center - Sioux Falls</strong>     <br>Contact: Site Public Contact <br>Phone: 605-312-3320 <br>Email: <a href=""mailto:OncologyClinicalTrialsSF@SanfordHealth.org"">OncologyClinicalTrialsSF@SanfordHealth.org</a>   </span> </div>                                   <h4>Tennessee</h4>                           <h5 class=""locationCity"">Collierville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Collierville</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                       <h5 class=""locationCity"">Memphis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Baptist Memorial Hospital and Cancer Center-Memphis</strong>     <br>Contact: Site Public Contact <br>Phone: 901-226-1366 <br>Email: <a href=""mailto:BCCclintrials@bmhcc.org"">BCCclintrials@bmhcc.org</a>   </span> </div>                                   <h4>Texas</h4>                           <h5 class=""locationCity"">Amarillo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Don and Sybil Harrington Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 806-212-1985 <br>Email: <a href=""mailto:Gina.Cravey@bsahs.org"">Gina.Cravey@bsahs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Dallas</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UT Southwestern Simmons Cancer Center - RedBird</strong>     <br>Contact: Site Public Contact <br>Phone: 214-648-7097 <br>Email: <a href=""mailto:canceranswerline@utsouthwestern.edu"">canceranswerline@utsouthwestern.edu</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UT Southwestern/Simmons Cancer Center-Dallas</strong>     <br>Contact: Site Public Contact <br>Phone: 214-648-7097 <br>Email: <a href=""mailto:canceranswerline@UTSouthwestern.edu"">canceranswerline@UTSouthwestern.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Fort Worth</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Tarrant County Hospital District/JPS Health Network</strong>     <br>Contact: Site Public Contact <br>Phone: 817-702-5913 <br>Email: <a href=""mailto:macosta02@jpshealth.org"">macosta02@jpshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UT Southwestern/Simmons Cancer Center-Fort Worth</strong>     <br>Contact: Site Public Contact <br>Phone: 214-648-7097 <br>Email: <a href=""mailto:canceranswerline@UTSouthwestern.edu"">canceranswerline@UTSouthwestern.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Richardson</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UT Southwestern Clinical Center at Richardson/Plano</strong>     <br>Contact: Site Public Contact <br>Phone: 972-669-7044 <br>Email: <a href=""mailto:Suzanne.cole@utsouthwestern.edu"">Suzanne.cole@utsouthwestern.edu</a>   </span> </div>                                   <h4>Vermont</h4>                           <h5 class=""locationCity"">Burlington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Vermont Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 802-656-4101 <br>Email: <a href=""mailto:rpo@uvm.edu"">rpo@uvm.edu</a>   </span> </div>                                   <h4>Washington</h4>                           <h5 class=""locationCity"">Renton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Valley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 425-228-3440 <br>Email: <a href=""mailto:research@valleymed.org"">research@valleymed.org</a>   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Appleton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">ThedaCare Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 920-364-3604 <br>Email: <a href=""mailto:ResearchDept@thedacare.org"">ResearchDept@thedacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Ashland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Duluth Clinic Ashland</strong>     <br>Contact: Site Public Contact <br>Phone: 218-786-3308 <br>Email: <a href=""mailto:CancerTrials@EssentiaHealth.org"">CancerTrials@EssentiaHealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Berlin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">ThedaCare Cancer Care - Berlin</strong>     <br>Contact: Site Public Contact <br>Phone: 920-364-3605 <br>Email: <a href=""mailto:ResearchDept@thedacare.org"">ResearchDept@thedacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Green Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Saint Mary's</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:ewd_research_admin@hshs.org"">ewd_research_admin@hshs.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center Green Bay</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:ewd_research_admin@hshs.org"">ewd_research_admin@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">La Crosse</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Gundersen Lutheran Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 608-775-2385 <br>Email: <a href=""mailto:cancerctr@gundersenhealth.org"">cancerctr@gundersenhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Menomonee Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Froedtert Menomonee Falls Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 262-257-5100   </span> </div>                                       <h5 class=""locationCity"">Milwaukee</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Medical College of Wisconsin</strong>     <br>Contact: Site Public Contact <br>Phone: 414-805-3666   </span> </div>                                       <h5 class=""locationCity"">Neenah</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">ThedaCare Regional Medical Center - Neenah</strong>     <br>Contact: Site Public Contact <br>Phone: 920-364-3605 <br>Email: <a href=""mailto:ResearchDept@thedacare.org"">ResearchDept@thedacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">New London</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">ThedaCare Cancer Care - New London</strong>     <br>Contact: Site Public Contact <br>Phone: 920-364-3605 <br>Email: <a href=""mailto:ResearchDept@thedacare.org"">ResearchDept@thedacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">New Richmond</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Center of Western Wisconsin</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Oak Creek</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Drexel Town Square Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 414-805-0505   </span> </div>                                       <h5 class=""locationCity"">Oshkosh</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">ThedaCare Cancer Care - Oshkosh</strong>     <br>Contact: Site Public Contact <br>Phone: 920-364-3605 <br>Email: <a href=""mailto:ResearchDept@thedacare.org"">ResearchDept@thedacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Shawano</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">ThedaCare Cancer Care - Shawano</strong>     <br>Contact: Site Public Contact <br>Phone: 920-364-3605 <br>Email: <a href=""mailto:ResearchDept@thedacare.org"">ResearchDept@thedacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sturgeon Bay</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Vincent Hospital Cancer Center at Sturgeon Bay</strong>     <br>Contact: Site Public Contact <br>Phone: 920-433-8889 <br>Email: <a href=""mailto:ewd_research_admin@hshs.org"">ewd_research_admin@hshs.org</a>   </span> </div>                                       <h5 class=""locationCity"">Waupaca</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">ThedaCare Cancer Care - Waupaca</strong>     <br>Contact: Site Public Contact <br>Phone: 920-364-3605 <br>Email: <a href=""mailto:ResearchDept@thedacare.org"">ResearchDept@thedacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">West Bend</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Froedtert West Bend Hospital/Kraemer Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 414-805-0505   </span> </div>                           			</div> 		</div> 			<div class=""trialContainer""> 			<h2 class=""hangingIndent"">8. Testing Ramipril to Prevent Memory Loss in People with Glioblastoma</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?loc=0&rl=2&tt=supportive_care&tt=health_services_research&tt=basic_science&id=NCI-2018-01807""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase NA</td> 					<td>Supportive care</td> 					<td>Closed to Accrual</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> WF-1801<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2018-01807<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT03475186"" target=""_blank"">NCT03475186</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase II trial studies how well ramipril works in preventing cognitive decline in patients with glioblastoma or gliosarcoma who are undergoing brain radiation therapy and chemotherapy with temozolomide. Adding ramipril to standard of care treatment may help to lower the chance of memory loss.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>Histologically proven diagnosis of glioblastoma or gliosarcoma (World Health Organization [WHO] grade IV) obtained at the time of a partial or gross total resection of the tumor. Patients who undergo a stereotactic needle biopsy alone are not eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>The tumor must have a supratentorial component</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>History/physical examination within 14 days prior to enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>The patient must have recovered from the effects of surgery, postoperative infection, and other complications before enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient planning to receive brain RT, and concurrent and adjuvant temozolomide chemotherapy for 6 weeks as per standard of care therapy; use of the Optune (also known as Tumor Treating Fields or TTFields) device is allowed at provider discretion, but must begin after the month 1 post RT (10 week [wk]) Neurocognitive-Patient-Reported Outcome (PRO) assessment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Study drug (ramipril) must be given &gt;= 21 days and =&lt; 42 days after surgery</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>All available brain magnetic resonance imaging (MRI) or computed tomography (CT) imaging reports from surgery to study completion must be submitted. This includes any post-operative or pre-radiation scan reports</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eastern Cooperative Oncology Group (ECOG) 0, 1 or 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Age &gt;= 18</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Absolute neutrophil count (ANC) &gt;= 1,500 cells/mm^3 (obtained within 14 days prior to enrollment)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Platelets &gt;= 100,000 cells/mm^3 (obtained within 14 days prior to enrollment)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Hemoglobin &gt;= 10.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] &gt;= 10.0 g/dl is acceptable) (obtained within 14 days prior to enrollment)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Blood urea nitrogen (BUN) =&lt; 30 mg/dl within 14 days prior to enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Creatinine =&lt; 1.7 mg/dl within 14 days prior to enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Total bilirubin =&lt; 2.0 mg/dl within 14 days prior to enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Alanine aminotransferase (ALT)/aspartate aminotransferase (AST) =&lt; 3 x normal range within 14 days prior to enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must provide study specific informed consent prior to study entry</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Baseline potassium level &lt; 5.0 mEq/L. High potassium values that are thought to be a result of sample hemolysis may be repeated to determine an accurate potassium level and to determine potential study eligibility. Likewise high potassium values thought to be a result of potassium supplementation may be repeated at an appropriate time (5 half-lives after supplement discontinuation) to determine potential study eligibility</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patient must be able to complete neurocognitive tests in the English language as they are not validated in other languages at this time</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Women of childbearing potential and male participants must practice adequate contraception</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>For females of child-bearing potential, negative serum or urine pregnancy test within 14 days of enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Local site must be able to follow the standard GBM radiation treatment dosimetry plan</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>For patients who will be treated with the Optune device in addition to standard of care radiation plus concurrent and adjuvant temozolomide, the following inclusion criteria also apply: * Patients must have only a supratentorial glioblastoma * The treating physician must be a qualified provider having successfully completed the training course provided by Novocure, the device manufacturer</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients with prior malignancies if all treatment for that malignancy was completed at least 2 years before registration and the patient has no evidence of disease</li> 												</ul> 						</div> 														<h4>Exclusion Criteria</h4> 										<div> 							<ul> 																<li>Prior allergic reaction or intolerance to angiotensin-converting enzyme (ACE) inhibitor</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Hypotension (&lt; 110 mg Hg systolic) at the time of enrollment</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Renal insufficiency with creatinine clearance of &lt; 40 ml/min (at time of enrollment)</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Solitary kidney or known renal artery stenosis</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Current ACE inhibitor or angiotensin receptor blocker use. Patients can come off ACE inhibitors or angiotensin receptor blockers for 1 week to be eligible for this study</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Prior invasive malignancy (except for non-melanomatous skin cancer) unless disease free for &gt;= 2 years. (For example, carcinoma in situ of the breast, oral cavity, and cervix are all permissible)</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Recurrent or multifocal malignant gliomas</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Metastases detected below the tentorium or beyond the cranial vault</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Prior chemotherapy or radiosensitizers for cancers of the head and neck region; note that prior chemotherapy for a different cancer is allowable, except prior temozolomide. Prior use of Gliadel wafers or any other intratumoral or intracavitary treatment are not permitted</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Prior radiotherapy to the head or neck (except for T1 glottic cancer), resulting in overlap of radiation fields</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Severe, active co-morbidity, defined as follows: * Acute bacterial or fungal infection requiring intravenous antibiotics at the time of enrollment * Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of enrollment * Known human immunodeficiency virus (HIV) positivity or acquired immune deficiency syndrome (AIDS) based upon current Centers for Disease Control and Prevention (CDC) definition; note, however, that HIV testing is not required for entry into this protocol. The need to exclude patients with AIDS from this protocol is necessary because the treatments involved in this protocol may be significantly immunosuppressive * Active connective tissue disorders, such as lupus or scleroderma, that in the opinion of the treating physician may put the patient at high risk for radiation toxicity * Any other major medical illnesses or psychiatric impairments that in the investigator&#39;s opinion will prevent administration or completion of protocol therapy</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the treatment involved in this study may be significantly teratogenic</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Pregnant or lactating women, due to possible adverse effects on the developing fetus or infant due to study drug</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Patients treated on any other therapeutic clinical protocols within 30 days prior to study entry or during participation in the study unless they involve standard of care or over the counter therapies or do not involve a drug therapy. Questions regarding eligibility for patients enrolled on other therapeutic clinical trials should be forwarded to the Wake Forest National Cancer Institute Community Oncology Research Program (NCORP) Research Base email (NCORP@wakehealth.edu) for review</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Patients planning to receive therapeutic antitumor agents (excluding use of the tumor treating fields [TTFields or Optune] device after the month 1 post RT [10 wk] Neurocognitive-PRO assessment) in addition to standard radiation and concurrent and adjuvant temozolomide are not eligible to participate in this study</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Patients with impaired decision-making capacity; this exclusion is necessary because such patients may not be able to adequately give informed consent</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>For patients who will be treated with the Optune device in addition to standard of care radiation plus concurrent and adjuvant temozolomide, the following exclusion criteria also apply: * Optune is not permitted in patients who have an active implanted medical device, skull defect (such as, missing bone with no replacement) or bullet fragments; examples of active electronic devices include deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, pacemakers, defibrillators, and programmatic shunts * Optune is not permitted in patients who are known to be sensitive to conductive hydrogels; examples of conductive hydrogels are gels used on electrocardiogram (ECG) stickers or transcutaneous electrical nerve stimulation (TENS) electrodes</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Patients being treated with Memantine, Donepezil, and/or other medications prescribed to enhance cognition</li> 												</ul> 						</div> 							 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVES:</p><p class='ctrp'>I. To assess the retention rate of patients at 10 weeks of ramipril treatment (6 weeks during radiation therapy [RT] and 4 weeks post RT) to determine whether or not we should proceed to a subsequent randomized study.</p><p class='ctrp'>II. To estimate the effect of 10 weeks of ramipril on neurocognitive function in patients with glioblastoma (GBM) receiving chemoradiotherapy.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES:</p><p class='ctrp'>I. To estimate the time to neurocognitive decline with GBM receiving chemoradiotherapy and ramipril.</p><p class='ctrp'>II. To estimate the effect of treatment with ramipril on and variability of specific non-memory cognitive functions including attention, executive function, visuo-motor skills, working memory, a screening measure of global cognitive function, mood, quality of life, fatigue and sleep disturbance.</p><p class='ctrp'>III. To collect preliminary data on the presence of apolipoprotein epsilon (ApoE) isoform 4 serum (peripheral blood lymphocyte) test positivity as measured by quantitative polymerase chain reaction (PCR).</p><p class='ctrp'>IV. To estimate neurocognitive function in surviving patients at the 4 month post RT endpoint.</p><p class='ctrp'>V. To estimate response as reported by treating physician assessments.</p><p class='ctrp'></p><p class='ctrp'>EXPLORATORY OBJECTIVE:</p><p class='ctrp'>I. To explore any subgroup differences for all secondary objectives measured at the post-RT 4 month visit by whether the patient received Optune (also known as Tumor-Treating Fields or TTFields) as part of their standard treatment following RT.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE:</p><p class='ctrp'>Beginning with standard of care RT and chemotherapy with temozolomide, patients receive ramipril orally (PO) once daily (QD) for 22 weeks (4 months post RT) in the absence of disease progression or unacceptable toxicity. After 1 month post RT, use of the Optune device may be used at the discretion of the treating physicians as per standard of care guidelines, timing and training. Patients also undergo collection of blood during screening and magnetic resonance imaging (MRI) or computed tomography (CT) scan throughout the trial.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>Wake Forest NCORP Research Base</div> 													<div>Principal Investigator: Michael D. Chan</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT03475186"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								     			</div> 		</div> 			<div class=""trialContainer""> 			<h2 class=""hangingIndent"">9. Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?loc=0&rl=2&tt=supportive_care&tt=health_services_research&tt=basic_science&id=NCI-2020-11651""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase III</td> 					<td>Supportive care</td> 					<td>Active</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> NRG-CC009<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2020-11651<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT04804644"" target=""_blank"">NCT04804644</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>Pathologically (histologically or cytologically) proven diagnosis of small cell lung cancer within 5 years of registration. If the original histologic proof of malignancy is greater than 5 years, then pathological (i.e., more recent) confirmation is required (e.g., from a systemic or brain metastasis); * Patients with de novo or recurrent small cell lung cancer are permitted.</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Brain metastases =&lt; 4 cm in largest diameter and outside a 5-mm margin around either hippocampus must be visible on contrast-enhanced magnetic resonance imaging (MRI) performed =&lt; 21 days prior to study entry. * The total tumor volume must be 30 cm^3 or less. Lesion volume will be approximated by measuring the lesion’s three perpendicular diameters on contrast enhanced, T1-weighted MRI and the product of those diameters will be divided by 2 to estimate the lesion volume (e.g. xyz/2). Alternatively, direct volumetric measurements via slice by slice contouring on a treatment planning software package can be used to calculate the total tumor volume. * Brain metastases can be diagnosed synchronous to the initial diagnosis of small cell lung cancer or metachronous to the initial diagnosis and management of small cell lung cancer. * Brain metastases must be diagnosed on MRI, which will include the following elements: ** REQUIRED MRI ELEMENTS *** Post gadolinium contrast-enhanced T1-weighted three-dimensional (3D) spoiled gradient (SPGR). Acceptable 3D SPGR sequences include magnetization prepared 3D gradient recalled echo (GRE) rapid gradient echo (MP-RAGE), turbo field echo (TFE) MRI, BRAVO (Brain Volume Imaging) or 3D Fast FE (field echo). The T1-weighted 3D scan should use the smallest possible axial slice thickness, not to exceed 1.5 mm. *** Pre-contrast T1 weighted imaging (3D imaging sequence strongly encouraged). *** A minimum of one axial T2 FLAIR (preferred) or T2 sequence is required. This can be acquired as a two dimensional (2D) or 3D image. If 2D, the images should be obtained in the axial plane. ** ADDITIONAL RECOMMENDATIONS *** Recommendation is that an axial T2 FLAIR (preferred) sequence be performed instead of a T2 sequence. *** Recommendation is that that pre-contrast 3D T1 be performed with the same parameters as the post-contrast 3D T1. *** Recommendation is that imaging be performed on a 3 Tesla (3T) MRI. *** Recommendation is that the study participants be scanned on the same MRI instrument at each time point. *** Recommendation is that if additional sequences are obtained, these should meet the criteria outlined in Kaufmann et al., 2020. *** If additional sequences are obtained, total imaging time should not exceed 60 minutes. *** If additional metastases not known at the time of registration/randomization or seen in the MRI used for eligibility are subsequently found on the radiation therapy (RT) planning MRI such that the total intacranial volume exceeds 30 cm^3, the patient is still considered eligible.</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>History/physical examination</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Age &gt;= 18</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Karnofsky performance status of &gt;= 70</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Creatinine clearance &gt;= 30 ml/min</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Following the diagnosis of brain metastases, patients can initiate and treat with systemic (chemotherapy and/or immunotherapy) before enrollment only if their brain metastases are asymptomatic and not located in eloquent locations (e.g., brainstem, pre-/post-central gyrus, visual cortex). However, within 21 days prior to enrollment, brain MRI must be repeated to confirm eligibility. * Patients with symptomatic brain metastases and/or brain metastases in eloquent locations (e.g., brainstem, pre-/post central gyrus, visual cortex) are eligible for enrollment on the trial; however, the specific treatment approach of starting with systemic therapy alone and delaying brain radiation is not recommended for these patients.</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Concurrent immunotherapy with brain radiation (SRS or HA-WBRT) is permitted.</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Negative urine or serum pregnancy test (in women of childbearing potential) within 14 days prior to registration. Women of childbearing potential and men who are sexually active must use contraception while on study.</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients may have had prior intracranial surgical resection.</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Because neurocognitive testing is the primary goal of this study, patients must be proficient in English or French Canadian.</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>The patient must provide study-specific informed consent prior to study entry. * Patients with impaired decision-making capacity are not permitted on study.</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>ELIGIBILITY CRITERIA PRIOR TO STEP 2 REGISTRATION</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>The following baseline neurocognitive tests must be completed within 21 days prior to Step 2 registration: HVLT-R, TMT, and COWA. The neurocognitive test will be uploaded into RAVE for evaluation by Dr. Wefel. Once the upload is complete, within 3 business days a notification will be sent via email to the RA to proceed to Step 2. * NOTE: Completed baseline neurocognitive tests can be uploaded at the time of Step 1 registration.</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>PRIOR TO STEP 2 REGISTRATION: The following baseline neurocognitive tests must be completed within 21 days prior to Step 2 registration: HVLT-R, TMT, and COWA. The neurocognitive tests will be uploaded into RAVE for evaluation by Dr. Wefel. Once the upload is complete, within 3 business days a notification will be sent via email to the RA to proceed to Step 2. NOTE: Completed baseline neurocognitive tests can be uploaded at the time of Step 1 registration.</li> 												</ul> 						</div> 														<h4>Exclusion Criteria</h4> 										<div> 							<ul> 																<li>Planned infusion of cytotoxic chemotherapy on the same day as SRS or HA-WBRT treatment. Patients may have had prior chemotherapy. Concurrent immunotherapy is permitted. * For patients receiving fractionated SRS on an every-other-day basis, planned infusion of cytotoxic chemotherapy is not permitted between SRS treatments.</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Brainstem metastasis &gt; 10 cm^3</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Prior allergic reaction to memantine.</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Patients with definitive leptomeningeal metastases.</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Known history of demyelinating disease such as multiple sclerosis.</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Contraindication to MR imaging such as implanted metal devices that are MRI-incompatible, allergy to MRI contrast that cannot be adequately addressed with pre-contrast medications, or foreign bodies that preclude MRI imaging. (Questions regarding MRI compatibility of implanted objects should be reviewed with the Radiology Department performing the MRI).</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Current use of (other N-methyl-D-aspartate [NMDA] antagonists) amantadine, ketamine, or dextromethorphan.</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Radiographic evidence of hydrocephalus or other architectural change of the ventricular system resulting in significant anatomic distortion of the hippocampus, including placement of external ventricular drain or ventriculoperitoneal shunt. * Mild cases of hydrocephalus not resulting in significant anatomic distortion of the hippocampus are permitted.</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Prior radiotherapy to the brain, including SRS, WBRT, or prophylactic cranial irradiation (PCI).</li> 												</ul> 						</div> 							 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE:</p><p class='ctrp'>I. Determine whether stereotactic radiosurgery (SRS) relative to whole brain radiotherapy with hippocampal avoidance (HA-WBRT) plus memantine hydrochloride (memantine) for brain metastases from small cell lung cancer (SCLC) prevents cognitive function failure as measured by cognitive decline on a battery of tests: the Hopkins Verbal Learning Test – Revised (HVLT-R), Controlled Oral Word Association (COWA) test, and the Trail Making Test (TMT).</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES:</p><p class='ctrp'>I. Determine whether SRS relative to HA-WBRT plus memantine for brain metastases from SCLC preserves cognitive function as separately measured by the HVLT-R, COWA, TMT Parts A and B, and Clinical Trial Battery Composite (CTB COMP).</p><p class='ctrp'>II. Assess perceived difficulties in cognitive abilities using Patient Reported Outcomes Measurement Information System (PROMIS) after SRS relative to HA-WBRT plus memantine for brain metastases from SCLC.</p><p class='ctrp'>III. Assess symptom burden using the MD Anderson Symptom Inventory for brain tumor (MDASI-BT) after SRS relative to HA-WBRT plus memantine for brain metastases from SCLC.</p><p class='ctrp'>IV. Compare cumulative incidence of intracranial disease progression after SRS relative to HA-WBRT plus memantine for brain metastases from SCLC.</p><p class='ctrp'>V. Compare overall survival after SRS relative to HA-WBRT plus memantine for brain metastases from SCLC.</p><p class='ctrp'>VI. Compare cumulative incidence of neurologic death after SRS relative to HA-WBRT plus memantine for brain metastases from SCLC.</p><p class='ctrp'>VII. Compare the number of salvage procedures used to manage recurrent intracranial disease following SRS relative to HA-WBRT plus memantine for SCLC brain metastases.</p><p class='ctrp'>VIII. Compare adverse events between the treatment arms according to the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version (v)5.0 criteria.</p><p class='ctrp'>IX. Compare the risk of developing cerebral necrosis between SRS and HA-WBRT plus memantine in patients receiving concurrent immunotherapy.</p><p class='ctrp'></p><p class='ctrp'>EXPLORATORY OBJECTIVES:</p><p class='ctrp'>I. Compare cumulative incidence of local brain recurrence, distant brain relapse, and leptomeningeal dissemination after SRS relative to HA-WBRT plus memantine for brain metastases from SCLC.</p><p class='ctrp'>II. Compare the cost of brain-related therapies and quality-adjusted life years in patients who receive SRS relative to HA-WBRT plus memantine for brain metastases from SCLC.</p><p class='ctrp'>III. Evaluate the time delay to salvage WBRT or HA-WBRT in patients enrolled on the SRS arm.</p><p class='ctrp'>IV. Evaluate whether a time delay for chemotherapy has an effect on overall survival in patients receiving HA WBRT plus memantine relative to SRS for brain metastases from SCLC.</p><p class='ctrp'>V. Evaluate baseline magnetic resonance (MR) imaging biomarkers of white matter injury and hippocampal volumetry as potential predictors of cognitive decline and differential benefit from SRS relative to HA-WBRT plus memantine for brain metastases from SCLC.</p><p class='ctrp'>VI. Evaluate the correlation between neurocognitive functioning and patient-reported outcomes.</p><p class='ctrp'>VII. Collect serum, plasma and imaging studies for future translational research analyses.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE: Patients are randomized to 1 of 2 arms.</p><p class='ctrp'></p><p class='ctrp'>ARM I: Patients undergo SRS over 1 day (in some cases several days).</p><p class='ctrp'></p><p class='ctrp'>ARM II: Patients undergo HA-WBRT once daily (QD) for 2 weeks in the absence of disease progression or unacceptable toxicity. Patients also receive memantine orally (PO) QD or twice daily (BID) for up to 24 weeks in the absence of disease progression or unacceptable toxicity. </p><p class='ctrp'></p><p class='ctrp'>Patients undergo blood sample collection and magnetic resonance imaging (MRI) throughout the study. </p><p class='ctrp'></p><p class='ctrp'>After completion of study treatment, patients are followed up every 2-3 months for 1 year, and then every 6 months thereafter.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>NRG Oncology</div> 													<div>Principal Investigator: Vinai Gondi</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT04804644"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								           <h3 class=""locationCountryLabel"">U.S.A.</h3>               <h4>California</h4>                           <h5 class=""locationCity"">Los Angeles</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Los Angeles General Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 323-865-0451 <br>Email: <a href=""mailto:uscnorrisinfo@med.usc.edu"">uscnorrisinfo@med.usc.edu</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">USC / Norris Comprehensive Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 323-865-0451   </span> </div>                                   <h4>Colorado</h4>                           <h5 class=""locationCity"">Aurora</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UCHealth University of Colorado Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 720-848-0650   </span> </div>                                       <h5 class=""locationCity"">Colorado Springs</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Hospital North</strong>     <br>Contact: Site Public Contact <br>Phone: 719-364-6700   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UCHealth Memorial Hospital Central</strong>     <br>Contact: Site Public Contact <br>Phone: 719-365-2406   </span> </div>                                   <h4>Connecticut</h4>                           <h5 class=""locationCity"">Greenwich</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Smilow Cancer Hospital Care Center at Greenwich</strong>     <br>Contact: Site Public Contact <br>Phone: 203-785-5702 <br>Email: <a href=""mailto:canceranswers@yale.edu"">canceranswers@yale.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Guilford</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Smilow Cancer Hospital Care Center - Guilford</strong>     <br>Contact: Site Public Contact <br>Phone: 203-785-5702 <br>Email: <a href=""mailto:canceranswers@yale.edu"">canceranswers@yale.edu</a>   </span> </div>                                       <h5 class=""locationCity"">New Haven</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Smilow Cancer Center/Yale-New Haven Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 203-785-5702 <br>Email: <a href=""mailto:canceranswers@yale.edu"">canceranswers@yale.edu</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Yale University</strong>     <br>Contact: Site Public Contact <br>Phone: 203-785-5702 <br>Email: <a href=""mailto:canceranswers@yale.edu"">canceranswers@yale.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Trumbull</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Smilow Cancer Hospital Care Center-Trumbull</strong>     <br>Contact: Site Public Contact <br>Phone: 203-785-5702 <br>Email: <a href=""mailto:canceranswers@yale.edu"">canceranswers@yale.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Waterford</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Smilow Cancer Hospital Care Center - Waterford</strong>     <br>Contact: Site Public Contact <br>Phone: 203-785-5702 <br>Email: <a href=""mailto:canceranswers@yale.edu"">canceranswers@yale.edu</a>   </span> </div>                                   <h4>Delaware</h4>                           <h5 class=""locationCity"">Lewes</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Newark</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Christiana Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delaware Clinical and Laboratory Physicians PA</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:mhayden@christianacare.org"">mhayden@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Helen F Graham Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Medical Oncology Hematology Consultants PA</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Rehoboth Beach</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Beebe Health Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 302-291-6730 <br>Email: <a href=""mailto:research@beebehealthcare.org"">research@beebehealthcare.org</a>   </span> </div>                                   <h4>Florida</h4>                           <h5 class=""locationCity"">Coral Gables</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UM Sylvester Comprehensive Cancer Center at Coral Gables</strong>     <br>Contact: Site Public Contact <br>Phone: 305-243-2647   </span> </div>                                       <h5 class=""locationCity"">Deerfield Beach</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UM Sylvester Comprehensive Cancer Center at Deerfield Beach</strong>     <br>Contact: Site Public Contact <br>Phone: 305-243-2647   </span> </div>                                       <h5 class=""locationCity"">Miami</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Miami Miller School of Medicine-Sylvester Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 305-243-2647   </span> </div>                                       <h5 class=""locationCity"">Tampa</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Moffitt Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-679-0775 <br>Email: <a href=""mailto:ClinicalTrials@moffitt.org"">ClinicalTrials@moffitt.org</a>   </span> </div>                                   <h4>Georgia</h4>                           <h5 class=""locationCity"">Atlanta</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Emory Saint Joseph's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 404-851-7115   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Emory University Hospital Midtown</strong>     <br>Contact: Site Public Contact <br>Phone: 888-946-7447   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Emory University Hospital/Winship Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 404-778-1868   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northside Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 404-303-3355 <br>Email: <a href=""mailto:ClinicalTrials@northside.com"">ClinicalTrials@northside.com</a>   </span> </div>                                       <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northside Hospital-Cherokee</strong>     <br>Contact: Site Public Contact <br>Phone: 404-303-3355 <br>Email: <a href=""mailto:clinical.trials@northside.com"">clinical.trials@northside.com</a>   </span> </div>                                       <h5 class=""locationCity"">Cumming</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northside Hospital-Forsyth</strong>     <br>Contact: Site Public Contact <br>Phone: 404-303-3355 <br>Email: <a href=""mailto:clinicaltrials@northside.com"">clinicaltrials@northside.com</a>   </span> </div>                                       <h5 class=""locationCity"">Savannah</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Memorial Health University Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 912-350-7887 <br>Email: <a href=""mailto:Lorraine.OHara@hcahealthcare.com"">Lorraine.OHara@hcahealthcare.com</a>   </span> </div>                                   <h4>Illinois</h4>                           <h5 class=""locationCity"">Aurora</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Rush - Copley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 630-978-6212 <br>Email: <a href=""mailto:Cancer.Research@rushcopley.com"">Cancer.Research@rushcopley.com</a>   </span> </div>                                       <h5 class=""locationCity"">Centralia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Centralia Oncology Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Chicago</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Chicago Comprehensive Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 773-702-8222 <br>Email: <a href=""mailto:cancerclinicaltrials@bsd.uchicago.edu"">cancerclinicaltrials@bsd.uchicago.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Danville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle at The Riverfront</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@Carle.com"">Research@Carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Decatur</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Specialists of Illinois - Decatur</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Decatur Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">DeKalb</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern Medicine Cancer Center Kishwaukee</strong>     <br>Contact: Site Public Contact <br>Phone: 630-352-5360 <br>Email: <a href=""mailto:Donald.Smith3@nm.org"">Donald.Smith3@nm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Effingham</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Physician Group-Effingham</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Crossroads Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Geneva</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern Medicine Cancer Center Delnor</strong>     <br>Contact: Site Public Contact <br>Phone: 630-352-5360 <br>Email: <a href=""mailto:Donald.Smith3@nm.org"">Donald.Smith3@nm.org</a>   </span> </div>                                       <h5 class=""locationCity"">Mattoon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Physician Group-Mattoon/Charleston</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">New Lenox</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UC Comprehensive Cancer Center at Silver Cross</strong>     <br>Contact: Site Public Contact <br>Phone: 773-702-8222 <br>Email: <a href=""mailto:cancerclinicaltrials@bsd.uchicago.edu"">cancerclinicaltrials@bsd.uchicago.edu</a>   </span> </div>                                       <h5 class=""locationCity"">O'Fallon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Care Center of O'Fallon</strong>     <br>Contact: Site Public Contact <br>Phone: 217-876-4762 <br>Email: <a href=""mailto:morganthaler.jodi@mhsil.com"">morganthaler.jodi@mhsil.com</a>   </span> </div>                                       <h5 class=""locationCity"">Peoria</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">OSF Saint Francis Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 309-243-3605 <br>Email: <a href=""mailto:andersonj@illinoiscancercare.com"">andersonj@illinoiscancercare.com</a>   </span> </div>                                       <h5 class=""locationCity"">Urbana</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carle Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The Carle Foundation Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 800-446-5532 <br>Email: <a href=""mailto:Research@carle.com"">Research@carle.com</a>   </span> </div>                                       <h5 class=""locationCity"">Warrenville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwestern Medicine Cancer Center Warrenville</strong>     <br>Contact: Site Public Contact <br>Phone: 630-352-5360 <br>Email: <a href=""mailto:Donald.Smith3@nm.org"">Donald.Smith3@nm.org</a>   </span> </div>                                   <h4>Indiana</h4>                           <h5 class=""locationCity"">Goshen</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Goshen Center for Cancer Care</strong>     <br>Contact: Site Public Contact <br>Phone: 574-364-2973 <br>Email: <a href=""mailto:cccois@goshenhealth.com"">cccois@goshenhealth.com</a>   </span> </div>                                   <h4>Iowa</h4>                           <h5 class=""locationCity"">Ames</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mary Greeley Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 515-956-4132   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McFarland Clinic - Ames</strong>     <br>Contact: Site Public Contact <br>Phone: 515-239-4734 <br>Email: <a href=""mailto:ksoder@mcfarlandclinic.com"">ksoder@mcfarlandclinic.com</a>   </span> </div>                                   <h4>Kentucky</h4>                           <h5 class=""locationCity"">Louisville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">The James Graham Brown Cancer Center at University of Louisville</strong>     <br>Contact: Site Public Contact <br>Phone: 502-562-3429   </span> </div>                                   <h4>Louisiana</h4>                           <h5 class=""locationCity"">Baton Rouge</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mary Bird Perkins Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 225-215-1353 <br>Email: <a href=""mailto:clinicalresearch@marybird.com"">clinicalresearch@marybird.com</a>   </span> </div>                                   <h4>Maryland</h4>                           <h5 class=""locationCity"">Baltimore</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MedStar Franklin Square Medical Center/Weinberg Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 443-777-7364   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Maryland/Greenebaum Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-888-8823   </span> </div>                                       <h5 class=""locationCity"">Bel Air</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UM Upper Chesapeake Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 443-643-3010   </span> </div>                                       <h5 class=""locationCity"">Columbia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Central Maryland Radiation Oncology in Howard County</strong>     <br>Contact: Site Public Contact <br>Phone: 443-546-1300   </span> </div>                                       <h5 class=""locationCity"">Easton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Maryland Shore Medical Center at Easton</strong>     <br>Contact: Site Public Contact <br>Phone: 410-822-1000 <br>Email: <a href=""mailto:Christina.weisenborn@umm.edu"">Christina.weisenborn@umm.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Ocean Pines</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">TidalHealth Richard A Henson Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 410-543-7067 <br>Email: <a href=""mailto:carol.messick@peninsula.org"">carol.messick@peninsula.org</a>   </span> </div>                                       <h5 class=""locationCity"">Salisbury</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">TidalHealth Peninsula Regional</strong>     <br>Contact: Site Public Contact <br>Phone: 410-543-7032 <br>Email: <a href=""mailto:monika.naegeli@peninsula.org"">monika.naegeli@peninsula.org</a>   </span> </div>                                   <h4>Massachusetts</h4>                           <h5 class=""locationCity"">Boston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Boston Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 617-638-8265   </span> </div>                                   <h4>Michigan</h4>                           <h5 class=""locationCity"">Ann Arbor</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Saint Joseph Mercy Hospital Ann Arbor</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Brighton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Brighton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Medical Center - Brighton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Canton</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Medical Center - Canton</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Caro</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Caro Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chelsea</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Chelsea Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology - Chelsea Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Livonia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health Saint Mary Mercy Livonia Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Marlette</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary's Oncology/Hematology Associates of Marlette</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Saginaw</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MyMichigan Medical Center Saginaw</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Oncology Hematology Associates of Saginaw Valley PC</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Tawas City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MyMichigan Medical Center Tawas</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">West Branch</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Mary's Oncology/Hematology Associates of West Branch</strong>     <br>Contact: Site Public Contact <br>Phone: 989-907-8411 <br>Email: <a href=""mailto:lori.srebinski@ascension.org"">lori.srebinski@ascension.org</a>   </span> </div>                                       <h5 class=""locationCity"">Ypsilanti</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Trinity Health  IHA Medical Group Hematology Oncology  Ann Arbor Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 734-712-7251 <br>Email: <a href=""mailto:MCRCwebsitecontactform@stjoeshealth.org"">MCRCwebsitecontactform@stjoeshealth.org</a>   </span> </div>                                   <h4>Minnesota</h4>                           <h5 class=""locationCity"">Bemidji</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Joe Lueken Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 218-333-5000 <br>Email: <a href=""mailto:OncologyClinicalTrialsFargo@sanfordhealth.org"">OncologyClinicalTrialsFargo@sanfordhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Coon Rapids</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Edina</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Southdale Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Maple Grove</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Fairview Clinics and Surgery Center Maple Grove</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Monticello</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Monticello Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Paul</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Regions Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Stillwater</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Lakeview Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                   <h4>Missouri</h4>                           <h5 class=""locationCity"">Cape Girardeau</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Francis Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 573-334-2230 <br>Email: <a href=""mailto:sfmc@sfmc.net"">sfmc@sfmc.net</a>   </span> </div>                                       <h5 class=""locationCity"">Farmington</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Parkland Health Center - Farmington</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Joplin</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Freeman Health System</strong>     <br>Contact: Site Public Contact <br>Phone: 417-347-4030 <br>Email: <a href=""mailto:LJCrockett@freemanhealth.com"">LJCrockett@freemanhealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Saint Louis</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Missouri Baptist Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Sainte Genevieve</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sainte Genevieve County Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Springfield</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Hospital Springfield</strong>     <br>Contact: Site Public Contact <br>Phone: 417-269-4520   </span> </div>                                       <h5 class=""locationCity"">Sullivan</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Missouri Baptist Sullivan Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                       <h5 class=""locationCity"">Sunset Hills</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">BJC Outpatient Center at Sunset Hills</strong>     <br>Contact: Site Public Contact <br>Phone: 314-996-5569   </span> </div>                                   <h4>Montana</h4>                           <h5 class=""locationCity"">Great Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Benefis Sletten Cancer Institute</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                       <h5 class=""locationCity"">Kalispell</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Kalispell Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 406-969-6060 <br>Email: <a href=""mailto:mccinfo@mtcancer.org"">mccinfo@mtcancer.org</a>   </span> </div>                                   <h4>New York</h4>                           <h5 class=""locationCity"">Canandiaqua</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sands Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 585-396-6161   </span> </div>                                       <h5 class=""locationCity"">Lake Success</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northwell Health/Center for Advanced Medicine</strong>     <br>Contact: Site Public Contact <br>Phone: 516-734-8896   </span> </div>                                       <h5 class=""locationCity"">Mount Kisco</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Northern Westchester Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 914-666-1366 <br>Email: <a href=""mailto:AMellor@northwell.edu"">AMellor@northwell.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Rochester</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Rochester</strong>     <br>Contact: Site Public Contact <br>Phone: 585-275-5830   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Wilmot Cancer Institute Radiation Oncology at Greece</strong>     <br>Contact: Site Public Contact <br>Phone: 585-758-7877   </span> </div>                                       <h5 class=""locationCity"">Syracuse</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">State University of New York Upstate Medical University</strong>     <br>Contact: Site Public Contact <br>Phone: 315-464-5476   </span> </div>                                       <h5 class=""locationCity"">Verona</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Upstate Cancer Center at Verona</strong>     <br>Contact: Site Public Contact <br>Phone: 315-464-8230 <br>Email: <a href=""mailto:McDowelE@upstate.edu"">McDowelE@upstate.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Webster</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Wilmot Cancer Institute at Webster</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:WCICTOresearch@urmc.rochester.edu"">WCICTOresearch@urmc.rochester.edu</a>   </span> </div>                                   <h4>North Carolina</h4>                           <h5 class=""locationCity"">Winston-Salem</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Wake Forest University Health Sciences</strong>     <br>Contact: Site Public Contact <br>Phone: 336-713-6771   </span> </div>                                   <h4>North Dakota</h4>                           <h5 class=""locationCity"">Bismarck</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Bismarck Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 701-323-5760 <br>Email: <a href=""mailto:OncologyClinicalTrialsFargo@sanfordhealth.org"">OncologyClinicalTrialsFargo@sanfordhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Fargo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Broadway Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 701-323-5760 <br>Email: <a href=""mailto:OncologyClinicalTrialsFargo@sanfordhealth.org"">OncologyClinicalTrialsFargo@sanfordhealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Roger Maris Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 701-234-6161 <br>Email: <a href=""mailto:OncologyClinicalTrialsFargo@sanfordhealth.org"">OncologyClinicalTrialsFargo@sanfordhealth.org</a>   </span> </div>                                   <h4>Ohio</h4>                           <h5 class=""locationCity"">Cincinnati</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Cincinnati Cancer Center-UC Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 513-584-7698 <br>Email: <a href=""mailto:cancer@uchealth.com"">cancer@uchealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Cleveland</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Case Western Reserve University</strong>     <br>Contact: Site Public Contact <br>Phone: 800-641-2422 <br>Email: <a href=""mailto:CTUReferral@UHhospitals.org"">CTUReferral@UHhospitals.org</a>   </span> </div>                                       <h5 class=""locationCity"">Columbus</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ohio State University Comprehensive Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 800-293-5066 <br>Email: <a href=""mailto:Jamesline@osumc.edu"">Jamesline@osumc.edu</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Riverside Methodist Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Delaware</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Delaware Health Center-Grady Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Grady Memorial Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-788-3860 <br>Email: <a href=""mailto:Jennifer.Sexton@ohiohealth.com"">Jennifer.Sexton@ohiohealth.com</a>   </span> </div>                                       <h5 class=""locationCity"">Mentor</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UH Seidman Cancer Center at Lake Health Mentor Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 800-641-2422 <br>Email: <a href=""mailto:CTUReferral@UHhospitals.org"">CTUReferral@UHhospitals.org</a>   </span> </div>                                       <h5 class=""locationCity"">Perrysburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health Perrysburg Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">Toledo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Mercy Health - Saint Anne Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 614-488-2745 <br>Email: <a href=""mailto:Jeffh@columbusccop.org"">Jeffh@columbusccop.org</a>   </span> </div>                                       <h5 class=""locationCity"">West Chester</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Cincinnati Cancer Center-West Chester</strong>     <br>Contact: Site Public Contact <br>Phone: 513-584-7698 <br>Email: <a href=""mailto:cancer@uchealth.com"">cancer@uchealth.com</a>   </span> </div>                                   <h4>Oklahoma</h4>                           <h5 class=""locationCity"">Oklahoma City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Oklahoma Health Sciences Center</strong>     <br>Contact: Site Public Contact <br>Phone: 405-271-8777 <br>Email: <a href=""mailto:ou-clinical-trials@ouhsc.edu"">ou-clinical-trials@ouhsc.edu</a>   </span> </div>                                   <h4>Pennsylvania</h4>                           <h5 class=""locationCity"">Altoona</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UPMC Altoona</strong>     <br>Contact: Site Public Contact <br>Phone: 412-339-5294 <br>Email: <a href=""mailto:Roster@nrgoncology.org"">Roster@nrgoncology.org</a>   </span> </div>                                       <h5 class=""locationCity"">Carlisle</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Carlisle Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 412-339-5294 <br>Email: <a href=""mailto:Roster@nrgoncology.org"">Roster@nrgoncology.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chadds Ford</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Christiana Care Health System-Concord Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 302-623-4450 <br>Email: <a href=""mailto:lbarone@christianacare.org"">lbarone@christianacare.org</a>   </span> </div>                                       <h5 class=""locationCity"">Chambersburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Chambersburg Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 412-339-5294 <br>Email: <a href=""mailto:Roster@nrgoncology.org"">Roster@nrgoncology.org</a>   </span> </div>                                       <h5 class=""locationCity"">Danville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-271-5251 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Ephrata</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ephrata Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 717-721-4840   </span> </div>                                       <h5 class=""locationCity"">Gettysburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Adams Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-441-7957   </span> </div>                                       <h5 class=""locationCity"">Greensburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UPMC Cancer Centers - Arnold Palmer Pavilion</strong>     <br>Contact: Site Public Contact <br>Phone: 724-838-1900   </span> </div>                                       <h5 class=""locationCity"">Harrisburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UPMC Pinnacle Cancer Center/Community Osteopathic Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 717-724-6765 <br>Email: <a href=""mailto:klitchfield@PINNACLEHEALTH.org"">klitchfield@PINNACLEHEALTH.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lebanon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sechler Family Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 717-741-8303 <br>Email: <a href=""mailto:doxenberg@wellspan.org"">doxenberg@wellspan.org</a>   </span> </div>                                       <h5 class=""locationCity"">Lewisburg</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Medical Oncology-Lewisburg</strong>     <br>Contact: Site Public Contact <br>Phone: 570-374-8555 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Monroeville</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UPMC Cancer Center - Monroeville</strong>     <br>Contact: Site Public Contact <br>Phone: 412-339-5294 <br>Email: <a href=""mailto:Roster@nrgoncology.org"">Roster@nrgoncology.org</a>   </span> </div>                                       <h5 class=""locationCity"">Philadelphia</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Jefferson Torresdale Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 215-600-9151 <br>Email: <a href=""mailto:ONCTrialNow@jefferson.edu"">ONCTrialNow@jefferson.edu</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Thomas Jefferson University Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 215-600-9151 <br>Email: <a href=""mailto:ONCTrialNow@jefferson.edu"">ONCTrialNow@jefferson.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Pittsburgh</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UPMC-Magee Womens Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 412-647-2811   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UPMC-Passavant Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 412-367-6454   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UPMC-Saint Clair Hospital Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 412-502-3920   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UPMC-Saint Margaret</strong>     <br>Contact: Site Public Contact <br>Phone: 412-784-4900   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UPMC-Shadyside Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 412-621-2334   </span> </div>                                       <h5 class=""locationCity"">Quakertown</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saint Luke's Hospital-Quakertown Campus</strong>     <br>Contact: Site Public Contact <br>Phone: 610-776-4714   </span> </div>                                       <h5 class=""locationCity"">Wilkes-Barre</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Geisinger Wyoming Valley/Henry Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 570-271-5251 <br>Email: <a href=""mailto:HemonCCTrials@geisinger.edu"">HemonCCTrials@geisinger.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Williamsport</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Divine Providence Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 412-339-5294 <br>Email: <a href=""mailto:Roster@nrgoncology.org"">Roster@nrgoncology.org</a>   </span> </div>                                       <h5 class=""locationCity"">York</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">UPMC Memorial</strong>     <br>Contact: Site Public Contact <br>Phone: 717-724-6760   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">WellSpan Health-York Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-441-7957   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">WellSpan Health-York Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 877-441-7957   </span> </div>                                   <h4>South Carolina</h4>                           <h5 class=""locationCity"">Florence</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">McLeod Regional Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 843-777-0770 <br>Email: <a href=""mailto:dorie.sturgill@mcleodhealth.org"">dorie.sturgill@mcleodhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Greenwood</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Self Regional Healthcare</strong>     <br>Contact: Site Public Contact <br>Phone: 864-725-4771 <br>Email: <a href=""mailto:nmcgaha@selfregional.org"">nmcgaha@selfregional.org</a>   </span> </div>                                   <h4>South Dakota</h4>                           <h5 class=""locationCity"">Sioux Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford Cancer Center Oncology Clinic</strong>     <br>Contact: Site Public Contact <br>Phone: 605-312-3320 <br>Email: <a href=""mailto:OncologyClinicTrialsSF@sanfordhealth.org"">OncologyClinicTrialsSF@sanfordhealth.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Sanford USD Medical Center - Sioux Falls</strong>     <br>Contact: Site Public Contact <br>Phone: 605-312-3320 <br>Email: <a href=""mailto:OncologyClinicalTrialsSF@SanfordHealth.org"">OncologyClinicalTrialsSF@SanfordHealth.org</a>   </span> </div>                                   <h4>Texas</h4>                           <h5 class=""locationCity"">Conroe</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MD Anderson in The Woodlands</strong>     <br>Contact: Site Public Contact <br>Phone: 866-632-6789 <br>Email: <a href=""mailto:askmdanderson@mdanderson.org"">askmdanderson@mdanderson.org</a>   </span> </div>                                       <h5 class=""locationCity"">Houston</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">M D Anderson Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-632-6789 <br>Email: <a href=""mailto:askmdanderson@mdanderson.org"">askmdanderson@mdanderson.org</a>   </span> </div>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MD Anderson West Houston</strong>     <br>Contact: Site Public Contact <br>Phone: 877-632-6789 <br>Email: <a href=""mailto:askmdanderson@mdanderson.org"">askmdanderson@mdanderson.org</a>   </span> </div>                                       <h5 class=""locationCity"">League City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MD Anderson League City</strong>     <br>Contact: Site Public Contact <br>Phone: 877-632-6789 <br>Email: <a href=""mailto:askmdanderson@mdanderson.org"">askmdanderson@mdanderson.org</a>   </span> </div>                                       <h5 class=""locationCity"">Sugar Land</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">MD Anderson in Sugar Land</strong>     <br>Contact: Site Public Contact <br>Phone: 877-632-6789 <br>Email: <a href=""mailto:askmdanderson@mdanderson.org"">askmdanderson@mdanderson.org</a>   </span> </div>                                   <h4>Wisconsin</h4>                           <h5 class=""locationCity"">Antigo</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Langlade Hospital and Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 715-623-9869 <br>Email: <a href=""mailto:Juli.Alford@aspirus.org"">Juli.Alford@aspirus.org</a>   </span> </div>                                       <h5 class=""locationCity"">La Crosse</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Gundersen Lutheran Medical Center</strong>     <br>Contact: Site Public Contact <br>Phone: 608-775-2385 <br>Email: <a href=""mailto:cancerctr@gundersenhealth.org"">cancerctr@gundersenhealth.org</a>   </span> </div>                                       <h5 class=""locationCity"">Madison</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">University of Wisconsin Carbone Cancer Center - University Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 800-622-8922 <br>Email: <a href=""mailto:clinicaltrials@cancer.wisc.edu"">clinicaltrials@cancer.wisc.edu</a>   </span> </div>                                       <h5 class=""locationCity"">Menomonee Falls</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Froedtert Menomonee Falls Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 262-257-5100   </span> </div>                                       <h5 class=""locationCity"">Milwaukee</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Medical College of Wisconsin</strong>     <br>Contact: Site Public Contact <br>Phone: 414-805-3666   </span> </div>                                       <h5 class=""locationCity"">New Richmond</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Cancer Center of Western Wisconsin</strong>     <br>Contact: Site Public Contact <br>Phone: 952-993-1517 <br>Email: <a href=""mailto:mmcorc@healthpartners.com"">mmcorc@healthpartners.com</a>   </span> </div>                                       <h5 class=""locationCity"">Oak Creek</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Drexel Town Square Health Center</strong>     <br>Contact: Site Public Contact <br>Phone: 414-805-0505   </span> </div>                                       <h5 class=""locationCity"">Rhinelander</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Saint Mary's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 715-847-2353 <br>Email: <a href=""mailto:Beth.Knetter@aspirus.org"">Beth.Knetter@aspirus.org</a>   </span> </div>                                       <h5 class=""locationCity"">Stevens Point</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Ascension Saint Michael's Hospital</strong>     <br>Contact: Site Public Contact <br>Phone: 715-847-2353 <br>Email: <a href=""mailto:Beth.Knetter@aspirus.org"">Beth.Knetter@aspirus.org</a>   </span> </div>                                       <h5 class=""locationCity"">Wausau</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Aspirus Regional Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 877-405-6866   </span> </div>                                       <h5 class=""locationCity"">West Bend</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Froedtert West Bend Hospital/Kraemer Cancer Center</strong>     <br>Contact: Site Public Contact <br>Phone: 414-805-0505   </span> </div>                                 <h3 class=""locationCountryLabel"">Canada</h3>               <h4>Quebec</h4>                           <h5 class=""locationCity"">Quebec City</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)</strong>     <br>Contact: Site Public Contact <br>Email: <a href=""mailto:rechclinique@crchuq.ulaval.ca"">rechclinique@crchuq.ulaval.ca</a>   </span> </div>                                   <h4>Saskatchewan</h4>                           <h5 class=""locationCity"">Regina</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Allan Blair Cancer Centre</strong>     <br>Contact: Site Public Contact <br>Phone: 306-766-2213   </span> </div>                                       <h5 class=""locationCity"">Saskatoon</h5>                                         <div itemprop=""location"" itemscope="""" itemtype=""http://schema.org/Place"" class=""locationBlock"">   <strong itemprop=""name"">Saskatoon Cancer Centre</strong>     <br>Contact: Site Public Contact <br>Phone: 306-655-2914   </span> </div>                           			</div> 		</div> 			<div class=""trialContainer""> 			<h2 class=""hangingIndent"">10. Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer</h2> 						<a class=""hangingIndent print-check-for-updates"" href=""/about-cancer/treatment/clinical-trials/search/v?loc=0&rl=2&tt=supportive_care&tt=health_services_research&tt=basic_science&id=NCI-2020-07169""><span>Check for Updates</span></a> 			<table class=""trialDataTable""> 				<tr class=""trialDataHeaderRow""> 					<td>Phase</td> 					<td>Type</td> 					<td>Status</td> 					<td>Age</td> 					<td>Trial IDs</td> 				</tr> 				<tr> 					<td>Phase II</td> 					<td>Supportive care</td> 					<td>Closed to Accrual and Intervention</td> 					<td>18 													and over 						 						</td> 					<td class=""trialIDCell""> 						<span class = ""dataTableIDLabel"">Primary ID</span> A222001<br> 						<span class = ""dataTableIDLabel"">Secondary IDs</span> NCI-2020-07169<br> 						<span class = ""dataTableIDLabel"">Clinicaltrials.gov ID</span> <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT04600336"" target=""_blank"">NCT04600336</a><br> 					</td> 			</table>  			<h3>Description</h3> 			<div>This phase II trial studies the effect of low and high dose oxybutynin in reducing hot flashes in patients with prostate cancer receiving hormone therapy. Hormone therapy (androgen deprivation therapy), is a treatment for prostate cancer that can stop or reduce the male hormone, testosterone. It may include medications to stop the body from producing testosterone or surgery to remove the testicles. Oxybutynin may help to reduce hot flashes in men being treated with hormone therapy.</div>  			<h3 class=""printHeading"">Eligibility Criteria</h3>  																																																																																																																																																																																																																																																																																																														<h4>Inclusion Criteria</h4> 										<div> 							<ul> 															<li>Men who are currently receiving androgen deprivation therapy (ADT) for the treatment of prostate cancer. ADT is defined by a history of orchiectomy, or ongoing usage of gonadotropin-releasing hormone agonists or antagonists. Men receiving abiraterone, but not enzalutamide, apalutamide, and darolutamide are eligible, as the latter three are metabolized by CYP3A4 and may affect oxybutynin serum concentrations</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Patients must be on a stable dose of all hormone-directed therapies for at least 28 days prior to registration and must not be planning to discontinue this therapy for at least 42 days following registration. Patients receiving radiation therapy during the study period are eligible</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eligible patient must have bothersome hot flashes for &gt;= 14 days prior to registration, defined by an occurrence of &gt;= 28 times per week and of sufficient severity to cause the patient to seek therapeutic intervention</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No current use or future planned use of any of the following agents during the study period: drugs that are not Food and Drug Administration (FDA) approved for use in humans, drugs with category X interactions with oxybutynin (e.g. other anti-cholinergic agents, eluxadoline, and potassium chloride), androgens, estrogens, progesterone analogs, gabapentin, cholinergic agonists, cholinesterase inhibitors, or complementary/alternative medicine taken for the purpose of managing hot flashes. No current or future planned use of strong CYP3A4 inhibitors (e.g. antipsychotic agents or macrolide antibiotics) during the study. Prior use of these agents is permitted as long as they are discontinued before registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>No current or prior use of oxybutynin as a treatment for hot flashes. Prior use of oxybutynin for other purposes (e.g. bladder symptoms) is allowed, as long as the patient has not taken any oxybutynin for 30 days prior to registration</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>International Prognostic Scoring System (IPSS) score &lt; 20, unless they have a post void residual confirmation of less than 300 cc residual in the bladder (that is that the patient is eligible with a higher IPSS score if a subsequent postvoid residual [PVR] test looks good)</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Life expectancy of greater than 6 months</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Age &gt;= 18 years</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>Eastern Cooperative Oncology Group (ECOG) performance status - 0, 1, or 2</li> 												</ul> 						</div> 										<div> 							<ul> 															<li>In order to complete the mandatory patient-completed measures, participants must be able to speak and/or read English</li> 												</ul> 						</div> 														<h4>Exclusion Criteria</h4> 										<div> 							<ul> 																<li>Patients with a history of any of the following contraindications to oxybutynin are not eligible: gastroparesis or gastrointestinal obstructive disorders; significant gastric reflux symptoms not controlled by medication; ulcerative colitis; narrow-angle glaucoma; urinary retention requiring indwelling or intermittent self-catheterization within the prior 6 months; hypersensitivity to oxybutynin or any other components of the product; current uncontrolled hyperthyroidism; uncontrolled coronary artery disease or a history of myocardial infarction within the prior 12 months; New York Heart Association (NYHA) class II-IV congestive heart failure; symptomatic cardiac arrhythmias; current uncontrolled hypertension (average systolic &gt; 140 mm Hg and diastolic &gt; 90 mm Hg); myasthenia gravis; or dementia</li> 												</ul> 						</div> 										<div> 							<ul> 																<li>Patients with urinary retention requiring indwelling or intermittent self-catheterization within the prior 6 months are not eligible</li> 												</ul> 						</div> 							 							<h3 class=""printHeading"">Trial Objectives and Outlines</h3> 				<div id=""trialObjectives""><p class='ctrp'>PRIMARY OBJECTIVE:</p><p class='ctrp'>I. To assess the effects of two doses of oxybutynin chloride (oxybutynin) on hot flash scores (determined by multiplying the frequency of each defined hot flash grade by the severity [grade 0: none, 1: mild, 2: moderate, 3: severe, and 4: very severe] and summing the values over a 24-hour period) relative to placebo.</p><p class='ctrp'></p><p class='ctrp'>SECONDARY OBJECTIVES:</p><p class='ctrp'>I. To assess study accrual rates and compliance with the therapy.</p><p class='ctrp'>II. To characterize the safety and adverse event profile of two doses of oxybutynin in the study population.</p><p class='ctrp'>III. To evaluate the consistency of the results across the various methods used to evaluate the efficacy of oxybutynin (i.e., hot flash scores versus hot flash frequencies, mean differences versus 50% or greater reduction since baseline, single day versus full week to define patients’ baseline hot flash scores).</p><p class='ctrp'>IV. To compare patient-reported quality of life and hot flash interference, as measured by the Hot Flash Related</p><p class='ctrp'>Daily Interference Scale (HFRDIS), across arms.</p><p class='ctrp'>V. To compare other changes in patient symptoms, as measured by the Symptom Experience Questionnaire, across arms.</p><p class='ctrp'></p><p class='ctrp'>OUTLINE: Patients are randomized to 1 of 4 arms.</p><p class='ctrp'></p><p class='ctrp'>ARM A: Patients receive low-dose oxybutynin chloride orally (PO) twice daily (BID) on days 8-49 (6 weeks) in the absence of unacceptable toxicity.</p><p class='ctrp'></p><p class='ctrp'>ARM B: Patients receive a low-dose placebo PO BID on days 8-49 (6 weeks). After 6 weeks, patients may cross over to Arm A per physician discretion.</p><p class='ctrp'></p><p class='ctrp'>ARM C: Patients receive high-dose oxybutynin chloride PO BID on days 8-49 (6 weeks) in the absence of unacceptable toxicity.</p><p class='ctrp'></p><p class='ctrp'>ARM D: Patients receive a high-dose placebo PO BID on days 8-49 (6 weeks). After 6 weeks, patients may cross over to Arm C per physician discretion.</p><p class='ctrp'></p><p class='ctrp'>After completion of study treatment, patients are followed up periodically. Patients who participate in the optional crossover phase are followed up at 6 weeks.</p></div> 			 							<h3 class=""printHeading"">Lead Organization</h3> 									<div>Alliance for Clinical Trials in Oncology</div> 													<div>Principal Investigator: Bradley J. Stish</div> 										<h3 class=""printHeading"">Locations & Contacts</h3> 			<div class=""locationNoteBlock""> 				<span>Note:</span> Information about participating sites on pharmaceutical industry trials may be incomplete, so please look up the <a class=""nctIdLink"" href=""http://clinicaltrials.gov/show/NCT04600336"" target=""_blank"">NCT number</a> on ClinicalTrials.gov 			</div> 			<div> 								     			</div> 		</div> 					</div> 			</div> 		</div> 	</div>      <script id=""print-script"">         const subject = ""Clinical Trials from the National Cancer Institute's Website"";         const body = `Print-Friendly Clinical Trial Descriptions  ${document.location}  Please note that the URL will expire after 90 days.  You can find educational materials about clinical trials on NCI's Web site at http://www.cancer.gov/clinicaltrials. NCI's Web site, www.cancer.gov, contains comprehensive information about cancer causes and prevention, screening and diagnosis, treatment and survivorship; clinical trials; statistics; funding, training and employment opportunities; and the institute and its programs.  You can also get cancer information online through the LiveHelp instant messaging service at http://livehelp.cancer.gov. If you live in the United States, you may call the NCI's Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) for cancer information in English and Spanish.`;          let newLink = 'mailto:?subject=' + encodeURIComponent(subject) + '&body=' + encodeURIComponent(body);          const mailtoLink = document.getElementById(""ctl10_EmailResults"");         mailtoLink.attributes['href'].value = newLink;     </script>  	<!-- DTM PAGEBOTTOM TAG - DO NOT MODIFY --> 	<script type=""text/javascript"">_satellite.pageBottom();</script> </body> </html>"
